_unit_id,_created_at,_id,_started_at,_tainted,_channel,_trust,_worker_id,_country,_region,_city,_ip,relations,step_1_select_the_valid_relations,step_2a_copy__paste_only_the_words_from_the_sentence_that_express_the_relation_you_selected_in_step1,step_2b_if_you_selected_none_in_step_1_explain_why,b1,b2,baselinedec,e1,e2,rel-type,sent_id,sentence,term1,term2
725257981,5/23/2015 20:28:01,1642356674,5/23/2015 20:26:22,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Some patients may require more basal insulin prevent PREPRANDIAL HYPERGLYCEMIA when using INSULIN ASPART,N/A,97,134,-1,121,148,TWrex-cause,800129-FS1,Some patients may require more basal insulin and a greater total daily insulin dosage to prevent PREPRANDIAL HYPERGLYCEMIA when using INSULIN ASPART than when using insulin human (regular.,PREPRANDIAL HYPERGLYCEMIA,INSULIN ASPART
725257981,5/23/2015 20:31:33,1642358428,5/23/2015 20:31:11,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],using,N/A,97,134,-1,121,148,TWrex-cause,800129-FS1,Some patients may require more basal insulin and a greater total daily insulin dosage to prevent PREPRANDIAL HYPERGLYCEMIA when using INSULIN ASPART than when using insulin human (regular.,PREPRANDIAL HYPERGLYCEMIA,INSULIN ASPART
725257981,5/23/2015 20:39:07,1642362264,5/23/2015 20:38:55,false,pocketmoneygpt,1,28884030,USA,WI,Minocqua,75.143.134.247,[PREVENTS],[PREVENTS],prevent,n/a,97,134,-1,121,148,TWrex-cause,800129-FS1,Some patients may require more basal insulin and a greater total daily insulin dosage to prevent PREPRANDIAL HYPERGLYCEMIA when using INSULIN ASPART than when using insulin human (regular.,PREPRANDIAL HYPERGLYCEMIA,INSULIN ASPART
725257981,5/23/2015 20:40:41,1642363281,5/23/2015 20:40:28,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],when using,n/a,97,134,-1,121,148,TWrex-cause,800129-FS1,Some patients may require more basal insulin and a greater total daily insulin dosage to prevent PREPRANDIAL HYPERGLYCEMIA when using INSULIN ASPART than when using insulin human (regular.,PREPRANDIAL HYPERGLYCEMIA,INSULIN ASPART
725257981,5/23/2015 20:41:58,1642363878,5/23/2015 20:41:49,false,clixsense,1,28457001,CAN,ON,North Bay,24.204.202.220,[PREVENTS],[PREVENTS],prevent,n/a,97,134,-1,121,148,TWrex-cause,800129-FS1,Some patients may require more basal insulin and a greater total daily insulin dosage to prevent PREPRANDIAL HYPERGLYCEMIA when using INSULIN ASPART than when using insulin human (regular.,PREPRANDIAL HYPERGLYCEMIA,INSULIN ASPART
725257981,5/23/2015 20:42:08,1642363975,5/23/2015 20:41:05,false,instagc,1,30880172,USA,CA,Los Angeles,166.170.50.98,[CONTRAINDICATES],[CONTRAINDICATES],may require greater total daily insulin to prevent,N/A,97,134,-1,121,148,TWrex-cause,800129-FS1,Some patients may require more basal insulin and a greater total daily insulin dosage to prevent PREPRANDIAL HYPERGLYCEMIA when using INSULIN ASPART than when using insulin human (regular.,PREPRANDIAL HYPERGLYCEMIA,INSULIN ASPART
725257981,5/23/2015 20:42:13,1642364014,5/23/2015 20:40:41,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,[PREVENTS],[PREVENTS],prevent PREPRANDIAL HYPERGLYCEMIA when using INSULIN ASPART,na,97,134,-1,121,148,TWrex-cause,800129-FS1,Some patients may require more basal insulin and a greater total daily insulin dosage to prevent PREPRANDIAL HYPERGLYCEMIA when using INSULIN ASPART than when using insulin human (regular.,PREPRANDIAL HYPERGLYCEMIA,INSULIN ASPART
725257981,5/23/2015 20:44:55,1642365618,5/23/2015 20:44:38,false,cointasker,1,21783324,NLD,"","",31.151.239.133,[PREVENTS],[PREVENTS],prevent,-,97,134,-1,121,148,TWrex-cause,800129-FS1,Some patients may require more basal insulin and a greater total daily insulin dosage to prevent PREPRANDIAL HYPERGLYCEMIA when using INSULIN ASPART than when using insulin human (regular.,PREPRANDIAL HYPERGLYCEMIA,INSULIN ASPART
725257981,5/23/2015 20:46:15,1642366526,5/23/2015 20:45:56,false,elite,1,31883685,GBR,H2,Accrington,80.47.186.28,[SIDE_EFFECT],[SIDE_EFFECT],when using,n/a,97,134,-1,121,148,TWrex-cause,800129-FS1,Some patients may require more basal insulin and a greater total daily insulin dosage to prevent PREPRANDIAL HYPERGLYCEMIA when using INSULIN ASPART than when using insulin human (regular.,PREPRANDIAL HYPERGLYCEMIA,INSULIN ASPART
725257981,5/23/2015 20:49:13,1642368238,5/23/2015 20:47:26,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,[SIDE_EFFECT],[SIDE_EFFECT],to prevent when using,N/A,97,134,-1,121,148,TWrex-cause,800129-FS1,Some patients may require more basal insulin and a greater total daily insulin dosage to prevent PREPRANDIAL HYPERGLYCEMIA when using INSULIN ASPART than when using insulin human (regular.,PREPRANDIAL HYPERGLYCEMIA,INSULIN ASPART
725257981,5/23/2015 20:54:45,1642371199,5/23/2015 20:54:17,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",to prevent,n/a,97,134,-1,121,148,TWrex-cause,800129-FS1,Some patients may require more basal insulin and a greater total daily insulin dosage to prevent PREPRANDIAL HYPERGLYCEMIA when using INSULIN ASPART than when using insulin human (regular.,PREPRANDIAL HYPERGLYCEMIA,INSULIN ASPART
725257981,5/23/2015 21:05:27,1642375942,5/23/2015 21:05:01,false,instagc,1,15864091,USA,OK,Oklahoma City,104.0.113.133,[PREVENTS],[PREVENTS],to prevent,n/a,97,134,-1,121,148,TWrex-cause,800129-FS1,Some patients may require more basal insulin and a greater total daily insulin dosage to prevent PREPRANDIAL HYPERGLYCEMIA when using INSULIN ASPART than when using insulin human (regular.,PREPRANDIAL HYPERGLYCEMIA,INSULIN ASPART
725257981,5/23/2015 21:28:57,1642387438,5/23/2015 21:28:20,false,neodev,1,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",using,N/A,97,134,-1,121,148,TWrex-cause,800129-FS1,Some patients may require more basal insulin and a greater total daily insulin dosage to prevent PREPRANDIAL HYPERGLYCEMIA when using INSULIN ASPART than when using insulin human (regular.,PREPRANDIAL HYPERGLYCEMIA,INSULIN ASPART
725257981,5/23/2015 21:29:40,1642387741,5/23/2015 21:28:42,false,prodege,1,24403612,CAN,ON,Bowmanville,99.252.243.178,[PREVENTS],[PREVENTS],prevent PREPRANDIAL HYPERGLYCEMIA when using INSULIN ASPART,N/A,97,134,-1,121,148,TWrex-cause,800129-FS1,Some patients may require more basal insulin and a greater total daily insulin dosage to prevent PREPRANDIAL HYPERGLYCEMIA when using INSULIN ASPART than when using insulin human (regular.,PREPRANDIAL HYPERGLYCEMIA,INSULIN ASPART
725257981,5/23/2015 21:30:22,1642388040,5/23/2015 21:28:57,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",Some patients may require more basal insulin and a greater total daily insulin dosage to prevent PREPRANDIAL HYPERGLYCEMIA when using INSULIN ASPART than when using insulin human (regular.,n/a,97,134,-1,121,148,TWrex-cause,800129-FS1,Some patients may require more basal insulin and a greater total daily insulin dosage to prevent PREPRANDIAL HYPERGLYCEMIA when using INSULIN ASPART than when using insulin human (regular.,PREPRANDIAL HYPERGLYCEMIA,INSULIN ASPART
725257982,5/23/2015 20:26:21,1642355903,5/23/2015 20:25:55,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],VALACICLOVIR for therapy for HERPES ZOSTER,N/A,62,0,-1,74,12,TWrex-cause,800404-FS1,VALACICLOVIR compared with acyclovir for improved therapy for HERPES ZOSTER in immunocompetent adults.,HERPES ZOSTER,VALACICLOVIR
725257982,5/23/2015 20:31:10,1642358273,5/23/2015 20:30:58,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],therapy,N/A,62,0,-1,74,12,TWrex-cause,800404-FS1,VALACICLOVIR compared with acyclovir for improved therapy for HERPES ZOSTER in immunocompetent adults.,HERPES ZOSTER,VALACICLOVIR
725257982,5/23/2015 20:38:53,1642362147,5/23/2015 20:38:42,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],therapy,n/a,62,0,-1,74,12,TWrex-cause,800404-FS1,VALACICLOVIR compared with acyclovir for improved therapy for HERPES ZOSTER in immunocompetent adults.,HERPES ZOSTER,VALACICLOVIR
725257982,5/23/2015 20:40:27,1642363117,5/23/2015 20:40:16,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],therapy,n/a,62,0,-1,74,12,TWrex-cause,800404-FS1,VALACICLOVIR compared with acyclovir for improved therapy for HERPES ZOSTER in immunocompetent adults.,HERPES ZOSTER,VALACICLOVIR
725257982,5/23/2015 20:40:40,1642363243,5/23/2015 20:39:36,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],VALACICLOVIR for therapy for HERPES ZOSTER,na,62,0,-1,74,12,TWrex-cause,800404-FS1,VALACICLOVIR compared with acyclovir for improved therapy for HERPES ZOSTER in immunocompetent adults.,HERPES ZOSTER,VALACICLOVIR
725257982,5/23/2015 20:41:04,1642363451,5/23/2015 20:39:58,false,instagc,1.0,30880172,USA,CA,Los Angeles,166.170.50.98,[OTHER],[OTHER],improved therapy,Treated by,62,0,-1,74,12,TWrex-cause,800404-FS1,VALACICLOVIR compared with acyclovir for improved therapy for HERPES ZOSTER in immunocompetent adults.,HERPES ZOSTER,VALACICLOVIR
725257982,5/23/2015 20:41:48,1642363815,5/23/2015 20:41:21,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],therapy,n/a,62,0,-1,74,12,TWrex-cause,800404-FS1,VALACICLOVIR compared with acyclovir for improved therapy for HERPES ZOSTER in immunocompetent adults.,HERPES ZOSTER,VALACICLOVIR
725257982,5/23/2015 20:44:36,1642365439,5/23/2015 20:44:25,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[TREATS],[TREATS],therapy,-,62,0,-1,74,12,TWrex-cause,800404-FS1,VALACICLOVIR compared with acyclovir for improved therapy for HERPES ZOSTER in immunocompetent adults.,HERPES ZOSTER,VALACICLOVIR
725257982,5/23/2015 20:45:55,1642366304,5/23/2015 20:45:38,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],therapy for,n/a,62,0,-1,74,12,TWrex-cause,800404-FS1,VALACICLOVIR compared with acyclovir for improved therapy for HERPES ZOSTER in immunocompetent adults.,HERPES ZOSTER,VALACICLOVIR
725257982,5/23/2015 20:47:20,1642367182,5/23/2015 20:46:27,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],therapy for,N/A,62,0,-1,74,12,TWrex-cause,800404-FS1,VALACICLOVIR compared with acyclovir for improved therapy for HERPES ZOSTER in immunocompetent adults.,HERPES ZOSTER,VALACICLOVIR
725257982,5/23/2015 20:54:16,1642370955,5/23/2015 20:54:04,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],improved therapy for,n/a,62,0,-1,74,12,TWrex-cause,800404-FS1,VALACICLOVIR compared with acyclovir for improved therapy for HERPES ZOSTER in immunocompetent adults.,HERPES ZOSTER,VALACICLOVIR
725257982,5/23/2015 21:05:00,1642375752,5/23/2015 21:04:38,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[TREATS],[TREATS],improved therapy for,n/a,62,0,-1,74,12,TWrex-cause,800404-FS1,VALACICLOVIR compared with acyclovir for improved therapy for HERPES ZOSTER in immunocompetent adults.,HERPES ZOSTER,VALACICLOVIR
725257982,5/23/2015 21:15:57,1642380960,5/23/2015 21:15:48,false,prodege,1,2143114,CAN,BC,Vancouver,24.85.153.181,[TREATS],[TREATS],compared,n/a,62,0,-1,74,12,TWrex-cause,800404-FS1,VALACICLOVIR compared with acyclovir for improved therapy for HERPES ZOSTER in immunocompetent adults.,HERPES ZOSTER,VALACICLOVIR
725257982,5/23/2015 21:28:18,1642387057,5/23/2015 21:27:35,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],for improved therapy,N/A,62,0,-1,74,12,TWrex-cause,800404-FS1,VALACICLOVIR compared with acyclovir for improved therapy for HERPES ZOSTER in immunocompetent adults.,HERPES ZOSTER,VALACICLOVIR
725257982,5/23/2015 21:28:41,1642387241,5/23/2015 21:28:06,false,prodege,1.0,24403612,CAN,ON,Bowmanville,99.252.243.178,[TREATS],[TREATS],VALACICLOVIR for improved therapy for HERPES ZOSTER,N/A,62,0,-1,74,12,TWrex-cause,800404-FS1,VALACICLOVIR compared with acyclovir for improved therapy for HERPES ZOSTER in immunocompetent adults.,HERPES ZOSTER,VALACICLOVIR
725257983,5/23/2015 22:03:31,1642403169,5/23/2015 22:02:57,false,neodev,1,30588889,NLD,07,Amsterdam,77.248.175.222,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",May present with,N/A,98,49,1,104,79,TWrex-cause,813838-FS1,May be associated with antiphospholipid syndrome PRIMARY PULMONARY HYPERTENSION  May present with DYSPNEA and physical findings of pulmonary hypertension as seen in chronic thromboembolic disease Pericarditis  May present with pleuritic chest pain similar to pulmonary embolism.,DYSPNEA,PRIMARY PULMONARY HYPERTENSION
725257983,5/23/2015 22:10:20,1642406697,5/23/2015 22:09:33,false,elite,1,30064988,GBR,B4,Bradford,92.22.135.10,[SYMPTOM],[SYMPTOM],present with,N/A,98,49,1,104,79,TWrex-cause,813838-FS1,May be associated with antiphospholipid syndrome PRIMARY PULMONARY HYPERTENSION  May present with DYSPNEA and physical findings of pulmonary hypertension as seen in chronic thromboembolic disease Pericarditis  May present with pleuritic chest pain similar to pulmonary embolism.,DYSPNEA,PRIMARY PULMONARY HYPERTENSION
725257983,5/23/2015 22:15:08,1642409042,5/23/2015 22:14:30,false,instagc,1,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],PRIMARY PULMONARY HYPERTENSION May present with DYSPNEA,n/a,98,49,1,104,79,TWrex-cause,813838-FS1,May be associated with antiphospholipid syndrome PRIMARY PULMONARY HYPERTENSION  May present with DYSPNEA and physical findings of pulmonary hypertension as seen in chronic thromboembolic disease Pericarditis  May present with pleuritic chest pain similar to pulmonary embolism.,DYSPNEA,PRIMARY PULMONARY HYPERTENSION
725257983,5/23/2015 22:21:33,1642412276,5/23/2015 22:20:04,false,neodev,1,27667288,CAN,MB,Brandon,216.36.154.251,[SYMPTOM],[SYMPTOM],May present with,n/a,98,49,1,104,79,TWrex-cause,813838-FS1,May be associated with antiphospholipid syndrome PRIMARY PULMONARY HYPERTENSION  May present with DYSPNEA and physical findings of pulmonary hypertension as seen in chronic thromboembolic disease Pericarditis  May present with pleuritic chest pain similar to pulmonary embolism.,DYSPNEA,PRIMARY PULMONARY HYPERTENSION
725257983,5/23/2015 22:23:47,1642413477,5/23/2015 22:22:11,false,gifthulk,1,18666417,USA,PA,Meadville,24.101.97.237,[SYMPTOM],[SYMPTOM],PRIMARY PULMONARY HYPERTENSION May present with DYSPNEA,N/A,98,49,1,104,79,TWrex-cause,813838-FS1,May be associated with antiphospholipid syndrome PRIMARY PULMONARY HYPERTENSION  May present with DYSPNEA and physical findings of pulmonary hypertension as seen in chronic thromboembolic disease Pericarditis  May present with pleuritic chest pain similar to pulmonary embolism.,DYSPNEA,PRIMARY PULMONARY HYPERTENSION
725257983,5/23/2015 22:25:05,1642414104,5/23/2015 22:23:58,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],May present with,N/A,98,49,1,104,79,TWrex-cause,813838-FS1,May be associated with antiphospholipid syndrome PRIMARY PULMONARY HYPERTENSION  May present with DYSPNEA and physical findings of pulmonary hypertension as seen in chronic thromboembolic disease Pericarditis  May present with pleuritic chest pain similar to pulmonary embolism.,DYSPNEA,PRIMARY PULMONARY HYPERTENSION
725257983,5/23/2015 22:26:37,1642414837,5/23/2015 22:26:08,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],thromboembolic disease,N/A,98,49,1,104,79,TWrex-cause,813838-FS1,May be associated with antiphospholipid syndrome PRIMARY PULMONARY HYPERTENSION  May present with DYSPNEA and physical findings of pulmonary hypertension as seen in chronic thromboembolic disease Pericarditis  May present with pleuritic chest pain similar to pulmonary embolism.,DYSPNEA,PRIMARY PULMONARY HYPERTENSION
725257983,5/23/2015 22:32:15,1642417622,5/23/2015 22:31:54,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,[ASSOCIATED_WITH],[ASSOCIATED_WITH],May be associated with antiphospholipid syndrome PRIMARY PULMONARY HYPERTENSION,n/a,98,49,1,104,79,TWrex-cause,813838-FS1,May be associated with antiphospholipid syndrome PRIMARY PULMONARY HYPERTENSION  May present with DYSPNEA and physical findings of pulmonary hypertension as seen in chronic thromboembolic disease Pericarditis  May present with pleuritic chest pain similar to pulmonary embolism.,DYSPNEA,PRIMARY PULMONARY HYPERTENSION
725257983,5/23/2015 22:36:04,1642419446,5/23/2015 22:35:30,false,clixsense,1,22947672,GBR,"","",88.144.127.68,[MANIFESTATION],[MANIFESTATION],PRIMARY PULMONARY HYPERTENSION May present with DYSPNEA,n/a,98,49,1,104,79,TWrex-cause,813838-FS1,May be associated with antiphospholipid syndrome PRIMARY PULMONARY HYPERTENSION  May present with DYSPNEA and physical findings of pulmonary hypertension as seen in chronic thromboembolic disease Pericarditis  May present with pleuritic chest pain similar to pulmonary embolism.,DYSPNEA,PRIMARY PULMONARY HYPERTENSION
725257983,5/23/2015 23:05:43,1642434463,5/23/2015 23:05:09,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,[SYMPTOM],[SYMPTOM],May present with,N/A,98,49,1,104,79,TWrex-cause,813838-FS1,May be associated with antiphospholipid syndrome PRIMARY PULMONARY HYPERTENSION  May present with DYSPNEA and physical findings of pulmonary hypertension as seen in chronic thromboembolic disease Pericarditis  May present with pleuritic chest pain similar to pulmonary embolism.,DYSPNEA,PRIMARY PULMONARY HYPERTENSION
725257983,5/23/2015 23:09:47,1642436116,5/23/2015 23:09:27,false,prodege,1,13300986,CAN,AB,Edmonton,68.150.40.134,[SYMPTOM],[SYMPTOM],May present with,n/a,98,49,1,104,79,TWrex-cause,813838-FS1,May be associated with antiphospholipid syndrome PRIMARY PULMONARY HYPERTENSION  May present with DYSPNEA and physical findings of pulmonary hypertension as seen in chronic thromboembolic disease Pericarditis  May present with pleuritic chest pain similar to pulmonary embolism.,DYSPNEA,PRIMARY PULMONARY HYPERTENSION
725257983,5/23/2015 23:12:13,1642437237,5/23/2015 23:11:31,false,neodev,1,29579905,GBR,"","",5.152.206.71,[ASSOCIATED_WITH] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]",with syndrome with with,N/A,98,49,1,104,79,TWrex-cause,813838-FS1,May be associated with antiphospholipid syndrome PRIMARY PULMONARY HYPERTENSION  May present with DYSPNEA and physical findings of pulmonary hypertension as seen in chronic thromboembolic disease Pericarditis  May present with pleuritic chest pain similar to pulmonary embolism.,DYSPNEA,PRIMARY PULMONARY HYPERTENSION
725257983,5/23/2015 23:12:18,1642437269,5/23/2015 23:11:39,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],present with,none,98,49,1,104,79,TWrex-cause,813838-FS1,May be associated with antiphospholipid syndrome PRIMARY PULMONARY HYPERTENSION  May present with DYSPNEA and physical findings of pulmonary hypertension as seen in chronic thromboembolic disease Pericarditis  May present with pleuritic chest pain similar to pulmonary embolism.,DYSPNEA,PRIMARY PULMONARY HYPERTENSION
725257983,5/23/2015 23:14:09,1642438055,5/23/2015 23:11:15,false,fusioncash,1,23163165,USA,GA,Marietta,71.199.144.152,[ASSOCIATED_WITH] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]",associated with with present with chest pain,n/a,98,49,1,104,79,TWrex-cause,813838-FS1,May be associated with antiphospholipid syndrome PRIMARY PULMONARY HYPERTENSION  May present with DYSPNEA and physical findings of pulmonary hypertension as seen in chronic thromboembolic disease Pericarditis  May present with pleuritic chest pain similar to pulmonary embolism.,DYSPNEA,PRIMARY PULMONARY HYPERTENSION
725257983,5/23/2015 23:15:05,1642438381,5/23/2015 23:14:28,false,instagc,1,24252915,GBR,K6,Portsmouth,78.146.11.229,[SYMPTOM],[SYMPTOM],May present with,N/a,98,49,1,104,79,TWrex-cause,813838-FS1,May be associated with antiphospholipid syndrome PRIMARY PULMONARY HYPERTENSION  May present with DYSPNEA and physical findings of pulmonary hypertension as seen in chronic thromboembolic disease Pericarditis  May present with pleuritic chest pain similar to pulmonary embolism.,DYSPNEA,PRIMARY PULMONARY HYPERTENSION
725257984,5/23/2015 23:33:59,1642446678,5/23/2015 23:33:34,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,188,160,-1,215,176,TWrex-cause,803083-FS1,"b ,   c ,   d ,   e  Fetal/Neonatal Morbidity  Some retrospective studies suggest increased risk of congenital malformations in infants of mothers who received CHLORDIAZEPOXIDE during the FIRST TRIMESTER OF PREGNANCY",FIRST TRIMESTER OF PREGNANCY,CHLORDIAZEPOXIDE
725257984,5/23/2015 23:40:26,1642449816,5/23/2015 23:39:26,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CONTRAINDICATES],[CONTRAINDICATES],increased risk,none,188,160,-1,215,176,TWrex-cause,803083-FS1,"b ,   c ,   d ,   e  Fetal/Neonatal Morbidity  Some retrospective studies suggest increased risk of congenital malformations in infants of mothers who received CHLORDIAZEPOXIDE during the FIRST TRIMESTER OF PREGNANCY",FIRST TRIMESTER OF PREGNANCY,CHLORDIAZEPOXIDE
725257984,5/23/2015 23:46:05,1642452535,5/23/2015 23:45:32,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,[CONTRAINDICATES],[CONTRAINDICATES],congenital malformations,N/A,188,160,-1,215,176,TWrex-cause,803083-FS1,"b ,   c ,   d ,   e  Fetal/Neonatal Morbidity  Some retrospective studies suggest increased risk of congenital malformations in infants of mothers who received CHLORDIAZEPOXIDE during the FIRST TRIMESTER OF PREGNANCY",FIRST TRIMESTER OF PREGNANCY,CHLORDIAZEPOXIDE
725257984,5/23/2015 23:49:46,1642454086,5/23/2015 23:49:33,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,[TREATS],[TREATS],received,n/a,188,160,-1,215,176,TWrex-cause,803083-FS1,"b ,   c ,   d ,   e  Fetal/Neonatal Morbidity  Some retrospective studies suggest increased risk of congenital malformations in infants of mothers who received CHLORDIAZEPOXIDE during the FIRST TRIMESTER OF PREGNANCY",FIRST TRIMESTER OF PREGNANCY,CHLORDIAZEPOXIDE
725257984,5/24/2015 00:33:37,1642472575,5/24/2015 00:33:00,false,instagc,1,27914150,USA,TX,Dallas,72.190.59.224,[CONTRAINDICATES],[CONTRAINDICATES],malformations,n/a,188,160,-1,215,176,TWrex-cause,803083-FS1,"b ,   c ,   d ,   e  Fetal/Neonatal Morbidity  Some retrospective studies suggest increased risk of congenital malformations in infants of mothers who received CHLORDIAZEPOXIDE during the FIRST TRIMESTER OF PREGNANCY",FIRST TRIMESTER OF PREGNANCY,CHLORDIAZEPOXIDE
725257984,5/24/2015 00:41:03,1642475796,5/24/2015 00:40:20,false,elite,1,30957357,CAN,BC,Kelowna,24.71.41.51,[OTHER],[OTHER],increased risk of congenital malformations received CHLORDIAZEPOXIDE,na,188,160,-1,215,176,TWrex-cause,803083-FS1,"b ,   c ,   d ,   e  Fetal/Neonatal Morbidity  Some retrospective studies suggest increased risk of congenital malformations in infants of mothers who received CHLORDIAZEPOXIDE during the FIRST TRIMESTER OF PREGNANCY",FIRST TRIMESTER OF PREGNANCY,CHLORDIAZEPOXIDE
725257984,5/24/2015 00:44:14,1642477075,5/24/2015 00:43:36,false,elite,1,31848723,USA,VA,Manassas,192.96.205.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],CHLORDIAZEPOXIDE FIRST TRIMESTER PREGNANCY,N/A,188,160,-1,215,176,TWrex-cause,803083-FS1,"b ,   c ,   d ,   e  Fetal/Neonatal Morbidity  Some retrospective studies suggest increased risk of congenital malformations in infants of mothers who received CHLORDIAZEPOXIDE during the FIRST TRIMESTER OF PREGNANCY",FIRST TRIMESTER OF PREGNANCY,CHLORDIAZEPOXIDE
725257984,5/24/2015 00:46:20,1642478017,5/24/2015 00:45:12,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,[ASSOCIATED_WITH],[ASSOCIATED_WITH],who received,N/A,188,160,-1,215,176,TWrex-cause,803083-FS1,"b ,   c ,   d ,   e  Fetal/Neonatal Morbidity  Some retrospective studies suggest increased risk of congenital malformations in infants of mothers who received CHLORDIAZEPOXIDE during the FIRST TRIMESTER OF PREGNANCY",FIRST TRIMESTER OF PREGNANCY,CHLORDIAZEPOXIDE
725257984,5/24/2015 01:03:24,1642483580,5/24/2015 01:02:06,false,neodev,1,31294288,USA,IL,Chicago,99.198.108.118,[ASSOCIATED_WITH] [TREATS],"[TREATS]
[ASSOCIATED_WITH]",during,N/A,188,160,-1,215,176,TWrex-cause,803083-FS1,"b ,   c ,   d ,   e  Fetal/Neonatal Morbidity  Some retrospective studies suggest increased risk of congenital malformations in infants of mothers who received CHLORDIAZEPOXIDE during the FIRST TRIMESTER OF PREGNANCY",FIRST TRIMESTER OF PREGNANCY,CHLORDIAZEPOXIDE
725257984,5/24/2015 01:35:17,1642493848,5/24/2015 01:34:01,false,clixsense,1,6375330,CAN,ON,Ottawa,209.195.106.138,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],who received during the,none,188,160,-1,215,176,TWrex-cause,803083-FS1,"b ,   c ,   d ,   e  Fetal/Neonatal Morbidity  Some retrospective studies suggest increased risk of congenital malformations in infants of mothers who received CHLORDIAZEPOXIDE during the FIRST TRIMESTER OF PREGNANCY",FIRST TRIMESTER OF PREGNANCY,CHLORDIAZEPOXIDE
725257984,5/24/2015 01:37:07,1642494473,5/24/2015 01:36:54,false,elite,1,31685662,USA,VA,Manassas,207.244.89.77,[CONTRAINDICATES],[CONTRAINDICATES],during,N/A,188,160,-1,215,176,TWrex-cause,803083-FS1,"b ,   c ,   d ,   e  Fetal/Neonatal Morbidity  Some retrospective studies suggest increased risk of congenital malformations in infants of mothers who received CHLORDIAZEPOXIDE during the FIRST TRIMESTER OF PREGNANCY",FIRST TRIMESTER OF PREGNANCY,CHLORDIAZEPOXIDE
725257984,5/24/2015 01:44:25,1642497186,5/24/2015 01:44:11,false,elite,1,31501118,USA,IL,Chicago,158.255.213.24,[SYMPTOM],[SYMPTOM],risk,N/A,188,160,-1,215,176,TWrex-cause,803083-FS1,"b ,   c ,   d ,   e  Fetal/Neonatal Morbidity  Some retrospective studies suggest increased risk of congenital malformations in infants of mothers who received CHLORDIAZEPOXIDE during the FIRST TRIMESTER OF PREGNANCY",FIRST TRIMESTER OF PREGNANCY,CHLORDIAZEPOXIDE
725257984,5/24/2015 01:51:10,1642499385,5/24/2015 01:50:55,false,elite,1,30655282,USA,AZ,Tempe,23.235.227.109,[LOCATION],[LOCATION],increased,N/A,188,160,-1,215,176,TWrex-cause,803083-FS1,"b ,   c ,   d ,   e  Fetal/Neonatal Morbidity  Some retrospective studies suggest increased risk of congenital malformations in infants of mothers who received CHLORDIAZEPOXIDE during the FIRST TRIMESTER OF PREGNANCY",FIRST TRIMESTER OF PREGNANCY,CHLORDIAZEPOXIDE
725257984,5/24/2015 01:57:35,1642501632,5/24/2015 01:57:22,false,elite,1,31227441,USA,IL,Chicago,173.193.202.116,[MANIFESTATION],[MANIFESTATION],retrospective,N/A,188,160,-1,215,176,TWrex-cause,803083-FS1,"b ,   c ,   d ,   e  Fetal/Neonatal Morbidity  Some retrospective studies suggest increased risk of congenital malformations in infants of mothers who received CHLORDIAZEPOXIDE during the FIRST TRIMESTER OF PREGNANCY",FIRST TRIMESTER OF PREGNANCY,CHLORDIAZEPOXIDE
725257984,5/24/2015 02:02:17,1642502900,5/24/2015 02:01:27,false,neodev,1,32562748,CAN,BC,Vancouver,108.180.140.140,[CAUSES] [SYMPTOM],"[CAUSES]
[SYMPTOM]",CHLORDIAZEPOXIDE PREGNANCY,I didn't,188,160,-1,215,176,TWrex-cause,803083-FS1,"b ,   c ,   d ,   e  Fetal/Neonatal Morbidity  Some retrospective studies suggest increased risk of congenital malformations in infants of mothers who received CHLORDIAZEPOXIDE during the FIRST TRIMESTER OF PREGNANCY",FIRST TRIMESTER OF PREGNANCY,CHLORDIAZEPOXIDE
725257985,5/23/2015 20:35:35,1642360384,5/23/2015 20:35:19,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],common diagnosis,N/A,55,120,1,65,132,TWrex-cause,814011-FS1,"Comments: • If a patient presents beyond 20 weeks with PROTEINURIA and hypertension, the most common diagnosis would be PREECLAMPSIA",PROTEINURIA,PREECLAMPSIA
725257985,5/23/2015 20:42:12,1642363990,5/23/2015 20:41:23,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[MANIFESTATION],[MANIFESTATION],If a patient presents with PROTEINURIA most common diagnosis would be PREECLAMPSIA,N/A,55,120,1,65,132,TWrex-cause,814011-FS1,"Comments: • If a patient presents beyond 20 weeks with PROTEINURIA and hypertension, the most common diagnosis would be PREECLAMPSIA",PROTEINURIA,PREECLAMPSIA
725257985,5/23/2015 20:44:45,1642365522,5/23/2015 20:44:31,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],diagnosis,n/a,55,120,1,65,132,TWrex-cause,814011-FS1,"Comments: • If a patient presents beyond 20 weeks with PROTEINURIA and hypertension, the most common diagnosis would be PREECLAMPSIA",PROTEINURIA,PREECLAMPSIA
725257985,5/23/2015 20:50:26,1642368869,5/23/2015 20:50:10,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosis,n/a,55,120,1,65,132,TWrex-cause,814011-FS1,"Comments: • If a patient presents beyond 20 weeks with PROTEINURIA and hypertension, the most common diagnosis would be PREECLAMPSIA",PROTEINURIA,PREECLAMPSIA
725257985,5/23/2015 20:54:08,1642370855,5/23/2015 20:53:32,false,instagc,1.0,30880172,USA,CA,Los Angeles,166.170.50.98,[ASSOCIATED_WITH],[ASSOCIATED_WITH],diagnosis,N/A,55,120,1,65,132,TWrex-cause,814011-FS1,"Comments: • If a patient presents beyond 20 weeks with PROTEINURIA and hypertension, the most common diagnosis would be PREECLAMPSIA",PROTEINURIA,PREECLAMPSIA
725257985,5/23/2015 20:58:58,1642373201,5/23/2015 20:58:35,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[ASSOCIATED_WITH] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]",most common diagnosis would be,n/a,55,120,1,65,132,TWrex-cause,814011-FS1,"Comments: • If a patient presents beyond 20 weeks with PROTEINURIA and hypertension, the most common diagnosis would be PREECLAMPSIA",PROTEINURIA,PREECLAMPSIA
725257985,5/23/2015 20:59:08,1642373347,5/23/2015 20:57:54,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],If patient presents with PROTEINURIA the most common diagnosis would be PREECLAMPSIA,n a,55,120,1,65,132,TWrex-cause,814011-FS1,"Comments: • If a patient presents beyond 20 weeks with PROTEINURIA and hypertension, the most common diagnosis would be PREECLAMPSIA",PROTEINURIA,PREECLAMPSIA
725257985,5/23/2015 21:02:20,1642374729,5/23/2015 21:01:34,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]",If a patient presents beyond 20 weeks with,N/A,55,120,1,65,132,TWrex-cause,814011-FS1,"Comments: • If a patient presents beyond 20 weeks with PROTEINURIA and hypertension, the most common diagnosis would be PREECLAMPSIA",PROTEINURIA,PREECLAMPSIA
725257985,5/23/2015 21:12:45,1642379592,5/23/2015 21:11:59,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[SYMPTOM],[SYMPTOM],common diagnosis,n/a,55,120,1,65,132,TWrex-cause,814011-FS1,"Comments: • If a patient presents beyond 20 weeks with PROTEINURIA and hypertension, the most common diagnosis would be PREECLAMPSIA",PROTEINURIA,PREECLAMPSIA
725257985,5/23/2015 21:37:20,1642391736,5/23/2015 21:36:55,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosis would be,N/A,55,120,1,65,132,TWrex-cause,814011-FS1,"Comments: • If a patient presents beyond 20 weeks with PROTEINURIA and hypertension, the most common diagnosis would be PREECLAMPSIA",PROTEINURIA,PREECLAMPSIA
725257985,5/23/2015 21:44:10,1642395037,5/23/2015 21:43:24,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"If a patient presents beyond 20 weeks with PROTEINURIA and hypertension, the most common diagnosis would be PREECLAMPSIA",n/a,55,120,1,65,132,TWrex-cause,814011-FS1,"Comments: • If a patient presents beyond 20 weeks with PROTEINURIA and hypertension, the most common diagnosis would be PREECLAMPSIA",PROTEINURIA,PREECLAMPSIA
725257985,5/23/2015 21:47:25,1642396543,5/23/2015 21:46:49,false,bitcoinget,1,21743413,USA,WA,Lynnwood,67.183.5.219,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],the most common diagnosis would be,N/A,55,120,1,65,132,TWrex-cause,814011-FS1,"Comments: • If a patient presents beyond 20 weeks with PROTEINURIA and hypertension, the most common diagnosis would be PREECLAMPSIA",PROTEINURIA,PREECLAMPSIA
725257985,5/23/2015 21:50:22,1642397899,5/23/2015 21:49:47,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[SYMPTOM],[SYMPTOM],diagnosis would be,N/A,55,120,1,65,132,TWrex-cause,814011-FS1,"Comments: • If a patient presents beyond 20 weeks with PROTEINURIA and hypertension, the most common diagnosis would be PREECLAMPSIA",PROTEINURIA,PREECLAMPSIA
725257985,5/23/2015 21:51:09,1642398199,5/23/2015 21:50:13,false,elite,1.0,30064988,GBR,B4,Bradford,92.22.135.10,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosis,N/A,55,120,1,65,132,TWrex-cause,814011-FS1,"Comments: • If a patient presents beyond 20 weeks with PROTEINURIA and hypertension, the most common diagnosis would be PREECLAMPSIA",PROTEINURIA,PREECLAMPSIA
725257985,5/23/2015 21:51:51,1642398456,5/23/2015 21:50:20,false,neodev,1,27039189,NLD,03,Warnsveld,213.93.50.164,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],the diagnosis would be,n/a,55,120,1,65,132,TWrex-cause,814011-FS1,"Comments: • If a patient presents beyond 20 weeks with PROTEINURIA and hypertension, the most common diagnosis would be PREECLAMPSIA",PROTEINURIA,PREECLAMPSIA
725257986,5/23/2015 22:21:12,1642412061,5/23/2015 22:20:29,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[NONE],[NONE],n/a,test done with tuberculosis using tuberclin,138,178,-1,149,188,TWrex-cause,803002-FS1,"von Pirquet's test    (               audio )  [Clemens Peter Johann von Pirquet, Austrian pediatrician, 1874 1929] A diagnostic test for TUBERCULOSIS in which a small amount of TUBERCULIN is applied to a scarified area of the skin of the arm.",TUBERCULOSIS,TUBERCULIN
725257986,5/23/2015 22:36:23,1642419626,5/23/2015 22:35:54,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],TUBERCULOSIS,N/A,138,178,-1,149,188,TWrex-cause,803002-FS1,"von Pirquet's test    (               audio )  [Clemens Peter Johann von Pirquet, Austrian pediatrician, 1874 1929] A diagnostic test for TUBERCULOSIS in which a small amount of TUBERCULIN is applied to a scarified area of the skin of the arm.",TUBERCULOSIS,TUBERCULIN
725257986,5/23/2015 22:40:02,1642421703,5/23/2015 22:39:26,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",von Pirquet's test A diagnostic test for TUBERCULOSIS in which small amount of TUBERCULIN is applied to a scarified area of the skin of the arm.,n/a,138,178,-1,149,188,TWrex-cause,803002-FS1,"von Pirquet's test    (               audio )  [Clemens Peter Johann von Pirquet, Austrian pediatrician, 1874 1929] A diagnostic test for TUBERCULOSIS in which a small amount of TUBERCULIN is applied to a scarified area of the skin of the arm.",TUBERCULOSIS,TUBERCULIN
725257986,5/23/2015 22:46:10,1642424763,5/23/2015 22:45:26,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],test for TUBERCULOSIS in which TUBERCULIN is applied to a scarified area of the skin,n/a,138,178,-1,149,188,TWrex-cause,803002-FS1,"von Pirquet's test    (               audio )  [Clemens Peter Johann von Pirquet, Austrian pediatrician, 1874 1929] A diagnostic test for TUBERCULOSIS in which a small amount of TUBERCULIN is applied to a scarified area of the skin of the arm.",TUBERCULOSIS,TUBERCULIN
725257986,5/23/2015 23:14:47,1642438301,5/23/2015 23:14:27,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnostic test,N/A,138,178,-1,149,188,TWrex-cause,803002-FS1,"von Pirquet's test    (               audio )  [Clemens Peter Johann von Pirquet, Austrian pediatrician, 1874 1929] A diagnostic test for TUBERCULOSIS in which a small amount of TUBERCULIN is applied to a scarified area of the skin of the arm.",TUBERCULOSIS,TUBERCULIN
725257986,5/23/2015 23:19:03,1642439979,5/23/2015 23:18:20,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnostic test,n/a,138,178,-1,149,188,TWrex-cause,803002-FS1,"von Pirquet's test    (               audio )  [Clemens Peter Johann von Pirquet, Austrian pediatrician, 1874 1929] A diagnostic test for TUBERCULOSIS in which a small amount of TUBERCULIN is applied to a scarified area of the skin of the arm.",TUBERCULOSIS,TUBERCULIN
725257986,5/23/2015 23:26:36,1642443323,5/23/2015 23:25:11,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnostic,none,138,178,-1,149,188,TWrex-cause,803002-FS1,"von Pirquet's test    (               audio )  [Clemens Peter Johann von Pirquet, Austrian pediatrician, 1874 1929] A diagnostic test for TUBERCULOSIS in which a small amount of TUBERCULIN is applied to a scarified area of the skin of the arm.",TUBERCULOSIS,TUBERCULIN
725257986,5/23/2015 23:28:01,1642443961,5/23/2015 23:27:34,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,138,178,-1,149,188,TWrex-cause,803002-FS1,"von Pirquet's test    (               audio )  [Clemens Peter Johann von Pirquet, Austrian pediatrician, 1874 1929] A diagnostic test for TUBERCULOSIS in which a small amount of TUBERCULIN is applied to a scarified area of the skin of the arm.",TUBERCULOSIS,TUBERCULIN
725257986,5/23/2015 23:30:18,1642445094,5/23/2015 23:29:14,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES] [LOCATION],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[LOCATION]",diagnostic test for area,n/a,138,178,-1,149,188,TWrex-cause,803002-FS1,"von Pirquet's test    (               audio )  [Clemens Peter Johann von Pirquet, Austrian pediatrician, 1874 1929] A diagnostic test for TUBERCULOSIS in which a small amount of TUBERCULIN is applied to a scarified area of the skin of the arm.",TUBERCULOSIS,TUBERCULIN
725257986,5/23/2015 23:37:55,1642448445,5/23/2015 23:37:35,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnostic,N/A,138,178,-1,149,188,TWrex-cause,803002-FS1,"von Pirquet's test    (               audio )  [Clemens Peter Johann von Pirquet, Austrian pediatrician, 1874 1929] A diagnostic test for TUBERCULOSIS in which a small amount of TUBERCULIN is applied to a scarified area of the skin of the arm.",TUBERCULOSIS,TUBERCULIN
725257986,5/23/2015 23:46:03,1642452531,5/23/2015 23:45:50,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],test for,n/a,138,178,-1,149,188,TWrex-cause,803002-FS1,"von Pirquet's test    (               audio )  [Clemens Peter Johann von Pirquet, Austrian pediatrician, 1874 1929] A diagnostic test for TUBERCULOSIS in which a small amount of TUBERCULIN is applied to a scarified area of the skin of the arm.",TUBERCULOSIS,TUBERCULIN
725257986,5/23/2015 23:55:17,1642456615,5/23/2015 23:55:04,false,neodev,1,32103286,USA,CA,San Jose,23.27.44.161,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,138,178,-1,149,188,TWrex-cause,803002-FS1,"von Pirquet's test    (               audio )  [Clemens Peter Johann von Pirquet, Austrian pediatrician, 1874 1929] A diagnostic test for TUBERCULOSIS in which a small amount of TUBERCULIN is applied to a scarified area of the skin of the arm.",TUBERCULOSIS,TUBERCULIN
725257986,5/24/2015 00:20:58,1642467745,5/24/2015 00:19:22,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnostic,na,138,178,-1,149,188,TWrex-cause,803002-FS1,"von Pirquet's test    (               audio )  [Clemens Peter Johann von Pirquet, Austrian pediatrician, 1874 1929] A diagnostic test for TUBERCULOSIS in which a small amount of TUBERCULIN is applied to a scarified area of the skin of the arm.",TUBERCULOSIS,TUBERCULIN
725257986,5/24/2015 00:23:03,1642468563,5/24/2015 00:22:46,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnostic,n/a,138,178,-1,149,188,TWrex-cause,803002-FS1,"von Pirquet's test    (               audio )  [Clemens Peter Johann von Pirquet, Austrian pediatrician, 1874 1929] A diagnostic test for TUBERCULOSIS in which a small amount of TUBERCULIN is applied to a scarified area of the skin of the arm.",TUBERCULOSIS,TUBERCULIN
725257986,5/24/2015 00:25:05,1642469463,5/24/2015 00:24:39,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],A diagnostic test for,n/a,138,178,-1,149,188,TWrex-cause,803002-FS1,"von Pirquet's test    (               audio )  [Clemens Peter Johann von Pirquet, Austrian pediatrician, 1874 1929] A diagnostic test for TUBERCULOSIS in which a small amount of TUBERCULIN is applied to a scarified area of the skin of the arm.",TUBERCULOSIS,TUBERCULIN
725257987,5/23/2015 22:21:46,1642412431,5/23/2015 22:21:33,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[IS_A],[IS_A],PRIMARY SYSTEMIC AMYLOIDOSIS is a MULTISYSTEM DISEASE,n/a,44,10,1,62,38,TWrex-cause,812871-FS1,"• Because PRIMARY SYSTEMIC AMYLOIDOSIS is a MULTISYSTEM DISEASE in most patients, it is important to recognize abnormal organ function/reserve before starting an aggressive treatment plan ( 39 ;  40.",MULTISYSTEM DISEASE,PRIMARY SYSTEMIC AMYLOIDOSIS
725257987,5/23/2015 22:37:23,1642420240,5/23/2015 22:36:42,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],MULTISYSTEM DISEASE,N/A,44,10,1,62,38,TWrex-cause,812871-FS1,"• Because PRIMARY SYSTEMIC AMYLOIDOSIS is a MULTISYSTEM DISEASE in most patients, it is important to recognize abnormal organ function/reserve before starting an aggressive treatment plan ( 39 ;  40.",MULTISYSTEM DISEASE,PRIMARY SYSTEMIC AMYLOIDOSIS
725257987,5/23/2015 22:41:17,1642422250,5/23/2015 22:40:42,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],"Because PRIMARY SYSTEMIC AMYLOIDOSIS MULTISYSTEM DISEASE most patients, it is important to recognize abnormal organ function/reserve before starting an aggressive treatment plan",n/a,44,10,1,62,38,TWrex-cause,812871-FS1,"• Because PRIMARY SYSTEMIC AMYLOIDOSIS is a MULTISYSTEM DISEASE in most patients, it is important to recognize abnormal organ function/reserve before starting an aggressive treatment plan ( 39 ;  40.",MULTISYSTEM DISEASE,PRIMARY SYSTEMIC AMYLOIDOSIS
725257987,5/23/2015 22:47:06,1642425406,5/23/2015 22:46:47,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[IS_A],[IS_A],PRIMARY SYSTEMIC AMYLOIDOSIS is a MULTISYSTEM DISEASE,n/a,44,10,1,62,38,TWrex-cause,812871-FS1,"• Because PRIMARY SYSTEMIC AMYLOIDOSIS is a MULTISYSTEM DISEASE in most patients, it is important to recognize abnormal organ function/reserve before starting an aggressive treatment plan ( 39 ;  40.",MULTISYSTEM DISEASE,PRIMARY SYSTEMIC AMYLOIDOSIS
725257987,5/23/2015 23:16:20,1642438942,5/23/2015 23:15:28,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[IS_A],[IS_A],is a,N/A,44,10,1,62,38,TWrex-cause,812871-FS1,"• Because PRIMARY SYSTEMIC AMYLOIDOSIS is a MULTISYSTEM DISEASE in most patients, it is important to recognize abnormal organ function/reserve before starting an aggressive treatment plan ( 39 ;  40.",MULTISYSTEM DISEASE,PRIMARY SYSTEMIC AMYLOIDOSIS
725257987,5/23/2015 23:20:24,1642440553,5/23/2015 23:19:48,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[IS_A],[IS_A],is a,n/a,44,10,1,62,38,TWrex-cause,812871-FS1,"• Because PRIMARY SYSTEMIC AMYLOIDOSIS is a MULTISYSTEM DISEASE in most patients, it is important to recognize abnormal organ function/reserve before starting an aggressive treatment plan ( 39 ;  40.",MULTISYSTEM DISEASE,PRIMARY SYSTEMIC AMYLOIDOSIS
725257987,5/23/2015 23:28:51,1642444312,5/23/2015 23:27:43,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[IS_A],[IS_A],is a,none,44,10,1,62,38,TWrex-cause,812871-FS1,"• Because PRIMARY SYSTEMIC AMYLOIDOSIS is a MULTISYSTEM DISEASE in most patients, it is important to recognize abnormal organ function/reserve before starting an aggressive treatment plan ( 39 ;  40.",MULTISYSTEM DISEASE,PRIMARY SYSTEMIC AMYLOIDOSIS
725257987,5/23/2015 23:29:42,1642444729,5/23/2015 23:28:58,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[IS_A],[IS_A],is a,N/A,44,10,1,62,38,TWrex-cause,812871-FS1,"• Because PRIMARY SYSTEMIC AMYLOIDOSIS is a MULTISYSTEM DISEASE in most patients, it is important to recognize abnormal organ function/reserve before starting an aggressive treatment plan ( 39 ;  40.",MULTISYSTEM DISEASE,PRIMARY SYSTEMIC AMYLOIDOSIS
725257987,5/23/2015 23:39:22,1642449245,5/23/2015 23:38:25,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[PART_OF],[PART_OF],PRIMARY SYSTEMIC AMYLOIDOSIS is a MULTISYSTEM DISEASE,N/A,44,10,1,62,38,TWrex-cause,812871-FS1,"• Because PRIMARY SYSTEMIC AMYLOIDOSIS is a MULTISYSTEM DISEASE in most patients, it is important to recognize abnormal organ function/reserve before starting an aggressive treatment plan ( 39 ;  40.",MULTISYSTEM DISEASE,PRIMARY SYSTEMIC AMYLOIDOSIS
725257987,5/23/2015 23:46:34,1642452751,5/23/2015 23:46:22,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[TREATS],[TREATS],treatment plan,n/a,44,10,1,62,38,TWrex-cause,812871-FS1,"• Because PRIMARY SYSTEMIC AMYLOIDOSIS is a MULTISYSTEM DISEASE in most patients, it is important to recognize abnormal organ function/reserve before starting an aggressive treatment plan ( 39 ;  40.",MULTISYSTEM DISEASE,PRIMARY SYSTEMIC AMYLOIDOSIS
725257987,5/23/2015 23:55:45,1642456868,5/23/2015 23:55:32,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.161,[PREVENTS] [LOCATION] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[LOCATION]
[NONE]",no,no,44,10,1,62,38,TWrex-cause,812871-FS1,"• Because PRIMARY SYSTEMIC AMYLOIDOSIS is a MULTISYSTEM DISEASE in most patients, it is important to recognize abnormal organ function/reserve before starting an aggressive treatment plan ( 39 ;  40.",MULTISYSTEM DISEASE,PRIMARY SYSTEMIC AMYLOIDOSIS
725257987,5/24/2015 00:24:14,1642469164,5/24/2015 00:24:03,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[IS_A],[IS_A],is a,n/a,44,10,1,62,38,TWrex-cause,812871-FS1,"• Because PRIMARY SYSTEMIC AMYLOIDOSIS is a MULTISYSTEM DISEASE in most patients, it is important to recognize abnormal organ function/reserve before starting an aggressive treatment plan ( 39 ;  40.",MULTISYSTEM DISEASE,PRIMARY SYSTEMIC AMYLOIDOSIS
725257987,5/24/2015 00:25:27,1642469637,5/24/2015 00:22:47,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[ASSOCIATED_WITH],[ASSOCIATED_WITH],is a,na,44,10,1,62,38,TWrex-cause,812871-FS1,"• Because PRIMARY SYSTEMIC AMYLOIDOSIS is a MULTISYSTEM DISEASE in most patients, it is important to recognize abnormal organ function/reserve before starting an aggressive treatment plan ( 39 ;  40.",MULTISYSTEM DISEASE,PRIMARY SYSTEMIC AMYLOIDOSIS
725257987,5/24/2015 00:37:02,1642474077,5/24/2015 00:36:19,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[IS_A],[IS_A],is a,N/A,44,10,1,62,38,TWrex-cause,812871-FS1,"• Because PRIMARY SYSTEMIC AMYLOIDOSIS is a MULTISYSTEM DISEASE in most patients, it is important to recognize abnormal organ function/reserve before starting an aggressive treatment plan ( 39 ;  40.",MULTISYSTEM DISEASE,PRIMARY SYSTEMIC AMYLOIDOSIS
725257987,5/24/2015 00:39:43,1642475158,5/24/2015 00:38:16,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[IS_A],[IS_A],is a,N/A,44,10,1,62,38,TWrex-cause,812871-FS1,"• Because PRIMARY SYSTEMIC AMYLOIDOSIS is a MULTISYSTEM DISEASE in most patients, it is important to recognize abnormal organ function/reserve before starting an aggressive treatment plan ( 39 ;  40.",MULTISYSTEM DISEASE,PRIMARY SYSTEMIC AMYLOIDOSIS
725257988,5/23/2015 22:18:08,1642410547,5/23/2015 22:17:37,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[IS_A] [PART_OF],"[IS_A]
[PART_OF]","Diarrhea, INFECTIOUS DIARRHEA",n/a,181,170,1,188,189,TWrex-cause,812992-FS1,"C]  Specific recommendation: • Obtain consultation with a gastroenterologist for colonoscopy and biopsies in patients with: ◊ Diarrhea, tenesmus, and bloody stools after INFECTIOUS DIARRHEA has been excluded with appropriate stool cultures ◊ Persistent DIARRHEA or tenesmus without a clear cause ◊ Extraintestinal rheumatologic or dermatologic manifestations.",DIARRHEA,INFECTIOUS DIARRHEA
725257988,5/23/2015 22:32:38,1642417774,5/23/2015 22:31:29,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[SYMPTOM],[SYMPTOM],"Diarrhea,",N/A,181,170,1,188,189,TWrex-cause,812992-FS1,"C]  Specific recommendation: • Obtain consultation with a gastroenterologist for colonoscopy and biopsies in patients with: ◊ Diarrhea, tenesmus, and bloody stools after INFECTIOUS DIARRHEA has been excluded with appropriate stool cultures ◊ Persistent DIARRHEA or tenesmus without a clear cause ◊ Extraintestinal rheumatologic or dermatologic manifestations.",DIARRHEA,INFECTIOUS DIARRHEA
725257988,5/23/2015 22:35:54,1642419335,5/23/2015 22:34:36,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[MANIFESTATION],[MANIFESTATION],INFECTIOUS DIARRHEA DIARRHEA without a clear cause manifestations.,N/A,181,170,1,188,189,TWrex-cause,812992-FS1,"C]  Specific recommendation: • Obtain consultation with a gastroenterologist for colonoscopy and biopsies in patients with: ◊ Diarrhea, tenesmus, and bloody stools after INFECTIOUS DIARRHEA has been excluded with appropriate stool cultures ◊ Persistent DIARRHEA or tenesmus without a clear cause ◊ Extraintestinal rheumatologic or dermatologic manifestations.",DIARRHEA,INFECTIOUS DIARRHEA
725257988,5/23/2015 22:36:30,1642419757,5/23/2015 22:35:49,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"Obtain consultation with gastroenterologist for colonoscopy biopsies in patients with: Diarrhea, tenesmus, bloody stools after INFECTIOUS DIARRHEA",n/a,181,170,1,188,189,TWrex-cause,812992-FS1,"C]  Specific recommendation: • Obtain consultation with a gastroenterologist for colonoscopy and biopsies in patients with: ◊ Diarrhea, tenesmus, and bloody stools after INFECTIOUS DIARRHEA has been excluded with appropriate stool cultures ◊ Persistent DIARRHEA or tenesmus without a clear cause ◊ Extraintestinal rheumatologic or dermatologic manifestations.",DIARRHEA,INFECTIOUS DIARRHEA
725257988,5/23/2015 22:36:41,1642419845,5/23/2015 22:35:19,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],with: Persistent,N/A,181,170,1,188,189,TWrex-cause,812992-FS1,"C]  Specific recommendation: • Obtain consultation with a gastroenterologist for colonoscopy and biopsies in patients with: ◊ Diarrhea, tenesmus, and bloody stools after INFECTIOUS DIARRHEA has been excluded with appropriate stool cultures ◊ Persistent DIARRHEA or tenesmus without a clear cause ◊ Extraintestinal rheumatologic or dermatologic manifestations.",DIARRHEA,INFECTIOUS DIARRHEA
725257988,5/23/2015 22:42:28,1642422921,5/23/2015 22:41:51,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[OTHER] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[OTHER]",INFECTIOUS DIARRHEA DIARRHEA,n/a,181,170,1,188,189,TWrex-cause,812992-FS1,"C]  Specific recommendation: • Obtain consultation with a gastroenterologist for colonoscopy and biopsies in patients with: ◊ Diarrhea, tenesmus, and bloody stools after INFECTIOUS DIARRHEA has been excluded with appropriate stool cultures ◊ Persistent DIARRHEA or tenesmus without a clear cause ◊ Extraintestinal rheumatologic or dermatologic manifestations.",DIARRHEA,INFECTIOUS DIARRHEA
725257988,5/23/2015 23:09:03,1642435858,5/23/2015 23:08:05,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[OTHER],[OTHER],Obtain consultation in patients with:,N/A,181,170,1,188,189,TWrex-cause,812992-FS1,"C]  Specific recommendation: • Obtain consultation with a gastroenterologist for colonoscopy and biopsies in patients with: ◊ Diarrhea, tenesmus, and bloody stools after INFECTIOUS DIARRHEA has been excluded with appropriate stool cultures ◊ Persistent DIARRHEA or tenesmus without a clear cause ◊ Extraintestinal rheumatologic or dermatologic manifestations.",DIARRHEA,INFECTIOUS DIARRHEA
725257988,5/23/2015 23:15:15,1642438472,5/23/2015 23:14:06,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[NONE],[NONE],n/a,they are just talking about different types of diarrhea and not specifically stating a relation between any of them,181,170,1,188,189,TWrex-cause,812992-FS1,"C]  Specific recommendation: • Obtain consultation with a gastroenterologist for colonoscopy and biopsies in patients with: ◊ Diarrhea, tenesmus, and bloody stools after INFECTIOUS DIARRHEA has been excluded with appropriate stool cultures ◊ Persistent DIARRHEA or tenesmus without a clear cause ◊ Extraintestinal rheumatologic or dermatologic manifestations.",DIARRHEA,INFECTIOUS DIARRHEA
725257988,5/23/2015 23:18:59,1642439971,5/23/2015 23:17:16,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],without a clear cause,none,181,170,1,188,189,TWrex-cause,812992-FS1,"C]  Specific recommendation: • Obtain consultation with a gastroenterologist for colonoscopy and biopsies in patients with: ◊ Diarrhea, tenesmus, and bloody stools after INFECTIOUS DIARRHEA has been excluded with appropriate stool cultures ◊ Persistent DIARRHEA or tenesmus without a clear cause ◊ Extraintestinal rheumatologic or dermatologic manifestations.",DIARRHEA,INFECTIOUS DIARRHEA
725257988,5/23/2015 23:22:37,1642441515,5/23/2015 23:22:09,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,181,170,1,188,189,TWrex-cause,812992-FS1,"C]  Specific recommendation: • Obtain consultation with a gastroenterologist for colonoscopy and biopsies in patients with: ◊ Diarrhea, tenesmus, and bloody stools after INFECTIOUS DIARRHEA has been excluded with appropriate stool cultures ◊ Persistent DIARRHEA or tenesmus without a clear cause ◊ Extraintestinal rheumatologic or dermatologic manifestations.",DIARRHEA,INFECTIOUS DIARRHEA
725257988,5/23/2015 23:23:23,1642441844,5/23/2015 23:22:11,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH] [MANIFESTATION],"[DIAGNOSE_BY_TEST_OR_DRUG]
[MANIFESTATION]
[ASSOCIATED_WITH]",colonoscopy biopsies in with: with cultures manifestations.,n/a,181,170,1,188,189,TWrex-cause,812992-FS1,"C]  Specific recommendation: • Obtain consultation with a gastroenterologist for colonoscopy and biopsies in patients with: ◊ Diarrhea, tenesmus, and bloody stools after INFECTIOUS DIARRHEA has been excluded with appropriate stool cultures ◊ Persistent DIARRHEA or tenesmus without a clear cause ◊ Extraintestinal rheumatologic or dermatologic manifestations.",DIARRHEA,INFECTIOUS DIARRHEA
725257988,5/23/2015 23:34:03,1642446704,5/23/2015 23:31:34,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[MANIFESTATION],[MANIFESTATION],manifestations.,N/A,181,170,1,188,189,TWrex-cause,812992-FS1,"C]  Specific recommendation: • Obtain consultation with a gastroenterologist for colonoscopy and biopsies in patients with: ◊ Diarrhea, tenesmus, and bloody stools after INFECTIOUS DIARRHEA has been excluded with appropriate stool cultures ◊ Persistent DIARRHEA or tenesmus without a clear cause ◊ Extraintestinal rheumatologic or dermatologic manifestations.",DIARRHEA,INFECTIOUS DIARRHEA
725257988,5/23/2015 23:43:20,1642451239,5/23/2015 23:42:58,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[SYMPTOM],[SYMPTOM],Persistent without a clear cause,n/a,181,170,1,188,189,TWrex-cause,812992-FS1,"C]  Specific recommendation: • Obtain consultation with a gastroenterologist for colonoscopy and biopsies in patients with: ◊ Diarrhea, tenesmus, and bloody stools after INFECTIOUS DIARRHEA has been excluded with appropriate stool cultures ◊ Persistent DIARRHEA or tenesmus without a clear cause ◊ Extraintestinal rheumatologic or dermatologic manifestations.",DIARRHEA,INFECTIOUS DIARRHEA
725257988,5/23/2015 23:52:03,1642455097,5/23/2015 23:51:47,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.161,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,181,170,1,188,189,TWrex-cause,812992-FS1,"C]  Specific recommendation: • Obtain consultation with a gastroenterologist for colonoscopy and biopsies in patients with: ◊ Diarrhea, tenesmus, and bloody stools after INFECTIOUS DIARRHEA has been excluded with appropriate stool cultures ◊ Persistent DIARRHEA or tenesmus without a clear cause ◊ Extraintestinal rheumatologic or dermatologic manifestations.",DIARRHEA,INFECTIOUS DIARRHEA
725257988,5/24/2015 00:13:27,1642464484,5/24/2015 00:11:51,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[CAUSES] [OTHER],"[CAUSES]
[OTHER]",without a clear cause,N/A,181,170,1,188,189,TWrex-cause,812992-FS1,"C]  Specific recommendation: • Obtain consultation with a gastroenterologist for colonoscopy and biopsies in patients with: ◊ Diarrhea, tenesmus, and bloody stools after INFECTIOUS DIARRHEA has been excluded with appropriate stool cultures ◊ Persistent DIARRHEA or tenesmus without a clear cause ◊ Extraintestinal rheumatologic or dermatologic manifestations.",DIARRHEA,INFECTIOUS DIARRHEA
725257989,5/23/2015 20:38:04,1642361669,5/23/2015 20:37:43,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[CONTRAINDICATES],[CONTRAINDICATES],resistant to,N/A,137,181,-1,166,190,TWrex-cause,803642-FS1,"2]  Horowitz LN, Spielman SR, Greenspan AM, Mintz GS, Morganroth J, Brown R, et al. Use of amiodarone in the treatment of persistent and PAROXYSMAL ATRIAL FIBRILLATION resistant to QUINIDINE therapy.",PAROXYSMAL ATRIAL FIBRILLATION,QUINIDINE
725257989,5/23/2015 20:46:24,1642366641,5/23/2015 20:46:08,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treatment of,n/a,137,181,-1,166,190,TWrex-cause,803642-FS1,"2]  Horowitz LN, Spielman SR, Greenspan AM, Mintz GS, Morganroth J, Brown R, et al. Use of amiodarone in the treatment of persistent and PAROXYSMAL ATRIAL FIBRILLATION resistant to QUINIDINE therapy.",PAROXYSMAL ATRIAL FIBRILLATION,QUINIDINE
725257989,5/23/2015 20:47:08,1642367026,5/23/2015 20:46:19,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CONTRAINDICATES],[CONTRAINDICATES],PAROXYSMAL ATRIAL FIBRILLATION resistant to QUINIDINE therapy.,N/A,137,181,-1,166,190,TWrex-cause,803642-FS1,"2]  Horowitz LN, Spielman SR, Greenspan AM, Mintz GS, Morganroth J, Brown R, et al. Use of amiodarone in the treatment of persistent and PAROXYSMAL ATRIAL FIBRILLATION resistant to QUINIDINE therapy.",PAROXYSMAL ATRIAL FIBRILLATION,QUINIDINE
725257989,5/23/2015 20:52:18,1642369935,5/23/2015 20:52:04,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],therapy.,n/a,137,181,-1,166,190,TWrex-cause,803642-FS1,"2]  Horowitz LN, Spielman SR, Greenspan AM, Mintz GS, Morganroth J, Brown R, et al. Use of amiodarone in the treatment of persistent and PAROXYSMAL ATRIAL FIBRILLATION resistant to QUINIDINE therapy.",PAROXYSMAL ATRIAL FIBRILLATION,QUINIDINE
725257989,5/23/2015 20:59:12,1642373355,5/23/2015 20:58:31,false,instagc,1.0,30880172,USA,CA,Los Angeles,166.170.50.98,[CONTRAINDICATES],[CONTRAINDICATES],resistant to,N/A,137,181,-1,166,190,TWrex-cause,803642-FS1,"2]  Horowitz LN, Spielman SR, Greenspan AM, Mintz GS, Morganroth J, Brown R, et al. Use of amiodarone in the treatment of persistent and PAROXYSMAL ATRIAL FIBRILLATION resistant to QUINIDINE therapy.",PAROXYSMAL ATRIAL FIBRILLATION,QUINIDINE
725257989,5/23/2015 21:01:01,1642374078,5/23/2015 21:00:31,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],treatment of,n/a,137,181,-1,166,190,TWrex-cause,803642-FS1,"2]  Horowitz LN, Spielman SR, Greenspan AM, Mintz GS, Morganroth J, Brown R, et al. Use of amiodarone in the treatment of persistent and PAROXYSMAL ATRIAL FIBRILLATION resistant to QUINIDINE therapy.",PAROXYSMAL ATRIAL FIBRILLATION,QUINIDINE
725257989,5/23/2015 21:05:06,1642375789,5/23/2015 21:04:34,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CONTRAINDICATES],[CONTRAINDICATES],PAROXYSMAL ATRIAL FIBRILLATION resistant to QUINIDINE therapy.,na,137,181,-1,166,190,TWrex-cause,803642-FS1,"2]  Horowitz LN, Spielman SR, Greenspan AM, Mintz GS, Morganroth J, Brown R, et al. Use of amiodarone in the treatment of persistent and PAROXYSMAL ATRIAL FIBRILLATION resistant to QUINIDINE therapy.",PAROXYSMAL ATRIAL FIBRILLATION,QUINIDINE
725257989,5/23/2015 21:09:46,1642378144,5/23/2015 21:09:21,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],resistant to,N/A,137,181,-1,166,190,TWrex-cause,803642-FS1,"2]  Horowitz LN, Spielman SR, Greenspan AM, Mintz GS, Morganroth J, Brown R, et al. Use of amiodarone in the treatment of persistent and PAROXYSMAL ATRIAL FIBRILLATION resistant to QUINIDINE therapy.",PAROXYSMAL ATRIAL FIBRILLATION,QUINIDINE
725257989,5/23/2015 21:40:18,1642393204,5/23/2015 21:39:50,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],treatment of,N/A,137,181,-1,166,190,TWrex-cause,803642-FS1,"2]  Horowitz LN, Spielman SR, Greenspan AM, Mintz GS, Morganroth J, Brown R, et al. Use of amiodarone in the treatment of persistent and PAROXYSMAL ATRIAL FIBRILLATION resistant to QUINIDINE therapy.",PAROXYSMAL ATRIAL FIBRILLATION,QUINIDINE
725257989,5/23/2015 21:51:17,1642398233,5/23/2015 21:50:23,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",Use of amiodarone in the treatment of persistent and PAROXYSMAL ATRIAL FIBRILLATION resistant to QUINIDINE therapy.,n/a,137,181,-1,166,190,TWrex-cause,803642-FS1,"2]  Horowitz LN, Spielman SR, Greenspan AM, Mintz GS, Morganroth J, Brown R, et al. Use of amiodarone in the treatment of persistent and PAROXYSMAL ATRIAL FIBRILLATION resistant to QUINIDINE therapy.",PAROXYSMAL ATRIAL FIBRILLATION,QUINIDINE
725257989,5/23/2015 21:51:22,1642398262,5/23/2015 21:51:01,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS] [OTHER],"[TREATS]
[OTHER]",resistant to therapy.,N/A,137,181,-1,166,190,TWrex-cause,803642-FS1,"2]  Horowitz LN, Spielman SR, Greenspan AM, Mintz GS, Morganroth J, Brown R, et al. Use of amiodarone in the treatment of persistent and PAROXYSMAL ATRIAL FIBRILLATION resistant to QUINIDINE therapy.",PAROXYSMAL ATRIAL FIBRILLATION,QUINIDINE
725257989,5/23/2015 21:53:44,1642399186,5/23/2015 21:53:07,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[OTHER],[OTHER],resistant to,N/A,137,181,-1,166,190,TWrex-cause,803642-FS1,"2]  Horowitz LN, Spielman SR, Greenspan AM, Mintz GS, Morganroth J, Brown R, et al. Use of amiodarone in the treatment of persistent and PAROXYSMAL ATRIAL FIBRILLATION resistant to QUINIDINE therapy.",PAROXYSMAL ATRIAL FIBRILLATION,QUINIDINE
725257989,5/23/2015 21:55:57,1642399998,5/23/2015 21:55:18,false,elite,1.0,30064988,GBR,B4,Bradford,92.22.135.10,[OTHER],[OTHER],resistant,N/A,137,181,-1,166,190,TWrex-cause,803642-FS1,"2]  Horowitz LN, Spielman SR, Greenspan AM, Mintz GS, Morganroth J, Brown R, et al. Use of amiodarone in the treatment of persistent and PAROXYSMAL ATRIAL FIBRILLATION resistant to QUINIDINE therapy.",PAROXYSMAL ATRIAL FIBRILLATION,QUINIDINE
725257989,5/23/2015 22:00:47,1642401882,5/23/2015 21:57:58,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[TREATS],[TREATS],to therapy.,n/a,137,181,-1,166,190,TWrex-cause,803642-FS1,"2]  Horowitz LN, Spielman SR, Greenspan AM, Mintz GS, Morganroth J, Brown R, et al. Use of amiodarone in the treatment of persistent and PAROXYSMAL ATRIAL FIBRILLATION resistant to QUINIDINE therapy.",PAROXYSMAL ATRIAL FIBRILLATION,QUINIDINE
725257989,5/23/2015 22:06:47,1642404842,5/23/2015 22:05:28,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],QUINIDINE therapy.,N/A,137,181,-1,166,190,TWrex-cause,803642-FS1,"2]  Horowitz LN, Spielman SR, Greenspan AM, Mintz GS, Morganroth J, Brown R, et al. Use of amiodarone in the treatment of persistent and PAROXYSMAL ATRIAL FIBRILLATION resistant to QUINIDINE therapy.",PAROXYSMAL ATRIAL FIBRILLATION,QUINIDINE
725257990,5/23/2015 23:31:49,1642445809,5/23/2015 23:31:32,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],therapy,N/A,211,306,-1,234,320,TWrex-cause,800136-FS1,"1  Pediatric Use  Safety and efficacy of insulin lispro in fixed combination with insulin lispro protamine not established in children   165  Insulin lispro has been used in children aged 3 18 years of age with TYPE 1 DIABETES MELLITUS  1 ,   51 ,   74   and preliminary data suggest no unusual effects of INSULIN LISPRO therapy in adolescents receiving the drug.",TYPE 1 DIABETES MELLITUS,INSULIN LISPRO
725257990,5/23/2015 23:34:36,1642446895,5/23/2015 23:34:09,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],therapy,none,211,306,-1,234,320,TWrex-cause,800136-FS1,"1  Pediatric Use  Safety and efficacy of insulin lispro in fixed combination with insulin lispro protamine not established in children   165  Insulin lispro has been used in children aged 3 18 years of age with TYPE 1 DIABETES MELLITUS  1 ,   51 ,   74   and preliminary data suggest no unusual effects of INSULIN LISPRO therapy in adolescents receiving the drug.",TYPE 1 DIABETES MELLITUS,INSULIN LISPRO
725257990,5/23/2015 23:42:10,1642450642,5/23/2015 23:41:21,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],used in therapy,N/A,211,306,-1,234,320,TWrex-cause,800136-FS1,"1  Pediatric Use  Safety and efficacy of insulin lispro in fixed combination with insulin lispro protamine not established in children   165  Insulin lispro has been used in children aged 3 18 years of age with TYPE 1 DIABETES MELLITUS  1 ,   51 ,   74   and preliminary data suggest no unusual effects of INSULIN LISPRO therapy in adolescents receiving the drug.",TYPE 1 DIABETES MELLITUS,INSULIN LISPRO
725257990,5/23/2015 23:48:15,1642453384,5/23/2015 23:47:55,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[SIDE_EFFECT],[SIDE_EFFECT],no unusual effects of,n/a,211,306,-1,234,320,TWrex-cause,800136-FS1,"1  Pediatric Use  Safety and efficacy of insulin lispro in fixed combination with insulin lispro protamine not established in children   165  Insulin lispro has been used in children aged 3 18 years of age with TYPE 1 DIABETES MELLITUS  1 ,   51 ,   74   and preliminary data suggest no unusual effects of INSULIN LISPRO therapy in adolescents receiving the drug.",TYPE 1 DIABETES MELLITUS,INSULIN LISPRO
725257990,5/23/2015 23:56:50,1642457317,5/23/2015 23:56:37,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.161,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,211,306,-1,234,320,TWrex-cause,800136-FS1,"1  Pediatric Use  Safety and efficacy of insulin lispro in fixed combination with insulin lispro protamine not established in children   165  Insulin lispro has been used in children aged 3 18 years of age with TYPE 1 DIABETES MELLITUS  1 ,   51 ,   74   and preliminary data suggest no unusual effects of INSULIN LISPRO therapy in adolescents receiving the drug.",TYPE 1 DIABETES MELLITUS,INSULIN LISPRO
725257990,5/24/2015 00:28:20,1642470614,5/24/2015 00:26:26,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],therapy,n/a,211,306,-1,234,320,TWrex-cause,800136-FS1,"1  Pediatric Use  Safety and efficacy of insulin lispro in fixed combination with insulin lispro protamine not established in children   165  Insulin lispro has been used in children aged 3 18 years of age with TYPE 1 DIABETES MELLITUS  1 ,   51 ,   74   and preliminary data suggest no unusual effects of INSULIN LISPRO therapy in adolescents receiving the drug.",TYPE 1 DIABETES MELLITUS,INSULIN LISPRO
725257990,5/24/2015 00:36:47,1642473993,5/24/2015 00:34:00,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[OTHER],[OTHER],INSULIN LISPRO therapy,na,211,306,-1,234,320,TWrex-cause,800136-FS1,"1  Pediatric Use  Safety and efficacy of insulin lispro in fixed combination with insulin lispro protamine not established in children   165  Insulin lispro has been used in children aged 3 18 years of age with TYPE 1 DIABETES MELLITUS  1 ,   51 ,   74   and preliminary data suggest no unusual effects of INSULIN LISPRO therapy in adolescents receiving the drug.",TYPE 1 DIABETES MELLITUS,INSULIN LISPRO
725257990,5/24/2015 00:41:44,1642476075,5/24/2015 00:40:34,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],efficacy of insulin lispro,N/A,211,306,-1,234,320,TWrex-cause,800136-FS1,"1  Pediatric Use  Safety and efficacy of insulin lispro in fixed combination with insulin lispro protamine not established in children   165  Insulin lispro has been used in children aged 3 18 years of age with TYPE 1 DIABETES MELLITUS  1 ,   51 ,   74   and preliminary data suggest no unusual effects of INSULIN LISPRO therapy in adolescents receiving the drug.",TYPE 1 DIABETES MELLITUS,INSULIN LISPRO
725257990,5/24/2015 00:41:53,1642476112,5/24/2015 00:41:30,false,elite,1.0,31848723,USA,VA,Manassas,192.96.205.155,[CAUSES],[CAUSES],TYPE DIABETES MELLITUS INSULIN LISPRO,N/A,211,306,-1,234,320,TWrex-cause,800136-FS1,"1  Pediatric Use  Safety and efficacy of insulin lispro in fixed combination with insulin lispro protamine not established in children   165  Insulin lispro has been used in children aged 3 18 years of age with TYPE 1 DIABETES MELLITUS  1 ,   51 ,   74   and preliminary data suggest no unusual effects of INSULIN LISPRO therapy in adolescents receiving the drug.",TYPE 1 DIABETES MELLITUS,INSULIN LISPRO
725257990,5/24/2015 00:51:10,1642479672,5/24/2015 00:50:12,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",suggest no unusual effects,N/A,211,306,-1,234,320,TWrex-cause,800136-FS1,"1  Pediatric Use  Safety and efficacy of insulin lispro in fixed combination with insulin lispro protamine not established in children   165  Insulin lispro has been used in children aged 3 18 years of age with TYPE 1 DIABETES MELLITUS  1 ,   51 ,   74   and preliminary data suggest no unusual effects of INSULIN LISPRO therapy in adolescents receiving the drug.",TYPE 1 DIABETES MELLITUS,INSULIN LISPRO
725257990,5/24/2015 01:28:10,1642491768,5/24/2015 01:26:07,false,clixsense,1.0,6375330,CAN,ON,Ottawa,209.195.106.138,[TREATS],[TREATS],therapy in adolescents,none,211,306,-1,234,320,TWrex-cause,800136-FS1,"1  Pediatric Use  Safety and efficacy of insulin lispro in fixed combination with insulin lispro protamine not established in children   165  Insulin lispro has been used in children aged 3 18 years of age with TYPE 1 DIABETES MELLITUS  1 ,   51 ,   74   and preliminary data suggest no unusual effects of INSULIN LISPRO therapy in adolescents receiving the drug.",TYPE 1 DIABETES MELLITUS,INSULIN LISPRO
725257990,5/24/2015 01:35:46,1642494026,5/24/2015 01:35:33,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],drug.,N/A,211,306,-1,234,320,TWrex-cause,800136-FS1,"1  Pediatric Use  Safety and efficacy of insulin lispro in fixed combination with insulin lispro protamine not established in children   165  Insulin lispro has been used in children aged 3 18 years of age with TYPE 1 DIABETES MELLITUS  1 ,   51 ,   74   and preliminary data suggest no unusual effects of INSULIN LISPRO therapy in adolescents receiving the drug.",TYPE 1 DIABETES MELLITUS,INSULIN LISPRO
725257990,5/24/2015 01:42:59,1642496631,5/24/2015 01:42:48,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[ASSOCIATED_WITH],[ASSOCIATED_WITH],combination,N/A,211,306,-1,234,320,TWrex-cause,800136-FS1,"1  Pediatric Use  Safety and efficacy of insulin lispro in fixed combination with insulin lispro protamine not established in children   165  Insulin lispro has been used in children aged 3 18 years of age with TYPE 1 DIABETES MELLITUS  1 ,   51 ,   74   and preliminary data suggest no unusual effects of INSULIN LISPRO therapy in adolescents receiving the drug.",TYPE 1 DIABETES MELLITUS,INSULIN LISPRO
725257990,5/24/2015 01:49:37,1642498820,5/24/2015 01:49:13,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],therapy,N/A,211,306,-1,234,320,TWrex-cause,800136-FS1,"1  Pediatric Use  Safety and efficacy of insulin lispro in fixed combination with insulin lispro protamine not established in children   165  Insulin lispro has been used in children aged 3 18 years of age with TYPE 1 DIABETES MELLITUS  1 ,   51 ,   74   and preliminary data suggest no unusual effects of INSULIN LISPRO therapy in adolescents receiving the drug.",TYPE 1 DIABETES MELLITUS,INSULIN LISPRO
725257990,5/24/2015 01:56:17,1642501237,5/24/2015 01:55:58,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[TREATS],[TREATS],therapy,N/A,211,306,-1,234,320,TWrex-cause,800136-FS1,"1  Pediatric Use  Safety and efficacy of insulin lispro in fixed combination with insulin lispro protamine not established in children   165  Insulin lispro has been used in children aged 3 18 years of age with TYPE 1 DIABETES MELLITUS  1 ,   51 ,   74   and preliminary data suggest no unusual effects of INSULIN LISPRO therapy in adolescents receiving the drug.",TYPE 1 DIABETES MELLITUS,INSULIN LISPRO
725257991,5/23/2015 21:44:07,1642395019,5/23/2015 21:43:25,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[PART_OF] [IS_A],"[IS_A]
[PART_OF]",are may be confused with,N/A,61,2,1,69,10,TWrex-cause,814414-FS1,• MIGRAINE and hemicrania continua are the two major primary HEADACHES that may be confused with tension type headache.,HEADACHES,MIGRAINE
725257991,5/23/2015 21:54:42,1642399577,5/23/2015 21:53:57,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[ASSOCIATED_WITH],[ASSOCIATED_WITH],are the primary,N/A,61,2,1,69,10,TWrex-cause,814414-FS1,• MIGRAINE and hemicrania continua are the two major primary HEADACHES that may be confused with tension type headache.,HEADACHES,MIGRAINE
725257991,5/23/2015 21:57:57,1642400744,5/23/2015 21:57:23,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[IS_A],[IS_A],are,N/A,61,2,1,69,10,TWrex-cause,814414-FS1,• MIGRAINE and hemicrania continua are the two major primary HEADACHES that may be confused with tension type headache.,HEADACHES,MIGRAINE
725257991,5/23/2015 21:58:14,1642400893,5/23/2015 21:57:22,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[MANIFESTATION],[MANIFESTATION],MIGRAINE and hemicrania continua are the two major primary HEADACHES that may be confused with tension type headache.,n/a,61,2,1,69,10,TWrex-cause,814414-FS1,• MIGRAINE and hemicrania continua are the two major primary HEADACHES that may be confused with tension type headache.,HEADACHES,MIGRAINE
725257991,5/23/2015 22:03:15,1642402955,5/23/2015 22:02:16,false,elite,1.0,30064988,GBR,B4,Bradford,92.22.135.10,[IS_A],[IS_A],major primary HEADACHES,N/A,61,2,1,69,10,TWrex-cause,814414-FS1,• MIGRAINE and hemicrania continua are the two major primary HEADACHES that may be confused with tension type headache.,HEADACHES,MIGRAINE
725257991,5/23/2015 22:09:45,1642406431,5/23/2015 22:09:32,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[IS_A],[IS_A],MIGRAINE primary HEADACHES,n/a,61,2,1,69,10,TWrex-cause,814414-FS1,• MIGRAINE and hemicrania continua are the two major primary HEADACHES that may be confused with tension type headache.,HEADACHES,MIGRAINE
725257991,5/23/2015 22:10:07,1642406612,5/23/2015 22:09:05,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[IS_A],[IS_A],MIGRAINE are HEADACHES,N/A,61,2,1,69,10,TWrex-cause,814414-FS1,• MIGRAINE and hemicrania continua are the two major primary HEADACHES that may be confused with tension type headache.,HEADACHES,MIGRAINE
725257991,5/23/2015 22:10:40,1642406890,5/23/2015 22:09:07,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[IS_A],[IS_A],are the two major primary,n/a,61,2,1,69,10,TWrex-cause,814414-FS1,• MIGRAINE and hemicrania continua are the two major primary HEADACHES that may be confused with tension type headache.,HEADACHES,MIGRAINE
725257991,5/23/2015 22:10:42,1642406898,5/23/2015 22:09:15,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[IS_A],[IS_A],are the two major primary,n/a,61,2,1,69,10,TWrex-cause,814414-FS1,• MIGRAINE and hemicrania continua are the two major primary HEADACHES that may be confused with tension type headache.,HEADACHES,MIGRAINE
725257991,5/23/2015 22:10:48,1642406965,5/23/2015 22:09:28,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[IS_A],[IS_A],are the major primary,N/A,61,2,1,69,10,TWrex-cause,814414-FS1,• MIGRAINE and hemicrania continua are the two major primary HEADACHES that may be confused with tension type headache.,HEADACHES,MIGRAINE
725257991,5/23/2015 22:20:03,1642411526,5/23/2015 22:19:35,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[PART_OF],[PART_OF],MIGRAINE are major primary HEADACHES,n/a,61,2,1,69,10,TWrex-cause,814414-FS1,• MIGRAINE and hemicrania continua are the two major primary HEADACHES that may be confused with tension type headache.,HEADACHES,MIGRAINE
725257991,5/23/2015 22:20:13,1642411549,5/23/2015 22:19:17,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[SYMPTOM],[SYMPTOM],MIGRAINE HEADACHES,N/A,61,2,1,69,10,TWrex-cause,814414-FS1,• MIGRAINE and hemicrania continua are the two major primary HEADACHES that may be confused with tension type headache.,HEADACHES,MIGRAINE
725257991,5/23/2015 22:26:05,1642414585,5/23/2015 22:25:32,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[SYMPTOM],[SYMPTOM],MIGRAINE and hemicrania continua are the two major primary HEADACHES that may be confused with tension type headache.,n/a,61,2,1,69,10,TWrex-cause,814414-FS1,• MIGRAINE and hemicrania continua are the two major primary HEADACHES that may be confused with tension type headache.,HEADACHES,MIGRAINE
725257991,5/23/2015 22:28:56,1642415843,5/23/2015 22:28:03,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[ASSOCIATED_WITH] [IS_A],"[ASSOCIATED_WITH]
[IS_A]",MIGRAINE and hemicrania two major primary HEADACHES,n/a,61,2,1,69,10,TWrex-cause,814414-FS1,• MIGRAINE and hemicrania continua are the two major primary HEADACHES that may be confused with tension type headache.,HEADACHES,MIGRAINE
725257991,5/23/2015 22:38:56,1642421099,5/23/2015 22:38:16,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",are the two major,N/A,61,2,1,69,10,TWrex-cause,814414-FS1,• MIGRAINE and hemicrania continua are the two major primary HEADACHES that may be confused with tension type headache.,HEADACHES,MIGRAINE
725257992,5/24/2015 00:39:55,1642475278,5/24/2015 00:39:41,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],treatment,n/a,93,38,-1,115,49,TWrex-cause,800535-FS1,"Larsen RA, Bozzette SA, Jones BE et alFLUCONAZOLE combined with flucytosine for treatment of CRYPTOCOCCAL MENINGITIS in patients with AIDS.",CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE
725257992,5/24/2015 00:48:22,1642478645,5/24/2015 00:48:04,false,elite,1.0,31848723,USA,VA,Manassas,192.96.205.155,[CAUSES],[CAUSES],alFLUCONAZOLE CRYPTOCOCCAL MENINGITIS,N/A,93,38,-1,115,49,TWrex-cause,800535-FS1,"Larsen RA, Bozzette SA, Jones BE et alFLUCONAZOLE combined with flucytosine for treatment of CRYPTOCOCCAL MENINGITIS in patients with AIDS.",CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE
725257992,5/24/2015 00:55:47,1642480975,5/24/2015 00:54:56,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[OTHER],[OTHER],treatment of CRYPTOCOCCAL MENINGITIS,NA,93,38,-1,115,49,TWrex-cause,800535-FS1,"Larsen RA, Bozzette SA, Jones BE et alFLUCONAZOLE combined with flucytosine for treatment of CRYPTOCOCCAL MENINGITIS in patients with AIDS.",CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE
725257992,5/24/2015 00:55:52,1642481063,5/24/2015 00:54:57,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,93,38,-1,115,49,TWrex-cause,800535-FS1,"Larsen RA, Bozzette SA, Jones BE et alFLUCONAZOLE combined with flucytosine for treatment of CRYPTOCOCCAL MENINGITIS in patients with AIDS.",CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE
725257992,5/24/2015 01:39:56,1642495470,5/24/2015 01:39:44,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],treatment,N/A,93,38,-1,115,49,TWrex-cause,800535-FS1,"Larsen RA, Bozzette SA, Jones BE et alFLUCONAZOLE combined with flucytosine for treatment of CRYPTOCOCCAL MENINGITIS in patients with AIDS.",CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE
725257992,5/24/2015 01:47:09,1642498001,5/24/2015 01:46:57,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],treatment,N/A,93,38,-1,115,49,TWrex-cause,800535-FS1,"Larsen RA, Bozzette SA, Jones BE et alFLUCONAZOLE combined with flucytosine for treatment of CRYPTOCOCCAL MENINGITIS in patients with AIDS.",CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE
725257992,5/24/2015 01:53:55,1642500342,5/24/2015 01:53:43,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],treatment,N/A,93,38,-1,115,49,TWrex-cause,800535-FS1,"Larsen RA, Bozzette SA, Jones BE et alFLUCONAZOLE combined with flucytosine for treatment of CRYPTOCOCCAL MENINGITIS in patients with AIDS.",CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE
725257992,5/24/2015 02:00:49,1642502532,5/24/2015 02:00:36,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[TREATS],[TREATS],treatment,N/A,93,38,-1,115,49,TWrex-cause,800535-FS1,"Larsen RA, Bozzette SA, Jones BE et alFLUCONAZOLE combined with flucytosine for treatment of CRYPTOCOCCAL MENINGITIS in patients with AIDS.",CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE
725257992,5/24/2015 02:08:27,1642504897,5/24/2015 02:08:16,false,elite,1,30654968,USA,OR,Portland,67.213.218.73,[TREATS],[TREATS],treatment,N/A,93,38,-1,115,49,TWrex-cause,800535-FS1,"Larsen RA, Bozzette SA, Jones BE et alFLUCONAZOLE combined with flucytosine for treatment of CRYPTOCOCCAL MENINGITIS in patients with AIDS.",CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE
725257992,5/24/2015 02:22:41,1642509773,5/24/2015 02:21:16,false,prodege,1,17379068,CAN,NB,Saint John,142.162.106.83,[ASSOCIATED_WITH],[ASSOCIATED_WITH],treatment,N/A,93,38,-1,115,49,TWrex-cause,800535-FS1,"Larsen RA, Bozzette SA, Jones BE et alFLUCONAZOLE combined with flucytosine for treatment of CRYPTOCOCCAL MENINGITIS in patients with AIDS.",CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE
725257992,5/24/2015 02:34:39,1642513359,5/24/2015 02:34:26,false,elite,1,32306791,USA,DE,Wilmington,199.58.86.213,[SYMPTOM],[SYMPTOM],alFLUCONAZOLE CRYPTOCOCCAL,N/A,93,38,-1,115,49,TWrex-cause,800535-FS1,"Larsen RA, Bozzette SA, Jones BE et alFLUCONAZOLE combined with flucytosine for treatment of CRYPTOCOCCAL MENINGITIS in patients with AIDS.",CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE
725257992,5/24/2015 02:37:28,1642514214,5/24/2015 02:37:16,false,elite,1,31913360,USA,VA,Manassas,207.244.77.3,[LOCATION],[LOCATION],treatment,hjj,93,38,-1,115,49,TWrex-cause,800535-FS1,"Larsen RA, Bozzette SA, Jones BE et alFLUCONAZOLE combined with flucytosine for treatment of CRYPTOCOCCAL MENINGITIS in patients with AIDS.",CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE
725257992,5/24/2015 02:56:05,1642519494,5/24/2015 02:55:38,false,clixsense,1,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],alFLUCONAZOLE combined with flucytosine for treatment of CRYPTOCOCCAL MENINGITIS,N/A,93,38,-1,115,49,TWrex-cause,800535-FS1,"Larsen RA, Bozzette SA, Jones BE et alFLUCONAZOLE combined with flucytosine for treatment of CRYPTOCOCCAL MENINGITIS in patients with AIDS.",CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE
725257992,5/24/2015 03:05:34,1642522457,5/24/2015 03:04:47,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[ASSOCIATED_WITH] [TREATS],"[TREATS]
[ASSOCIATED_WITH]",with treatment of,n/a,93,38,-1,115,49,TWrex-cause,800535-FS1,"Larsen RA, Bozzette SA, Jones BE et alFLUCONAZOLE combined with flucytosine for treatment of CRYPTOCOCCAL MENINGITIS in patients with AIDS.",CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE
725257992,5/24/2015 03:32:27,1642529744,5/24/2015 03:31:59,false,neodev,1,32216655,NLD,07,Amsterdam,145.100.72.168,[TREATS],[TREATS],for treatment of CRYPTOCOCCAL,n/a,93,38,-1,115,49,TWrex-cause,800535-FS1,"Larsen RA, Bozzette SA, Jones BE et alFLUCONAZOLE combined with flucytosine for treatment of CRYPTOCOCCAL MENINGITIS in patients with AIDS.",CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE
725257993,5/23/2015 23:33:11,1642446394,5/23/2015 23:32:57,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],cause,N/A,81,0,1,89,12,TWrex-cause,812999-FS1,"FIBROMYALGIA is a common nonarticular disorder of unknown cause characterized by ACHY PAIN tenderness, and stiffness of muscles, areas of tendon insertions, and adjacent soft tissues.",ACHY PAIN,FIBROMYALGIA
725257993,5/23/2015 23:38:04,1642448512,5/23/2015 23:36:59,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],cause,none,81,0,1,89,12,TWrex-cause,812999-FS1,"FIBROMYALGIA is a common nonarticular disorder of unknown cause characterized by ACHY PAIN tenderness, and stiffness of muscles, areas of tendon insertions, and adjacent soft tissues.",ACHY PAIN,FIBROMYALGIA
725257993,5/23/2015 23:44:45,1642451905,5/23/2015 23:44:16,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[SYMPTOM],[SYMPTOM],characterized,N/A,81,0,1,89,12,TWrex-cause,812999-FS1,"FIBROMYALGIA is a common nonarticular disorder of unknown cause characterized by ACHY PAIN tenderness, and stiffness of muscles, areas of tendon insertions, and adjacent soft tissues.",ACHY PAIN,FIBROMYALGIA
725257993,5/23/2015 23:49:19,1642453870,5/23/2015 23:49:04,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[SYMPTOM],[SYMPTOM],characterized by,n/a,81,0,1,89,12,TWrex-cause,812999-FS1,"FIBROMYALGIA is a common nonarticular disorder of unknown cause characterized by ACHY PAIN tenderness, and stiffness of muscles, areas of tendon insertions, and adjacent soft tissues.",ACHY PAIN,FIBROMYALGIA
725257993,5/23/2015 23:57:41,1642457751,5/23/2015 23:57:33,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.161,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,81,0,1,89,12,TWrex-cause,812999-FS1,"FIBROMYALGIA is a common nonarticular disorder of unknown cause characterized by ACHY PAIN tenderness, and stiffness of muscles, areas of tendon insertions, and adjacent soft tissues.",ACHY PAIN,FIBROMYALGIA
725257993,5/24/2015 00:32:44,1642472175,5/24/2015 00:32:27,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[MANIFESTATION],[MANIFESTATION],characterized by,n/a,81,0,1,89,12,TWrex-cause,812999-FS1,"FIBROMYALGIA is a common nonarticular disorder of unknown cause characterized by ACHY PAIN tenderness, and stiffness of muscles, areas of tendon insertions, and adjacent soft tissues.",ACHY PAIN,FIBROMYALGIA
725257993,5/24/2015 00:39:32,1642475094,5/24/2015 00:38:50,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[OTHER],[OTHER],characterized by ACHY PAIN,na,81,0,1,89,12,TWrex-cause,812999-FS1,"FIBROMYALGIA is a common nonarticular disorder of unknown cause characterized by ACHY PAIN tenderness, and stiffness of muscles, areas of tendon insertions, and adjacent soft tissues.",ACHY PAIN,FIBROMYALGIA
725257993,5/24/2015 00:43:13,1642476722,5/24/2015 00:42:54,false,elite,1.0,31848723,USA,VA,Manassas,192.96.205.155,[CAUSES],[CAUSES],FIBROMYALGIA ACHY PAIN,N/A,81,0,1,89,12,TWrex-cause,812999-FS1,"FIBROMYALGIA is a common nonarticular disorder of unknown cause characterized by ACHY PAIN tenderness, and stiffness of muscles, areas of tendon insertions, and adjacent soft tissues.",ACHY PAIN,FIBROMYALGIA
725257993,5/24/2015 00:44:55,1642477346,5/24/2015 00:43:55,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[SYMPTOM],[SYMPTOM],characterized by,N/A,81,0,1,89,12,TWrex-cause,812999-FS1,"FIBROMYALGIA is a common nonarticular disorder of unknown cause characterized by ACHY PAIN tenderness, and stiffness of muscles, areas of tendon insertions, and adjacent soft tissues.",ACHY PAIN,FIBROMYALGIA
725257993,5/24/2015 00:59:19,1642482247,5/24/2015 00:57:45,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH] [CAUSES],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[ASSOCIATED_WITH]",cause characterized by,N/A,81,0,1,89,12,TWrex-cause,812999-FS1,"FIBROMYALGIA is a common nonarticular disorder of unknown cause characterized by ACHY PAIN tenderness, and stiffness of muscles, areas of tendon insertions, and adjacent soft tissues.",ACHY PAIN,FIBROMYALGIA
725257993,5/24/2015 01:32:54,1642493035,5/24/2015 01:32:13,false,clixsense,1.0,6375330,CAN,ON,Ottawa,209.195.106.138,[MANIFESTATION],[MANIFESTATION],characterized by,none,81,0,1,89,12,TWrex-cause,812999-FS1,"FIBROMYALGIA is a common nonarticular disorder of unknown cause characterized by ACHY PAIN tenderness, and stiffness of muscles, areas of tendon insertions, and adjacent soft tissues.",ACHY PAIN,FIBROMYALGIA
725257993,5/24/2015 01:36:40,1642494341,5/24/2015 01:36:29,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[CAUSES],[CAUSES],cause,N/A,81,0,1,89,12,TWrex-cause,812999-FS1,"FIBROMYALGIA is a common nonarticular disorder of unknown cause characterized by ACHY PAIN tenderness, and stiffness of muscles, areas of tendon insertions, and adjacent soft tissues.",ACHY PAIN,FIBROMYALGIA
725257993,5/24/2015 01:43:51,1642496957,5/24/2015 01:43:41,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[CAUSES],[CAUSES],cause,N/A,81,0,1,89,12,TWrex-cause,812999-FS1,"FIBROMYALGIA is a common nonarticular disorder of unknown cause characterized by ACHY PAIN tenderness, and stiffness of muscles, areas of tendon insertions, and adjacent soft tissues.",ACHY PAIN,FIBROMYALGIA
725257993,5/24/2015 01:50:38,1642499186,5/24/2015 01:50:25,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[CAUSES],[CAUSES],cause,N/A,81,0,1,89,12,TWrex-cause,812999-FS1,"FIBROMYALGIA is a common nonarticular disorder of unknown cause characterized by ACHY PAIN tenderness, and stiffness of muscles, areas of tendon insertions, and adjacent soft tissues.",ACHY PAIN,FIBROMYALGIA
725257993,5/24/2015 01:57:05,1642501517,5/24/2015 01:56:51,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[CAUSES],[CAUSES],cause,N/A,81,0,1,89,12,TWrex-cause,812999-FS1,"FIBROMYALGIA is a common nonarticular disorder of unknown cause characterized by ACHY PAIN tenderness, and stiffness of muscles, areas of tendon insertions, and adjacent soft tissues.",ACHY PAIN,FIBROMYALGIA
725257994,5/23/2015 20:38:57,1642362193,5/23/2015 20:38:15,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],in patient with,N/A,177,134,-1,196,144,TWrex-cause,803408-FS1,"Hewitt RG, Morse GD, Lawrence WD et al. Pharmacokinetics and pharmacodynamics of granulocyte macrophage colony stimulating factor and ZIDOVUDINE in patient with AIDS and severe AIDS RELATED COMPLEX.",AIDS RELATED COMPLEX,ZIDOVUDINE
725257994,5/23/2015 20:46:41,1642366748,5/23/2015 20:46:25,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],stimulating factor,n/a,177,134,-1,196,144,TWrex-cause,803408-FS1,"Hewitt RG, Morse GD, Lawrence WD et al. Pharmacokinetics and pharmacodynamics of granulocyte macrophage colony stimulating factor and ZIDOVUDINE in patient with AIDS and severe AIDS RELATED COMPLEX.",AIDS RELATED COMPLEX,ZIDOVUDINE
725257994,5/23/2015 20:47:57,1642367572,5/23/2015 20:47:09,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],ZIDOVUDINE in patient with AIDS RELATED COMPLEX.,N/A,177,134,-1,196,144,TWrex-cause,803408-FS1,"Hewitt RG, Morse GD, Lawrence WD et al. Pharmacokinetics and pharmacodynamics of granulocyte macrophage colony stimulating factor and ZIDOVUDINE in patient with AIDS and severe AIDS RELATED COMPLEX.",AIDS RELATED COMPLEX,ZIDOVUDINE
725257994,5/23/2015 20:52:43,1642370201,5/23/2015 20:52:22,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],in patient with,n/a,177,134,-1,196,144,TWrex-cause,803408-FS1,"Hewitt RG, Morse GD, Lawrence WD et al. Pharmacokinetics and pharmacodynamics of granulocyte macrophage colony stimulating factor and ZIDOVUDINE in patient with AIDS and severe AIDS RELATED COMPLEX.",AIDS RELATED COMPLEX,ZIDOVUDINE
725257994,5/23/2015 21:00:21,1642373786,5/23/2015 20:59:13,false,instagc,1.0,30880172,USA,CA,Los Angeles,166.170.50.98,[ASSOCIATED_WITH],[ASSOCIATED_WITH],stimulating factor in patient with,N/A,177,134,-1,196,144,TWrex-cause,803408-FS1,"Hewitt RG, Morse GD, Lawrence WD et al. Pharmacokinetics and pharmacodynamics of granulocyte macrophage colony stimulating factor and ZIDOVUDINE in patient with AIDS and severe AIDS RELATED COMPLEX.",AIDS RELATED COMPLEX,ZIDOVUDINE
725257994,5/23/2015 21:01:39,1642374457,5/23/2015 21:01:05,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],stimulating factor and in patient,n/a,177,134,-1,196,144,TWrex-cause,803408-FS1,"Hewitt RG, Morse GD, Lawrence WD et al. Pharmacokinetics and pharmacodynamics of granulocyte macrophage colony stimulating factor and ZIDOVUDINE in patient with AIDS and severe AIDS RELATED COMPLEX.",AIDS RELATED COMPLEX,ZIDOVUDINE
725257994,5/23/2015 21:06:34,1642376550,5/23/2015 21:05:08,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],ZIDOVUDINE in patient with AIDS RELATED COMPLEX.,na,177,134,-1,196,144,TWrex-cause,803408-FS1,"Hewitt RG, Morse GD, Lawrence WD et al. Pharmacokinetics and pharmacodynamics of granulocyte macrophage colony stimulating factor and ZIDOVUDINE in patient with AIDS and severe AIDS RELATED COMPLEX.",AIDS RELATED COMPLEX,ZIDOVUDINE
725257994,5/23/2015 21:10:39,1642378614,5/23/2015 21:09:50,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],in patient with,N/A,177,134,-1,196,144,TWrex-cause,803408-FS1,"Hewitt RG, Morse GD, Lawrence WD et al. Pharmacokinetics and pharmacodynamics of granulocyte macrophage colony stimulating factor and ZIDOVUDINE in patient with AIDS and severe AIDS RELATED COMPLEX.",AIDS RELATED COMPLEX,ZIDOVUDINE
725257994,5/23/2015 21:41:00,1642393480,5/23/2015 21:40:19,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",stimulating,N/A,177,134,-1,196,144,TWrex-cause,803408-FS1,"Hewitt RG, Morse GD, Lawrence WD et al. Pharmacokinetics and pharmacodynamics of granulocyte macrophage colony stimulating factor and ZIDOVUDINE in patient with AIDS and severe AIDS RELATED COMPLEX.",AIDS RELATED COMPLEX,ZIDOVUDINE
725257994,5/23/2015 21:52:03,1642398536,5/23/2015 21:51:24,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]",in patient with,N/A,177,134,-1,196,144,TWrex-cause,803408-FS1,"Hewitt RG, Morse GD, Lawrence WD et al. Pharmacokinetics and pharmacodynamics of granulocyte macrophage colony stimulating factor and ZIDOVUDINE in patient with AIDS and severe AIDS RELATED COMPLEX.",AIDS RELATED COMPLEX,ZIDOVUDINE
725257994,5/23/2015 21:52:36,1642398723,5/23/2015 21:51:18,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[OTHER],[OTHER],Pharmacokinetics and pharmacodynamics of granulocyte macrophage colony stimulating factor and ZIDOVUDINE in patient with AIDS and severe AIDS RELATED COMPLEX.,n/a,177,134,-1,196,144,TWrex-cause,803408-FS1,"Hewitt RG, Morse GD, Lawrence WD et al. Pharmacokinetics and pharmacodynamics of granulocyte macrophage colony stimulating factor and ZIDOVUDINE in patient with AIDS and severe AIDS RELATED COMPLEX.",AIDS RELATED COMPLEX,ZIDOVUDINE
725257994,5/23/2015 21:54:40,1642399574,5/23/2015 21:53:45,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[OTHER],[OTHER],in patient with,N/A,177,134,-1,196,144,TWrex-cause,803408-FS1,"Hewitt RG, Morse GD, Lawrence WD et al. Pharmacokinetics and pharmacodynamics of granulocyte macrophage colony stimulating factor and ZIDOVUDINE in patient with AIDS and severe AIDS RELATED COMPLEX.",AIDS RELATED COMPLEX,ZIDOVUDINE
725257994,5/23/2015 21:57:15,1642400467,5/23/2015 21:56:00,false,elite,1.0,30064988,GBR,B4,Bradford,92.22.135.10,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,177,134,-1,196,144,TWrex-cause,803408-FS1,"Hewitt RG, Morse GD, Lawrence WD et al. Pharmacokinetics and pharmacodynamics of granulocyte macrophage colony stimulating factor and ZIDOVUDINE in patient with AIDS and severe AIDS RELATED COMPLEX.",AIDS RELATED COMPLEX,ZIDOVUDINE
725257994,5/23/2015 22:02:37,1642402661,5/23/2015 22:00:53,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],stimulating factor in,n/a,177,134,-1,196,144,TWrex-cause,803408-FS1,"Hewitt RG, Morse GD, Lawrence WD et al. Pharmacokinetics and pharmacodynamics of granulocyte macrophage colony stimulating factor and ZIDOVUDINE in patient with AIDS and severe AIDS RELATED COMPLEX.",AIDS RELATED COMPLEX,ZIDOVUDINE
725257994,5/23/2015 22:06:42,1642404743,5/23/2015 22:05:27,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],pharmacodynamics of ZIDOVUDINE in patient with AIDS RELATED COMPLEX.,N/A,177,134,-1,196,144,TWrex-cause,803408-FS1,"Hewitt RG, Morse GD, Lawrence WD et al. Pharmacokinetics and pharmacodynamics of granulocyte macrophage colony stimulating factor and ZIDOVUDINE in patient with AIDS and severe AIDS RELATED COMPLEX.",AIDS RELATED COMPLEX,ZIDOVUDINE
725257995,5/23/2015 22:20:28,1642411656,5/23/2015 22:20:15,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],STABLE SUSTAINED VT can be treated with LIDOCAINE,n/a,0,58,-1,18,67,TWrex-cause,803409-FS1,"STABLE SUSTAINED VT can be treated with IV drugs, usually LIDOCAINE (see  Table 75 2 ), which acts quickly but is frequently ineffective.",STABLE SUSTAINED VT,LIDOCAINE
725257995,5/23/2015 22:35:53,1642419332,5/23/2015 22:35:23,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],STABLE SUSTAINED VT,N/A,0,58,-1,18,67,TWrex-cause,803409-FS1,"STABLE SUSTAINED VT can be treated with IV drugs, usually LIDOCAINE (see  Table 75 2 ), which acts quickly but is frequently ineffective.",STABLE SUSTAINED VT,LIDOCAINE
725257995,5/23/2015 22:39:26,1642421302,5/23/2015 22:39:07,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],"STABLE SUSTAINED VT can be treated with IV drugs, usually LIDOCAINE",n/a,0,58,-1,18,67,TWrex-cause,803409-FS1,"STABLE SUSTAINED VT can be treated with IV drugs, usually LIDOCAINE (see  Table 75 2 ), which acts quickly but is frequently ineffective.",STABLE SUSTAINED VT,LIDOCAINE
725257995,5/23/2015 22:42:58,1642423165,5/23/2015 22:42:04,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],STABLE SUSTAINED VT can be treated with LIDOCAINE,N/A,0,58,-1,18,67,TWrex-cause,803409-FS1,"STABLE SUSTAINED VT can be treated with IV drugs, usually LIDOCAINE (see  Table 75 2 ), which acts quickly but is frequently ineffective.",STABLE SUSTAINED VT,LIDOCAINE
725257995,5/23/2015 22:45:24,1642424307,5/23/2015 22:45:06,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[TREATS],[TREATS],STABLE SUSTAINED VT can be treated with LIDOCAINE,n/a,0,58,-1,18,67,TWrex-cause,803409-FS1,"STABLE SUSTAINED VT can be treated with IV drugs, usually LIDOCAINE (see  Table 75 2 ), which acts quickly but is frequently ineffective.",STABLE SUSTAINED VT,LIDOCAINE
725257995,5/23/2015 22:45:45,1642424506,5/23/2015 22:44:22,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treated,N/A,0,58,-1,18,67,TWrex-cause,803409-FS1,"STABLE SUSTAINED VT can be treated with IV drugs, usually LIDOCAINE (see  Table 75 2 ), which acts quickly but is frequently ineffective.",STABLE SUSTAINED VT,LIDOCAINE
725257995,5/23/2015 23:14:26,1642438147,5/23/2015 23:13:02,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[TREATS],[TREATS],treated with,N/A,0,58,-1,18,67,TWrex-cause,803409-FS1,"STABLE SUSTAINED VT can be treated with IV drugs, usually LIDOCAINE (see  Table 75 2 ), which acts quickly but is frequently ineffective.",STABLE SUSTAINED VT,LIDOCAINE
725257995,5/23/2015 23:18:19,1642439652,5/23/2015 23:17:46,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[TREATS],[TREATS],treated,n/a,0,58,-1,18,67,TWrex-cause,803409-FS1,"STABLE SUSTAINED VT can be treated with IV drugs, usually LIDOCAINE (see  Table 75 2 ), which acts quickly but is frequently ineffective.",STABLE SUSTAINED VT,LIDOCAINE
725257995,5/23/2015 23:25:10,1642442668,5/23/2015 23:23:39,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],treated,none,0,58,-1,18,67,TWrex-cause,803409-FS1,"STABLE SUSTAINED VT can be treated with IV drugs, usually LIDOCAINE (see  Table 75 2 ), which acts quickly but is frequently ineffective.",STABLE SUSTAINED VT,LIDOCAINE
725257995,5/23/2015 23:27:30,1642443684,5/23/2015 23:26:31,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treated,N/A,0,58,-1,18,67,TWrex-cause,803409-FS1,"STABLE SUSTAINED VT can be treated with IV drugs, usually LIDOCAINE (see  Table 75 2 ), which acts quickly but is frequently ineffective.",STABLE SUSTAINED VT,LIDOCAINE
725257995,5/23/2015 23:29:13,1642444524,5/23/2015 23:28:34,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[TREATS] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]",treated with,n/a,0,58,-1,18,67,TWrex-cause,803409-FS1,"STABLE SUSTAINED VT can be treated with IV drugs, usually LIDOCAINE (see  Table 75 2 ), which acts quickly but is frequently ineffective.",STABLE SUSTAINED VT,LIDOCAINE
725257995,5/23/2015 23:37:34,1642448301,5/23/2015 23:37:00,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[CONTRAINDICATES] [TREATS],"[TREATS]
[CONTRAINDICATES]",treated,N/A,0,58,-1,18,67,TWrex-cause,803409-FS1,"STABLE SUSTAINED VT can be treated with IV drugs, usually LIDOCAINE (see  Table 75 2 ), which acts quickly but is frequently ineffective.",STABLE SUSTAINED VT,LIDOCAINE
725257995,5/23/2015 23:45:49,1642452433,5/23/2015 23:45:28,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[TREATS],[TREATS],treated,n/a,0,58,-1,18,67,TWrex-cause,803409-FS1,"STABLE SUSTAINED VT can be treated with IV drugs, usually LIDOCAINE (see  Table 75 2 ), which acts quickly but is frequently ineffective.",STABLE SUSTAINED VT,LIDOCAINE
725257995,5/23/2015 23:54:49,1642456370,5/23/2015 23:54:30,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.161,[PREVENTS] [CAUSES] [LOCATION] [NONE],"[PREVENTS]
[CAUSES]
[LOCATION]
[NONE]",no,no,0,58,-1,18,67,TWrex-cause,803409-FS1,"STABLE SUSTAINED VT can be treated with IV drugs, usually LIDOCAINE (see  Table 75 2 ), which acts quickly but is frequently ineffective.",STABLE SUSTAINED VT,LIDOCAINE
725257995,5/24/2015 00:16:40,1642465734,5/24/2015 00:14:08,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[TREATS],[TREATS],can be treated,N/A,0,58,-1,18,67,TWrex-cause,803409-FS1,"STABLE SUSTAINED VT can be treated with IV drugs, usually LIDOCAINE (see  Table 75 2 ), which acts quickly but is frequently ineffective.",STABLE SUSTAINED VT,LIDOCAINE
725257996,5/23/2015 22:19:50,1642411463,5/23/2015 22:19:38,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],alDRONABINOL as a treatment for ANOREXIA,n/a,67,37,-1,74,47,TWrex-cause,800659-FS1,"Beal JE, Olson R, Laubenstein L et alDRONABINOL as a treatment for ANOREXIA associated with weight loss in patients with AIDS.",ANOREXIA,DRONABINOL
725257996,5/23/2015 22:35:03,1642418916,5/23/2015 22:34:16,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],ANOREXIA,N/A,67,37,-1,74,47,TWrex-cause,800659-FS1,"Beal JE, Olson R, Laubenstein L et alDRONABINOL as a treatment for ANOREXIA associated with weight loss in patients with AIDS.",ANOREXIA,DRONABINOL
725257996,5/23/2015 22:38:35,1642420806,5/23/2015 22:38:15,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],alDRONABINOL as treatment for ANOREXIA associated with weight loss in patients with AIDS.,n/a,67,37,-1,74,47,TWrex-cause,800659-FS1,"Beal JE, Olson R, Laubenstein L et alDRONABINOL as a treatment for ANOREXIA associated with weight loss in patients with AIDS.",ANOREXIA,DRONABINOL
725257996,5/23/2015 22:40:32,1642421896,5/23/2015 22:39:31,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],alDRONABINOL as treatment for ANOREXIA,N/A,67,37,-1,74,47,TWrex-cause,800659-FS1,"Beal JE, Olson R, Laubenstein L et alDRONABINOL as a treatment for ANOREXIA associated with weight loss in patients with AIDS.",ANOREXIA,DRONABINOL
725257996,5/23/2015 22:43:02,1642423194,5/23/2015 22:41:42,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treatment,N/A,67,37,-1,74,47,TWrex-cause,800659-FS1,"Beal JE, Olson R, Laubenstein L et alDRONABINOL as a treatment for ANOREXIA associated with weight loss in patients with AIDS.",ANOREXIA,DRONABINOL
725257996,5/23/2015 22:44:39,1642423918,5/23/2015 22:44:17,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[TREATS],[TREATS],alDRONABINOL treatment for ANOREXIA,na,67,37,-1,74,47,TWrex-cause,800659-FS1,"Beal JE, Olson R, Laubenstein L et alDRONABINOL as a treatment for ANOREXIA associated with weight loss in patients with AIDS.",ANOREXIA,DRONABINOL
725257996,5/23/2015 23:12:29,1642437324,5/23/2015 23:12:05,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[TREATS],[TREATS],treatment for,N/A,67,37,-1,74,47,TWrex-cause,800659-FS1,"Beal JE, Olson R, Laubenstein L et alDRONABINOL as a treatment for ANOREXIA associated with weight loss in patients with AIDS.",ANOREXIA,DRONABINOL
725257996,5/23/2015 23:17:16,1642439270,5/23/2015 23:17:02,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[TREATS],[TREATS],treatment,n/a,67,37,-1,74,47,TWrex-cause,800659-FS1,"Beal JE, Olson R, Laubenstein L et alDRONABINOL as a treatment for ANOREXIA associated with weight loss in patients with AIDS.",ANOREXIA,DRONABINOL
725257996,5/23/2015 23:22:50,1642441621,5/23/2015 23:22:31,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],treatment,none,67,37,-1,74,47,TWrex-cause,800659-FS1,"Beal JE, Olson R, Laubenstein L et alDRONABINOL as a treatment for ANOREXIA associated with weight loss in patients with AIDS.",ANOREXIA,DRONABINOL
725257996,5/23/2015 23:25:48,1642442930,5/23/2015 23:25:13,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,67,37,-1,74,47,TWrex-cause,800659-FS1,"Beal JE, Olson R, Laubenstein L et alDRONABINOL as a treatment for ANOREXIA associated with weight loss in patients with AIDS.",ANOREXIA,DRONABINOL
725257996,5/23/2015 23:27:46,1642443843,5/23/2015 23:27:06,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[TREATS] [ASSOCIATED_WITH] [IS_A],"[TREATS]
[ASSOCIATED_WITH]
[IS_A]",a treatment for associated with in with,n/a,67,37,-1,74,47,TWrex-cause,800659-FS1,"Beal JE, Olson R, Laubenstein L et alDRONABINOL as a treatment for ANOREXIA associated with weight loss in patients with AIDS.",ANOREXIA,DRONABINOL
725257996,5/23/2015 23:36:32,1642447754,5/23/2015 23:35:45,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[PREVENTS],[PREVENTS],treatment,N/A,67,37,-1,74,47,TWrex-cause,800659-FS1,"Beal JE, Olson R, Laubenstein L et alDRONABINOL as a treatment for ANOREXIA associated with weight loss in patients with AIDS.",ANOREXIA,DRONABINOL
725257996,5/23/2015 23:44:54,1642451947,5/23/2015 23:44:42,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[TREATS],[TREATS],treatment for,n/a,67,37,-1,74,47,TWrex-cause,800659-FS1,"Beal JE, Olson R, Laubenstein L et alDRONABINOL as a treatment for ANOREXIA associated with weight loss in patients with AIDS.",ANOREXIA,DRONABINOL
725257996,5/23/2015 23:53:56,1642456002,5/23/2015 23:53:25,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.161,[PREVENTS] [CAUSES] [LOCATION] [NONE],"[PREVENTS]
[CAUSES]
[LOCATION]
[NONE]",no,no,67,37,-1,74,47,TWrex-cause,800659-FS1,"Beal JE, Olson R, Laubenstein L et alDRONABINOL as a treatment for ANOREXIA associated with weight loss in patients with AIDS.",ANOREXIA,DRONABINOL
725257996,5/24/2015 00:12:29,1642464057,5/24/2015 00:12:13,false,neodev,1,30749660,USA,NC,Durham,24.211.188.217,[PREVENTS] [DIAGNOSE_BY_TEST_OR_DRUG],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]",treatment for ANOREXIA,n/a,67,37,-1,74,47,TWrex-cause,800659-FS1,"Beal JE, Olson R, Laubenstein L et alDRONABINOL as a treatment for ANOREXIA associated with weight loss in patients with AIDS.",ANOREXIA,DRONABINOL
725257997,5/23/2015 20:37:29,1642361283,5/23/2015 20:36:27,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[NONE],[NONE],N/A,Cannot be determined,94,54,1,106,82,TWrex-cause,813172-FS1,"polydactyly, retinitis pigmentosa, mental retardation MULTIPLE LENTIGINES SYNDROME  Deafness, SHORT STATURE cardiac defects, multiple lentigines, genital or urologic defects Rud syndrome  Congenital ichthyosis, mental retardation, epilepsy Cerebellar ataxia and hypogonadotropic hypogonadism  Cerebellar ataxia, pes cavus deformity of the chest, spina bifida A large number of hypothalamic syndromes associated with hypogonadotropic hypogonadism have been described.",SHORT STATURE,MULTIPLE LENTIGINES SYNDROME
725257997,5/23/2015 20:45:49,1642366189,5/23/2015 20:44:13,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[MANIFESTATION],[MANIFESTATION],MULTIPLE LENTIGINES SYNDROME SHORT STATURE,N/A,94,54,1,106,82,TWrex-cause,813172-FS1,"polydactyly, retinitis pigmentosa, mental retardation MULTIPLE LENTIGINES SYNDROME  Deafness, SHORT STATURE cardiac defects, multiple lentigines, genital or urologic defects Rud syndrome  Congenital ichthyosis, mental retardation, epilepsy Cerebellar ataxia and hypogonadotropic hypogonadism  Cerebellar ataxia, pes cavus deformity of the chest, spina bifida A large number of hypothalamic syndromes associated with hypogonadotropic hypogonadism have been described.",SHORT STATURE,MULTIPLE LENTIGINES SYNDROME
725257997,5/23/2015 20:45:53,1642366256,5/23/2015 20:45:36,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,n/a,94,54,1,106,82,TWrex-cause,813172-FS1,"polydactyly, retinitis pigmentosa, mental retardation MULTIPLE LENTIGINES SYNDROME  Deafness, SHORT STATURE cardiac defects, multiple lentigines, genital or urologic defects Rud syndrome  Congenital ichthyosis, mental retardation, epilepsy Cerebellar ataxia and hypogonadotropic hypogonadism  Cerebellar ataxia, pes cavus deformity of the chest, spina bifida A large number of hypothalamic syndromes associated with hypogonadotropic hypogonadism have been described.",SHORT STATURE,MULTIPLE LENTIGINES SYNDROME
725257997,5/23/2015 20:51:46,1642369651,5/23/2015 20:51:21,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[PART_OF],[PART_OF],associated with,n/a,94,54,1,106,82,TWrex-cause,813172-FS1,"polydactyly, retinitis pigmentosa, mental retardation MULTIPLE LENTIGINES SYNDROME  Deafness, SHORT STATURE cardiac defects, multiple lentigines, genital or urologic defects Rud syndrome  Congenital ichthyosis, mental retardation, epilepsy Cerebellar ataxia and hypogonadotropic hypogonadism  Cerebellar ataxia, pes cavus deformity of the chest, spina bifida A large number of hypothalamic syndromes associated with hypogonadotropic hypogonadism have been described.",SHORT STATURE,MULTIPLE LENTIGINES SYNDROME
725257997,5/23/2015 20:57:49,1642372651,5/23/2015 20:56:53,false,instagc,1.0,30880172,USA,CA,Los Angeles,166.170.50.98,[PART_OF] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[PART_OF]",associated with,N/A,94,54,1,106,82,TWrex-cause,813172-FS1,"polydactyly, retinitis pigmentosa, mental retardation MULTIPLE LENTIGINES SYNDROME  Deafness, SHORT STATURE cardiac defects, multiple lentigines, genital or urologic defects Rud syndrome  Congenital ichthyosis, mental retardation, epilepsy Cerebellar ataxia and hypogonadotropic hypogonadism  Cerebellar ataxia, pes cavus deformity of the chest, spina bifida A large number of hypothalamic syndromes associated with hypogonadotropic hypogonadism have been described.",SHORT STATURE,MULTIPLE LENTIGINES SYNDROME
725257997,5/23/2015 21:00:13,1642373759,5/23/2015 20:59:52,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[NONE],[NONE],n/a,different conditions listed,94,54,1,106,82,TWrex-cause,813172-FS1,"polydactyly, retinitis pigmentosa, mental retardation MULTIPLE LENTIGINES SYNDROME  Deafness, SHORT STATURE cardiac defects, multiple lentigines, genital or urologic defects Rud syndrome  Congenital ichthyosis, mental retardation, epilepsy Cerebellar ataxia and hypogonadotropic hypogonadism  Cerebellar ataxia, pes cavus deformity of the chest, spina bifida A large number of hypothalamic syndromes associated with hypogonadotropic hypogonadism have been described.",SHORT STATURE,MULTIPLE LENTIGINES SYNDROME
725257997,5/23/2015 21:02:57,1642374895,5/23/2015 21:01:43,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],MULTIPLE LENTIGINES SYNDROME SHORT STATURE,na,94,54,1,106,82,TWrex-cause,813172-FS1,"polydactyly, retinitis pigmentosa, mental retardation MULTIPLE LENTIGINES SYNDROME  Deafness, SHORT STATURE cardiac defects, multiple lentigines, genital or urologic defects Rud syndrome  Congenital ichthyosis, mental retardation, epilepsy Cerebellar ataxia and hypogonadotropic hypogonadism  Cerebellar ataxia, pes cavus deformity of the chest, spina bifida A large number of hypothalamic syndromes associated with hypogonadotropic hypogonadism have been described.",SHORT STATURE,MULTIPLE LENTIGINES SYNDROME
725257997,5/23/2015 21:08:37,1642377601,5/23/2015 21:07:18,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],SYNDROME,N/A,94,54,1,106,82,TWrex-cause,813172-FS1,"polydactyly, retinitis pigmentosa, mental retardation MULTIPLE LENTIGINES SYNDROME  Deafness, SHORT STATURE cardiac defects, multiple lentigines, genital or urologic defects Rud syndrome  Congenital ichthyosis, mental retardation, epilepsy Cerebellar ataxia and hypogonadotropic hypogonadism  Cerebellar ataxia, pes cavus deformity of the chest, spina bifida A large number of hypothalamic syndromes associated with hypogonadotropic hypogonadism have been described.",SHORT STATURE,MULTIPLE LENTIGINES SYNDROME
725257997,5/23/2015 21:39:07,1642392645,5/23/2015 21:38:43,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,94,54,1,106,82,TWrex-cause,813172-FS1,"polydactyly, retinitis pigmentosa, mental retardation MULTIPLE LENTIGINES SYNDROME  Deafness, SHORT STATURE cardiac defects, multiple lentigines, genital or urologic defects Rud syndrome  Congenital ichthyosis, mental retardation, epilepsy Cerebellar ataxia and hypogonadotropic hypogonadism  Cerebellar ataxia, pes cavus deformity of the chest, spina bifida A large number of hypothalamic syndromes associated with hypogonadotropic hypogonadism have been described.",SHORT STATURE,MULTIPLE LENTIGINES SYNDROME
725257997,5/23/2015 21:49:32,1642397436,5/23/2015 21:47:51,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[LOCATION] [MANIFESTATION],"[LOCATION]
[MANIFESTATION]","polydactyly, retinitis pigmentosa, mental retardation MULTIPLE LENTIGINES SYNDROME Deafness, SHORT STATURE cardiac defects, multiple lentigines, genital or urologic defects Rud syndrome Congenital ichthyosis, mental retardation, epilepsy Cerebellar ataxia and hypogonadotropic hypogonadism Cerebellar ataxia, pes cavus deformity of the chest, spina bifida A large number of hypothalamic syndromes associated with hypogonadotropic hypogonadism have been described.",n/a,94,54,1,106,82,TWrex-cause,813172-FS1,"polydactyly, retinitis pigmentosa, mental retardation MULTIPLE LENTIGINES SYNDROME  Deafness, SHORT STATURE cardiac defects, multiple lentigines, genital or urologic defects Rud syndrome  Congenital ichthyosis, mental retardation, epilepsy Cerebellar ataxia and hypogonadotropic hypogonadism  Cerebellar ataxia, pes cavus deformity of the chest, spina bifida A large number of hypothalamic syndromes associated with hypogonadotropic hypogonadism have been described.",SHORT STATURE,MULTIPLE LENTIGINES SYNDROME
725257997,5/23/2015 21:50:27,1642397946,5/23/2015 21:49:14,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[MANIFESTATION],[MANIFESTATION],associated with hypogonadotropic hypogonadism have been described.,N/A,94,54,1,106,82,TWrex-cause,813172-FS1,"polydactyly, retinitis pigmentosa, mental retardation MULTIPLE LENTIGINES SYNDROME  Deafness, SHORT STATURE cardiac defects, multiple lentigines, genital or urologic defects Rud syndrome  Congenital ichthyosis, mental retardation, epilepsy Cerebellar ataxia and hypogonadotropic hypogonadism  Cerebellar ataxia, pes cavus deformity of the chest, spina bifida A large number of hypothalamic syndromes associated with hypogonadotropic hypogonadism have been described.",SHORT STATURE,MULTIPLE LENTIGINES SYNDROME
725257997,5/23/2015 21:52:45,1642398762,5/23/2015 21:51:38,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[OTHER],[OTHER],associated with,N/A,94,54,1,106,82,TWrex-cause,813172-FS1,"polydactyly, retinitis pigmentosa, mental retardation MULTIPLE LENTIGINES SYNDROME  Deafness, SHORT STATURE cardiac defects, multiple lentigines, genital or urologic defects Rud syndrome  Congenital ichthyosis, mental retardation, epilepsy Cerebellar ataxia and hypogonadotropic hypogonadism  Cerebellar ataxia, pes cavus deformity of the chest, spina bifida A large number of hypothalamic syndromes associated with hypogonadotropic hypogonadism have been described.",SHORT STATURE,MULTIPLE LENTIGINES SYNDROME
725257997,5/23/2015 21:54:18,1642399428,5/23/2015 21:53:34,false,elite,1.0,30064988,GBR,B4,Bradford,92.22.135.10,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,94,54,1,106,82,TWrex-cause,813172-FS1,"polydactyly, retinitis pigmentosa, mental retardation MULTIPLE LENTIGINES SYNDROME  Deafness, SHORT STATURE cardiac defects, multiple lentigines, genital or urologic defects Rud syndrome  Congenital ichthyosis, mental retardation, epilepsy Cerebellar ataxia and hypogonadotropic hypogonadism  Cerebellar ataxia, pes cavus deformity of the chest, spina bifida A large number of hypothalamic syndromes associated with hypogonadotropic hypogonadism have been described.",SHORT STATURE,MULTIPLE LENTIGINES SYNDROME
725257997,5/23/2015 21:55:11,1642399735,5/23/2015 21:54:01,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[SYMPTOM],[SYMPTOM],associated with,n/a,94,54,1,106,82,TWrex-cause,813172-FS1,"polydactyly, retinitis pigmentosa, mental retardation MULTIPLE LENTIGINES SYNDROME  Deafness, SHORT STATURE cardiac defects, multiple lentigines, genital or urologic defects Rud syndrome  Congenital ichthyosis, mental retardation, epilepsy Cerebellar ataxia and hypogonadotropic hypogonadism  Cerebellar ataxia, pes cavus deformity of the chest, spina bifida A large number of hypothalamic syndromes associated with hypogonadotropic hypogonadism have been described.",SHORT STATURE,MULTIPLE LENTIGINES SYNDROME
725257997,5/23/2015 22:05:27,1642403958,5/23/2015 22:04:13,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[SYMPTOM],[SYMPTOM],MULTIPLE LENTIGINES SHORT STATURE hypothalamic syndromes associated,N/A,94,54,1,106,82,TWrex-cause,813172-FS1,"polydactyly, retinitis pigmentosa, mental retardation MULTIPLE LENTIGINES SYNDROME  Deafness, SHORT STATURE cardiac defects, multiple lentigines, genital or urologic defects Rud syndrome  Congenital ichthyosis, mental retardation, epilepsy Cerebellar ataxia and hypogonadotropic hypogonadism  Cerebellar ataxia, pes cavus deformity of the chest, spina bifida A large number of hypothalamic syndromes associated with hypogonadotropic hypogonadism have been described.",SHORT STATURE,MULTIPLE LENTIGINES SYNDROME
725257998,5/23/2015 20:24:59,1642355238,5/23/2015 20:24:23,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[PREVENTS],[PREVENTS],FONDAPARINUX VERSUS POSTOPERATIVE enoxaparin for prevention of VENOUS THROMBOEMBOLISM,N/A,77,14,-1,98,47,TWrex-cause,804584-FS1,Postoperative FONDAPARINUX VERSUS POSTOPERATIVE enoxaparin for prevention of VENOUS THROMBOEMBOLISM after elective hip replacement surgery: a randomised double blind trial.,VENOUS THROMBOEMBOLISM,FONDAPARINUX VERSUS POSTOPERATIVE
725257998,5/23/2015 20:30:36,1642357983,5/23/2015 20:30:23,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[PREVENTS],[PREVENTS],for prevention,N/A,77,14,-1,98,47,TWrex-cause,804584-FS1,Postoperative FONDAPARINUX VERSUS POSTOPERATIVE enoxaparin for prevention of VENOUS THROMBOEMBOLISM after elective hip replacement surgery: a randomised double blind trial.,VENOUS THROMBOEMBOLISM,FONDAPARINUX VERSUS POSTOPERATIVE
725257998,5/23/2015 20:38:00,1642361649,5/23/2015 20:37:09,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[PREVENTS],[PREVENTS],FONDAPARINUX VERSUS POSTOPERATIVE enoxaparin for prevention of VENOUS THROMBOEMBOLISM,na,77,14,-1,98,47,TWrex-cause,804584-FS1,Postoperative FONDAPARINUX VERSUS POSTOPERATIVE enoxaparin for prevention of VENOUS THROMBOEMBOLISM after elective hip replacement surgery: a randomised double blind trial.,VENOUS THROMBOEMBOLISM,FONDAPARINUX VERSUS POSTOPERATIVE
725257998,5/23/2015 20:38:11,1642361715,5/23/2015 20:37:52,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[PREVENTS],[PREVENTS],prevention,n/a,77,14,-1,98,47,TWrex-cause,804584-FS1,Postoperative FONDAPARINUX VERSUS POSTOPERATIVE enoxaparin for prevention of VENOUS THROMBOEMBOLISM after elective hip replacement surgery: a randomised double blind trial.,VENOUS THROMBOEMBOLISM,FONDAPARINUX VERSUS POSTOPERATIVE
725257998,5/23/2015 20:38:46,1642362043,5/23/2015 20:38:21,false,instagc,1.0,30880172,USA,CA,Los Angeles,166.170.50.98,[PREVENTS],[PREVENTS],prevention of,N/A,77,14,-1,98,47,TWrex-cause,804584-FS1,Postoperative FONDAPARINUX VERSUS POSTOPERATIVE enoxaparin for prevention of VENOUS THROMBOEMBOLISM after elective hip replacement surgery: a randomised double blind trial.,VENOUS THROMBOEMBOLISM,FONDAPARINUX VERSUS POSTOPERATIVE
725257998,5/23/2015 20:39:57,1642362755,5/23/2015 20:39:44,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[PREVENTS],[PREVENTS],prevention,n/a,77,14,-1,98,47,TWrex-cause,804584-FS1,Postoperative FONDAPARINUX VERSUS POSTOPERATIVE enoxaparin for prevention of VENOUS THROMBOEMBOLISM after elective hip replacement surgery: a randomised double blind trial.,VENOUS THROMBOEMBOLISM,FONDAPARINUX VERSUS POSTOPERATIVE
725257998,5/23/2015 20:40:52,1642363338,5/23/2015 20:40:42,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[PREVENTS],[PREVENTS],prevention,n/a,77,14,-1,98,47,TWrex-cause,804584-FS1,Postoperative FONDAPARINUX VERSUS POSTOPERATIVE enoxaparin for prevention of VENOUS THROMBOEMBOLISM after elective hip replacement surgery: a randomised double blind trial.,VENOUS THROMBOEMBOLISM,FONDAPARINUX VERSUS POSTOPERATIVE
725257998,5/23/2015 20:43:42,1642364858,5/23/2015 20:43:27,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[PREVENTS],[PREVENTS],prevention,-,77,14,-1,98,47,TWrex-cause,804584-FS1,Postoperative FONDAPARINUX VERSUS POSTOPERATIVE enoxaparin for prevention of VENOUS THROMBOEMBOLISM after elective hip replacement surgery: a randomised double blind trial.,VENOUS THROMBOEMBOLISM,FONDAPARINUX VERSUS POSTOPERATIVE
725257998,5/23/2015 20:43:43,1642364860,5/23/2015 20:42:59,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[PREVENTS],[PREVENTS],prevention of,N/A,77,14,-1,98,47,TWrex-cause,804584-FS1,Postoperative FONDAPARINUX VERSUS POSTOPERATIVE enoxaparin for prevention of VENOUS THROMBOEMBOLISM after elective hip replacement surgery: a randomised double blind trial.,VENOUS THROMBOEMBOLISM,FONDAPARINUX VERSUS POSTOPERATIVE
725257998,5/23/2015 20:45:17,1642365842,5/23/2015 20:44:59,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[PREVENTS],[PREVENTS],for prevention of,n/a,77,14,-1,98,47,TWrex-cause,804584-FS1,Postoperative FONDAPARINUX VERSUS POSTOPERATIVE enoxaparin for prevention of VENOUS THROMBOEMBOLISM after elective hip replacement surgery: a randomised double blind trial.,VENOUS THROMBOEMBOLISM,FONDAPARINUX VERSUS POSTOPERATIVE
725257998,5/23/2015 20:53:40,1642370673,5/23/2015 20:53:28,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[PREVENTS],[PREVENTS],prevention of,n/a,77,14,-1,98,47,TWrex-cause,804584-FS1,Postoperative FONDAPARINUX VERSUS POSTOPERATIVE enoxaparin for prevention of VENOUS THROMBOEMBOLISM after elective hip replacement surgery: a randomised double blind trial.,VENOUS THROMBOEMBOLISM,FONDAPARINUX VERSUS POSTOPERATIVE
725257998,5/23/2015 21:03:44,1642375254,5/23/2015 21:03:15,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[PREVENTS],[PREVENTS],for prevention of,n/a,77,14,-1,98,47,TWrex-cause,804584-FS1,Postoperative FONDAPARINUX VERSUS POSTOPERATIVE enoxaparin for prevention of VENOUS THROMBOEMBOLISM after elective hip replacement surgery: a randomised double blind trial.,VENOUS THROMBOEMBOLISM,FONDAPARINUX VERSUS POSTOPERATIVE
725257998,5/23/2015 21:15:36,1642380789,5/23/2015 21:15:24,false,prodege,1.0,2143114,CAN,BC,Vancouver,24.85.153.181,[TREATS],[TREATS],Postoperative,n/aa,77,14,-1,98,47,TWrex-cause,804584-FS1,Postoperative FONDAPARINUX VERSUS POSTOPERATIVE enoxaparin for prevention of VENOUS THROMBOEMBOLISM after elective hip replacement surgery: a randomised double blind trial.,VENOUS THROMBOEMBOLISM,FONDAPARINUX VERSUS POSTOPERATIVE
725257998,5/23/2015 21:16:04,1642381005,5/23/2015 21:15:55,false,tremorgames,1,17272211,USA,PA,Havertown,173.49.116.92,[PREVENTS],[PREVENTS],prevention,N/A,77,14,-1,98,47,TWrex-cause,804584-FS1,Postoperative FONDAPARINUX VERSUS POSTOPERATIVE enoxaparin for prevention of VENOUS THROMBOEMBOLISM after elective hip replacement surgery: a randomised double blind trial.,VENOUS THROMBOEMBOLISM,FONDAPARINUX VERSUS POSTOPERATIVE
725257998,5/23/2015 21:27:34,1642386710,5/23/2015 21:27:02,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[PREVENTS],[PREVENTS],for prevention of,N/A,77,14,-1,98,47,TWrex-cause,804584-FS1,Postoperative FONDAPARINUX VERSUS POSTOPERATIVE enoxaparin for prevention of VENOUS THROMBOEMBOLISM after elective hip replacement surgery: a randomised double blind trial.,VENOUS THROMBOEMBOLISM,FONDAPARINUX VERSUS POSTOPERATIVE
725257999,5/23/2015 20:39:37,1642362574,5/23/2015 20:39:14,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[ASSOCIATED_WITH],[ASSOCIATED_WITH],of,N/A,8,16,-1,11,52,TWrex-cause,805278-FS1,Reduced PAIN of INTRAARTICULAR HYALURONATE INJECTION with the reciprocating procedure device.,PAIN,INTRAARTICULAR HYALURONATE INJECTION
725257999,5/23/2015 20:47:12,1642367082,5/23/2015 20:46:54,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],of,n/a,8,16,-1,11,52,TWrex-cause,805278-FS1,Reduced PAIN of INTRAARTICULAR HYALURONATE INJECTION with the reciprocating procedure device.,PAIN,INTRAARTICULAR HYALURONATE INJECTION
725257999,5/23/2015 20:49:20,1642368286,5/23/2015 20:48:27,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES],[CAUSES],PAIN of INTRAARTICULAR HYALURONATE,N/A,8,16,-1,11,52,TWrex-cause,805278-FS1,Reduced PAIN of INTRAARTICULAR HYALURONATE INJECTION with the reciprocating procedure device.,PAIN,INTRAARTICULAR HYALURONATE INJECTION
725257999,5/23/2015 20:53:18,1642370500,5/23/2015 20:53:03,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[PART_OF],[PART_OF],of,n/a,8,16,-1,11,52,TWrex-cause,805278-FS1,Reduced PAIN of INTRAARTICULAR HYALURONATE INJECTION with the reciprocating procedure device.,PAIN,INTRAARTICULAR HYALURONATE INJECTION
725257999,5/23/2015 21:01:35,1642374438,5/23/2015 21:01:03,false,instagc,1.0,30880172,USA,CA,Los Angeles,166.170.50.98,[SYMPTOM],[SYMPTOM],of,N/A,8,16,-1,11,52,TWrex-cause,805278-FS1,Reduced PAIN of INTRAARTICULAR HYALURONATE INJECTION with the reciprocating procedure device.,PAIN,INTRAARTICULAR HYALURONATE INJECTION
725257999,5/23/2015 21:02:18,1642374673,5/23/2015 21:01:53,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[ASSOCIATED_WITH],[ASSOCIATED_WITH],of,n/a,8,16,-1,11,52,TWrex-cause,805278-FS1,Reduced PAIN of INTRAARTICULAR HYALURONATE INJECTION with the reciprocating procedure device.,PAIN,INTRAARTICULAR HYALURONATE INJECTION
725257999,5/23/2015 21:07:33,1642377178,5/23/2015 21:07:01,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],Reduced PAIN INTRAARTICULAR HYALURONATE INJECTION,na,8,16,-1,11,52,TWrex-cause,805278-FS1,Reduced PAIN of INTRAARTICULAR HYALURONATE INJECTION with the reciprocating procedure device.,PAIN,INTRAARTICULAR HYALURONATE INJECTION
725257999,5/23/2015 21:11:44,1642379113,5/23/2015 21:11:08,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES] [SYMPTOM],"[CAUSES]
[SYMPTOM]",of,N/A,8,16,-1,11,52,TWrex-cause,805278-FS1,Reduced PAIN of INTRAARTICULAR HYALURONATE INJECTION with the reciprocating procedure device.,PAIN,INTRAARTICULAR HYALURONATE INJECTION
725257999,5/23/2015 21:41:51,1642393858,5/23/2015 21:41:26,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[SYMPTOM],[SYMPTOM],Reduced with,N/A,8,16,-1,11,52,TWrex-cause,805278-FS1,Reduced PAIN of INTRAARTICULAR HYALURONATE INJECTION with the reciprocating procedure device.,PAIN,INTRAARTICULAR HYALURONATE INJECTION
725257999,5/23/2015 21:52:41,1642398726,5/23/2015 21:52:21,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[PART_OF],[PART_OF],of,N/A,8,16,-1,11,52,TWrex-cause,805278-FS1,Reduced PAIN of INTRAARTICULAR HYALURONATE INJECTION with the reciprocating procedure device.,PAIN,INTRAARTICULAR HYALURONATE INJECTION
725257999,5/23/2015 21:54:15,1642399404,5/23/2015 21:53:32,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[OTHER],[OTHER],Reduced PAIN of INTRAARTICULAR HYALURONATE INJECTION with the reciprocating procedure device.,n/a,8,16,-1,11,52,TWrex-cause,805278-FS1,Reduced PAIN of INTRAARTICULAR HYALURONATE INJECTION with the reciprocating procedure device.,PAIN,INTRAARTICULAR HYALURONATE INJECTION
725257999,5/23/2015 21:55:58,1642400002,5/23/2015 21:54:54,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[MANIFESTATION],[MANIFESTATION],of,N/A,8,16,-1,11,52,TWrex-cause,805278-FS1,Reduced PAIN of INTRAARTICULAR HYALURONATE INJECTION with the reciprocating procedure device.,PAIN,INTRAARTICULAR HYALURONATE INJECTION
725257999,5/23/2015 22:00:05,1642401573,5/23/2015 21:59:29,false,elite,1.0,30064988,GBR,B4,Bradford,92.22.135.10,[SYMPTOM],[SYMPTOM],of,N/A,8,16,-1,11,52,TWrex-cause,805278-FS1,Reduced PAIN of INTRAARTICULAR HYALURONATE INJECTION with the reciprocating procedure device.,PAIN,INTRAARTICULAR HYALURONATE INJECTION
725257999,5/23/2015 22:04:50,1642403704,5/23/2015 22:04:19,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[TREATS],[TREATS],Reduced of,n/a,8,16,-1,11,52,TWrex-cause,805278-FS1,Reduced PAIN of INTRAARTICULAR HYALURONATE INJECTION with the reciprocating procedure device.,PAIN,INTRAARTICULAR HYALURONATE INJECTION
725257999,5/23/2015 22:08:10,1642405580,5/23/2015 22:06:43,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],Reduced PAIN of INTRAARTICULAR HYALURONATE INJECTION,N/A,8,16,-1,11,52,TWrex-cause,805278-FS1,Reduced PAIN of INTRAARTICULAR HYALURONATE INJECTION with the reciprocating procedure device.,PAIN,INTRAARTICULAR HYALURONATE INJECTION
725258000,5/23/2015 20:34:38,1642360021,5/23/2015 20:34:25,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[CAUSES],[CAUSES],caused by,N/A,28,81,1,40,94,TWrex-cause,815079-FS1,"Tinea Capitis  Treatment of TINEA CAPITIS (scalp ringworm) caused by susceptible DERMATOPHYTES (e.g.,  Trichophyton ,  Microsporum.",TINEA CAPITIS,DERMATOPHYTES
725258000,5/23/2015 20:39:59,1642362766,5/23/2015 20:39:31,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES],[CAUSES],TINEA CAPITIS caused by DERMATOPHYTES,N/A,28,81,1,40,94,TWrex-cause,815079-FS1,"Tinea Capitis  Treatment of TINEA CAPITIS (scalp ringworm) caused by susceptible DERMATOPHYTES (e.g.,  Trichophyton ,  Microsporum.",TINEA CAPITIS,DERMATOPHYTES
725258000,5/23/2015 20:43:52,1642364933,5/23/2015 20:43:39,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],caused by,n/a,28,81,1,40,94,TWrex-cause,815079-FS1,"Tinea Capitis  Treatment of TINEA CAPITIS (scalp ringworm) caused by susceptible DERMATOPHYTES (e.g.,  Trichophyton ,  Microsporum.",TINEA CAPITIS,DERMATOPHYTES
725258000,5/23/2015 20:48:13,1642367725,5/23/2015 20:48:04,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[CAUSES],[CAUSES],caused,-,28,81,1,40,94,TWrex-cause,815079-FS1,"Tinea Capitis  Treatment of TINEA CAPITIS (scalp ringworm) caused by susceptible DERMATOPHYTES (e.g.,  Trichophyton ,  Microsporum.",TINEA CAPITIS,DERMATOPHYTES
725258000,5/23/2015 20:49:31,1642368371,5/23/2015 20:49:16,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],caused by,n/a,28,81,1,40,94,TWrex-cause,815079-FS1,"Tinea Capitis  Treatment of TINEA CAPITIS (scalp ringworm) caused by susceptible DERMATOPHYTES (e.g.,  Trichophyton ,  Microsporum.",TINEA CAPITIS,DERMATOPHYTES
725258000,5/23/2015 20:52:14,1642369886,5/23/2015 20:50:57,false,instagc,1.0,30880172,USA,CA,Los Angeles,166.170.50.98,[OTHER],[OTHER],caused by,Caused by,28,81,1,40,94,TWrex-cause,815079-FS1,"Tinea Capitis  Treatment of TINEA CAPITIS (scalp ringworm) caused by susceptible DERMATOPHYTES (e.g.,  Trichophyton ,  Microsporum.",TINEA CAPITIS,DERMATOPHYTES
725258000,5/23/2015 20:53:46,1642370704,5/23/2015 20:52:52,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],TINEA CAPITIS caused by DERMATOPHYTES,na,28,81,1,40,94,TWrex-cause,815079-FS1,"Tinea Capitis  Treatment of TINEA CAPITIS (scalp ringworm) caused by susceptible DERMATOPHYTES (e.g.,  Trichophyton ,  Microsporum.",TINEA CAPITIS,DERMATOPHYTES
725258000,5/23/2015 20:57:55,1642372704,5/23/2015 20:57:40,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],caused by,n/a,28,81,1,40,94,TWrex-cause,815079-FS1,"Tinea Capitis  Treatment of TINEA CAPITIS (scalp ringworm) caused by susceptible DERMATOPHYTES (e.g.,  Trichophyton ,  Microsporum.",TINEA CAPITIS,DERMATOPHYTES
725258000,5/23/2015 20:59:19,1642373391,5/23/2015 20:59:00,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],caused by,N/A,28,81,1,40,94,TWrex-cause,815079-FS1,"Tinea Capitis  Treatment of TINEA CAPITIS (scalp ringworm) caused by susceptible DERMATOPHYTES (e.g.,  Trichophyton ,  Microsporum.",TINEA CAPITIS,DERMATOPHYTES
725258000,5/23/2015 21:11:04,1642378812,5/23/2015 21:10:29,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[CAUSES],[CAUSES],caused by susceptible DERMATOPHYTES,n/a,28,81,1,40,94,TWrex-cause,815079-FS1,"Tinea Capitis  Treatment of TINEA CAPITIS (scalp ringworm) caused by susceptible DERMATOPHYTES (e.g.,  Trichophyton ,  Microsporum.",TINEA CAPITIS,DERMATOPHYTES
725258000,5/23/2015 21:35:48,1642390923,5/23/2015 21:35:28,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[CAUSES],[CAUSES],caused by,N/A,28,81,1,40,94,TWrex-cause,815079-FS1,"Tinea Capitis  Treatment of TINEA CAPITIS (scalp ringworm) caused by susceptible DERMATOPHYTES (e.g.,  Trichophyton ,  Microsporum.",TINEA CAPITIS,DERMATOPHYTES
725258000,5/23/2015 21:40:59,1642393478,5/23/2015 21:39:55,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES] [TREATS],"[TREATS]
[CAUSES]","Tinea Capitis Treatment of TINEA CAPITIS (scalp ringworm) caused by susceptible DERMATOPHYTES (e.g., Trichophyton Microsporum.",n/a,28,81,1,40,94,TWrex-cause,815079-FS1,"Tinea Capitis  Treatment of TINEA CAPITIS (scalp ringworm) caused by susceptible DERMATOPHYTES (e.g.,  Trichophyton ,  Microsporum.",TINEA CAPITIS,DERMATOPHYTES
725258000,5/23/2015 21:45:37,1642395731,5/23/2015 21:45:11,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES],[CAUSES],caused by susceptible,N/A,28,81,1,40,94,TWrex-cause,815079-FS1,"Tinea Capitis  Treatment of TINEA CAPITIS (scalp ringworm) caused by susceptible DERMATOPHYTES (e.g.,  Trichophyton ,  Microsporum.",TINEA CAPITIS,DERMATOPHYTES
725258000,5/23/2015 21:48:37,1642397037,5/23/2015 21:47:52,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[TREATS],[TREATS],Treatment of,n/a,28,81,1,40,94,TWrex-cause,815079-FS1,"Tinea Capitis  Treatment of TINEA CAPITIS (scalp ringworm) caused by susceptible DERMATOPHYTES (e.g.,  Trichophyton ,  Microsporum.",TINEA CAPITIS,DERMATOPHYTES
725258000,5/23/2015 21:49:20,1642397378,5/23/2015 21:49:05,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[CAUSES],[CAUSES],caused by,N/A,28,81,1,40,94,TWrex-cause,815079-FS1,"Tinea Capitis  Treatment of TINEA CAPITIS (scalp ringworm) caused by susceptible DERMATOPHYTES (e.g.,  Trichophyton ,  Microsporum.",TINEA CAPITIS,DERMATOPHYTES
725258001,5/23/2015 21:43:23,1642394607,5/23/2015 21:42:58,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[MANIFESTATION],[MANIFESTATION],as manifestation of,N/A,80,126,1,92,156,TWrex-cause,813573-FS1,"2]  Bonamico M, Scire G, Mariani P, Pasquino AM, Triglione P, Scaccia S, et al. SHORT STATURE as the primary manifestation of MONOSYMPTOMATIC CELIAC DISEASE",SHORT STATURE,MONOSYMPTOMATIC CELIAC DISEASE
725258001,5/23/2015 21:53:55,1642399262,5/23/2015 21:53:35,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[MANIFESTATION],[MANIFESTATION],as the primary manifestation of,N/A,80,126,1,92,156,TWrex-cause,813573-FS1,"2]  Bonamico M, Scire G, Mariani P, Pasquino AM, Triglione P, Scaccia S, et al. SHORT STATURE as the primary manifestation of MONOSYMPTOMATIC CELIAC DISEASE",SHORT STATURE,MONOSYMPTOMATIC CELIAC DISEASE
725258001,5/23/2015 21:57:20,1642400524,5/23/2015 21:56:29,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",SHORT STATURE as the primary manifestation of MONOSYMPTOMATIC CELIAC DISEASE,n/a,80,126,1,92,156,TWrex-cause,813573-FS1,"2]  Bonamico M, Scire G, Mariani P, Pasquino AM, Triglione P, Scaccia S, et al. SHORT STATURE as the primary manifestation of MONOSYMPTOMATIC CELIAC DISEASE",SHORT STATURE,MONOSYMPTOMATIC CELIAC DISEASE
725258001,5/23/2015 21:57:21,1642400525,5/23/2015 21:57:08,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[MANIFESTATION],[MANIFESTATION],manifestation,N/A,80,126,1,92,156,TWrex-cause,813573-FS1,"2]  Bonamico M, Scire G, Mariani P, Pasquino AM, Triglione P, Scaccia S, et al. SHORT STATURE as the primary manifestation of MONOSYMPTOMATIC CELIAC DISEASE",SHORT STATURE,MONOSYMPTOMATIC CELIAC DISEASE
725258001,5/23/2015 22:02:13,1642402512,5/23/2015 22:01:38,false,elite,1.0,30064988,GBR,B4,Bradford,92.22.135.10,[MANIFESTATION],[MANIFESTATION],primary manifestation,N/A,80,126,1,92,156,TWrex-cause,813573-FS1,"2]  Bonamico M, Scire G, Mariani P, Pasquino AM, Triglione P, Scaccia S, et al. SHORT STATURE as the primary manifestation of MONOSYMPTOMATIC CELIAC DISEASE",SHORT STATURE,MONOSYMPTOMATIC CELIAC DISEASE
725258001,5/23/2015 22:09:04,1642406032,5/23/2015 22:08:12,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[MANIFESTATION],[MANIFESTATION],SHORT STATURE primary manifestation of MONOSYMPTOMATIC CELIAC DISEASE,N/A,80,126,1,92,156,TWrex-cause,813573-FS1,"2]  Bonamico M, Scire G, Mariani P, Pasquino AM, Triglione P, Scaccia S, et al. SHORT STATURE as the primary manifestation of MONOSYMPTOMATIC CELIAC DISEASE",SHORT STATURE,MONOSYMPTOMATIC CELIAC DISEASE
725258001,5/23/2015 22:09:06,1642406079,5/23/2015 22:07:56,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[MANIFESTATION],[MANIFESTATION],as the primary manifestation of,n/a,80,126,1,92,156,TWrex-cause,813573-FS1,"2]  Bonamico M, Scire G, Mariani P, Pasquino AM, Triglione P, Scaccia S, et al. SHORT STATURE as the primary manifestation of MONOSYMPTOMATIC CELIAC DISEASE",SHORT STATURE,MONOSYMPTOMATIC CELIAC DISEASE
725258001,5/23/2015 22:09:13,1642406171,5/23/2015 22:08:17,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[MANIFESTATION],[MANIFESTATION],as the primary manifestation of,n/a,80,126,1,92,156,TWrex-cause,813573-FS1,"2]  Bonamico M, Scire G, Mariani P, Pasquino AM, Triglione P, Scaccia S, et al. SHORT STATURE as the primary manifestation of MONOSYMPTOMATIC CELIAC DISEASE",SHORT STATURE,MONOSYMPTOMATIC CELIAC DISEASE
725258001,5/23/2015 22:09:27,1642406285,5/23/2015 22:08:10,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[MANIFESTATION],[MANIFESTATION],manifestation of,N/A,80,126,1,92,156,TWrex-cause,813573-FS1,"2]  Bonamico M, Scire G, Mariani P, Pasquino AM, Triglione P, Scaccia S, et al. SHORT STATURE as the primary manifestation of MONOSYMPTOMATIC CELIAC DISEASE",SHORT STATURE,MONOSYMPTOMATIC CELIAC DISEASE
725258001,5/23/2015 22:09:32,1642406313,5/23/2015 22:09:16,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[MANIFESTATION],[MANIFESTATION],STATURE as primary manifestation of MONOSYMPTOMATIC CELIAC DISEASE,n/a,80,126,1,92,156,TWrex-cause,813573-FS1,"2]  Bonamico M, Scire G, Mariani P, Pasquino AM, Triglione P, Scaccia S, et al. SHORT STATURE as the primary manifestation of MONOSYMPTOMATIC CELIAC DISEASE",SHORT STATURE,MONOSYMPTOMATIC CELIAC DISEASE
725258001,5/23/2015 22:19:16,1642411206,5/23/2015 22:16:43,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[SYMPTOM],[SYMPTOM],MONOSYMPTOMATIC,N/A,80,126,1,92,156,TWrex-cause,813573-FS1,"2]  Bonamico M, Scire G, Mariani P, Pasquino AM, Triglione P, Scaccia S, et al. SHORT STATURE as the primary manifestation of MONOSYMPTOMATIC CELIAC DISEASE",SHORT STATURE,MONOSYMPTOMATIC CELIAC DISEASE
725258001,5/23/2015 22:19:34,1642411365,5/23/2015 22:19:08,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[MANIFESTATION],[MANIFESTATION],SHORT STATURE the primary manifestation of MONOSYMPTOMATIC CELIAC DISEASE,n/a,80,126,1,92,156,TWrex-cause,813573-FS1,"2]  Bonamico M, Scire G, Mariani P, Pasquino AM, Triglione P, Scaccia S, et al. SHORT STATURE as the primary manifestation of MONOSYMPTOMATIC CELIAC DISEASE",SHORT STATURE,MONOSYMPTOMATIC CELIAC DISEASE
725258001,5/23/2015 22:25:32,1642414321,5/23/2015 22:25:05,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[MANIFESTATION],[MANIFESTATION],primary manifestation of MONOSYMPTOMATIC CELIAC DISEASE,n/a,80,126,1,92,156,TWrex-cause,813573-FS1,"2]  Bonamico M, Scire G, Mariani P, Pasquino AM, Triglione P, Scaccia S, et al. SHORT STATURE as the primary manifestation of MONOSYMPTOMATIC CELIAC DISEASE",SHORT STATURE,MONOSYMPTOMATIC CELIAC DISEASE
725258001,5/23/2015 22:28:03,1642415397,5/23/2015 22:27:37,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[MANIFESTATION],[MANIFESTATION],SHORT STATURE as the primary manifestation of MONOSYMPTOMATIC CELIAC DISEASE,n/a,80,126,1,92,156,TWrex-cause,813573-FS1,"2]  Bonamico M, Scire G, Mariani P, Pasquino AM, Triglione P, Scaccia S, et al. SHORT STATURE as the primary manifestation of MONOSYMPTOMATIC CELIAC DISEASE",SHORT STATURE,MONOSYMPTOMATIC CELIAC DISEASE
725258001,5/23/2015 22:38:07,1642420590,5/23/2015 22:35:53,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[MANIFESTATION],[MANIFESTATION],as the primary manifestation,N/A,80,126,1,92,156,TWrex-cause,813573-FS1,"2]  Bonamico M, Scire G, Mariani P, Pasquino AM, Triglione P, Scaccia S, et al. SHORT STATURE as the primary manifestation of MONOSYMPTOMATIC CELIAC DISEASE",SHORT STATURE,MONOSYMPTOMATIC CELIAC DISEASE
725258002,5/23/2015 20:35:00,1642360159,5/23/2015 20:34:40,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[CONTRAINDICATES],[CONTRAINDICATES],avoided while the woman is receiving,N/A,5,60,-1,13,71,TWrex-cause,803137-FS1,1 •  PREGNANCY must be avoided while the woman is receiving LEFLUNOMIDE and prior to completion of the drug elimination procedure following discontinuance of the drug.,PREGNANCY,LEFLUNOMIDE
725258002,5/23/2015 20:40:36,1642363210,5/23/2015 20:40:00,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CONTRAINDICATES],[CONTRAINDICATES],PREGNANCY must be avoided while receiving LEFLUNOMIDE,N/A,5,60,-1,13,71,TWrex-cause,803137-FS1,1 •  PREGNANCY must be avoided while the woman is receiving LEFLUNOMIDE and prior to completion of the drug elimination procedure following discontinuance of the drug.,PREGNANCY,LEFLUNOMIDE
725258002,5/23/2015 20:44:08,1642365204,5/23/2015 20:43:53,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CONTRAINDICATES],[CONTRAINDICATES],must be avoided,n/a,5,60,-1,13,71,TWrex-cause,803137-FS1,1 •  PREGNANCY must be avoided while the woman is receiving LEFLUNOMIDE and prior to completion of the drug elimination procedure following discontinuance of the drug.,PREGNANCY,LEFLUNOMIDE
725258002,5/23/2015 20:48:27,1642367852,5/23/2015 20:48:15,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[OTHER],[OTHER],avoided,-,5,60,-1,13,71,TWrex-cause,803137-FS1,1 •  PREGNANCY must be avoided while the woman is receiving LEFLUNOMIDE and prior to completion of the drug elimination procedure following discontinuance of the drug.,PREGNANCY,LEFLUNOMIDE
725258002,5/23/2015 20:49:47,1642368492,5/23/2015 20:49:32,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CONTRAINDICATES],[CONTRAINDICATES],must be avoided,n/a,5,60,-1,13,71,TWrex-cause,803137-FS1,1 •  PREGNANCY must be avoided while the woman is receiving LEFLUNOMIDE and prior to completion of the drug elimination procedure following discontinuance of the drug.,PREGNANCY,LEFLUNOMIDE
725258002,5/23/2015 20:52:49,1642370242,5/23/2015 20:52:16,false,instagc,1.0,30880172,USA,CA,Los Angeles,166.170.50.98,[CONTRAINDICATES],[CONTRAINDICATES],must be avoided while the woman is receiving,N/A,5,60,-1,13,71,TWrex-cause,803137-FS1,1 •  PREGNANCY must be avoided while the woman is receiving LEFLUNOMIDE and prior to completion of the drug elimination procedure following discontinuance of the drug.,PREGNANCY,LEFLUNOMIDE
725258002,5/23/2015 20:56:18,1642371959,5/23/2015 20:53:47,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CONTRAINDICATES],[CONTRAINDICATES],PREGNANCY must be avoided while receiving LEFLUNOMIDE,na,5,60,-1,13,71,TWrex-cause,803137-FS1,1 •  PREGNANCY must be avoided while the woman is receiving LEFLUNOMIDE and prior to completion of the drug elimination procedure following discontinuance of the drug.,PREGNANCY,LEFLUNOMIDE
725258002,5/23/2015 20:58:15,1642372878,5/23/2015 20:57:56,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CONTRAINDICATES],[CONTRAINDICATES],must be avoided while receiving,n/a,5,60,-1,13,71,TWrex-cause,803137-FS1,1 •  PREGNANCY must be avoided while the woman is receiving LEFLUNOMIDE and prior to completion of the drug elimination procedure following discontinuance of the drug.,PREGNANCY,LEFLUNOMIDE
725258002,5/23/2015 21:00:56,1642374061,5/23/2015 20:59:23,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS] [OTHER],"[TREATS]
[OTHER]",must be avoided while the woman is receiving,N/A,5,60,-1,13,71,TWrex-cause,803137-FS1,1 •  PREGNANCY must be avoided while the woman is receiving LEFLUNOMIDE and prior to completion of the drug elimination procedure following discontinuance of the drug.,PREGNANCY,LEFLUNOMIDE
725258002,5/23/2015 21:11:24,1642378972,5/23/2015 21:11:04,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[CONTRAINDICATES],[CONTRAINDICATES],PREGNANCY must be avoided while receiving,n/a,5,60,-1,13,71,TWrex-cause,803137-FS1,1 •  PREGNANCY must be avoided while the woman is receiving LEFLUNOMIDE and prior to completion of the drug elimination procedure following discontinuance of the drug.,PREGNANCY,LEFLUNOMIDE
725258002,5/23/2015 21:36:29,1642391295,5/23/2015 21:35:49,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[CONTRAINDICATES],[CONTRAINDICATES],must be avoided,N/A,5,60,-1,13,71,TWrex-cause,803137-FS1,1 •  PREGNANCY must be avoided while the woman is receiving LEFLUNOMIDE and prior to completion of the drug elimination procedure following discontinuance of the drug.,PREGNANCY,LEFLUNOMIDE
725258002,5/23/2015 21:42:04,1642393954,5/23/2015 21:41:00,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SIDE_EFFECT] [MANIFESTATION] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[MANIFESTATION]
[SIDE_EFFECT]",PREGNANCY must be avoided while the woman is receiving LEFLUNOMIDE and prior to completion of the drug elimination procedure following discontinuance of the drug.,n/a,5,60,-1,13,71,TWrex-cause,803137-FS1,1 •  PREGNANCY must be avoided while the woman is receiving LEFLUNOMIDE and prior to completion of the drug elimination procedure following discontinuance of the drug.,PREGNANCY,LEFLUNOMIDE
725258002,5/23/2015 21:46:01,1642395970,5/23/2015 21:45:38,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[OTHER],[OTHER],must be avoided while the woman is receiving,N/A,5,60,-1,13,71,TWrex-cause,803137-FS1,1 •  PREGNANCY must be avoided while the woman is receiving LEFLUNOMIDE and prior to completion of the drug elimination procedure following discontinuance of the drug.,PREGNANCY,LEFLUNOMIDE
725258002,5/23/2015 21:49:58,1642397642,5/23/2015 21:48:39,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[CONTRAINDICATES],[CONTRAINDICATES],must be avoided,n/a,5,60,-1,13,71,TWrex-cause,803137-FS1,1 •  PREGNANCY must be avoided while the woman is receiving LEFLUNOMIDE and prior to completion of the drug elimination procedure following discontinuance of the drug.,PREGNANCY,LEFLUNOMIDE
725258002,5/23/2015 21:50:20,1642397886,5/23/2015 21:49:13,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[CONTRAINDICATES],[CONTRAINDICATES],must be avoided while the woman is receiving,n/a,5,60,-1,13,71,TWrex-cause,803137-FS1,1 •  PREGNANCY must be avoided while the woman is receiving LEFLUNOMIDE and prior to completion of the drug elimination procedure following discontinuance of the drug.,PREGNANCY,LEFLUNOMIDE
725258003,5/23/2015 22:17:16,1642410107,5/23/2015 22:16:41,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[IS_A],[IS_A],INTESTINAL BOTULISM most common form of BOTULINUM TOXIN POISONING,n/a,2,60,1,20,85,TWrex-cause,811431-FS1,• INTESTINAL BOTULISM in infants is the most common form of BOTULINUM TOXIN POISONING with approximately 100 cases in the U.S. annually.,INTESTINAL BOTULISM,BOTULINUM TOXIN POISONING
725258003,5/23/2015 22:30:53,1642416822,5/23/2015 22:29:47,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],TOXIN POISONING,N/A,2,60,1,20,85,TWrex-cause,811431-FS1,• INTESTINAL BOTULISM in infants is the most common form of BOTULINUM TOXIN POISONING with approximately 100 cases in the U.S. annually.,INTESTINAL BOTULISM,BOTULINUM TOXIN POISONING
725258003,5/23/2015 22:32:40,1642417781,5/23/2015 22:31:28,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[IS_A],[IS_A],INTESTINAL BOTULISM is the most common form of BOTULINUM TOXIN POISONING,N/A,2,60,1,20,85,TWrex-cause,811431-FS1,• INTESTINAL BOTULISM in infants is the most common form of BOTULINUM TOXIN POISONING with approximately 100 cases in the U.S. annually.,INTESTINAL BOTULISM,BOTULINUM TOXIN POISONING
725258003,5/23/2015 22:33:51,1642418354,5/23/2015 22:32:45,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[IS_A],[IS_A],most common form of,N/A,2,60,1,20,85,TWrex-cause,811431-FS1,• INTESTINAL BOTULISM in infants is the most common form of BOTULINUM TOXIN POISONING with approximately 100 cases in the U.S. annually.,INTESTINAL BOTULISM,BOTULINUM TOXIN POISONING
725258003,5/23/2015 22:35:24,1642419113,5/23/2015 22:35:00,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[CAUSES],[CAUSES],INTESTINAL BOTULISM infants is the most common form of BOTULINUM TOXIN POISONING,n/a,2,60,1,20,85,TWrex-cause,811431-FS1,• INTESTINAL BOTULISM in infants is the most common form of BOTULINUM TOXIN POISONING with approximately 100 cases in the U.S. annually.,INTESTINAL BOTULISM,BOTULINUM TOXIN POISONING
725258003,5/23/2015 22:41:25,1642422351,5/23/2015 22:40:18,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[MANIFESTATION],[MANIFESTATION],INTESTINAL BOTULISM is form of BOTULINUM TOXIN POISONING,n/a,2,60,1,20,85,TWrex-cause,811431-FS1,• INTESTINAL BOTULISM in infants is the most common form of BOTULINUM TOXIN POISONING with approximately 100 cases in the U.S. annually.,INTESTINAL BOTULISM,BOTULINUM TOXIN POISONING
725258003,5/23/2015 23:07:42,1642435329,5/23/2015 23:07:25,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[IS_A],[IS_A],the most common form of,N/A,2,60,1,20,85,TWrex-cause,811431-FS1,• INTESTINAL BOTULISM in infants is the most common form of BOTULINUM TOXIN POISONING with approximately 100 cases in the U.S. annually.,INTESTINAL BOTULISM,BOTULINUM TOXIN POISONING
725258003,5/23/2015 23:13:05,1642437589,5/23/2015 23:12:37,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[ASSOCIATED_WITH],[ASSOCIATED_WITH],most common form of,n/a,2,60,1,20,85,TWrex-cause,811431-FS1,• INTESTINAL BOTULISM in infants is the most common form of BOTULINUM TOXIN POISONING with approximately 100 cases in the U.S. annually.,INTESTINAL BOTULISM,BOTULINUM TOXIN POISONING
725258003,5/23/2015 23:16:16,1642438915,5/23/2015 23:15:13,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],common form,none,2,60,1,20,85,TWrex-cause,811431-FS1,• INTESTINAL BOTULISM in infants is the most common form of BOTULINUM TOXIN POISONING with approximately 100 cases in the U.S. annually.,INTESTINAL BOTULISM,BOTULINUM TOXIN POISONING
725258003,5/23/2015 23:21:23,1642440862,5/23/2015 23:20:24,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[ASSOCIATED_WITH] [LOCATION],"[LOCATION]
[ASSOCIATED_WITH]",INTESTINAL with,n/a,2,60,1,20,85,TWrex-cause,811431-FS1,• INTESTINAL BOTULISM in infants is the most common form of BOTULINUM TOXIN POISONING with approximately 100 cases in the U.S. annually.,INTESTINAL BOTULISM,BOTULINUM TOXIN POISONING
725258003,5/23/2015 23:21:23,1642440867,5/23/2015 23:20:26,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[ASSOCIATED_WITH],[ASSOCIATED_WITH],most common form of,N/A,2,60,1,20,85,TWrex-cause,811431-FS1,• INTESTINAL BOTULISM in infants is the most common form of BOTULINUM TOXIN POISONING with approximately 100 cases in the U.S. annually.,INTESTINAL BOTULISM,BOTULINUM TOXIN POISONING
725258003,5/23/2015 23:31:08,1642445505,5/23/2015 23:30:39,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[LOCATION],[LOCATION],common form,N/A,2,60,1,20,85,TWrex-cause,811431-FS1,• INTESTINAL BOTULISM in infants is the most common form of BOTULINUM TOXIN POISONING with approximately 100 cases in the U.S. annually.,INTESTINAL BOTULISM,BOTULINUM TOXIN POISONING
725258003,5/23/2015 23:42:42,1642450860,5/23/2015 23:42:26,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[MANIFESTATION],[MANIFESTATION],common form,n/a,2,60,1,20,85,TWrex-cause,811431-FS1,• INTESTINAL BOTULISM in infants is the most common form of BOTULINUM TOXIN POISONING with approximately 100 cases in the U.S. annually.,INTESTINAL BOTULISM,BOTULINUM TOXIN POISONING
725258003,5/23/2015 23:51:13,1642454663,5/23/2015 23:51:03,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.161,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,2,60,1,20,85,TWrex-cause,811431-FS1,• INTESTINAL BOTULISM in infants is the most common form of BOTULINUM TOXIN POISONING with approximately 100 cases in the U.S. annually.,INTESTINAL BOTULISM,BOTULINUM TOXIN POISONING
725258003,5/24/2015 00:07:16,1642461805,5/24/2015 00:06:11,false,neodev,1,11382239,AUS,02,Strathfield,60.241.129.81,[IS_A],[IS_A],common form,N/A,2,60,1,20,85,TWrex-cause,811431-FS1,• INTESTINAL BOTULISM in infants is the most common form of BOTULINUM TOXIN POISONING with approximately 100 cases in the U.S. annually.,INTESTINAL BOTULISM,BOTULINUM TOXIN POISONING
725258004,5/23/2015 22:18:31,1642410775,5/23/2015 22:18:09,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],AEROBIC AND ANAEROBIC BACTERIA BACTERIAL VAGINOSIS.,n/a,121,32,1,139,62,TWrex-cause,812004-FS1,PID usually also involves other AEROBIC AND ANAEROBIC BACTERIA including pathogens involved in bacterial vaginosis (see  BACTERIAL VAGINOSIS.,BACTERIAL VAGINOSIS,AEROBIC AND ANAEROBIC BACTERIA
725258004,5/23/2015 22:33:31,1642418170,5/23/2015 22:32:40,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],ANAEROBIC BACTERIA,N/A,121,32,1,139,62,TWrex-cause,812004-FS1,PID usually also involves other AEROBIC AND ANAEROBIC BACTERIA including pathogens involved in bacterial vaginosis (see  BACTERIAL VAGINOSIS.,BACTERIAL VAGINOSIS,AEROBIC AND ANAEROBIC BACTERIA
725258004,5/23/2015 22:37:12,1642420169,5/23/2015 22:36:32,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[CAUSES],[CAUSES],PID usually also involves other AEROBIC AND ANAEROBIC BACTERIA including pathogens involved in bacterial vaginosis,n/a,121,32,1,139,62,TWrex-cause,812004-FS1,PID usually also involves other AEROBIC AND ANAEROBIC BACTERIA including pathogens involved in bacterial vaginosis (see  BACTERIAL VAGINOSIS.,BACTERIAL VAGINOSIS,AEROBIC AND ANAEROBIC BACTERIA
725258004,5/23/2015 22:37:37,1642420362,5/23/2015 22:35:54,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[IS_A],[IS_A],involves other AEROBIC AND ANAEROBIC BACTERIA BACTERIAL VAGINOSIS.,N/A,121,32,1,139,62,TWrex-cause,812004-FS1,PID usually also involves other AEROBIC AND ANAEROBIC BACTERIA including pathogens involved in bacterial vaginosis (see  BACTERIAL VAGINOSIS.,BACTERIAL VAGINOSIS,AEROBIC AND ANAEROBIC BACTERIA
725258004,5/23/2015 22:38:53,1642421017,5/23/2015 22:36:44,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[ASSOCIATED_WITH],[ASSOCIATED_WITH],involved in,N/A,121,32,1,139,62,TWrex-cause,812004-FS1,PID usually also involves other AEROBIC AND ANAEROBIC BACTERIA including pathogens involved in bacterial vaginosis (see  BACTERIAL VAGINOSIS.,BACTERIAL VAGINOSIS,AEROBIC AND ANAEROBIC BACTERIA
725258004,5/23/2015 22:43:18,1642423335,5/23/2015 22:42:29,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[PART_OF],[PART_OF],AEROBIC AND ANAEROBIC BACTERIA including BACTERIAL VAGINOSIS.,n/a,121,32,1,139,62,TWrex-cause,812004-FS1,PID usually also involves other AEROBIC AND ANAEROBIC BACTERIA including pathogens involved in bacterial vaginosis (see  BACTERIAL VAGINOSIS.,BACTERIAL VAGINOSIS,AEROBIC AND ANAEROBIC BACTERIA
725258004,5/23/2015 23:09:54,1642436173,5/23/2015 23:09:04,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[CAUSES],[CAUSES],involved in,N/A,121,32,1,139,62,TWrex-cause,812004-FS1,PID usually also involves other AEROBIC AND ANAEROBIC BACTERIA including pathogens involved in bacterial vaginosis (see  BACTERIAL VAGINOSIS.,BACTERIAL VAGINOSIS,AEROBIC AND ANAEROBIC BACTERIA
725258004,5/23/2015 23:16:11,1642438886,5/23/2015 23:15:16,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[ASSOCIATED_WITH],[ASSOCIATED_WITH],also involves,n/a,121,32,1,139,62,TWrex-cause,812004-FS1,PID usually also involves other AEROBIC AND ANAEROBIC BACTERIA including pathogens involved in bacterial vaginosis (see  BACTERIAL VAGINOSIS.,BACTERIAL VAGINOSIS,AEROBIC AND ANAEROBIC BACTERIA
725258004,5/23/2015 23:19:51,1642440300,5/23/2015 23:19:00,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],involves,none,121,32,1,139,62,TWrex-cause,812004-FS1,PID usually also involves other AEROBIC AND ANAEROBIC BACTERIA including pathogens involved in bacterial vaginosis (see  BACTERIAL VAGINOSIS.,BACTERIAL VAGINOSIS,AEROBIC AND ANAEROBIC BACTERIA
725258004,5/23/2015 23:23:12,1642441780,5/23/2015 23:22:38,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[ASSOCIATED_WITH],[ASSOCIATED_WITH],involved in,N/A,121,32,1,139,62,TWrex-cause,812004-FS1,PID usually also involves other AEROBIC AND ANAEROBIC BACTERIA including pathogens involved in bacterial vaginosis (see  BACTERIAL VAGINOSIS.,BACTERIAL VAGINOSIS,AEROBIC AND ANAEROBIC BACTERIA
725258004,5/23/2015 23:24:32,1642442335,5/23/2015 23:23:24,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[PART_OF] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[PART_OF]",involves including involved in,n/a,121,32,1,139,62,TWrex-cause,812004-FS1,PID usually also involves other AEROBIC AND ANAEROBIC BACTERIA including pathogens involved in bacterial vaginosis (see  BACTERIAL VAGINOSIS.,BACTERIAL VAGINOSIS,AEROBIC AND ANAEROBIC BACTERIA
725258004,5/23/2015 23:34:39,1642446904,5/23/2015 23:34:05,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[LOCATION],[LOCATION],involved in,N/A,121,32,1,139,62,TWrex-cause,812004-FS1,PID usually also involves other AEROBIC AND ANAEROBIC BACTERIA including pathogens involved in bacterial vaginosis (see  BACTERIAL VAGINOSIS.,BACTERIAL VAGINOSIS,AEROBIC AND ANAEROBIC BACTERIA
725258004,5/23/2015 23:43:41,1642451385,5/23/2015 23:43:22,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[PART_OF],[PART_OF],involves,n/a,121,32,1,139,62,TWrex-cause,812004-FS1,PID usually also involves other AEROBIC AND ANAEROBIC BACTERIA including pathogens involved in bacterial vaginosis (see  BACTERIAL VAGINOSIS.,BACTERIAL VAGINOSIS,AEROBIC AND ANAEROBIC BACTERIA
725258004,5/23/2015 23:52:18,1642455276,5/23/2015 23:52:06,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.161,[TREATS] [PREVENTS] [CAUSES] [NONE],"[TREATS]
[PREVENTS]
[CAUSES]
[NONE]",no,no,121,32,1,139,62,TWrex-cause,812004-FS1,PID usually also involves other AEROBIC AND ANAEROBIC BACTERIA including pathogens involved in bacterial vaginosis (see  BACTERIAL VAGINOSIS.,BACTERIAL VAGINOSIS,AEROBIC AND ANAEROBIC BACTERIA
725258004,5/24/2015 00:09:12,1642462517,5/24/2015 00:08:22,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[PREVENTS] [DIAGNOSE_BY_TEST_OR_DRUG],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]",including pathogens involved in bacterial vaginosis,n/a,121,32,1,139,62,TWrex-cause,812004-FS1,PID usually also involves other AEROBIC AND ANAEROBIC BACTERIA including pathogens involved in bacterial vaginosis (see  BACTERIAL VAGINOSIS.,BACTERIAL VAGINOSIS,AEROBIC AND ANAEROBIC BACTERIA
725258005,5/24/2015 00:40:39,1642475624,5/24/2015 00:39:56,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[PART_OF],[PART_OF],components of,n/a,0,84,1,31,95,TWrex-cause,810223-FS1,"ACELLULAR (A) PERTUSSIS VACCINES containing semipurified or purified components of  B PERTUSSIS  (eg, pertussis toxin; filamentous hemagglutinin; fimbriae; and pertactin, a protein) and D and T (DTaP) are usually preferred because they less often cause fever and local reactions.",ACELLULAR (A) PERTUSSIS VACCINES,B PERTUSSIS
725258005,5/24/2015 00:48:44,1642478804,5/24/2015 00:48:24,false,elite,1.0,31848723,USA,VA,Manassas,192.96.205.155,[CAUSES],[CAUSES],ACELLULAR PERTUSSIS VACCINES PERTUSSIS,N/A,0,84,1,31,95,TWrex-cause,810223-FS1,"ACELLULAR (A) PERTUSSIS VACCINES containing semipurified or purified components of  B PERTUSSIS  (eg, pertussis toxin; filamentous hemagglutinin; fimbriae; and pertactin, a protein) and D and T (DTaP) are usually preferred because they less often cause fever and local reactions.",ACELLULAR (A) PERTUSSIS VACCINES,B PERTUSSIS
725258005,5/24/2015 00:56:24,1642481252,5/24/2015 00:55:54,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[PART_OF],[PART_OF],containing components of,N/A,0,84,1,31,95,TWrex-cause,810223-FS1,"ACELLULAR (A) PERTUSSIS VACCINES containing semipurified or purified components of  B PERTUSSIS  (eg, pertussis toxin; filamentous hemagglutinin; fimbriae; and pertactin, a protein) and D and T (DTaP) are usually preferred because they less often cause fever and local reactions.",ACELLULAR (A) PERTUSSIS VACCINES,B PERTUSSIS
725258005,5/24/2015 00:56:33,1642481274,5/24/2015 00:55:48,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[OTHER],[OTHER],containing components of B PERTUSSIS,NA,0,84,1,31,95,TWrex-cause,810223-FS1,"ACELLULAR (A) PERTUSSIS VACCINES containing semipurified or purified components of  B PERTUSSIS  (eg, pertussis toxin; filamentous hemagglutinin; fimbriae; and pertactin, a protein) and D and T (DTaP) are usually preferred because they less often cause fever and local reactions.",ACELLULAR (A) PERTUSSIS VACCINES,B PERTUSSIS
725258005,5/24/2015 01:40:09,1642495560,5/24/2015 01:39:57,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[PART_OF],[PART_OF],components,N/A,0,84,1,31,95,TWrex-cause,810223-FS1,"ACELLULAR (A) PERTUSSIS VACCINES containing semipurified or purified components of  B PERTUSSIS  (eg, pertussis toxin; filamentous hemagglutinin; fimbriae; and pertactin, a protein) and D and T (DTaP) are usually preferred because they less often cause fever and local reactions.",ACELLULAR (A) PERTUSSIS VACCINES,B PERTUSSIS
725258005,5/24/2015 01:47:23,1642498083,5/24/2015 01:47:11,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[PART_OF],[PART_OF],components,N/A,0,84,1,31,95,TWrex-cause,810223-FS1,"ACELLULAR (A) PERTUSSIS VACCINES containing semipurified or purified components of  B PERTUSSIS  (eg, pertussis toxin; filamentous hemagglutinin; fimbriae; and pertactin, a protein) and D and T (DTaP) are usually preferred because they less often cause fever and local reactions.",ACELLULAR (A) PERTUSSIS VACCINES,B PERTUSSIS
725258005,5/24/2015 01:54:09,1642500412,5/24/2015 01:53:57,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[CAUSES],[CAUSES],because,N/A,0,84,1,31,95,TWrex-cause,810223-FS1,"ACELLULAR (A) PERTUSSIS VACCINES containing semipurified or purified components of  B PERTUSSIS  (eg, pertussis toxin; filamentous hemagglutinin; fimbriae; and pertactin, a protein) and D and T (DTaP) are usually preferred because they less often cause fever and local reactions.",ACELLULAR (A) PERTUSSIS VACCINES,B PERTUSSIS
725258005,5/24/2015 02:01:05,1642502639,5/24/2015 02:00:51,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[CAUSES],[CAUSES],cause,N/A,0,84,1,31,95,TWrex-cause,810223-FS1,"ACELLULAR (A) PERTUSSIS VACCINES containing semipurified or purified components of  B PERTUSSIS  (eg, pertussis toxin; filamentous hemagglutinin; fimbriae; and pertactin, a protein) and D and T (DTaP) are usually preferred because they less often cause fever and local reactions.",ACELLULAR (A) PERTUSSIS VACCINES,B PERTUSSIS
725258005,5/24/2015 02:08:42,1642504933,5/24/2015 02:08:29,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[CAUSES],[CAUSES],cause,N/A,0,84,1,31,95,TWrex-cause,810223-FS1,"ACELLULAR (A) PERTUSSIS VACCINES containing semipurified or purified components of  B PERTUSSIS  (eg, pertussis toxin; filamentous hemagglutinin; fimbriae; and pertactin, a protein) and D and T (DTaP) are usually preferred because they less often cause fever and local reactions.",ACELLULAR (A) PERTUSSIS VACCINES,B PERTUSSIS
725258005,5/24/2015 02:23:57,1642510079,5/24/2015 02:22:43,false,prodege,1.0,17379068,CAN,NB,Saint John,142.162.106.83,[PART_OF],[PART_OF],containing,N/A,0,84,1,31,95,TWrex-cause,810223-FS1,"ACELLULAR (A) PERTUSSIS VACCINES containing semipurified or purified components of  B PERTUSSIS  (eg, pertussis toxin; filamentous hemagglutinin; fimbriae; and pertactin, a protein) and D and T (DTaP) are usually preferred because they less often cause fever and local reactions.",ACELLULAR (A) PERTUSSIS VACCINES,B PERTUSSIS
725258005,5/24/2015 02:34:57,1642513458,5/24/2015 02:34:42,false,elite,1.0,32306791,USA,DE,Wilmington,199.58.86.213,[SYMPTOM],[SYMPTOM],PERTUSSIS protein),N/A,0,84,1,31,95,TWrex-cause,810223-FS1,"ACELLULAR (A) PERTUSSIS VACCINES containing semipurified or purified components of  B PERTUSSIS  (eg, pertussis toxin; filamentous hemagglutinin; fimbriae; and pertactin, a protein) and D and T (DTaP) are usually preferred because they less often cause fever and local reactions.",ACELLULAR (A) PERTUSSIS VACCINES,B PERTUSSIS
725258005,5/24/2015 02:37:40,1642514277,5/24/2015 02:37:29,false,elite,1.0,31913360,USA,VA,Manassas,207.244.77.3,[CAUSES],[CAUSES],PERTUSSIS,jjj,0,84,1,31,95,TWrex-cause,810223-FS1,"ACELLULAR (A) PERTUSSIS VACCINES containing semipurified or purified components of  B PERTUSSIS  (eg, pertussis toxin; filamentous hemagglutinin; fimbriae; and pertactin, a protein) and D and T (DTaP) are usually preferred because they less often cause fever and local reactions.",ACELLULAR (A) PERTUSSIS VACCINES,B PERTUSSIS
725258005,5/24/2015 02:57:29,1642519919,5/24/2015 02:56:06,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[PART_OF],[PART_OF],ACELLULAR (A) PERTUSSIS VACCINES containing B PERTUSSIS,N/A,0,84,1,31,95,TWrex-cause,810223-FS1,"ACELLULAR (A) PERTUSSIS VACCINES containing semipurified or purified components of  B PERTUSSIS  (eg, pertussis toxin; filamentous hemagglutinin; fimbriae; and pertactin, a protein) and D and T (DTaP) are usually preferred because they less often cause fever and local reactions.",ACELLULAR (A) PERTUSSIS VACCINES,B PERTUSSIS
725258005,5/24/2015 03:07:07,1642523013,5/24/2015 03:05:35,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[CAUSES] [LOCATION] [OTHER],"[CAUSES]
[LOCATION]
[OTHER]",containing components cause local,N/a,0,84,1,31,95,TWrex-cause,810223-FS1,"ACELLULAR (A) PERTUSSIS VACCINES containing semipurified or purified components of  B PERTUSSIS  (eg, pertussis toxin; filamentous hemagglutinin; fimbriae; and pertactin, a protein) and D and T (DTaP) are usually preferred because they less often cause fever and local reactions.",ACELLULAR (A) PERTUSSIS VACCINES,B PERTUSSIS
725258005,5/24/2015 03:29:07,1642528908,5/24/2015 03:28:22,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[PART_OF],[PART_OF],containing components of B PERTUSSIS,n/a,0,84,1,31,95,TWrex-cause,810223-FS1,"ACELLULAR (A) PERTUSSIS VACCINES containing semipurified or purified components of  B PERTUSSIS  (eg, pertussis toxin; filamentous hemagglutinin; fimbriae; and pertactin, a protein) and D and T (DTaP) are usually preferred because they less often cause fever and local reactions.",ACELLULAR (A) PERTUSSIS VACCINES,B PERTUSSIS
725258006,5/24/2015 00:37:52,1642474450,5/24/2015 00:37:09,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],effect.,n/a,15,108,-1,29,121,TWrex-cause,803932-FS1,"In adults with TYPE 2 DIABETES children, and women with gestational diabetes, insulin analogues and regular HUMAN INSULIN do not differ in effect.",TYPE 2 DIABETES,HUMAN INSULIN
725258006,5/24/2015 00:47:03,1642478212,5/24/2015 00:46:42,false,elite,1.0,31848723,USA,VA,Manassas,192.96.205.155,[SYMPTOM],[SYMPTOM],TYPE DIABETES INSULIN,N/A,15,108,-1,29,121,TWrex-cause,803932-FS1,"In adults with TYPE 2 DIABETES children, and women with gestational diabetes, insulin analogues and regular HUMAN INSULIN do not differ in effect.",TYPE 2 DIABETES,HUMAN INSULIN
725258006,5/24/2015 00:52:56,1642480125,5/24/2015 00:51:55,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],in effect.,N/A,15,108,-1,29,121,TWrex-cause,803932-FS1,"In adults with TYPE 2 DIABETES children, and women with gestational diabetes, insulin analogues and regular HUMAN INSULIN do not differ in effect.",TYPE 2 DIABETES,HUMAN INSULIN
725258006,5/24/2015 00:53:11,1642480191,5/24/2015 00:52:32,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[OTHER],[OTHER],in effect.,NA,15,108,-1,29,121,TWrex-cause,803932-FS1,"In adults with TYPE 2 DIABETES children, and women with gestational diabetes, insulin analogues and regular HUMAN INSULIN do not differ in effect.",TYPE 2 DIABETES,HUMAN INSULIN
725258006,5/24/2015 01:11:52,1642486640,5/24/2015 01:11:06,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[DIAGNOSE_BY_TEST_OR_DRUG] [SIDE_EFFECT] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[SIDE_EFFECT]",do not differ in effect.,N/A,15,108,-1,29,121,TWrex-cause,803932-FS1,"In adults with TYPE 2 DIABETES children, and women with gestational diabetes, insulin analogues and regular HUMAN INSULIN do not differ in effect.",TYPE 2 DIABETES,HUMAN INSULIN
725258006,5/24/2015 01:39:01,1642495186,5/24/2015 01:38:46,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[LOCATION],[LOCATION],insulin,N/A,15,108,-1,29,121,TWrex-cause,803932-FS1,"In adults with TYPE 2 DIABETES children, and women with gestational diabetes, insulin analogues and regular HUMAN INSULIN do not differ in effect.",TYPE 2 DIABETES,HUMAN INSULIN
725258006,5/24/2015 01:46:17,1642497761,5/24/2015 01:46:02,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[CAUSES],[CAUSES],with,N/A,15,108,-1,29,121,TWrex-cause,803932-FS1,"In adults with TYPE 2 DIABETES children, and women with gestational diabetes, insulin analogues and regular HUMAN INSULIN do not differ in effect.",TYPE 2 DIABETES,HUMAN INSULIN
725258006,5/24/2015 01:53:00,1642500036,5/24/2015 01:52:48,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[SYMPTOM],[SYMPTOM],gestational,N/A,15,108,-1,29,121,TWrex-cause,803932-FS1,"In adults with TYPE 2 DIABETES children, and women with gestational diabetes, insulin analogues and regular HUMAN INSULIN do not differ in effect.",TYPE 2 DIABETES,HUMAN INSULIN
725258006,5/24/2015 01:59:52,1642502241,5/24/2015 01:59:38,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[CAUSES],[CAUSES],gestational,N/A,15,108,-1,29,121,TWrex-cause,803932-FS1,"In adults with TYPE 2 DIABETES children, and women with gestational diabetes, insulin analogues and regular HUMAN INSULIN do not differ in effect.",TYPE 2 DIABETES,HUMAN INSULIN
725258006,5/24/2015 02:07:32,1642504550,5/24/2015 02:07:18,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[SYMPTOM],[SYMPTOM],"diabetes,",N/A,15,108,-1,29,121,TWrex-cause,803932-FS1,"In adults with TYPE 2 DIABETES children, and women with gestational diabetes, insulin analogues and regular HUMAN INSULIN do not differ in effect.",TYPE 2 DIABETES,HUMAN INSULIN
725258006,5/24/2015 02:15:05,1642506942,5/24/2015 02:13:28,false,prodege,1.0,17379068,CAN,NB,Saint John,142.162.106.83,[ASSOCIATED_WITH],[ASSOCIATED_WITH],differ effect.,N/A,15,108,-1,29,121,TWrex-cause,803932-FS1,"In adults with TYPE 2 DIABETES children, and women with gestational diabetes, insulin analogues and regular HUMAN INSULIN do not differ in effect.",TYPE 2 DIABETES,HUMAN INSULIN
725258006,5/24/2015 02:33:22,1642512876,5/24/2015 02:33:06,false,elite,1.0,32306791,USA,DE,Wilmington,199.58.86.213,[CAUSES],[CAUSES],HUMAN INSULIN,N/A,15,108,-1,29,121,TWrex-cause,803932-FS1,"In adults with TYPE 2 DIABETES children, and women with gestational diabetes, insulin analogues and regular HUMAN INSULIN do not differ in effect.",TYPE 2 DIABETES,HUMAN INSULIN
725258006,5/24/2015 02:36:37,1642514008,5/24/2015 02:36:26,false,elite,1.0,31913360,USA,VA,Manassas,207.244.77.3,[LOCATION],[LOCATION],insulin,gh,15,108,-1,29,121,TWrex-cause,803932-FS1,"In adults with TYPE 2 DIABETES children, and women with gestational diabetes, insulin analogues and regular HUMAN INSULIN do not differ in effect.",TYPE 2 DIABETES,HUMAN INSULIN
725258006,5/24/2015 02:47:05,1642517049,5/24/2015 02:46:52,false,neodev,1.0,32562748,CAN,BC,Vancouver,108.180.140.140,[PREVENTS] [SYMPTOM],"[PREVENTS]
[SYMPTOM]","TYPE 2 DIABETES gestational diabetes,",N/A,15,108,-1,29,121,TWrex-cause,803932-FS1,"In adults with TYPE 2 DIABETES children, and women with gestational diabetes, insulin analogues and regular HUMAN INSULIN do not differ in effect.",TYPE 2 DIABETES,HUMAN INSULIN
725258006,5/24/2015 02:54:28,1642519019,5/24/2015 02:54:10,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],In adults TYPE 2 DIABETES HUMAN INSULIN do effect.,N/A,15,108,-1,29,121,TWrex-cause,803932-FS1,"In adults with TYPE 2 DIABETES children, and women with gestational diabetes, insulin analogues and regular HUMAN INSULIN do not differ in effect.",TYPE 2 DIABETES,HUMAN INSULIN
725258007,5/23/2015 20:36:26,1642360811,5/23/2015 20:36:10,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],Drug Treatment for,N/A,351,256,-1,369,268,TWrex-cause,803812-FS1,"BC]  Specific recommendation: • Treat patients with secondary or tertiary hyperparathyroidism with: ◊ Phosphate binders to keep serum phosphate levels as close to the normal range as possible ◊ Either calcitriol or noncalcemic vitamin D analogues, such as PARICALCITOL or doxercalciferol, as needed to lower PTH levels • See table  Drug Treatment for HYPERPARATHYROIDISM",HYPERPARATHYROIDISM,PARICALCITOL
725258007,5/23/2015 20:44:12,1642365213,5/23/2015 20:43:24,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],PARICALCITOL See table Drug Treatment for HYPERPARATHYROIDISM,N/A,351,256,-1,369,268,TWrex-cause,803812-FS1,"BC]  Specific recommendation: • Treat patients with secondary or tertiary hyperparathyroidism with: ◊ Phosphate binders to keep serum phosphate levels as close to the normal range as possible ◊ Either calcitriol or noncalcemic vitamin D analogues, such as PARICALCITOL or doxercalciferol, as needed to lower PTH levels • See table  Drug Treatment for HYPERPARATHYROIDISM",HYPERPARATHYROIDISM,PARICALCITOL
725258007,5/23/2015 20:45:35,1642366000,5/23/2015 20:45:18,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],as needed,n/a,351,256,-1,369,268,TWrex-cause,803812-FS1,"BC]  Specific recommendation: • Treat patients with secondary or tertiary hyperparathyroidism with: ◊ Phosphate binders to keep serum phosphate levels as close to the normal range as possible ◊ Either calcitriol or noncalcemic vitamin D analogues, such as PARICALCITOL or doxercalciferol, as needed to lower PTH levels • See table  Drug Treatment for HYPERPARATHYROIDISM",HYPERPARATHYROIDISM,PARICALCITOL
725258007,5/23/2015 20:51:20,1642369404,5/23/2015 20:51:01,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],Treat with:,n/a,351,256,-1,369,268,TWrex-cause,803812-FS1,"BC]  Specific recommendation: • Treat patients with secondary or tertiary hyperparathyroidism with: ◊ Phosphate binders to keep serum phosphate levels as close to the normal range as possible ◊ Either calcitriol or noncalcemic vitamin D analogues, such as PARICALCITOL or doxercalciferol, as needed to lower PTH levels • See table  Drug Treatment for HYPERPARATHYROIDISM",HYPERPARATHYROIDISM,PARICALCITOL
725258007,5/23/2015 20:56:51,1642372239,5/23/2015 20:55:57,false,instagc,1.0,30880172,USA,CA,Los Angeles,166.170.50.98,[OTHER],[OTHER],Treatment for,Treated by,351,256,-1,369,268,TWrex-cause,803812-FS1,"BC]  Specific recommendation: • Treat patients with secondary or tertiary hyperparathyroidism with: ◊ Phosphate binders to keep serum phosphate levels as close to the normal range as possible ◊ Either calcitriol or noncalcemic vitamin D analogues, such as PARICALCITOL or doxercalciferol, as needed to lower PTH levels • See table  Drug Treatment for HYPERPARATHYROIDISM",HYPERPARATHYROIDISM,PARICALCITOL
725258007,5/23/2015 20:59:51,1642373650,5/23/2015 20:59:33,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],Treatment for,n/a,351,256,-1,369,268,TWrex-cause,803812-FS1,"BC]  Specific recommendation: • Treat patients with secondary or tertiary hyperparathyroidism with: ◊ Phosphate binders to keep serum phosphate levels as close to the normal range as possible ◊ Either calcitriol or noncalcemic vitamin D analogues, such as PARICALCITOL or doxercalciferol, as needed to lower PTH levels • See table  Drug Treatment for HYPERPARATHYROIDISM",HYPERPARATHYROIDISM,PARICALCITOL
725258007,5/23/2015 21:01:40,1642374458,5/23/2015 21:01:10,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],PARICALCITOL Drug Treatment for HYPERPARATHYROIDISM,na,351,256,-1,369,268,TWrex-cause,803812-FS1,"BC]  Specific recommendation: • Treat patients with secondary or tertiary hyperparathyroidism with: ◊ Phosphate binders to keep serum phosphate levels as close to the normal range as possible ◊ Either calcitriol or noncalcemic vitamin D analogues, such as PARICALCITOL or doxercalciferol, as needed to lower PTH levels • See table  Drug Treatment for HYPERPARATHYROIDISM",HYPERPARATHYROIDISM,PARICALCITOL
725258007,5/23/2015 21:07:11,1642376941,5/23/2015 21:05:51,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],Drug Treatment,N/A,351,256,-1,369,268,TWrex-cause,803812-FS1,"BC]  Specific recommendation: • Treat patients with secondary or tertiary hyperparathyroidism with: ◊ Phosphate binders to keep serum phosphate levels as close to the normal range as possible ◊ Either calcitriol or noncalcemic vitamin D analogues, such as PARICALCITOL or doxercalciferol, as needed to lower PTH levels • See table  Drug Treatment for HYPERPARATHYROIDISM",HYPERPARATHYROIDISM,PARICALCITOL
725258007,5/23/2015 21:38:42,1642392437,5/23/2015 21:38:10,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],needed Treatment for,n/a,351,256,-1,369,268,TWrex-cause,803812-FS1,"BC]  Specific recommendation: • Treat patients with secondary or tertiary hyperparathyroidism with: ◊ Phosphate binders to keep serum phosphate levels as close to the normal range as possible ◊ Either calcitriol or noncalcemic vitamin D analogues, such as PARICALCITOL or doxercalciferol, as needed to lower PTH levels • See table  Drug Treatment for HYPERPARATHYROIDISM",HYPERPARATHYROIDISM,PARICALCITOL
725258007,5/23/2015 21:47:50,1642396738,5/23/2015 21:46:22,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [PREVENTS] [TREATS],"[TREATS]
[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]","Specific recommendation: Treat patients with secondary or tertiary hyperparathyroidism with: Phosphate binders to keep serum phosphate levels as close to the normal range as possible Either calcitriol or noncalcemic vitamin D analogues, such as PARICALCITOL or doxercalciferol, as needed to lower PTH levels See table Drug Treatment for HYPERPARATHYROIDISM",n/a,351,256,-1,369,268,TWrex-cause,803812-FS1,"BC]  Specific recommendation: • Treat patients with secondary or tertiary hyperparathyroidism with: ◊ Phosphate binders to keep serum phosphate levels as close to the normal range as possible ◊ Either calcitriol or noncalcemic vitamin D analogues, such as PARICALCITOL or doxercalciferol, as needed to lower PTH levels • See table  Drug Treatment for HYPERPARATHYROIDISM",HYPERPARATHYROIDISM,PARICALCITOL
725258007,5/23/2015 21:49:13,1642397341,5/23/2015 21:48:14,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],as needed to lower,N/A,351,256,-1,369,268,TWrex-cause,803812-FS1,"BC]  Specific recommendation: • Treat patients with secondary or tertiary hyperparathyroidism with: ◊ Phosphate binders to keep serum phosphate levels as close to the normal range as possible ◊ Either calcitriol or noncalcemic vitamin D analogues, such as PARICALCITOL or doxercalciferol, as needed to lower PTH levels • See table  Drug Treatment for HYPERPARATHYROIDISM",HYPERPARATHYROIDISM,PARICALCITOL
725258007,5/23/2015 21:51:37,1642398373,5/23/2015 21:51:16,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],Treatment,N/A,351,256,-1,369,268,TWrex-cause,803812-FS1,"BC]  Specific recommendation: • Treat patients with secondary or tertiary hyperparathyroidism with: ◊ Phosphate binders to keep serum phosphate levels as close to the normal range as possible ◊ Either calcitriol or noncalcemic vitamin D analogues, such as PARICALCITOL or doxercalciferol, as needed to lower PTH levels • See table  Drug Treatment for HYPERPARATHYROIDISM",HYPERPARATHYROIDISM,PARICALCITOL
725258007,5/23/2015 21:53:32,1642399049,5/23/2015 21:52:52,false,elite,1.0,30064988,GBR,B4,Bradford,92.22.135.10,[TREATS],[TREATS],Drug Treatment,N/A,351,256,-1,369,268,TWrex-cause,803812-FS1,"BC]  Specific recommendation: • Treat patients with secondary or tertiary hyperparathyroidism with: ◊ Phosphate binders to keep serum phosphate levels as close to the normal range as possible ◊ Either calcitriol or noncalcemic vitamin D analogues, such as PARICALCITOL or doxercalciferol, as needed to lower PTH levels • See table  Drug Treatment for HYPERPARATHYROIDISM",HYPERPARATHYROIDISM,PARICALCITOL
725258007,5/23/2015 21:54:04,1642399314,5/23/2015 21:53:15,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[TREATS],[TREATS],Treatment for,n/a,351,256,-1,369,268,TWrex-cause,803812-FS1,"BC]  Specific recommendation: • Treat patients with secondary or tertiary hyperparathyroidism with: ◊ Phosphate binders to keep serum phosphate levels as close to the normal range as possible ◊ Either calcitriol or noncalcemic vitamin D analogues, such as PARICALCITOL or doxercalciferol, as needed to lower PTH levels • See table  Drug Treatment for HYPERPARATHYROIDISM",HYPERPARATHYROIDISM,PARICALCITOL
725258007,5/23/2015 21:57:57,1642400742,5/23/2015 21:57:00,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[TREATS],[TREATS],Treatment for,n/a,351,256,-1,369,268,TWrex-cause,803812-FS1,"BC]  Specific recommendation: • Treat patients with secondary or tertiary hyperparathyroidism with: ◊ Phosphate binders to keep serum phosphate levels as close to the normal range as possible ◊ Either calcitriol or noncalcemic vitamin D analogues, such as PARICALCITOL or doxercalciferol, as needed to lower PTH levels • See table  Drug Treatment for HYPERPARATHYROIDISM",HYPERPARATHYROIDISM,PARICALCITOL
725258008,5/23/2015 22:02:55,1642402760,5/23/2015 22:02:01,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[IS_A],[IS_A],is a,N/A,0,80,1,18,92,TWrex-cause,810500-FS1,ECTHYMA GANGRENOSUM in neutropenic patients is a skin lesion pathognomonic for  P AERUGINOSA,ECTHYMA GANGRENOSUM,P AERUGINOSA
725258008,5/23/2015 22:09:31,1642406315,5/23/2015 22:08:50,false,elite,1.0,30064988,GBR,B4,Bradford,92.22.135.10,[MANIFESTATION],[MANIFESTATION],pathognomonic,N/A,0,80,1,18,92,TWrex-cause,810500-FS1,ECTHYMA GANGRENOSUM in neutropenic patients is a skin lesion pathognomonic for  P AERUGINOSA,ECTHYMA GANGRENOSUM,P AERUGINOSA
725258008,5/23/2015 22:14:29,1642408790,5/23/2015 22:14:09,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],ECTHYMA GANGRENOSUM in patients is a pathognomonic for P AERUGINOSA,n/a,0,80,1,18,92,TWrex-cause,810500-FS1,ECTHYMA GANGRENOSUM in neutropenic patients is a skin lesion pathognomonic for  P AERUGINOSA,ECTHYMA GANGRENOSUM,P AERUGINOSA
725258008,5/23/2015 22:20:04,1642411531,5/23/2015 22:18:37,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[IS_A],[IS_A],is a,n/a,0,80,1,18,92,TWrex-cause,810500-FS1,ECTHYMA GANGRENOSUM in neutropenic patients is a skin lesion pathognomonic for  P AERUGINOSA,ECTHYMA GANGRENOSUM,P AERUGINOSA
725258008,5/23/2015 22:20:45,1642411880,5/23/2015 22:19:34,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[IS_A],[IS_A],is a skin lesion pathognomonic for,n/a,0,80,1,18,92,TWrex-cause,810500-FS1,ECTHYMA GANGRENOSUM in neutropenic patients is a skin lesion pathognomonic for  P AERUGINOSA,ECTHYMA GANGRENOSUM,P AERUGINOSA
725258008,5/23/2015 22:22:10,1642412696,5/23/2015 22:20:18,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES],[CAUSES],ECTHYMA GANGRENOSUM skin lesion pathognomonic for P AERUGINOSA,N/A,0,80,1,18,92,TWrex-cause,810500-FS1,ECTHYMA GANGRENOSUM in neutropenic patients is a skin lesion pathognomonic for  P AERUGINOSA,ECTHYMA GANGRENOSUM,P AERUGINOSA
725258008,5/23/2015 22:23:56,1642413541,5/23/2015 22:22:46,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],lesion pathognomonic for P AERUGINOSA,N/A,0,80,1,18,92,TWrex-cause,810500-FS1,ECTHYMA GANGRENOSUM in neutropenic patients is a skin lesion pathognomonic for  P AERUGINOSA,ECTHYMA GANGRENOSUM,P AERUGINOSA
725258008,5/23/2015 22:26:07,1642414573,5/23/2015 22:25:40,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[LOCATION],[LOCATION],ECTHYMA GANGRENOSUM,N/A,0,80,1,18,92,TWrex-cause,810500-FS1,ECTHYMA GANGRENOSUM in neutropenic patients is a skin lesion pathognomonic for  P AERUGINOSA,ECTHYMA GANGRENOSUM,P AERUGINOSA
725258008,5/23/2015 22:31:53,1642417388,5/23/2015 22:31:22,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[ASSOCIATED_WITH],[ASSOCIATED_WITH],ECTHYMA GANGRENOSUM neutropenic patients skin lesion pathognomonic for P AERUGINOSA,n/a,0,80,1,18,92,TWrex-cause,810500-FS1,ECTHYMA GANGRENOSUM in neutropenic patients is a skin lesion pathognomonic for  P AERUGINOSA,ECTHYMA GANGRENOSUM,P AERUGINOSA
725258008,5/23/2015 22:35:28,1642419148,5/23/2015 22:34:55,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[TREATS],[TREATS],ECTHYMA GANGRENOSUM for P AERUGINOSA,n/a,0,80,1,18,92,TWrex-cause,810500-FS1,ECTHYMA GANGRENOSUM in neutropenic patients is a skin lesion pathognomonic for  P AERUGINOSA,ECTHYMA GANGRENOSUM,P AERUGINOSA
725258008,5/23/2015 23:05:07,1642434274,5/23/2015 23:04:07,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[TREATS],[TREATS],pathognomonic,N/A,0,80,1,18,92,TWrex-cause,810500-FS1,ECTHYMA GANGRENOSUM in neutropenic patients is a skin lesion pathognomonic for  P AERUGINOSA,ECTHYMA GANGRENOSUM,P AERUGINOSA
725258008,5/23/2015 23:09:26,1642435998,5/23/2015 23:08:50,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[ASSOCIATED_WITH],[ASSOCIATED_WITH],in neutropenic patients is a skin lesion,n/a,0,80,1,18,92,TWrex-cause,810500-FS1,ECTHYMA GANGRENOSUM in neutropenic patients is a skin lesion pathognomonic for  P AERUGINOSA,ECTHYMA GANGRENOSUM,P AERUGINOSA
725258008,5/23/2015 23:11:14,1642436773,5/23/2015 23:09:32,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[IS_A] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]",in is a,n/a,0,80,1,18,92,TWrex-cause,810500-FS1,ECTHYMA GANGRENOSUM in neutropenic patients is a skin lesion pathognomonic for  P AERUGINOSA,ECTHYMA GANGRENOSUM,P AERUGINOSA
725258008,5/23/2015 23:11:18,1642436813,5/23/2015 23:10:04,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A],[IS_A],is a,N/A,0,80,1,18,92,TWrex-cause,810500-FS1,ECTHYMA GANGRENOSUM in neutropenic patients is a skin lesion pathognomonic for  P AERUGINOSA,ECTHYMA GANGRENOSUM,P AERUGINOSA
725258008,5/23/2015 23:11:39,1642436971,5/23/2015 23:11:02,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],pathognomonic,none,0,80,1,18,92,TWrex-cause,810500-FS1,ECTHYMA GANGRENOSUM in neutropenic patients is a skin lesion pathognomonic for  P AERUGINOSA,ECTHYMA GANGRENOSUM,P AERUGINOSA
725258009,5/24/2015 00:36:30,1642473826,5/24/2015 00:36:16,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[CAUSES],[CAUSES],disturbed by,n/a,0,104,1,10,110,TWrex-cause,815080-FS1,SEASICKNESS has such a remarkable effect because both the sense of sight and touch are disturbed by the MOTION of a craft on water.,SEASICKNESS,MOTION
725258009,5/24/2015 00:46:01,1642477886,5/24/2015 00:45:46,false,elite,1.0,31848723,USA,VA,Manassas,192.96.205.155,[SYMPTOM],[SYMPTOM],SEASICKNESS MOTION,N/A,0,104,1,10,110,TWrex-cause,815080-FS1,SEASICKNESS has such a remarkable effect because both the sense of sight and touch are disturbed by the MOTION of a craft on water.,SEASICKNESS,MOTION
725258009,5/24/2015 00:49:51,1642479252,5/24/2015 00:48:58,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],disturbed by,N/A,0,104,1,10,110,TWrex-cause,815080-FS1,SEASICKNESS has such a remarkable effect because both the sense of sight and touch are disturbed by the MOTION of a craft on water.,SEASICKNESS,MOTION
725258009,5/24/2015 00:50:05,1642479333,5/24/2015 00:49:37,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[OTHER],[OTHER],are disturbed by the MOTION,NA,0,104,1,10,110,TWrex-cause,815080-FS1,SEASICKNESS has such a remarkable effect because both the sense of sight and touch are disturbed by the MOTION of a craft on water.,SEASICKNESS,MOTION
725258009,5/24/2015 01:09:19,1642485742,5/24/2015 01:08:23,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[ASSOCIATED_WITH] [SIDE_EFFECT],"[ASSOCIATED_WITH]
[SIDE_EFFECT]",remarkable effect because disturbed by,N/A,0,104,1,10,110,TWrex-cause,815080-FS1,SEASICKNESS has such a remarkable effect because both the sense of sight and touch are disturbed by the MOTION of a craft on water.,SEASICKNESS,MOTION
725258009,5/24/2015 01:38:16,1642494899,5/24/2015 01:38:02,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[CAUSES],[CAUSES],by,N/A,0,104,1,10,110,TWrex-cause,815080-FS1,SEASICKNESS has such a remarkable effect because both the sense of sight and touch are disturbed by the MOTION of a craft on water.,SEASICKNESS,MOTION
725258009,5/24/2015 01:45:34,1642497571,5/24/2015 01:45:23,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[CAUSES],[CAUSES],because,N/A,0,104,1,10,110,TWrex-cause,815080-FS1,SEASICKNESS has such a remarkable effect because both the sense of sight and touch are disturbed by the MOTION of a craft on water.,SEASICKNESS,MOTION
725258009,5/24/2015 01:52:20,1642499872,5/24/2015 01:52:05,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[CAUSES],[CAUSES],because,N/A,0,104,1,10,110,TWrex-cause,815080-FS1,SEASICKNESS has such a remarkable effect because both the sense of sight and touch are disturbed by the MOTION of a craft on water.,SEASICKNESS,MOTION
725258009,5/24/2015 01:58:50,1642502005,5/24/2015 01:58:37,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[CAUSES],[CAUSES],because,N/A,0,104,1,10,110,TWrex-cause,815080-FS1,SEASICKNESS has such a remarkable effect because both the sense of sight and touch are disturbed by the MOTION of a craft on water.,SEASICKNESS,MOTION
725258009,5/24/2015 02:04:07,1642503461,5/24/2015 02:03:54,false,elite,1,31502056,USA,VA,Manassas,198.7.58.103,[SIDE_EFFECT],[SIDE_EFFECT],effect,N/A,0,104,1,10,110,TWrex-cause,815080-FS1,SEASICKNESS has such a remarkable effect because both the sense of sight and touch are disturbed by the MOTION of a craft on water.,SEASICKNESS,MOTION
725258009,5/24/2015 02:06:49,1642504276,5/24/2015 02:06:37,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[SYMPTOM],[SYMPTOM],has,N/A,0,104,1,10,110,TWrex-cause,815080-FS1,SEASICKNESS has such a remarkable effect because both the sense of sight and touch are disturbed by the MOTION of a craft on water.,SEASICKNESS,MOTION
725258009,5/24/2015 02:10:31,1642505517,5/24/2015 02:09:36,false,prodege,1.0,17379068,CAN,NB,Saint John,142.162.106.83,[SYMPTOM],[SYMPTOM],disturbed,N/A,0,104,1,10,110,TWrex-cause,815080-FS1,SEASICKNESS has such a remarkable effect because both the sense of sight and touch are disturbed by the MOTION of a craft on water.,SEASICKNESS,MOTION
725258009,5/24/2015 02:32:18,1642512479,5/24/2015 02:31:55,false,elite,1.0,32306791,USA,DE,Wilmington,199.58.86.213,[LOCATION],[LOCATION],SEASICKNESS MOTION,N/A,0,104,1,10,110,TWrex-cause,815080-FS1,SEASICKNESS has such a remarkable effect because both the sense of sight and touch are disturbed by the MOTION of a craft on water.,SEASICKNESS,MOTION
725258009,5/24/2015 02:35:46,1642513729,5/24/2015 02:35:31,false,elite,1.0,31913360,USA,VA,Manassas,207.244.77.2,[MANIFESTATION],[MANIFESTATION],are,;l;,0,104,1,10,110,TWrex-cause,815080-FS1,SEASICKNESS has such a remarkable effect because both the sense of sight and touch are disturbed by the MOTION of a craft on water.,SEASICKNESS,MOTION
725258009,5/24/2015 02:46:26,1642516891,5/24/2015 02:45:49,false,neodev,1.0,32562748,CAN,BC,Vancouver,108.180.140.140,[DIAGNOSE_BY_TEST_OR_DRUG] [SYMPTOM],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SYMPTOM]",SEASICKNESS and MOTION,N/A,0,104,1,10,110,TWrex-cause,815080-FS1,SEASICKNESS has such a remarkable effect because both the sense of sight and touch are disturbed by the MOTION of a craft on water.,SEASICKNESS,MOTION
725258010,5/24/2015 00:38:20,1642474648,5/24/2015 00:37:53,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[PREVENTS],[PREVENTS],prevention,n/a,147,94,-1,178,124,TWrex-cause,803660-FS1,"1]  Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, et al. Long term, LOW INTENSITY WARFARIN THERAPY for the prevention of RECURRENT VENOUS THROMBOEMBOLISM",RECURRENT VENOUS THROMBOEMBOLISM,LOW INTENSITY WARFARIN THERAPY
725258010,5/24/2015 00:47:23,1642478339,5/24/2015 00:47:05,false,elite,1.0,31848723,USA,VA,Manassas,192.96.205.155,[CAUSES],[CAUSES],LOW INTENSITY WARFARIN THERAPY THROMBOEMBOLISM,N/A,147,94,-1,178,124,TWrex-cause,803660-FS1,"1]  Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, et al. Long term, LOW INTENSITY WARFARIN THERAPY for the prevention of RECURRENT VENOUS THROMBOEMBOLISM",RECURRENT VENOUS THROMBOEMBOLISM,LOW INTENSITY WARFARIN THERAPY
725258010,5/24/2015 00:53:14,1642480222,5/24/2015 00:52:57,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[PREVENTS],[PREVENTS],prevention of,N/A,147,94,-1,178,124,TWrex-cause,803660-FS1,"1]  Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, et al. Long term, LOW INTENSITY WARFARIN THERAPY for the prevention of RECURRENT VENOUS THROMBOEMBOLISM",RECURRENT VENOUS THROMBOEMBOLISM,LOW INTENSITY WARFARIN THERAPY
725258010,5/24/2015 00:53:40,1642480276,5/24/2015 00:53:13,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[OTHER],[OTHER],prevention of RECURRENT VENOUS THROMBOEMBOLISM,NA,147,94,-1,178,124,TWrex-cause,803660-FS1,"1]  Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, et al. Long term, LOW INTENSITY WARFARIN THERAPY for the prevention of RECURRENT VENOUS THROMBOEMBOLISM",RECURRENT VENOUS THROMBOEMBOLISM,LOW INTENSITY WARFARIN THERAPY
725258010,5/24/2015 01:12:40,1642486971,5/24/2015 01:12:05,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[PREVENTS],[PREVENTS],for the prevention of,N/A,147,94,-1,178,124,TWrex-cause,803660-FS1,"1]  Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, et al. Long term, LOW INTENSITY WARFARIN THERAPY for the prevention of RECURRENT VENOUS THROMBOEMBOLISM",RECURRENT VENOUS THROMBOEMBOLISM,LOW INTENSITY WARFARIN THERAPY
725258010,5/24/2015 01:39:14,1642495243,5/24/2015 01:39:03,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[PREVENTS],[PREVENTS],prevention,N/A,147,94,-1,178,124,TWrex-cause,803660-FS1,"1]  Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, et al. Long term, LOW INTENSITY WARFARIN THERAPY for the prevention of RECURRENT VENOUS THROMBOEMBOLISM",RECURRENT VENOUS THROMBOEMBOLISM,LOW INTENSITY WARFARIN THERAPY
725258010,5/24/2015 01:46:31,1642497833,5/24/2015 01:46:18,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[PREVENTS],[PREVENTS],prevention,N/A,147,94,-1,178,124,TWrex-cause,803660-FS1,"1]  Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, et al. Long term, LOW INTENSITY WARFARIN THERAPY for the prevention of RECURRENT VENOUS THROMBOEMBOLISM",RECURRENT VENOUS THROMBOEMBOLISM,LOW INTENSITY WARFARIN THERAPY
725258010,5/24/2015 01:53:14,1642500124,5/24/2015 01:53:02,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[PREVENTS],[PREVENTS],prevention,N/A,147,94,-1,178,124,TWrex-cause,803660-FS1,"1]  Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, et al. Long term, LOW INTENSITY WARFARIN THERAPY for the prevention of RECURRENT VENOUS THROMBOEMBOLISM",RECURRENT VENOUS THROMBOEMBOLISM,LOW INTENSITY WARFARIN THERAPY
725258010,5/24/2015 02:00:07,1642502344,5/24/2015 01:59:54,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[PREVENTS],[PREVENTS],prevention,N/A,147,94,-1,178,124,TWrex-cause,803660-FS1,"1]  Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, et al. Long term, LOW INTENSITY WARFARIN THERAPY for the prevention of RECURRENT VENOUS THROMBOEMBOLISM",RECURRENT VENOUS THROMBOEMBOLISM,LOW INTENSITY WARFARIN THERAPY
725258010,5/24/2015 02:07:47,1642504648,5/24/2015 02:07:34,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[PREVENTS],[PREVENTS],prevention,N/A,147,94,-1,178,124,TWrex-cause,803660-FS1,"1]  Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, et al. Long term, LOW INTENSITY WARFARIN THERAPY for the prevention of RECURRENT VENOUS THROMBOEMBOLISM",RECURRENT VENOUS THROMBOEMBOLISM,LOW INTENSITY WARFARIN THERAPY
725258010,5/24/2015 02:17:43,1642508015,5/24/2015 02:15:06,false,prodege,1.0,17379068,CAN,NB,Saint John,142.162.106.83,[PREVENTS],[PREVENTS],prevention,N/A,147,94,-1,178,124,TWrex-cause,803660-FS1,"1]  Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, et al. Long term, LOW INTENSITY WARFARIN THERAPY for the prevention of RECURRENT VENOUS THROMBOEMBOLISM",RECURRENT VENOUS THROMBOEMBOLISM,LOW INTENSITY WARFARIN THERAPY
725258010,5/24/2015 02:33:41,1642512955,5/24/2015 02:33:25,false,elite,1.0,32306791,USA,DE,Wilmington,199.58.86.213,[CAUSES],[CAUSES],Long INTENSITY,N/A,147,94,-1,178,124,TWrex-cause,803660-FS1,"1]  Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, et al. Long term, LOW INTENSITY WARFARIN THERAPY for the prevention of RECURRENT VENOUS THROMBOEMBOLISM",RECURRENT VENOUS THROMBOEMBOLISM,LOW INTENSITY WARFARIN THERAPY
725258010,5/24/2015 02:36:52,1642514080,5/24/2015 02:36:38,false,elite,1.0,31913360,USA,VA,Manassas,207.244.77.3,[LOCATION],[LOCATION],INTENSITY,hhhgh,147,94,-1,178,124,TWrex-cause,803660-FS1,"1]  Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, et al. Long term, LOW INTENSITY WARFARIN THERAPY for the prevention of RECURRENT VENOUS THROMBOEMBOLISM",RECURRENT VENOUS THROMBOEMBOLISM,LOW INTENSITY WARFARIN THERAPY
725258010,5/24/2015 02:47:15,1642517115,5/24/2015 02:47:06,false,neodev,1.0,32562748,CAN,BC,Vancouver,108.180.140.140,[CAUSES] [CONTRAINDICATES],"[CAUSES]
[CONTRAINDICATES]",RECURRENT VENOUS THROMBOEMBOLISM,N/A,147,94,-1,178,124,TWrex-cause,803660-FS1,"1]  Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, et al. Long term, LOW INTENSITY WARFARIN THERAPY for the prevention of RECURRENT VENOUS THROMBOEMBOLISM",RECURRENT VENOUS THROMBOEMBOLISM,LOW INTENSITY WARFARIN THERAPY
725258010,5/24/2015 02:54:53,1642519177,5/24/2015 02:54:30,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[PREVENTS],[PREVENTS],LOW INTENSITY WARFARIN THERAPY for the prevention of RECURRENT VENOUS THROMBOEMBOLISM,N/A,147,94,-1,178,124,TWrex-cause,803660-FS1,"1]  Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, et al. Long term, LOW INTENSITY WARFARIN THERAPY for the prevention of RECURRENT VENOUS THROMBOEMBOLISM",RECURRENT VENOUS THROMBOEMBOLISM,LOW INTENSITY WARFARIN THERAPY
725258011,5/23/2015 20:36:09,1642360648,5/23/2015 20:35:51,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],for,N/A,46,0,-1,58,41,TWrex-cause,803942-FS1,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT for ANAL FISSURES: long term efficacy in routine clinical practice.,ANAL FISSURES,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT
725258011,5/23/2015 20:43:23,1642364622,5/23/2015 20:42:54,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT for ANAL FISSURES:,N/A,46,0,-1,58,41,TWrex-cause,803942-FS1,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT for ANAL FISSURES: long term efficacy in routine clinical practice.,ANAL FISSURES,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT
725258011,5/23/2015 20:45:17,1642365840,5/23/2015 20:45:03,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],for,n/a,46,0,-1,58,41,TWrex-cause,803942-FS1,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT for ANAL FISSURES: long term efficacy in routine clinical practice.,ANAL FISSURES,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT
725258011,5/23/2015 20:51:00,1642369237,5/23/2015 20:50:43,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],for,n/a,46,0,-1,58,41,TWrex-cause,803942-FS1,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT for ANAL FISSURES: long term efficacy in routine clinical practice.,ANAL FISSURES,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT
725258011,5/23/2015 20:55:55,1642371695,5/23/2015 20:55:02,false,instagc,1.0,30880172,USA,CA,Los Angeles,166.170.50.98,[OTHER],[OTHER],for,Treated by,46,0,-1,58,41,TWrex-cause,803942-FS1,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT for ANAL FISSURES: long term efficacy in routine clinical practice.,ANAL FISSURES,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT
725258011,5/23/2015 20:59:32,1642373536,5/23/2015 20:59:13,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],for long term efficacy,n/a,46,0,-1,58,41,TWrex-cause,803942-FS1,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT for ANAL FISSURES: long term efficacy in routine clinical practice.,ANAL FISSURES,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT
725258011,5/23/2015 21:01:07,1642374201,5/23/2015 20:59:43,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],GLYCERYL TRINITRATE OINTMENT for ANAL FISSURES:,na,46,0,-1,58,41,TWrex-cause,803942-FS1,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT for ANAL FISSURES: long term efficacy in routine clinical practice.,ANAL FISSURES,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT
725258011,5/23/2015 21:05:46,1642376082,5/23/2015 21:03:45,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],for,N/A,46,0,-1,58,41,TWrex-cause,803942-FS1,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT for ANAL FISSURES: long term efficacy in routine clinical practice.,ANAL FISSURES,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT
725258011,5/23/2015 21:38:08,1642392168,5/23/2015 21:37:43,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],for efficacy,n/a,46,0,-1,58,41,TWrex-cause,803942-FS1,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT for ANAL FISSURES: long term efficacy in routine clinical practice.,ANAL FISSURES,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT
725258011,5/23/2015 21:46:20,1642396126,5/23/2015 21:45:11,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[PREVENTS] [DIAGNOSE_BY_TEST_OR_DRUG],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]",TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT for ANAL FISSURES: long term efficacy in routine clinical practice.,n/a,46,0,-1,58,41,TWrex-cause,803942-FS1,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT for ANAL FISSURES: long term efficacy in routine clinical practice.,ANAL FISSURES,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT
725258011,5/23/2015 21:48:13,1642396900,5/23/2015 21:47:46,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],for,N/A,46,0,-1,58,41,TWrex-cause,803942-FS1,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT for ANAL FISSURES: long term efficacy in routine clinical practice.,ANAL FISSURES,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT
725258011,5/23/2015 21:51:15,1642398231,5/23/2015 21:50:48,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[CAUSES],[CAUSES],long term efficacy,N/A,46,0,-1,58,41,TWrex-cause,803942-FS1,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT for ANAL FISSURES: long term efficacy in routine clinical practice.,ANAL FISSURES,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT
725258011,5/23/2015 21:52:51,1642398798,5/23/2015 21:52:00,false,elite,1.0,30064988,GBR,B4,Bradford,92.22.135.10,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",long term efficacy,N/A,46,0,-1,58,41,TWrex-cause,803942-FS1,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT for ANAL FISSURES: long term efficacy in routine clinical practice.,ANAL FISSURES,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT
725258011,5/23/2015 21:53:14,1642398958,5/23/2015 21:51:53,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[TREATS],[TREATS],for,n/a,46,0,-1,58,41,TWrex-cause,803942-FS1,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT for ANAL FISSURES: long term efficacy in routine clinical practice.,ANAL FISSURES,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT
725258011,5/23/2015 21:53:51,1642399223,5/23/2015 21:52:00,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[TREATS],[TREATS],for,n/a,46,0,-1,58,41,TWrex-cause,803942-FS1,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT for ANAL FISSURES: long term efficacy in routine clinical practice.,ANAL FISSURES,TOPICAL 0.2% GLYCERYL TRINITRATE OINTMENT
725258012,5/23/2015 22:13:11,1642408102,5/23/2015 22:12:40,false,elite,1.0,30064988,GBR,B4,Bradford,92.22.135.10,[TREATS],[TREATS],treatment,N/A,229,187,-1,264,208,TWrex-cause,800435-FS1,"1]  Guillevin L, Cordier JF, Lhote F, Cohen P, Jarrousse B, Royer I, et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and ORAL CYCLOPHOSPHAMIDE in the treatment of GENERALIZED WEGENER'S GRANULOMATOSIS",GENERALIZED WEGENER'S GRANULOMATOSIS,ORAL CYCLOPHOSPHAMIDE
725258012,5/23/2015 22:16:23,1642409632,5/23/2015 22:16:02,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],ORAL CYCLOPHOSPHAMIDE in the treatment of GENERALIZED WEGENER'S GRANULOMATOSIS,n/a,229,187,-1,264,208,TWrex-cause,800435-FS1,"1]  Guillevin L, Cordier JF, Lhote F, Cohen P, Jarrousse B, Royer I, et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and ORAL CYCLOPHOSPHAMIDE in the treatment of GENERALIZED WEGENER'S GRANULOMATOSIS",GENERALIZED WEGENER'S GRANULOMATOSIS,ORAL CYCLOPHOSPHAMIDE
725258012,5/23/2015 22:29:15,1642415969,5/23/2015 22:28:22,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],steroids,N/A,229,187,-1,264,208,TWrex-cause,800435-FS1,"1]  Guillevin L, Cordier JF, Lhote F, Cohen P, Jarrousse B, Royer I, et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and ORAL CYCLOPHOSPHAMIDE in the treatment of GENERALIZED WEGENER'S GRANULOMATOSIS",GENERALIZED WEGENER'S GRANULOMATOSIS,ORAL CYCLOPHOSPHAMIDE
725258012,5/23/2015 22:29:32,1642416157,5/23/2015 22:27:38,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"Guillevin L, Cordier JF, Lhote F, Cohen P, Jarrousse B, Royer I, randomized trial comparing ORAL CYCLOPHOSPHAMIDE in treatment of GENERALIZED WEGENER'S GRANULOMATOSIS",N/A,229,187,-1,264,208,TWrex-cause,800435-FS1,"1]  Guillevin L, Cordier JF, Lhote F, Cohen P, Jarrousse B, Royer I, et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and ORAL CYCLOPHOSPHAMIDE in the treatment of GENERALIZED WEGENER'S GRANULOMATOSIS",GENERALIZED WEGENER'S GRANULOMATOSIS,ORAL CYCLOPHOSPHAMIDE
725258012,5/23/2015 22:31:31,1642417164,5/23/2015 22:30:17,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treatment of,N/A,229,187,-1,264,208,TWrex-cause,800435-FS1,"1]  Guillevin L, Cordier JF, Lhote F, Cohen P, Jarrousse B, Royer I, et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and ORAL CYCLOPHOSPHAMIDE in the treatment of GENERALIZED WEGENER'S GRANULOMATOSIS",GENERALIZED WEGENER'S GRANULOMATOSIS,ORAL CYCLOPHOSPHAMIDE
725258012,5/23/2015 22:34:25,1642418673,5/23/2015 22:33:59,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",randomized trial comparing steroids and pulse cyclophosphamide versus steroids and ORAL CYCLOPHOSPHAMIDE in the treatment GENERALIZED WEGENER'S GRANULOMATOSIS,n/a,229,187,-1,264,208,TWrex-cause,800435-FS1,"1]  Guillevin L, Cordier JF, Lhote F, Cohen P, Jarrousse B, Royer I, et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and ORAL CYCLOPHOSPHAMIDE in the treatment of GENERALIZED WEGENER'S GRANULOMATOSIS",GENERALIZED WEGENER'S GRANULOMATOSIS,ORAL CYCLOPHOSPHAMIDE
725258012,5/23/2015 22:39:44,1642421470,5/23/2015 22:39:09,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[TREATS],[TREATS],ORAL CYCLOPHOSPHAMIDE in the treatment of GENERALIZED WEGENER'S GRANULOMATOSIS,n/a,229,187,-1,264,208,TWrex-cause,800435-FS1,"1]  Guillevin L, Cordier JF, Lhote F, Cohen P, Jarrousse B, Royer I, et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and ORAL CYCLOPHOSPHAMIDE in the treatment of GENERALIZED WEGENER'S GRANULOMATOSIS",GENERALIZED WEGENER'S GRANULOMATOSIS,ORAL CYCLOPHOSPHAMIDE
725258012,5/23/2015 23:07:02,1642434985,5/23/2015 23:06:45,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[TREATS],[TREATS],treatment of,N/A,229,187,-1,264,208,TWrex-cause,800435-FS1,"1]  Guillevin L, Cordier JF, Lhote F, Cohen P, Jarrousse B, Royer I, et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and ORAL CYCLOPHOSPHAMIDE in the treatment of GENERALIZED WEGENER'S GRANULOMATOSIS",GENERALIZED WEGENER'S GRANULOMATOSIS,ORAL CYCLOPHOSPHAMIDE
725258012,5/23/2015 23:12:11,1642437217,5/23/2015 23:11:25,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[TREATS],[TREATS],treatment of,n/a,229,187,-1,264,208,TWrex-cause,800435-FS1,"1]  Guillevin L, Cordier JF, Lhote F, Cohen P, Jarrousse B, Royer I, et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and ORAL CYCLOPHOSPHAMIDE in the treatment of GENERALIZED WEGENER'S GRANULOMATOSIS",GENERALIZED WEGENER'S GRANULOMATOSIS,ORAL CYCLOPHOSPHAMIDE
725258012,5/23/2015 23:14:27,1642438157,5/23/2015 23:14:07,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],treatment,none,229,187,-1,264,208,TWrex-cause,800435-FS1,"1]  Guillevin L, Cordier JF, Lhote F, Cohen P, Jarrousse B, Royer I, et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and ORAL CYCLOPHOSPHAMIDE in the treatment of GENERALIZED WEGENER'S GRANULOMATOSIS",GENERALIZED WEGENER'S GRANULOMATOSIS,ORAL CYCLOPHOSPHAMIDE
725258012,5/23/2015 23:14:50,1642438320,5/23/2015 23:14:03,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[TREATS] [PART_OF],"[TREATS]
[PART_OF]",treatment of,N/A,229,187,-1,264,208,TWrex-cause,800435-FS1,"1]  Guillevin L, Cordier JF, Lhote F, Cohen P, Jarrousse B, Royer I, et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and ORAL CYCLOPHOSPHAMIDE in the treatment of GENERALIZED WEGENER'S GRANULOMATOSIS",GENERALIZED WEGENER'S GRANULOMATOSIS,ORAL CYCLOPHOSPHAMIDE
725258012,5/23/2015 23:19:50,1642440287,5/23/2015 23:18:49,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",trial comparing in the treatment of,n/a,229,187,-1,264,208,TWrex-cause,800435-FS1,"1]  Guillevin L, Cordier JF, Lhote F, Cohen P, Jarrousse B, Royer I, et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and ORAL CYCLOPHOSPHAMIDE in the treatment of GENERALIZED WEGENER'S GRANULOMATOSIS",GENERALIZED WEGENER'S GRANULOMATOSIS,ORAL CYCLOPHOSPHAMIDE
725258012,5/23/2015 23:19:55,1642440336,5/23/2015 23:19:26,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,229,187,-1,264,208,TWrex-cause,800435-FS1,"1]  Guillevin L, Cordier JF, Lhote F, Cohen P, Jarrousse B, Royer I, et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and ORAL CYCLOPHOSPHAMIDE in the treatment of GENERALIZED WEGENER'S GRANULOMATOSIS",GENERALIZED WEGENER'S GRANULOMATOSIS,ORAL CYCLOPHOSPHAMIDE
725258012,5/23/2015 23:29:19,1642444569,5/23/2015 23:27:44,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],treatment,N/A,229,187,-1,264,208,TWrex-cause,800435-FS1,"1]  Guillevin L, Cordier JF, Lhote F, Cohen P, Jarrousse B, Royer I, et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and ORAL CYCLOPHOSPHAMIDE in the treatment of GENERALIZED WEGENER'S GRANULOMATOSIS",GENERALIZED WEGENER'S GRANULOMATOSIS,ORAL CYCLOPHOSPHAMIDE
725258012,5/23/2015 23:42:10,1642450652,5/23/2015 23:41:56,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[TREATS],[TREATS],treatment,n/a,229,187,-1,264,208,TWrex-cause,800435-FS1,"1]  Guillevin L, Cordier JF, Lhote F, Cohen P, Jarrousse B, Royer I, et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and ORAL CYCLOPHOSPHAMIDE in the treatment of GENERALIZED WEGENER'S GRANULOMATOSIS",GENERALIZED WEGENER'S GRANULOMATOSIS,ORAL CYCLOPHOSPHAMIDE
725258013,5/23/2015 23:25:17,1642442703,5/23/2015 23:24:07,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[NONE],[NONE],n/a,it states that the pain is not caused by endometriosis in this particular type of case so therefore there is no relation between the two,139,111,1,142,124,TWrex-cause,813507-FS1,"• In women with a normal pelvic exam, failure to improve with a GnRH agonist typically excludes a diagnosis of ENDOMETRIOSIS as a cause of PAIN",PAIN,ENDOMETRIOSIS
725258013,5/23/2015 23:31:30,1642445687,5/23/2015 23:31:05,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosis,N/A,139,111,1,142,124,TWrex-cause,813507-FS1,"• In women with a normal pelvic exam, failure to improve with a GnRH agonist typically excludes a diagnosis of ENDOMETRIOSIS as a cause of PAIN",PAIN,ENDOMETRIOSIS
725258013,5/23/2015 23:34:08,1642446724,5/23/2015 23:33:04,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],excludes diagnosis,none,139,111,1,142,124,TWrex-cause,813507-FS1,"• In women with a normal pelvic exam, failure to improve with a GnRH agonist typically excludes a diagnosis of ENDOMETRIOSIS as a cause of PAIN",PAIN,ENDOMETRIOSIS
725258013,5/23/2015 23:41:20,1642450290,5/23/2015 23:40:58,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[SYMPTOM],[SYMPTOM],cause of PAIN,N/A,139,111,1,142,124,TWrex-cause,813507-FS1,"• In women with a normal pelvic exam, failure to improve with a GnRH agonist typically excludes a diagnosis of ENDOMETRIOSIS as a cause of PAIN",PAIN,ENDOMETRIOSIS
725258013,5/23/2015 23:47:54,1642453190,5/23/2015 23:47:40,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[CAUSES],[CAUSES],cause of,n/a,139,111,1,142,124,TWrex-cause,813507-FS1,"• In women with a normal pelvic exam, failure to improve with a GnRH agonist typically excludes a diagnosis of ENDOMETRIOSIS as a cause of PAIN",PAIN,ENDOMETRIOSIS
725258013,5/23/2015 23:56:35,1642457238,5/23/2015 23:56:24,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.161,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,139,111,1,142,124,TWrex-cause,813507-FS1,"• In women with a normal pelvic exam, failure to improve with a GnRH agonist typically excludes a diagnosis of ENDOMETRIOSIS as a cause of PAIN",PAIN,ENDOMETRIOSIS
725258013,5/24/2015 00:26:25,1642469967,5/24/2015 00:26:00,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[CAUSES],[CAUSES],cause,n/a,139,111,1,142,124,TWrex-cause,813507-FS1,"• In women with a normal pelvic exam, failure to improve with a GnRH agonist typically excludes a diagnosis of ENDOMETRIOSIS as a cause of PAIN",PAIN,ENDOMETRIOSIS
725258013,5/24/2015 00:33:59,1642472777,5/24/2015 00:32:42,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[SYMPTOM],[SYMPTOM],cause of,na,139,111,1,142,124,TWrex-cause,813507-FS1,"• In women with a normal pelvic exam, failure to improve with a GnRH agonist typically excludes a diagnosis of ENDOMETRIOSIS as a cause of PAIN",PAIN,ENDOMETRIOSIS
725258013,5/24/2015 00:40:33,1642475582,5/24/2015 00:39:09,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[NONE],[NONE],N/A,"""excludes"" so the two are not related.",139,111,1,142,124,TWrex-cause,813507-FS1,"• In women with a normal pelvic exam, failure to improve with a GnRH agonist typically excludes a diagnosis of ENDOMETRIOSIS as a cause of PAIN",PAIN,ENDOMETRIOSIS
725258013,5/24/2015 00:41:27,1642475929,5/24/2015 00:41:06,false,elite,1.0,31848723,USA,VA,Manassas,192.96.205.155,[SYMPTOM],[SYMPTOM],ENDOMETRIOSIS PAIN,N/A,139,111,1,142,124,TWrex-cause,813507-FS1,"• In women with a normal pelvic exam, failure to improve with a GnRH agonist typically excludes a diagnosis of ENDOMETRIOSIS as a cause of PAIN",PAIN,ENDOMETRIOSIS
725258013,5/24/2015 00:49:57,1642479280,5/24/2015 00:49:05,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[CAUSES],[CAUSES],as a cause of,N/A,139,111,1,142,124,TWrex-cause,813507-FS1,"• In women with a normal pelvic exam, failure to improve with a GnRH agonist typically excludes a diagnosis of ENDOMETRIOSIS as a cause of PAIN",PAIN,ENDOMETRIOSIS
725258013,5/24/2015 00:57:04,1642481421,5/24/2015 00:56:54,false,neodev,1.0,31789301,USA,CA,San Jose,23.27.44.199,[NONE],[NONE],no,no,139,111,1,142,124,TWrex-cause,813507-FS1,"• In women with a normal pelvic exam, failure to improve with a GnRH agonist typically excludes a diagnosis of ENDOMETRIOSIS as a cause of PAIN",PAIN,ENDOMETRIOSIS
725258013,5/24/2015 01:26:06,1642491118,5/24/2015 01:24:58,false,clixsense,1.0,6375330,CAN,ON,Ottawa,209.195.106.138,[CAUSES],[CAUSES],as a cause,None,139,111,1,142,124,TWrex-cause,813507-FS1,"• In women with a normal pelvic exam, failure to improve with a GnRH agonist typically excludes a diagnosis of ENDOMETRIOSIS as a cause of PAIN",PAIN,ENDOMETRIOSIS
725258013,5/24/2015 01:35:31,1642493942,5/24/2015 01:35:19,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[CAUSES],[CAUSES],cause,N/A,139,111,1,142,124,TWrex-cause,813507-FS1,"• In women with a normal pelvic exam, failure to improve with a GnRH agonist typically excludes a diagnosis of ENDOMETRIOSIS as a cause of PAIN",PAIN,ENDOMETRIOSIS
725258013,5/24/2015 01:42:46,1642496558,5/24/2015 01:42:36,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosis,N/A,139,111,1,142,124,TWrex-cause,813507-FS1,"• In women with a normal pelvic exam, failure to improve with a GnRH agonist typically excludes a diagnosis of ENDOMETRIOSIS as a cause of PAIN",PAIN,ENDOMETRIOSIS
725258014,5/24/2015 00:39:40,1642475144,5/24/2015 00:38:51,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],treatment,n/a,142,83,-1,170,94,TWrex-cause,800836-FS1,Corticosteroids and colchicine can be used in severe refractory cases.[17][18][19] THALIDOMIDE has been used successfully in the treatment of ERYTHEMA NODOSUM LEPROSUM[20] and it was approved by the U.S. FDA for this use in July 1998.[21.,ERYTHEMA NODOSUM LEPROSUM[20],THALIDOMIDE
725258014,5/24/2015 00:48:01,1642478535,5/24/2015 00:47:43,false,elite,1.0,31848723,USA,VA,Manassas,192.96.205.155,[SYMPTOM],[SYMPTOM],THALIDOMIDE ERYTHEMA NODOSUM LEPROSUM[20],N/A,142,83,-1,170,94,TWrex-cause,800836-FS1,Corticosteroids and colchicine can be used in severe refractory cases.[17][18][19] THALIDOMIDE has been used successfully in the treatment of ERYTHEMA NODOSUM LEPROSUM[20] and it was approved by the U.S. FDA for this use in July 1998.[21.,ERYTHEMA NODOSUM LEPROSUM[20],THALIDOMIDE
725258014,5/24/2015 00:54:56,1642480660,5/24/2015 00:54:18,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,142,83,-1,170,94,TWrex-cause,800836-FS1,Corticosteroids and colchicine can be used in severe refractory cases.[17][18][19] THALIDOMIDE has been used successfully in the treatment of ERYTHEMA NODOSUM LEPROSUM[20] and it was approved by the U.S. FDA for this use in July 1998.[21.,ERYTHEMA NODOSUM LEPROSUM[20],THALIDOMIDE
725258014,5/24/2015 00:54:55,1642480661,5/24/2015 00:54:14,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[OTHER],[OTHER],treatment of ERYTHEMA,NA,142,83,-1,170,94,TWrex-cause,800836-FS1,Corticosteroids and colchicine can be used in severe refractory cases.[17][18][19] THALIDOMIDE has been used successfully in the treatment of ERYTHEMA NODOSUM LEPROSUM[20] and it was approved by the U.S. FDA for this use in July 1998.[21.,ERYTHEMA NODOSUM LEPROSUM[20],THALIDOMIDE
725258014,5/24/2015 01:14:40,1642487800,5/24/2015 01:13:49,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[TREATS],[TREATS],in the treatment of,N/A,142,83,-1,170,94,TWrex-cause,800836-FS1,Corticosteroids and colchicine can be used in severe refractory cases.[17][18][19] THALIDOMIDE has been used successfully in the treatment of ERYTHEMA NODOSUM LEPROSUM[20] and it was approved by the U.S. FDA for this use in July 1998.[21.,ERYTHEMA NODOSUM LEPROSUM[20],THALIDOMIDE
725258014,5/24/2015 01:39:42,1642495402,5/24/2015 01:39:29,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],treatment,N/A,142,83,-1,170,94,TWrex-cause,800836-FS1,Corticosteroids and colchicine can be used in severe refractory cases.[17][18][19] THALIDOMIDE has been used successfully in the treatment of ERYTHEMA NODOSUM LEPROSUM[20] and it was approved by the U.S. FDA for this use in July 1998.[21.,ERYTHEMA NODOSUM LEPROSUM[20],THALIDOMIDE
725258014,5/24/2015 01:46:55,1642497947,5/24/2015 01:46:45,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],treatment,N/A,142,83,-1,170,94,TWrex-cause,800836-FS1,Corticosteroids and colchicine can be used in severe refractory cases.[17][18][19] THALIDOMIDE has been used successfully in the treatment of ERYTHEMA NODOSUM LEPROSUM[20] and it was approved by the U.S. FDA for this use in July 1998.[21.,ERYTHEMA NODOSUM LEPROSUM[20],THALIDOMIDE
725258014,5/24/2015 01:53:41,1642500250,5/24/2015 01:53:29,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],treatment,N/A,142,83,-1,170,94,TWrex-cause,800836-FS1,Corticosteroids and colchicine can be used in severe refractory cases.[17][18][19] THALIDOMIDE has been used successfully in the treatment of ERYTHEMA NODOSUM LEPROSUM[20] and it was approved by the U.S. FDA for this use in July 1998.[21.,ERYTHEMA NODOSUM LEPROSUM[20],THALIDOMIDE
725258014,5/24/2015 02:00:34,1642502454,5/24/2015 02:00:23,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[TREATS],[TREATS],treatment,N/A,142,83,-1,170,94,TWrex-cause,800836-FS1,Corticosteroids and colchicine can be used in severe refractory cases.[17][18][19] THALIDOMIDE has been used successfully in the treatment of ERYTHEMA NODOSUM LEPROSUM[20] and it was approved by the U.S. FDA for this use in July 1998.[21.,ERYTHEMA NODOSUM LEPROSUM[20],THALIDOMIDE
725258014,5/24/2015 02:08:14,1642504825,5/24/2015 02:08:01,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[TREATS],[TREATS],treatment,N/A,142,83,-1,170,94,TWrex-cause,800836-FS1,Corticosteroids and colchicine can be used in severe refractory cases.[17][18][19] THALIDOMIDE has been used successfully in the treatment of ERYTHEMA NODOSUM LEPROSUM[20] and it was approved by the U.S. FDA for this use in July 1998.[21.,ERYTHEMA NODOSUM LEPROSUM[20],THALIDOMIDE
725258014,5/24/2015 02:21:15,1642509289,5/24/2015 02:19:48,false,prodege,1.0,17379068,CAN,NB,Saint John,142.162.106.83,[ASSOCIATED_WITH],[ASSOCIATED_WITH],treatment,N/A,142,83,-1,170,94,TWrex-cause,800836-FS1,Corticosteroids and colchicine can be used in severe refractory cases.[17][18][19] THALIDOMIDE has been used successfully in the treatment of ERYTHEMA NODOSUM LEPROSUM[20] and it was approved by the U.S. FDA for this use in July 1998.[21.,ERYTHEMA NODOSUM LEPROSUM[20],THALIDOMIDE
725258014,5/24/2015 02:34:22,1642513242,5/24/2015 02:34:05,false,elite,1.0,32306791,USA,DE,Wilmington,199.58.86.213,[SIDE_EFFECT],[SIDE_EFFECT],ERYTHEMA LEPROSUM[20],N/A,142,83,-1,170,94,TWrex-cause,800836-FS1,Corticosteroids and colchicine can be used in severe refractory cases.[17][18][19] THALIDOMIDE has been used successfully in the treatment of ERYTHEMA NODOSUM LEPROSUM[20] and it was approved by the U.S. FDA for this use in July 1998.[21.,ERYTHEMA NODOSUM LEPROSUM[20],THALIDOMIDE
725258014,5/24/2015 02:37:14,1642514148,5/24/2015 02:37:04,false,elite,1.0,31913360,USA,VA,Manassas,207.244.77.3,[MANIFESTATION],[MANIFESTATION],been,hjhj,142,83,-1,170,94,TWrex-cause,800836-FS1,Corticosteroids and colchicine can be used in severe refractory cases.[17][18][19] THALIDOMIDE has been used successfully in the treatment of ERYTHEMA NODOSUM LEPROSUM[20] and it was approved by the U.S. FDA for this use in July 1998.[21.,ERYTHEMA NODOSUM LEPROSUM[20],THALIDOMIDE
725258014,5/24/2015 02:55:37,1642519387,5/24/2015 02:55:12,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],THALIDOMIDE has been used successfully in the treatment of ERYTHEMA NODOSUM LEPROSUM[20],N/A,142,83,-1,170,94,TWrex-cause,800836-FS1,Corticosteroids and colchicine can be used in severe refractory cases.[17][18][19] THALIDOMIDE has been used successfully in the treatment of ERYTHEMA NODOSUM LEPROSUM[20] and it was approved by the U.S. FDA for this use in July 1998.[21.,ERYTHEMA NODOSUM LEPROSUM[20],THALIDOMIDE
725258014,5/24/2015 03:04:46,1642522221,5/24/2015 03:03:44,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[TREATS],[TREATS],used treatment,n/a,142,83,-1,170,94,TWrex-cause,800836-FS1,Corticosteroids and colchicine can be used in severe refractory cases.[17][18][19] THALIDOMIDE has been used successfully in the treatment of ERYTHEMA NODOSUM LEPROSUM[20] and it was approved by the U.S. FDA for this use in July 1998.[21.,ERYTHEMA NODOSUM LEPROSUM[20],THALIDOMIDE
725258015,5/23/2015 20:24:21,1642354936,5/23/2015 20:23:39,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],Removal of PHEOCHROMOCYTOMA may cure HYPERTENSION,N/A,42,11,1,53,27,TWrex-cause,813350-FS1,Removal of PHEOCHROMOCYTOMA may also cure HYPERTENSION ( 77.,HYPERTENSION,PHEOCHROMOCYTOMA
725258015,5/23/2015 20:30:22,1642357834,5/23/2015 20:30:06,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[PREVENTS],[PREVENTS],may also cure,N/A,42,11,1,53,27,TWrex-cause,813350-FS1,Removal of PHEOCHROMOCYTOMA may also cure HYPERTENSION ( 77.,HYPERTENSION,PHEOCHROMOCYTOMA
725258015,5/23/2015 20:37:07,1642361149,5/23/2015 20:36:40,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],PHEOCHROMOCYTOMA may cure HYPERTENSION,na,42,11,1,53,27,TWrex-cause,813350-FS1,Removal of PHEOCHROMOCYTOMA may also cure HYPERTENSION ( 77.,HYPERTENSION,PHEOCHROMOCYTOMA
725258015,5/23/2015 20:37:51,1642361518,5/23/2015 20:37:38,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],cure,n/a,42,11,1,53,27,TWrex-cause,813350-FS1,Removal of PHEOCHROMOCYTOMA may also cure HYPERTENSION ( 77.,HYPERTENSION,PHEOCHROMOCYTOMA
725258015,5/23/2015 20:38:17,1642361750,5/23/2015 20:37:48,false,instagc,1.0,30880172,USA,CA,Los Angeles,166.170.50.98,[TREATS],[TREATS],also cure,N/A,42,11,1,53,27,TWrex-cause,813350-FS1,Removal of PHEOCHROMOCYTOMA may also cure HYPERTENSION ( 77.,HYPERTENSION,PHEOCHROMOCYTOMA
725258015,5/23/2015 20:39:43,1642362675,5/23/2015 20:39:24,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[PREVENTS],[PREVENTS],may also cure,n/a,42,11,1,53,27,TWrex-cause,813350-FS1,Removal of PHEOCHROMOCYTOMA may also cure HYPERTENSION ( 77.,HYPERTENSION,PHEOCHROMOCYTOMA
725258015,5/23/2015 20:40:42,1642363279,5/23/2015 20:40:29,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],cure,n/a,42,11,1,53,27,TWrex-cause,813350-FS1,Removal of PHEOCHROMOCYTOMA may also cure HYPERTENSION ( 77.,HYPERTENSION,PHEOCHROMOCYTOMA
725258015,5/23/2015 20:42:55,1642364357,5/23/2015 20:40:47,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],may also cure,N/A,42,11,1,53,27,TWrex-cause,813350-FS1,Removal of PHEOCHROMOCYTOMA may also cure HYPERTENSION ( 77.,HYPERTENSION,PHEOCHROMOCYTOMA
725258015,5/23/2015 20:43:26,1642364652,5/23/2015 20:43:14,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[TREATS],[TREATS],cure,-,42,11,1,53,27,TWrex-cause,813350-FS1,Removal of PHEOCHROMOCYTOMA may also cure HYPERTENSION ( 77.,HYPERTENSION,PHEOCHROMOCYTOMA
725258015,5/23/2015 20:44:57,1642365654,5/23/2015 20:44:44,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],cure,n/a,42,11,1,53,27,TWrex-cause,813350-FS1,Removal of PHEOCHROMOCYTOMA may also cure HYPERTENSION ( 77.,HYPERTENSION,PHEOCHROMOCYTOMA
725258015,5/23/2015 20:53:27,1642370556,5/23/2015 20:53:15,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],may also cure,n/a,42,11,1,53,27,TWrex-cause,813350-FS1,Removal of PHEOCHROMOCYTOMA may also cure HYPERTENSION ( 77.,HYPERTENSION,PHEOCHROMOCYTOMA
725258015,5/23/2015 21:02:16,1642374662,5/23/2015 21:01:40,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[TREATS],[TREATS],Removal of may also cure,n/a,42,11,1,53,27,TWrex-cause,813350-FS1,Removal of PHEOCHROMOCYTOMA may also cure HYPERTENSION ( 77.,HYPERTENSION,PHEOCHROMOCYTOMA
725258015,5/23/2015 21:15:23,1642380729,5/23/2015 21:15:02,false,prodege,1.0,2143114,CAN,BC,Vancouver,24.85.153.181,[PART_OF],[PART_OF],Removal,n/a,42,11,1,53,27,TWrex-cause,813350-FS1,Removal of PHEOCHROMOCYTOMA may also cure HYPERTENSION ( 77.,HYPERTENSION,PHEOCHROMOCYTOMA
725258015,5/23/2015 21:15:54,1642380931,5/23/2015 21:15:34,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[PREVENTS],[PREVENTS],Removal,N/A,42,11,1,53,27,TWrex-cause,813350-FS1,Removal of PHEOCHROMOCYTOMA may also cure HYPERTENSION ( 77.,HYPERTENSION,PHEOCHROMOCYTOMA
725258015,5/23/2015 21:30:56,1642388346,5/23/2015 21:30:01,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[SYMPTOM],[SYMPTOM],may cure,N/A,42,11,1,53,27,TWrex-cause,813350-FS1,Removal of PHEOCHROMOCYTOMA may also cure HYPERTENSION ( 77.,HYPERTENSION,PHEOCHROMOCYTOMA
725258016,5/23/2015 22:19:37,1642411367,5/23/2015 22:18:50,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CONTRAINDICATES],[CONTRAINDICATES],PROGESTERONE capsules are contraindicated in women with suspected PREGNANCY,n/a,92,7,-1,100,19,TWrex-cause,803310-FS1,101 •  PROGESTERONE capsules are contraindicated in pregnant women and those with suspected PREGNANCY,PREGNANCY,PROGESTERONE
725258016,5/23/2015 22:34:15,1642418574,5/23/2015 22:33:54,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[SYMPTOM],[SYMPTOM],PREGNANCY,N/A,92,7,-1,100,19,TWrex-cause,803310-FS1,101 •  PROGESTERONE capsules are contraindicated in pregnant women and those with suspected PREGNANCY,PREGNANCY,PROGESTERONE
725258016,5/23/2015 22:38:15,1642420673,5/23/2015 22:37:42,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[CONTRAINDICATES],[CONTRAINDICATES],PROGESTERONE capsules are contraindicated in pregnant,n/a,92,7,-1,100,19,TWrex-cause,803310-FS1,101 •  PROGESTERONE capsules are contraindicated in pregnant women and those with suspected PREGNANCY,PREGNANCY,PROGESTERONE
725258016,5/23/2015 22:39:30,1642421320,5/23/2015 22:38:36,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CONTRAINDICATES],[CONTRAINDICATES],PROGESTERONE are contraindicated in PREGNANCY,N/A,92,7,-1,100,19,TWrex-cause,803310-FS1,101 •  PROGESTERONE capsules are contraindicated in pregnant women and those with suspected PREGNANCY,PREGNANCY,PROGESTERONE
725258016,5/23/2015 22:41:39,1642422516,5/23/2015 22:40:21,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CONTRAINDICATES],[CONTRAINDICATES],contraindicated,N/A,92,7,-1,100,19,TWrex-cause,803310-FS1,101 •  PROGESTERONE capsules are contraindicated in pregnant women and those with suspected PREGNANCY,PREGNANCY,PROGESTERONE
725258016,5/23/2015 22:44:15,1642423744,5/23/2015 22:43:48,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[CONTRAINDICATES],[CONTRAINDICATES],PROGESTERONE capsules are contraindicated in PREGNANCY,n/a,92,7,-1,100,19,TWrex-cause,803310-FS1,101 •  PROGESTERONE capsules are contraindicated in pregnant women and those with suspected PREGNANCY,PREGNANCY,PROGESTERONE
725258016,5/23/2015 23:12:04,1642437156,5/23/2015 23:11:15,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[CONTRAINDICATES],[CONTRAINDICATES],contraindicated,N/A,92,7,-1,100,19,TWrex-cause,803310-FS1,101 •  PROGESTERONE capsules are contraindicated in pregnant women and those with suspected PREGNANCY,PREGNANCY,PROGESTERONE
725258016,5/23/2015 23:17:02,1642439183,5/23/2015 23:16:42,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[CONTRAINDICATES],[CONTRAINDICATES],are contraindicated,n/a,92,7,-1,100,19,TWrex-cause,803310-FS1,101 •  PROGESTERONE capsules are contraindicated in pregnant women and those with suspected PREGNANCY,PREGNANCY,PROGESTERONE
725258016,5/23/2015 23:22:30,1642441460,5/23/2015 23:21:33,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CONTRAINDICATES],[CONTRAINDICATES],contraindicated,none,92,7,-1,100,19,TWrex-cause,803310-FS1,101 •  PROGESTERONE capsules are contraindicated in pregnant women and those with suspected PREGNANCY,PREGNANCY,PROGESTERONE
725258016,5/23/2015 23:25:06,1642442604,5/23/2015 23:24:17,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CONTRAINDICATES],[CONTRAINDICATES],contraindicated,N/A,92,7,-1,100,19,TWrex-cause,803310-FS1,101 •  PROGESTERONE capsules are contraindicated in pregnant women and those with suspected PREGNANCY,PREGNANCY,PROGESTERONE
725258016,5/23/2015 23:27:05,1642443563,5/23/2015 23:26:21,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[CONTRAINDICATES] [ASSOCIATED_WITH],"[CONTRAINDICATES]
[ASSOCIATED_WITH]",contraindicated with,n/a,92,7,-1,100,19,TWrex-cause,803310-FS1,101 •  PROGESTERONE capsules are contraindicated in pregnant women and those with suspected PREGNANCY,PREGNANCY,PROGESTERONE
725258016,5/23/2015 23:35:43,1642447480,5/23/2015 23:35:15,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[CONTRAINDICATES],[CONTRAINDICATES],contraindicated,N/A,92,7,-1,100,19,TWrex-cause,803310-FS1,101 •  PROGESTERONE capsules are contraindicated in pregnant women and those with suspected PREGNANCY,PREGNANCY,PROGESTERONE
725258016,5/23/2015 23:44:41,1642451865,5/23/2015 23:44:29,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[CONTRAINDICATES],[CONTRAINDICATES],contraindicated,n/a,92,7,-1,100,19,TWrex-cause,803310-FS1,101 •  PROGESTERONE capsules are contraindicated in pregnant women and those with suspected PREGNANCY,PREGNANCY,PROGESTERONE
725258016,5/23/2015 23:53:23,1642455814,5/23/2015 23:53:05,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.161,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,92,7,-1,100,19,TWrex-cause,803310-FS1,101 •  PROGESTERONE capsules are contraindicated in pregnant women and those with suspected PREGNANCY,PREGNANCY,PROGESTERONE
725258016,5/24/2015 00:11:24,1642463526,5/24/2015 00:10:06,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[CONTRAINDICATES],[CONTRAINDICATES],capsules are contraindicated,N/A,92,7,-1,100,19,TWrex-cause,803310-FS1,101 •  PROGESTERONE capsules are contraindicated in pregnant women and those with suspected PREGNANCY,PREGNANCY,PROGESTERONE
725258017,5/23/2015 23:17:07,1642439205,5/23/2015 23:16:20,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[SYMPTOM],[SYMPTOM],"suggestive symptoms, particularly",N/A,84,11,1,103,13,TWrex-cause,812662-FS1,"Diagnosis  PV must be considered in patients with suggestive symptoms, particularly BUDD CHIARI SYNDROME but is often first suspected because of an abnormal CBC (eg, Hct > 54% in men or > 49% in women.",BUDD CHIARI SYNDROME,PV
725258017,5/23/2015 23:21:23,1642440847,5/23/2015 23:20:25,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],abnormal CBC,n/a,84,11,1,103,13,TWrex-cause,812662-FS1,"Diagnosis  PV must be considered in patients with suggestive symptoms, particularly BUDD CHIARI SYNDROME but is often first suspected because of an abnormal CBC (eg, Hct > 54% in men or > 49% in women.",BUDD CHIARI SYNDROME,PV
725258017,5/23/2015 23:30:12,1642445041,5/23/2015 23:29:44,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],suspected because of an,N/A,84,11,1,103,13,TWrex-cause,812662-FS1,"Diagnosis  PV must be considered in patients with suggestive symptoms, particularly BUDD CHIARI SYNDROME but is often first suspected because of an abnormal CBC (eg, Hct > 54% in men or > 49% in women.",BUDD CHIARI SYNDROME,PV
725258017,5/23/2015 23:30:32,1642445254,5/23/2015 23:28:52,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[SYMPTOM],[SYMPTOM],"suggestive symptoms,",none,84,11,1,103,13,TWrex-cause,812662-FS1,"Diagnosis  PV must be considered in patients with suggestive symptoms, particularly BUDD CHIARI SYNDROME but is often first suspected because of an abnormal CBC (eg, Hct > 54% in men or > 49% in women.",BUDD CHIARI SYNDROME,PV
725258017,5/23/2015 23:39:50,1642449424,5/23/2015 23:39:23,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[CAUSES] [SYMPTOM],"[CAUSES]
[SYMPTOM]","must be considered symptoms,",N/A,84,11,1,103,13,TWrex-cause,812662-FS1,"Diagnosis  PV must be considered in patients with suggestive symptoms, particularly BUDD CHIARI SYNDROME but is often first suspected because of an abnormal CBC (eg, Hct > 54% in men or > 49% in women.",BUDD CHIARI SYNDROME,PV
725258017,5/23/2015 23:46:48,1642452850,5/23/2015 23:46:35,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[SYMPTOM],[SYMPTOM],"suggestive symptoms,",n/a,84,11,1,103,13,TWrex-cause,812662-FS1,"Diagnosis  PV must be considered in patients with suggestive symptoms, particularly BUDD CHIARI SYNDROME but is often first suspected because of an abnormal CBC (eg, Hct > 54% in men or > 49% in women.",BUDD CHIARI SYNDROME,PV
725258017,5/23/2015 23:55:58,1642456968,5/23/2015 23:55:48,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.161,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,84,11,1,103,13,TWrex-cause,812662-FS1,"Diagnosis  PV must be considered in patients with suggestive symptoms, particularly BUDD CHIARI SYNDROME but is often first suspected because of an abnormal CBC (eg, Hct > 54% in men or > 49% in women.",BUDD CHIARI SYNDROME,PV
725258017,5/24/2015 00:24:46,1642469350,5/24/2015 00:24:15,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[SYMPTOM],[SYMPTOM],suspected,n/a,84,11,1,103,13,TWrex-cause,812662-FS1,"Diagnosis  PV must be considered in patients with suggestive symptoms, particularly BUDD CHIARI SYNDROME but is often first suspected because of an abnormal CBC (eg, Hct > 54% in men or > 49% in women.",BUDD CHIARI SYNDROME,PV
725258017,5/24/2015 00:29:55,1642471090,5/24/2015 00:29:36,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[ASSOCIATED_WITH],[ASSOCIATED_WITH],must be considered,na,84,11,1,103,13,TWrex-cause,812662-FS1,"Diagnosis  PV must be considered in patients with suggestive symptoms, particularly BUDD CHIARI SYNDROME but is often first suspected because of an abnormal CBC (eg, Hct > 54% in men or > 49% in women.",BUDD CHIARI SYNDROME,PV
725258017,5/24/2015 00:37:42,1642474371,5/24/2015 00:37:04,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[SYMPTOM],[SYMPTOM],suspected because of,N/A,84,11,1,103,13,TWrex-cause,812662-FS1,"Diagnosis  PV must be considered in patients with suggestive symptoms, particularly BUDD CHIARI SYNDROME but is often first suspected because of an abnormal CBC (eg, Hct > 54% in men or > 49% in women.",BUDD CHIARI SYNDROME,PV
725258017,5/24/2015 00:40:08,1642475363,5/24/2015 00:39:20,false,elite,1.0,31848723,USA,VA,Manassas,192.96.205.155,[DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]",BUDD CHIARI SYNDROME CBC,N/A,84,11,1,103,13,TWrex-cause,812662-FS1,"Diagnosis  PV must be considered in patients with suggestive symptoms, particularly BUDD CHIARI SYNDROME but is often first suspected because of an abnormal CBC (eg, Hct > 54% in men or > 49% in women.",BUDD CHIARI SYNDROME,PV
725258017,5/24/2015 00:41:12,1642475854,5/24/2015 00:40:10,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[PART_OF]","must be considered in patients with suggestive symptoms,",N/A,84,11,1,103,13,TWrex-cause,812662-FS1,"Diagnosis  PV must be considered in patients with suggestive symptoms, particularly BUDD CHIARI SYNDROME but is often first suspected because of an abnormal CBC (eg, Hct > 54% in men or > 49% in women.",BUDD CHIARI SYNDROME,PV
725258017,5/24/2015 00:56:28,1642481257,5/24/2015 00:56:17,false,neodev,1.0,31789301,USA,CA,San Jose,23.27.44.199,[NONE],[NONE],no,no,84,11,1,103,13,TWrex-cause,812662-FS1,"Diagnosis  PV must be considered in patients with suggestive symptoms, particularly BUDD CHIARI SYNDROME but is often first suspected because of an abnormal CBC (eg, Hct > 54% in men or > 49% in women.",BUDD CHIARI SYNDROME,PV
725258017,5/24/2015 01:22:28,1642490217,5/24/2015 01:20:56,false,clixsense,1.0,6375330,CAN,ON,Ottawa,209.195.106.138,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Diagnosis,None,84,11,1,103,13,TWrex-cause,812662-FS1,"Diagnosis  PV must be considered in patients with suggestive symptoms, particularly BUDD CHIARI SYNDROME but is often first suspected because of an abnormal CBC (eg, Hct > 54% in men or > 49% in women.",BUDD CHIARI SYNDROME,PV
725258017,5/24/2015 01:34:51,1642493668,5/24/2015 01:34:28,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[SYMPTOM],[SYMPTOM],"symptoms,",N/A,84,11,1,103,13,TWrex-cause,812662-FS1,"Diagnosis  PV must be considered in patients with suggestive symptoms, particularly BUDD CHIARI SYNDROME but is often first suspected because of an abnormal CBC (eg, Hct > 54% in men or > 49% in women.",BUDD CHIARI SYNDROME,PV
725258018,5/23/2015 21:57:00,1642400364,5/23/2015 21:56:39,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],for acute and chronic,N/A,71,38,-1,74,48,TWrex-cause,803433-FS1,"Wiffen PJ, McQuay HJ, Edwards JE et alGABAPENTIN for acute and chronic PAIN",PAIN,GABAPENTIN
725258018,5/23/2015 22:00:22,1642401686,5/23/2015 22:00:08,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],for,N/A,71,38,-1,74,48,TWrex-cause,803433-FS1,"Wiffen PJ, McQuay HJ, Edwards JE et alGABAPENTIN for acute and chronic PAIN",PAIN,GABAPENTIN
725258018,5/23/2015 22:06:44,1642404757,5/23/2015 22:06:15,false,elite,1.0,30064988,GBR,B4,Bradford,92.22.135.10,[TREATS],[TREATS],for,N/A,71,38,-1,74,48,TWrex-cause,803433-FS1,"Wiffen PJ, McQuay HJ, Edwards JE et alGABAPENTIN for acute and chronic PAIN",PAIN,GABAPENTIN
725258018,5/23/2015 22:11:57,1642407463,5/23/2015 22:11:42,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],alGABAPENTIN for acute and chronic PAIN,n/a,71,38,-1,74,48,TWrex-cause,803433-FS1,"Wiffen PJ, McQuay HJ, Edwards JE et alGABAPENTIN for acute and chronic PAIN",PAIN,GABAPENTIN
725258018,5/23/2015 22:15:48,1642409359,5/23/2015 22:15:04,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],alGABAPENTIN for PAIN,N/A,71,38,-1,74,48,TWrex-cause,803433-FS1,"Wiffen PJ, McQuay HJ, Edwards JE et alGABAPENTIN for acute and chronic PAIN",PAIN,GABAPENTIN
725258018,5/23/2015 22:15:50,1642409361,5/23/2015 22:14:49,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[TREATS],[TREATS],for acute and chronic,n/a,71,38,-1,74,48,TWrex-cause,803433-FS1,"Wiffen PJ, McQuay HJ, Edwards JE et alGABAPENTIN for acute and chronic PAIN",PAIN,GABAPENTIN
725258018,5/23/2015 22:16:19,1642409592,5/23/2015 22:15:44,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[TREATS],[TREATS],for acute and chronic,n/a,71,38,-1,74,48,TWrex-cause,803433-FS1,"Wiffen PJ, McQuay HJ, Edwards JE et alGABAPENTIN for acute and chronic PAIN",PAIN,GABAPENTIN
725258018,5/23/2015 22:17:53,1642410415,5/23/2015 22:16:48,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],for acute and chronic PAIN,N/A,71,38,-1,74,48,TWrex-cause,803433-FS1,"Wiffen PJ, McQuay HJ, Edwards JE et alGABAPENTIN for acute and chronic PAIN",PAIN,GABAPENTIN
725258018,5/23/2015 22:22:14,1642412730,5/23/2015 22:22:00,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[SYMPTOM],[SYMPTOM],chronic PAIN,N/A,71,38,-1,74,48,TWrex-cause,803433-FS1,"Wiffen PJ, McQuay HJ, Edwards JE et alGABAPENTIN for acute and chronic PAIN",PAIN,GABAPENTIN
725258018,5/23/2015 22:22:47,1642412996,5/23/2015 22:21:58,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[TREATS],[TREATS],alGABAPENTIN for acute and chronic PAIN,n/a,71,38,-1,74,48,TWrex-cause,803433-FS1,"Wiffen PJ, McQuay HJ, Edwards JE et alGABAPENTIN for acute and chronic PAIN",PAIN,GABAPENTIN
725258018,5/23/2015 22:28:58,1642415838,5/23/2015 22:28:28,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],alGABAPENTIN for acute and chronic PAIN,n/a,71,38,-1,74,48,TWrex-cause,803433-FS1,"Wiffen PJ, McQuay HJ, Edwards JE et alGABAPENTIN for acute and chronic PAIN",PAIN,GABAPENTIN
725258018,5/23/2015 22:32:30,1642417679,5/23/2015 22:32:13,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[TREATS],[TREATS],alGABAPENTIN for acute and chronic PAIN,n/a,71,38,-1,74,48,TWrex-cause,803433-FS1,"Wiffen PJ, McQuay HJ, Edwards JE et alGABAPENTIN for acute and chronic PAIN",PAIN,GABAPENTIN
725258018,5/23/2015 22:58:29,1642430997,5/23/2015 22:58:10,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[TREATS],[TREATS],for,N/A,71,38,-1,74,48,TWrex-cause,803433-FS1,"Wiffen PJ, McQuay HJ, Edwards JE et alGABAPENTIN for acute and chronic PAIN",PAIN,GABAPENTIN
725258018,5/23/2015 23:04:36,1642434010,5/23/2015 23:02:37,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",PAIN,n/a,71,38,-1,74,48,TWrex-cause,803433-FS1,"Wiffen PJ, McQuay HJ, Edwards JE et alGABAPENTIN for acute and chronic PAIN",PAIN,GABAPENTIN
725258018,5/23/2015 23:05:42,1642434461,5/23/2015 23:05:13,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[TREATS],[TREATS],for acute and chronic,n/a,71,38,-1,74,48,TWrex-cause,803433-FS1,"Wiffen PJ, McQuay HJ, Edwards JE et alGABAPENTIN for acute and chronic PAIN",PAIN,GABAPENTIN
725258019,5/23/2015 21:56:38,1642400232,5/23/2015 21:56:23,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],in the therapy of,N/A,47,0,-1,66,10,TWrex-cause,804401-FS1,"FAMOTIDINE once a day in the therapy of acute, BENIGN GASTRIC ULCER: a world wide experience.",BENIGN GASTRIC ULCER,FAMOTIDINE
725258019,5/23/2015 22:00:06,1642401593,5/23/2015 21:59:30,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],therapy,N/A,47,0,-1,66,10,TWrex-cause,804401-FS1,"FAMOTIDINE once a day in the therapy of acute, BENIGN GASTRIC ULCER: a world wide experience.",BENIGN GASTRIC ULCER,FAMOTIDINE
725258019,5/23/2015 22:06:12,1642404406,5/23/2015 22:05:42,false,elite,1.0,30064988,GBR,B4,Bradford,92.22.135.10,[TREATS],[TREATS],therapy,N/A,47,0,-1,66,10,TWrex-cause,804401-FS1,"FAMOTIDINE once a day in the therapy of acute, BENIGN GASTRIC ULCER: a world wide experience.",BENIGN GASTRIC ULCER,FAMOTIDINE
725258019,5/23/2015 22:11:41,1642407325,5/23/2015 22:11:24,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],FAMOTIDINE once a day in therapy of BENIGN GASTRIC ULCER:,n/a,47,0,-1,66,10,TWrex-cause,804401-FS1,"FAMOTIDINE once a day in the therapy of acute, BENIGN GASTRIC ULCER: a world wide experience.",BENIGN GASTRIC ULCER,FAMOTIDINE
725258019,5/23/2015 22:14:48,1642408940,5/23/2015 22:14:16,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[TREATS],[TREATS],in the therapy of,n/a,47,0,-1,66,10,TWrex-cause,804401-FS1,"FAMOTIDINE once a day in the therapy of acute, BENIGN GASTRIC ULCER: a world wide experience.",BENIGN GASTRIC ULCER,FAMOTIDINE
725258019,5/23/2015 22:15:03,1642409020,5/23/2015 22:14:21,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],FAMOTIDINE in therapy of BENIGN GASTRIC ULCER:,N/A,47,0,-1,66,10,TWrex-cause,804401-FS1,"FAMOTIDINE once a day in the therapy of acute, BENIGN GASTRIC ULCER: a world wide experience.",BENIGN GASTRIC ULCER,FAMOTIDINE
725258019,5/23/2015 22:15:43,1642409339,5/23/2015 22:15:07,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[TREATS],[TREATS],in the therapy of,n/a,47,0,-1,66,10,TWrex-cause,804401-FS1,"FAMOTIDINE once a day in the therapy of acute, BENIGN GASTRIC ULCER: a world wide experience.",BENIGN GASTRIC ULCER,FAMOTIDINE
725258019,5/23/2015 22:16:47,1642409867,5/23/2015 22:15:35,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],therapy of,N/A,47,0,-1,66,10,TWrex-cause,804401-FS1,"FAMOTIDINE once a day in the therapy of acute, BENIGN GASTRIC ULCER: a world wide experience.",BENIGN GASTRIC ULCER,FAMOTIDINE
725258019,5/23/2015 22:21:58,1642412550,5/23/2015 22:21:29,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[SYMPTOM],[SYMPTOM],GASTRIC ULCER:,N/A,47,0,-1,66,10,TWrex-cause,804401-FS1,"FAMOTIDINE once a day in the therapy of acute, BENIGN GASTRIC ULCER: a world wide experience.",BENIGN GASTRIC ULCER,FAMOTIDINE
725258019,5/23/2015 22:21:58,1642412551,5/23/2015 22:21:42,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[TREATS],[TREATS],"FAMOTIDINE therapy of acute, BENIGN GASTRIC ULCER:",n/a,47,0,-1,66,10,TWrex-cause,804401-FS1,"FAMOTIDINE once a day in the therapy of acute, BENIGN GASTRIC ULCER: a world wide experience.",BENIGN GASTRIC ULCER,FAMOTIDINE
725258019,5/23/2015 22:28:27,1642415679,5/23/2015 22:28:02,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],"FAMOTIDINE once a day the therapy of acute, BENIGN GASTRIC ULCER:",n/a,47,0,-1,66,10,TWrex-cause,804401-FS1,"FAMOTIDINE once a day in the therapy of acute, BENIGN GASTRIC ULCER: a world wide experience.",BENIGN GASTRIC ULCER,FAMOTIDINE
725258019,5/23/2015 22:32:12,1642417564,5/23/2015 22:31:48,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[TREATS],[TREATS],"FAMOTIDINE therapy of acute, BENIGN GASTRIC ULCER:",n/a,47,0,-1,66,10,TWrex-cause,804401-FS1,"FAMOTIDINE once a day in the therapy of acute, BENIGN GASTRIC ULCER: a world wide experience.",BENIGN GASTRIC ULCER,FAMOTIDINE
725258019,5/23/2015 22:58:10,1642430860,5/23/2015 22:57:51,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[TREATS],[TREATS],therapy,N/A,47,0,-1,66,10,TWrex-cause,804401-FS1,"FAMOTIDINE once a day in the therapy of acute, BENIGN GASTRIC ULCER: a world wide experience.",BENIGN GASTRIC ULCER,FAMOTIDINE
725258019,5/23/2015 23:02:36,1642433080,5/23/2015 23:01:51,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[TREATS],[TREATS],once a day therapy,n/a,47,0,-1,66,10,TWrex-cause,804401-FS1,"FAMOTIDINE once a day in the therapy of acute, BENIGN GASTRIC ULCER: a world wide experience.",BENIGN GASTRIC ULCER,FAMOTIDINE
725258019,5/23/2015 23:05:12,1642434308,5/23/2015 23:04:16,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[TREATS],[TREATS],in the therapy of,n/a,47,0,-1,66,10,TWrex-cause,804401-FS1,"FAMOTIDINE once a day in the therapy of acute, BENIGN GASTRIC ULCER: a world wide experience.",BENIGN GASTRIC ULCER,FAMOTIDINE
725258020,5/23/2015 20:25:53,1642355682,5/23/2015 20:25:01,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],DRUG INDUCED PHOTOSENSITIVITY: DRUGS may develop dermatitis or sunburn exposure to light,N/A,0,57,1,28,62,TWrex-cause,811333-FS1,DRUG INDUCED PHOTOSENSITIVITY: Individuals using certain DRUGS or other chemicals may develop dermatitis or sunburn after exposure to light of an intensity or duration that normally would not have affected them.,DRUG INDUCED PHOTOSENSITIVITY,DRUGS
725258020,5/23/2015 20:30:57,1642358099,5/23/2015 20:30:37,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],using,N/A,0,57,1,28,62,TWrex-cause,811333-FS1,DRUG INDUCED PHOTOSENSITIVITY: Individuals using certain DRUGS or other chemicals may develop dermatitis or sunburn after exposure to light of an intensity or duration that normally would not have affected them.,DRUG INDUCED PHOTOSENSITIVITY,DRUGS
725258020,5/23/2015 20:38:41,1642362011,5/23/2015 20:38:18,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[SIDE_EFFECT],[SIDE_EFFECT],develop,n/a,0,57,1,28,62,TWrex-cause,811333-FS1,DRUG INDUCED PHOTOSENSITIVITY: Individuals using certain DRUGS or other chemicals may develop dermatitis or sunburn after exposure to light of an intensity or duration that normally would not have affected them.,DRUG INDUCED PHOTOSENSITIVITY,DRUGS
725258020,5/23/2015 20:39:34,1642362554,5/23/2015 20:38:03,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],DRUG INDUCED PHOTOSENSITIVITY: Individuals using certain DRUGS,na,0,57,1,28,62,TWrex-cause,811333-FS1,DRUG INDUCED PHOTOSENSITIVITY: Individuals using certain DRUGS or other chemicals may develop dermatitis or sunburn after exposure to light of an intensity or duration that normally would not have affected them.,DRUG INDUCED PHOTOSENSITIVITY,DRUGS
725258020,5/23/2015 20:39:56,1642362754,5/23/2015 20:38:48,false,instagc,1.0,30880172,USA,CA,Los Angeles,166.170.50.98,[CAUSES],[CAUSES],develop after exposure that normally would not have affected them.,N/A,0,57,1,28,62,TWrex-cause,811333-FS1,DRUG INDUCED PHOTOSENSITIVITY: Individuals using certain DRUGS or other chemicals may develop dermatitis or sunburn after exposure to light of an intensity or duration that normally would not have affected them.,DRUG INDUCED PHOTOSENSITIVITY,DRUGS
725258020,5/23/2015 20:40:15,1642362952,5/23/2015 20:39:58,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],may develop,n/a,0,57,1,28,62,TWrex-cause,811333-FS1,DRUG INDUCED PHOTOSENSITIVITY: Individuals using certain DRUGS or other chemicals may develop dermatitis or sunburn after exposure to light of an intensity or duration that normally would not have affected them.,DRUG INDUCED PHOTOSENSITIVITY,DRUGS
725258020,5/23/2015 20:41:21,1642363613,5/23/2015 20:40:53,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[SIDE_EFFECT],[SIDE_EFFECT],may develop,n/a,0,57,1,28,62,TWrex-cause,811333-FS1,DRUG INDUCED PHOTOSENSITIVITY: Individuals using certain DRUGS or other chemicals may develop dermatitis or sunburn after exposure to light of an intensity or duration that normally would not have affected them.,DRUG INDUCED PHOTOSENSITIVITY,DRUGS
725258020,5/23/2015 20:44:23,1642365342,5/23/2015 20:43:44,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[MANIFESTATION],[MANIFESTATION],develop,-,0,57,1,28,62,TWrex-cause,811333-FS1,DRUG INDUCED PHOTOSENSITIVITY: Individuals using certain DRUGS or other chemicals may develop dermatitis or sunburn after exposure to light of an intensity or duration that normally would not have affected them.,DRUG INDUCED PHOTOSENSITIVITY,DRUGS
725258020,5/23/2015 20:45:37,1642366031,5/23/2015 20:45:18,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],INDUCED,n/a,0,57,1,28,62,TWrex-cause,811333-FS1,DRUG INDUCED PHOTOSENSITIVITY: Individuals using certain DRUGS or other chemicals may develop dermatitis or sunburn after exposure to light of an intensity or duration that normally would not have affected them.,DRUG INDUCED PHOTOSENSITIVITY,DRUGS
725258020,5/23/2015 20:46:21,1642366563,5/23/2015 20:43:48,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],using certain,N/A,0,57,1,28,62,TWrex-cause,811333-FS1,DRUG INDUCED PHOTOSENSITIVITY: Individuals using certain DRUGS or other chemicals may develop dermatitis or sunburn after exposure to light of an intensity or duration that normally would not have affected them.,DRUG INDUCED PHOTOSENSITIVITY,DRUGS
725258020,5/23/2015 20:54:03,1642370844,5/23/2015 20:53:40,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],may develop,n/a,0,57,1,28,62,TWrex-cause,811333-FS1,DRUG INDUCED PHOTOSENSITIVITY: Individuals using certain DRUGS or other chemicals may develop dermatitis or sunburn after exposure to light of an intensity or duration that normally would not have affected them.,DRUG INDUCED PHOTOSENSITIVITY,DRUGS
725258020,5/23/2015 21:04:37,1642375616,5/23/2015 21:03:45,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[MANIFESTATION] [SIDE_EFFECT],"[MANIFESTATION]
[SIDE_EFFECT]",using certain may develop,n/a,0,57,1,28,62,TWrex-cause,811333-FS1,DRUG INDUCED PHOTOSENSITIVITY: Individuals using certain DRUGS or other chemicals may develop dermatitis or sunburn after exposure to light of an intensity or duration that normally would not have affected them.,DRUG INDUCED PHOTOSENSITIVITY,DRUGS
725258020,5/23/2015 21:15:47,1642380883,5/23/2015 21:15:37,false,prodege,1.0,2143114,CAN,BC,Vancouver,24.85.153.181,[PREVENTS],[PREVENTS],INDUCED,n/a,0,57,1,28,62,TWrex-cause,811333-FS1,DRUG INDUCED PHOTOSENSITIVITY: Individuals using certain DRUGS or other chemicals may develop dermatitis or sunburn after exposure to light of an intensity or duration that normally would not have affected them.,DRUG INDUCED PHOTOSENSITIVITY,DRUGS
725258020,5/23/2015 21:28:06,1642386948,5/23/2015 21:27:27,false,prodege,1.0,24403612,CAN,ON,Bowmanville,99.252.243.178,[SIDE_EFFECT],[SIDE_EFFECT],DRUG INDUCED PHOTOSENSITIVITY: using DRUGS,N/A,0,57,1,28,62,TWrex-cause,811333-FS1,DRUG INDUCED PHOTOSENSITIVITY: Individuals using certain DRUGS or other chemicals may develop dermatitis or sunburn after exposure to light of an intensity or duration that normally would not have affected them.,DRUG INDUCED PHOTOSENSITIVITY,DRUGS
725258020,5/23/2015 21:28:56,1642387426,5/23/2015 21:27:16,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES] [CONTRAINDICATES] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[CONTRAINDICATES]",DRUG INDUCED PHOTOSENSITIVITY: Individuals using certain DRUGS or other chemicals may develop dermatitis or sunburn after exposure to light of an intensity or duration that normally would not have affected them.,n/a,0,57,1,28,62,TWrex-cause,811333-FS1,DRUG INDUCED PHOTOSENSITIVITY: Individuals using certain DRUGS or other chemicals may develop dermatitis or sunburn after exposure to light of an intensity or duration that normally would not have affected them.,DRUG INDUCED PHOTOSENSITIVITY,DRUGS
725258021,5/23/2015 21:55:06,1642399723,5/23/2015 21:54:43,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],in,N/A,89,59,-1,110,77,TWrex-cause,803439-FS1,"Balbiani L, Coppola F, Blajman C et al. Navelbine (NVB) vs NVB PLUS CISPLATIN (P) in non SMALL CELL LUNG CANCER (NSCLC.",SMALL CELL LUNG CANCER,NVB PLUS CISPLATIN
725258021,5/23/2015 21:58:28,1642400998,5/23/2015 21:57:57,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[PART_OF],[PART_OF],in,N/A,89,59,-1,110,77,TWrex-cause,803439-FS1,"Balbiani L, Coppola F, Blajman C et al. Navelbine (NVB) vs NVB PLUS CISPLATIN (P) in non SMALL CELL LUNG CANCER (NSCLC.",SMALL CELL LUNG CANCER,NVB PLUS CISPLATIN
725258021,5/23/2015 21:59:14,1642401300,5/23/2015 21:58:14,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[LOCATION] [TREATS],"[TREATS]
[LOCATION]",Navelbine (NVB) vs NVB PLUS CISPLATIN (P) in non SMALL CELL LUNG CANCER (NSCLC.,n/a,89,59,-1,110,77,TWrex-cause,803439-FS1,"Balbiani L, Coppola F, Blajman C et al. Navelbine (NVB) vs NVB PLUS CISPLATIN (P) in non SMALL CELL LUNG CANCER (NSCLC.",SMALL CELL LUNG CANCER,NVB PLUS CISPLATIN
725258021,5/23/2015 22:04:05,1642403362,5/23/2015 22:03:18,false,elite,1.0,30064988,GBR,B4,Bradford,92.22.135.10,[OTHER],[OTHER],Navelbine (NVB) vs NVB PLUS CISPLATIN,N/A,89,59,-1,110,77,TWrex-cause,803439-FS1,"Balbiani L, Coppola F, Blajman C et al. Navelbine (NVB) vs NVB PLUS CISPLATIN (P) in non SMALL CELL LUNG CANCER (NSCLC.",SMALL CELL LUNG CANCER,NVB PLUS CISPLATIN
725258021,5/23/2015 22:10:14,1642406655,5/23/2015 22:09:46,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],NVB PLUS CISPLATIN in non SMALL CELL LUNG CANCER,n/a,89,59,-1,110,77,TWrex-cause,803439-FS1,"Balbiani L, Coppola F, Blajman C et al. Navelbine (NVB) vs NVB PLUS CISPLATIN (P) in non SMALL CELL LUNG CANCER (NSCLC.",SMALL CELL LUNG CANCER,NVB PLUS CISPLATIN
725258021,5/23/2015 22:11:18,1642407200,5/23/2015 22:10:08,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],NVB PLUS CISPLATIN in SMALL CELL LUNG,N/A,89,59,-1,110,77,TWrex-cause,803439-FS1,"Balbiani L, Coppola F, Blajman C et al. Navelbine (NVB) vs NVB PLUS CISPLATIN (P) in non SMALL CELL LUNG CANCER (NSCLC.",SMALL CELL LUNG CANCER,NVB PLUS CISPLATIN
725258021,5/23/2015 22:11:53,1642407441,5/23/2015 22:10:43,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[OTHER],[OTHER],in non,n/a,89,59,-1,110,77,TWrex-cause,803439-FS1,"Balbiani L, Coppola F, Blajman C et al. Navelbine (NVB) vs NVB PLUS CISPLATIN (P) in non SMALL CELL LUNG CANCER (NSCLC.",SMALL CELL LUNG CANCER,NVB PLUS CISPLATIN
725258021,5/23/2015 22:11:53,1642407450,5/23/2015 22:10:41,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],in non,n/a,89,59,-1,110,77,TWrex-cause,803439-FS1,"Balbiani L, Coppola F, Blajman C et al. Navelbine (NVB) vs NVB PLUS CISPLATIN (P) in non SMALL CELL LUNG CANCER (NSCLC.",SMALL CELL LUNG CANCER,NVB PLUS CISPLATIN
725258021,5/23/2015 22:12:36,1642407830,5/23/2015 22:10:50,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],vs in non,N/A,89,59,-1,110,77,TWrex-cause,803439-FS1,"Balbiani L, Coppola F, Blajman C et al. Navelbine (NVB) vs NVB PLUS CISPLATIN (P) in non SMALL CELL LUNG CANCER (NSCLC.",SMALL CELL LUNG CANCER,NVB PLUS CISPLATIN
725258021,5/23/2015 22:20:21,1642411607,5/23/2015 22:20:05,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[SYMPTOM],[SYMPTOM],in non,n/a,89,59,-1,110,77,TWrex-cause,803439-FS1,"Balbiani L, Coppola F, Blajman C et al. Navelbine (NVB) vs NVB PLUS CISPLATIN (P) in non SMALL CELL LUNG CANCER (NSCLC.",SMALL CELL LUNG CANCER,NVB PLUS CISPLATIN
725258021,5/23/2015 22:20:39,1642411815,5/23/2015 22:20:14,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],CANCER,N/A,89,59,-1,110,77,TWrex-cause,803439-FS1,"Balbiani L, Coppola F, Blajman C et al. Navelbine (NVB) vs NVB PLUS CISPLATIN (P) in non SMALL CELL LUNG CANCER (NSCLC.",SMALL CELL LUNG CANCER,NVB PLUS CISPLATIN
725258021,5/23/2015 22:26:38,1642414848,5/23/2015 22:26:07,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],Navelbine (NVB) vs NVB PLUS CISPLATIN (P) in non SMALL CELL LUNG CANCER,n/a,89,59,-1,110,77,TWrex-cause,803439-FS1,"Balbiani L, Coppola F, Blajman C et al. Navelbine (NVB) vs NVB PLUS CISPLATIN (P) in non SMALL CELL LUNG CANCER (NSCLC.",SMALL CELL LUNG CANCER,NVB PLUS CISPLATIN
725258021,5/23/2015 22:29:33,1642416170,5/23/2015 22:28:57,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[TREATS],[TREATS],NVB PLUS CISPLATIN (P) in non SMALL CELL LUNG CANCER,n/a,89,59,-1,110,77,TWrex-cause,803439-FS1,"Balbiani L, Coppola F, Blajman C et al. Navelbine (NVB) vs NVB PLUS CISPLATIN (P) in non SMALL CELL LUNG CANCER (NSCLC.",SMALL CELL LUNG CANCER,NVB PLUS CISPLATIN
725258021,5/23/2015 22:39:51,1642421539,5/23/2015 22:39:07,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[ASSOCIATED_WITH],[ASSOCIATED_WITH],in non,N/A,89,59,-1,110,77,TWrex-cause,803439-FS1,"Balbiani L, Coppola F, Blajman C et al. Navelbine (NVB) vs NVB PLUS CISPLATIN (P) in non SMALL CELL LUNG CANCER (NSCLC.",SMALL CELL LUNG CANCER,NVB PLUS CISPLATIN
725258021,5/23/2015 22:56:00,1642429829,5/23/2015 22:55:29,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[ASSOCIATED_WITH],[ASSOCIATED_WITH],in,N/A,89,59,-1,110,77,TWrex-cause,803439-FS1,"Balbiani L, Coppola F, Blajman C et al. Navelbine (NVB) vs NVB PLUS CISPLATIN (P) in non SMALL CELL LUNG CANCER (NSCLC.",SMALL CELL LUNG CANCER,NVB PLUS CISPLATIN
725258022,5/24/2015 00:42:11,1642476301,5/24/2015 00:41:38,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[PREVENTS],[PREVENTS],Prevention,n/a,119,157,-1,133,180,TWrex-cause,800843-FS1,"Yaws, Pinta, and Bejel  >     IM  Penicillin G benzathine: A single dose of 300,000 units in children    Prevention of RHEUMATIC FEVER Recurrence  >     IM  PENICILLIN G BENZATHINE: 1.2 million units once every 3 4 weeks.",RHEUMATIC FEVER,PENICILLIN G BENZATHINE
725258022,5/24/2015 00:50:32,1642479464,5/24/2015 00:49:05,false,elite,1.0,31848723,USA,VA,Manassas,192.96.205.155,[SYMPTOM],[SYMPTOM],RHEUMATIC FEVER PENICILLIN BENZATHINE:,N/A,119,157,-1,133,180,TWrex-cause,800843-FS1,"Yaws, Pinta, and Bejel  >     IM  Penicillin G benzathine: A single dose of 300,000 units in children    Prevention of RHEUMATIC FEVER Recurrence  >     IM  PENICILLIN G BENZATHINE: 1.2 million units once every 3 4 weeks.",RHEUMATIC FEVER,PENICILLIN G BENZATHINE
725258022,5/24/2015 00:57:54,1642481703,5/24/2015 00:57:21,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[PREVENTS],[PREVENTS],Prevention of,N/A,119,157,-1,133,180,TWrex-cause,800843-FS1,"Yaws, Pinta, and Bejel  >     IM  Penicillin G benzathine: A single dose of 300,000 units in children    Prevention of RHEUMATIC FEVER Recurrence  >     IM  PENICILLIN G BENZATHINE: 1.2 million units once every 3 4 weeks.",RHEUMATIC FEVER,PENICILLIN G BENZATHINE
725258022,5/24/2015 00:58:14,1642481786,5/24/2015 00:57:35,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[OTHER],[OTHER],Prevention of RHEUMATIC FEVER,NA,119,157,-1,133,180,TWrex-cause,800843-FS1,"Yaws, Pinta, and Bejel  >     IM  Penicillin G benzathine: A single dose of 300,000 units in children    Prevention of RHEUMATIC FEVER Recurrence  >     IM  PENICILLIN G BENZATHINE: 1.2 million units once every 3 4 weeks.",RHEUMATIC FEVER,PENICILLIN G BENZATHINE
725258022,5/24/2015 01:40:47,1642495806,5/24/2015 01:40:32,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[CONTRAINDICATES],[CONTRAINDICATES],units,N/A,119,157,-1,133,180,TWrex-cause,800843-FS1,"Yaws, Pinta, and Bejel  >     IM  Penicillin G benzathine: A single dose of 300,000 units in children    Prevention of RHEUMATIC FEVER Recurrence  >     IM  PENICILLIN G BENZATHINE: 1.2 million units once every 3 4 weeks.",RHEUMATIC FEVER,PENICILLIN G BENZATHINE
725258022,5/24/2015 01:47:48,1642498231,5/24/2015 01:47:37,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[PREVENTS],[PREVENTS],Prevention,N/A,119,157,-1,133,180,TWrex-cause,800843-FS1,"Yaws, Pinta, and Bejel  >     IM  Penicillin G benzathine: A single dose of 300,000 units in children    Prevention of RHEUMATIC FEVER Recurrence  >     IM  PENICILLIN G BENZATHINE: 1.2 million units once every 3 4 weeks.",RHEUMATIC FEVER,PENICILLIN G BENZATHINE
725258022,5/24/2015 01:54:36,1642500592,5/24/2015 01:54:25,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[PREVENTS],[PREVENTS],Prevention,N/A,119,157,-1,133,180,TWrex-cause,800843-FS1,"Yaws, Pinta, and Bejel  >     IM  Penicillin G benzathine: A single dose of 300,000 units in children    Prevention of RHEUMATIC FEVER Recurrence  >     IM  PENICILLIN G BENZATHINE: 1.2 million units once every 3 4 weeks.",RHEUMATIC FEVER,PENICILLIN G BENZATHINE
725258022,5/24/2015 02:01:36,1642502748,5/24/2015 02:01:23,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[PREVENTS],[PREVENTS],Prevention,N/A,119,157,-1,133,180,TWrex-cause,800843-FS1,"Yaws, Pinta, and Bejel  >     IM  Penicillin G benzathine: A single dose of 300,000 units in children    Prevention of RHEUMATIC FEVER Recurrence  >     IM  PENICILLIN G BENZATHINE: 1.2 million units once every 3 4 weeks.",RHEUMATIC FEVER,PENICILLIN G BENZATHINE
725258022,5/24/2015 02:09:10,1642505001,5/24/2015 02:08:58,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[PREVENTS],[PREVENTS],Prevention,N/A,119,157,-1,133,180,TWrex-cause,800843-FS1,"Yaws, Pinta, and Bejel  >     IM  Penicillin G benzathine: A single dose of 300,000 units in children    Prevention of RHEUMATIC FEVER Recurrence  >     IM  PENICILLIN G BENZATHINE: 1.2 million units once every 3 4 weeks.",RHEUMATIC FEVER,PENICILLIN G BENZATHINE
725258022,5/24/2015 02:26:18,1642510691,5/24/2015 02:25:15,false,prodege,1.0,17379068,CAN,NB,Saint John,142.162.106.83,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Prevention,N/A,119,157,-1,133,180,TWrex-cause,800843-FS1,"Yaws, Pinta, and Bejel  >     IM  Penicillin G benzathine: A single dose of 300,000 units in children    Prevention of RHEUMATIC FEVER Recurrence  >     IM  PENICILLIN G BENZATHINE: 1.2 million units once every 3 4 weeks.",RHEUMATIC FEVER,PENICILLIN G BENZATHINE
725258022,5/24/2015 02:36:02,1642513828,5/24/2015 02:35:25,false,elite,1.0,32306791,USA,DE,Wilmington,199.58.86.213,[CAUSES],[CAUSES],RHEUMATIC FEVER,N/A,119,157,-1,133,180,TWrex-cause,800843-FS1,"Yaws, Pinta, and Bejel  >     IM  Penicillin G benzathine: A single dose of 300,000 units in children    Prevention of RHEUMATIC FEVER Recurrence  >     IM  PENICILLIN G BENZATHINE: 1.2 million units once every 3 4 weeks.",RHEUMATIC FEVER,PENICILLIN G BENZATHINE
725258022,5/24/2015 02:58:09,1642520116,5/24/2015 02:57:52,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[PREVENTS],[PREVENTS],Prevention of RHEUMATIC FEVER Recurrence IM PENICILLIN G BENZATHINE:,N/A,119,157,-1,133,180,TWrex-cause,800843-FS1,"Yaws, Pinta, and Bejel  >     IM  Penicillin G benzathine: A single dose of 300,000 units in children    Prevention of RHEUMATIC FEVER Recurrence  >     IM  PENICILLIN G BENZATHINE: 1.2 million units once every 3 4 weeks.",RHEUMATIC FEVER,PENICILLIN G BENZATHINE
725258022,5/24/2015 03:33:55,1642530083,5/24/2015 03:32:27,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[PREVENTS],[PREVENTS],Prevention of RHEUMATIC,n/a,119,157,-1,133,180,TWrex-cause,800843-FS1,"Yaws, Pinta, and Bejel  >     IM  Penicillin G benzathine: A single dose of 300,000 units in children    Prevention of RHEUMATIC FEVER Recurrence  >     IM  PENICILLIN G BENZATHINE: 1.2 million units once every 3 4 weeks.",RHEUMATIC FEVER,PENICILLIN G BENZATHINE
725258022,5/24/2015 04:36:06,1642543966,5/24/2015 04:35:30,false,gifthunterclub,1,24043308,GBR,"","",94.102.147.250,[PREVENTS],[PREVENTS],Prevention,N/A,119,157,-1,133,180,TWrex-cause,800843-FS1,"Yaws, Pinta, and Bejel  >     IM  Penicillin G benzathine: A single dose of 300,000 units in children    Prevention of RHEUMATIC FEVER Recurrence  >     IM  PENICILLIN G BENZATHINE: 1.2 million units once every 3 4 weeks.",RHEUMATIC FEVER,PENICILLIN G BENZATHINE
725258022,5/24/2015 04:40:34,1642544844,5/24/2015 04:40:18,false,superrewards,1,24796792,USA,NY,New York,72.80.63.240,[TREATS],[TREATS],Recurrence,n/a,119,157,-1,133,180,TWrex-cause,800843-FS1,"Yaws, Pinta, and Bejel  >     IM  Penicillin G benzathine: A single dose of 300,000 units in children    Prevention of RHEUMATIC FEVER Recurrence  >     IM  PENICILLIN G BENZATHINE: 1.2 million units once every 3 4 weeks.",RHEUMATIC FEVER,PENICILLIN G BENZATHINE
725258023,5/24/2015 00:36:44,1642473977,5/24/2015 00:36:31,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,n/a,112,0,1,118,18,TWrex-cause,814209-FS1,"VESTIBULAR SEIZURE familial conditions, and multiple sclerosis are all structural abnormalities associated with VERTIGO",VERTIGO,VESTIBULAR SEIZURE
725258023,5/24/2015 00:46:20,1642478022,5/24/2015 00:46:04,false,elite,1.0,31848723,USA,VA,Manassas,192.96.205.155,[CAUSES],[CAUSES],VESTIBULAR SEIZURE VERTIGO,N/A,112,0,1,118,18,TWrex-cause,814209-FS1,"VESTIBULAR SEIZURE familial conditions, and multiple sclerosis are all structural abnormalities associated with VERTIGO",VERTIGO,VESTIBULAR SEIZURE
725258023,5/24/2015 00:50:46,1642479512,5/24/2015 00:49:51,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,112,0,1,118,18,TWrex-cause,814209-FS1,"VESTIBULAR SEIZURE familial conditions, and multiple sclerosis are all structural abnormalities associated with VERTIGO",VERTIGO,VESTIBULAR SEIZURE
725258023,5/24/2015 00:51:58,1642479909,5/24/2015 00:50:06,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,NA,112,0,1,118,18,TWrex-cause,814209-FS1,"VESTIBULAR SEIZURE familial conditions, and multiple sclerosis are all structural abnormalities associated with VERTIGO",VERTIGO,VESTIBULAR SEIZURE
725258023,5/24/2015 01:10:00,1642485973,5/24/2015 01:09:27,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,112,0,1,118,18,TWrex-cause,814209-FS1,"VESTIBULAR SEIZURE familial conditions, and multiple sclerosis are all structural abnormalities associated with VERTIGO",VERTIGO,VESTIBULAR SEIZURE
725258023,5/24/2015 01:38:30,1642494985,5/24/2015 01:38:17,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,112,0,1,118,18,TWrex-cause,814209-FS1,"VESTIBULAR SEIZURE familial conditions, and multiple sclerosis are all structural abnormalities associated with VERTIGO",VERTIGO,VESTIBULAR SEIZURE
725258023,5/24/2015 01:45:47,1642497643,5/24/2015 01:45:36,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,112,0,1,118,18,TWrex-cause,814209-FS1,"VESTIBULAR SEIZURE familial conditions, and multiple sclerosis are all structural abnormalities associated with VERTIGO",VERTIGO,VESTIBULAR SEIZURE
725258023,5/24/2015 01:52:35,1642499945,5/24/2015 01:52:21,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,112,0,1,118,18,TWrex-cause,814209-FS1,"VESTIBULAR SEIZURE familial conditions, and multiple sclerosis are all structural abnormalities associated with VERTIGO",VERTIGO,VESTIBULAR SEIZURE
725258023,5/24/2015 01:59:05,1642502055,5/24/2015 01:58:52,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,112,0,1,118,18,TWrex-cause,814209-FS1,"VESTIBULAR SEIZURE familial conditions, and multiple sclerosis are all structural abnormalities associated with VERTIGO",VERTIGO,VESTIBULAR SEIZURE
725258023,5/24/2015 02:04:30,1642503645,5/24/2015 02:04:21,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,112,0,1,118,18,TWrex-cause,814209-FS1,"VESTIBULAR SEIZURE familial conditions, and multiple sclerosis are all structural abnormalities associated with VERTIGO",VERTIGO,VESTIBULAR SEIZURE
725258023,5/24/2015 02:07:02,1642504347,5/24/2015 02:06:51,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,112,0,1,118,18,TWrex-cause,814209-FS1,"VESTIBULAR SEIZURE familial conditions, and multiple sclerosis are all structural abnormalities associated with VERTIGO",VERTIGO,VESTIBULAR SEIZURE
725258023,5/24/2015 02:12:04,1642505950,5/24/2015 02:10:32,false,prodege,1.0,17379068,CAN,NB,Saint John,142.162.106.83,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,112,0,1,118,18,TWrex-cause,814209-FS1,"VESTIBULAR SEIZURE familial conditions, and multiple sclerosis are all structural abnormalities associated with VERTIGO",VERTIGO,VESTIBULAR SEIZURE
725258023,5/24/2015 02:32:44,1642512611,5/24/2015 02:32:20,false,elite,1.0,32306791,USA,DE,Wilmington,199.58.86.213,[CAUSES],[CAUSES],structural VERTIGO,N/A,112,0,1,118,18,TWrex-cause,814209-FS1,"VESTIBULAR SEIZURE familial conditions, and multiple sclerosis are all structural abnormalities associated with VERTIGO",VERTIGO,VESTIBULAR SEIZURE
725258023,5/24/2015 02:36:06,1642513838,5/24/2015 02:35:47,false,elite,1.0,31913360,USA,VA,Manassas,207.244.77.2,[LOCATION],[LOCATION],structural,.;;;;,112,0,1,118,18,TWrex-cause,814209-FS1,"VESTIBULAR SEIZURE familial conditions, and multiple sclerosis are all structural abnormalities associated with VERTIGO",VERTIGO,VESTIBULAR SEIZURE
725258023,5/24/2015 02:46:37,1642516935,5/24/2015 02:46:27,false,neodev,1.0,32562748,CAN,BC,Vancouver,108.180.140.140,[LOCATION] [MANIFESTATION],"[LOCATION]
[MANIFESTATION]",VESTIBULAR SEIZURE VERTIGO,N/A,112,0,1,118,18,TWrex-cause,814209-FS1,"VESTIBULAR SEIZURE familial conditions, and multiple sclerosis are all structural abnormalities associated with VERTIGO",VERTIGO,VESTIBULAR SEIZURE
725258024,5/23/2015 20:33:07,1642359277,5/23/2015 20:32:52,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[PREVENTS],[PREVENTS],to prevent some,N/A,60,33,-1,78,43,TWrex-cause,804409-FS1,Annotation: how do we get enough FOLIC ACID to prevent some NEURAL TUBE DEFECTS,NEURAL TUBE DEFECTS,FOLIC ACID
725258024,5/23/2015 20:35:59,1642360577,5/23/2015 20:35:25,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[PREVENTS],[PREVENTS],FOLIC ACID to prevent some NEURAL TUBE DEFECTS,N/A,60,33,-1,78,43,TWrex-cause,804409-FS1,Annotation: how do we get enough FOLIC ACID to prevent some NEURAL TUBE DEFECTS,NEURAL TUBE DEFECTS,FOLIC ACID
725258024,5/23/2015 20:40:40,1642363248,5/23/2015 20:40:30,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[PREVENTS],[PREVENTS],prevent,n/a,60,33,-1,78,43,TWrex-cause,804409-FS1,Annotation: how do we get enough FOLIC ACID to prevent some NEURAL TUBE DEFECTS,NEURAL TUBE DEFECTS,FOLIC ACID
725258024,5/23/2015 20:42:20,1642364054,5/23/2015 20:42:06,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[PREVENTS],[PREVENTS],prevent,n/a,60,33,-1,78,43,TWrex-cause,804409-FS1,Annotation: how do we get enough FOLIC ACID to prevent some NEURAL TUBE DEFECTS,NEURAL TUBE DEFECTS,FOLIC ACID
725258024,5/23/2015 20:46:43,1642366757,5/23/2015 20:46:34,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[PREVENTS],[PREVENTS],prevent,-,60,33,-1,78,43,TWrex-cause,804409-FS1,Annotation: how do we get enough FOLIC ACID to prevent some NEURAL TUBE DEFECTS,NEURAL TUBE DEFECTS,FOLIC ACID
725258024,5/23/2015 20:47:59,1642367599,5/23/2015 20:47:46,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[PREVENTS],[PREVENTS],to prevent,n/a,60,33,-1,78,43,TWrex-cause,804409-FS1,Annotation: how do we get enough FOLIC ACID to prevent some NEURAL TUBE DEFECTS,NEURAL TUBE DEFECTS,FOLIC ACID
725258024,5/23/2015 20:48:08,1642367705,5/23/2015 20:47:37,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[PREVENTS],[PREVENTS],FOLIC ACID to prevent NEURAL TUBE DEFECTS,na,60,33,-1,78,43,TWrex-cause,804409-FS1,Annotation: how do we get enough FOLIC ACID to prevent some NEURAL TUBE DEFECTS,NEURAL TUBE DEFECTS,FOLIC ACID
725258024,5/23/2015 20:48:17,1642367751,5/23/2015 20:47:33,false,instagc,1.0,30880172,USA,CA,Los Angeles,166.170.50.98,[OTHER],[OTHER],prevent,Prevented by,60,33,-1,78,43,TWrex-cause,804409-FS1,Annotation: how do we get enough FOLIC ACID to prevent some NEURAL TUBE DEFECTS,NEURAL TUBE DEFECTS,FOLIC ACID
725258024,5/23/2015 20:56:08,1642371886,5/23/2015 20:55:48,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[PREVENTS],[PREVENTS],to prevent,N/A,60,33,-1,78,43,TWrex-cause,804409-FS1,Annotation: how do we get enough FOLIC ACID to prevent some NEURAL TUBE DEFECTS,NEURAL TUBE DEFECTS,FOLIC ACID
725258024,5/23/2015 20:56:33,1642372054,5/23/2015 20:56:21,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[PREVENTS],[PREVENTS],to prevent,n/a,60,33,-1,78,43,TWrex-cause,804409-FS1,Annotation: how do we get enough FOLIC ACID to prevent some NEURAL TUBE DEFECTS,NEURAL TUBE DEFECTS,FOLIC ACID
725258024,5/23/2015 21:08:42,1642377628,5/23/2015 21:08:18,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[PREVENTS],[PREVENTS],ACID to prevent NEURAL TUBE DEFECTS,n/a,60,33,-1,78,43,TWrex-cause,804409-FS1,Annotation: how do we get enough FOLIC ACID to prevent some NEURAL TUBE DEFECTS,NEURAL TUBE DEFECTS,FOLIC ACID
725258024,5/23/2015 21:32:51,1642389305,5/23/2015 21:32:26,false,prodege,1.0,24403612,CAN,ON,Bowmanville,99.252.243.178,[PREVENTS],[PREVENTS],FOLIC ACID prevent NEURAL TUBE DEFECTS,N/A,60,33,-1,78,43,TWrex-cause,804409-FS1,Annotation: how do we get enough FOLIC ACID to prevent some NEURAL TUBE DEFECTS,NEURAL TUBE DEFECTS,FOLIC ACID
725258024,5/23/2015 21:33:32,1642389680,5/23/2015 21:32:32,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[PREVENTS],[PREVENTS],to prevent,N/A,60,33,-1,78,43,TWrex-cause,804409-FS1,Annotation: how do we get enough FOLIC ACID to prevent some NEURAL TUBE DEFECTS,NEURAL TUBE DEFECTS,FOLIC ACID
725258024,5/23/2015 21:36:29,1642391293,5/23/2015 21:36:12,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[PREVENTS],[PREVENTS],to prevent,N/A,60,33,-1,78,43,TWrex-cause,804409-FS1,Annotation: how do we get enough FOLIC ACID to prevent some NEURAL TUBE DEFECTS,NEURAL TUBE DEFECTS,FOLIC ACID
725258024,5/23/2015 21:36:50,1642391446,5/23/2015 21:35:42,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[MANIFESTATION] [IS_A] [PREVENTS],"[PREVENTS]
[MANIFESTATION]
[IS_A]",Annotation: how do we get enough FOLIC ACID to prevent some NEURAL TUBE DEFECTS,n/a,60,33,-1,78,43,TWrex-cause,804409-FS1,Annotation: how do we get enough FOLIC ACID to prevent some NEURAL TUBE DEFECTS,NEURAL TUBE DEFECTS,FOLIC ACID
725258025,5/24/2015 00:38:50,1642474810,5/24/2015 00:38:21,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[PREVENTS],[PREVENTS],reduce,n/a,39,62,-1,44,72,TWrex-cause,804010-FS1,"Osborne JP, Cocksedge S. Children with ASTHMA: will nebulised SALBUTAMOL reduce hospital admissions.",ASTHMA,SALBUTAMOL
725258025,5/24/2015 00:47:40,1642478422,5/24/2015 00:47:25,false,elite,1.0,31848723,USA,VA,Manassas,192.96.205.155,[CAUSES],[CAUSES],ASTHMA: SALBUTAMOL,N/A,39,62,-1,44,72,TWrex-cause,804010-FS1,"Osborne JP, Cocksedge S. Children with ASTHMA: will nebulised SALBUTAMOL reduce hospital admissions.",ASTHMA,SALBUTAMOL
725258025,5/24/2015 00:54:14,1642480438,5/24/2015 00:53:41,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[OTHER],[OTHER],SALBUTAMOL reduce hospital admissions.,NA,39,62,-1,44,72,TWrex-cause,804010-FS1,"Osborne JP, Cocksedge S. Children with ASTHMA: will nebulised SALBUTAMOL reduce hospital admissions.",ASTHMA,SALBUTAMOL
725258025,5/24/2015 00:54:17,1642480464,5/24/2015 00:53:15,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[PREVENTS],[PREVENTS],reduce,N/A,39,62,-1,44,72,TWrex-cause,804010-FS1,"Osborne JP, Cocksedge S. Children with ASTHMA: will nebulised SALBUTAMOL reduce hospital admissions.",ASTHMA,SALBUTAMOL
725258025,5/24/2015 01:13:39,1642487367,5/24/2015 01:12:51,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[DIAGNOSE_BY_TEST_OR_DRUG] [MANIFESTATION],"[DIAGNOSE_BY_TEST_OR_DRUG]
[MANIFESTATION]",will nebulised,N/A,39,62,-1,44,72,TWrex-cause,804010-FS1,"Osborne JP, Cocksedge S. Children with ASTHMA: will nebulised SALBUTAMOL reduce hospital admissions.",ASTHMA,SALBUTAMOL
725258025,5/24/2015 01:39:27,1642495346,5/24/2015 01:39:15,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[LOCATION],[LOCATION],hospital,N/A,39,62,-1,44,72,TWrex-cause,804010-FS1,"Osborne JP, Cocksedge S. Children with ASTHMA: will nebulised SALBUTAMOL reduce hospital admissions.",ASTHMA,SALBUTAMOL
725258025,5/24/2015 01:46:43,1642497870,5/24/2015 01:46:32,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[MANIFESTATION],[MANIFESTATION],nebulised,N/A,39,62,-1,44,72,TWrex-cause,804010-FS1,"Osborne JP, Cocksedge S. Children with ASTHMA: will nebulised SALBUTAMOL reduce hospital admissions.",ASTHMA,SALBUTAMOL
725258025,5/24/2015 01:53:28,1642500177,5/24/2015 01:53:16,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],reduce,N/A,39,62,-1,44,72,TWrex-cause,804010-FS1,"Osborne JP, Cocksedge S. Children with ASTHMA: will nebulised SALBUTAMOL reduce hospital admissions.",ASTHMA,SALBUTAMOL
725258025,5/24/2015 02:00:20,1642502402,5/24/2015 02:00:10,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[TREATS],[TREATS],reduce,N/A,39,62,-1,44,72,TWrex-cause,804010-FS1,"Osborne JP, Cocksedge S. Children with ASTHMA: will nebulised SALBUTAMOL reduce hospital admissions.",ASTHMA,SALBUTAMOL
725258025,5/24/2015 02:08:00,1642504710,5/24/2015 02:07:48,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[SYMPTOM],[SYMPTOM],with,N/A,39,62,-1,44,72,TWrex-cause,804010-FS1,"Osborne JP, Cocksedge S. Children with ASTHMA: will nebulised SALBUTAMOL reduce hospital admissions.",ASTHMA,SALBUTAMOL
725258025,5/24/2015 02:19:46,1642508815,5/24/2015 02:17:44,false,prodege,1.0,17379068,CAN,NB,Saint John,142.162.106.83,[TREATS],[TREATS],nebulised,N/A,39,62,-1,44,72,TWrex-cause,804010-FS1,"Osborne JP, Cocksedge S. Children with ASTHMA: will nebulised SALBUTAMOL reduce hospital admissions.",ASTHMA,SALBUTAMOL
725258025,5/24/2015 02:34:02,1642513052,5/24/2015 02:33:44,false,elite,1.0,32306791,USA,DE,Wilmington,199.58.86.213,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Children ASTHMA:,N/A,39,62,-1,44,72,TWrex-cause,804010-FS1,"Osborne JP, Cocksedge S. Children with ASTHMA: will nebulised SALBUTAMOL reduce hospital admissions.",ASTHMA,SALBUTAMOL
725258025,5/24/2015 02:37:03,1642514109,5/24/2015 02:36:53,false,elite,1.0,31913360,USA,VA,Manassas,207.244.77.3,[SYMPTOM],[SYMPTOM],admissions.,hhh,39,62,-1,44,72,TWrex-cause,804010-FS1,"Osborne JP, Cocksedge S. Children with ASTHMA: will nebulised SALBUTAMOL reduce hospital admissions.",ASTHMA,SALBUTAMOL
725258025,5/24/2015 02:47:25,1642517148,5/24/2015 02:47:16,false,neodev,1.0,32562748,CAN,BC,Vancouver,108.180.140.140,[LOCATION] [CAUSES],"[CAUSES]
[LOCATION]",ASTHMA: nebulised SALBUTAMOL,N/A,39,62,-1,44,72,TWrex-cause,804010-FS1,"Osborne JP, Cocksedge S. Children with ASTHMA: will nebulised SALBUTAMOL reduce hospital admissions.",ASTHMA,SALBUTAMOL
725258025,5/24/2015 02:55:11,1642519284,5/24/2015 02:54:54,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[TREATS],[TREATS],Children with ASTHMA: SALBUTAMOL reduce hospital admissions.,N/A,39,62,-1,44,72,TWrex-cause,804010-FS1,"Osborne JP, Cocksedge S. Children with ASTHMA: will nebulised SALBUTAMOL reduce hospital admissions.",ASTHMA,SALBUTAMOL
725258026,5/23/2015 22:18:48,1642410959,5/23/2015 22:18:32,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],PAIN ASSOCIATED WITH DYSMENORRHEA suggests ENDOMETRIOSIS,n/a,40,113,1,72,126,TWrex-cause,813882-FS1,"More chronic, cyclic pain, particularly PAIN ASSOCIATED WITH DYSMENORRHEA dyspareunia, and menorrhagia, suggests ENDOMETRIOSIS or adenomyosis.",PAIN ASSOCIATED WITH DYSMENORRHEA,ENDOMETRIOSIS
725258026,5/23/2015 22:33:54,1642418367,5/23/2015 22:33:32,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[SYMPTOM],[SYMPTOM],"chronic, pain,",N/A,40,113,1,72,126,TWrex-cause,813882-FS1,"More chronic, cyclic pain, particularly PAIN ASSOCIATED WITH DYSMENORRHEA dyspareunia, and menorrhagia, suggests ENDOMETRIOSIS or adenomyosis.",PAIN ASSOCIATED WITH DYSMENORRHEA,ENDOMETRIOSIS
725258026,5/23/2015 22:37:41,1642420411,5/23/2015 22:37:13,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[CAUSES] [ASSOCIATED_WITH],"[CAUSES]
[ASSOCIATED_WITH]","More chronic, cyclic pain, particularly PAIN ASSOCIATED WITH dyspareunia, menorrhagia, suggests ENDOMETRIOSIS or adenomyosis.",n/a,40,113,1,72,126,TWrex-cause,813882-FS1,"More chronic, cyclic pain, particularly PAIN ASSOCIATED WITH DYSMENORRHEA dyspareunia, and menorrhagia, suggests ENDOMETRIOSIS or adenomyosis.",PAIN ASSOCIATED WITH DYSMENORRHEA,ENDOMETRIOSIS
725258026,5/23/2015 22:38:34,1642420823,5/23/2015 22:37:38,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[SYMPTOM],[SYMPTOM],PAIN ASSOCIATED WITH DYSMENORRHEA suggests,N/A,40,113,1,72,126,TWrex-cause,813882-FS1,"More chronic, cyclic pain, particularly PAIN ASSOCIATED WITH DYSMENORRHEA dyspareunia, and menorrhagia, suggests ENDOMETRIOSIS or adenomyosis.",PAIN ASSOCIATED WITH DYSMENORRHEA,ENDOMETRIOSIS
725258026,5/23/2015 22:40:19,1642421799,5/23/2015 22:38:55,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],suggests,N/A,40,113,1,72,126,TWrex-cause,813882-FS1,"More chronic, cyclic pain, particularly PAIN ASSOCIATED WITH DYSMENORRHEA dyspareunia, and menorrhagia, suggests ENDOMETRIOSIS or adenomyosis.",PAIN ASSOCIATED WITH DYSMENORRHEA,ENDOMETRIOSIS
725258026,5/23/2015 22:43:47,1642423494,5/23/2015 22:43:20,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[SYMPTOM] [OTHER],"[SYMPTOM]
[OTHER]",PAIN ASSOCIATED WITH DYSMENORRHEA suggests ENDOMETRIOSIS,n/a,40,113,1,72,126,TWrex-cause,813882-FS1,"More chronic, cyclic pain, particularly PAIN ASSOCIATED WITH DYSMENORRHEA dyspareunia, and menorrhagia, suggests ENDOMETRIOSIS or adenomyosis.",PAIN ASSOCIATED WITH DYSMENORRHEA,ENDOMETRIOSIS
725258026,5/23/2015 23:11:13,1642436761,5/23/2015 23:09:55,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[SYMPTOM],[SYMPTOM],suggests,N/A,40,113,1,72,126,TWrex-cause,813882-FS1,"More chronic, cyclic pain, particularly PAIN ASSOCIATED WITH DYSMENORRHEA dyspareunia, and menorrhagia, suggests ENDOMETRIOSIS or adenomyosis.",PAIN ASSOCIATED WITH DYSMENORRHEA,ENDOMETRIOSIS
725258026,5/23/2015 23:16:40,1642439041,5/23/2015 23:16:12,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[SYMPTOM],[SYMPTOM],suggests,n/a,40,113,1,72,126,TWrex-cause,813882-FS1,"More chronic, cyclic pain, particularly PAIN ASSOCIATED WITH DYSMENORRHEA dyspareunia, and menorrhagia, suggests ENDOMETRIOSIS or adenomyosis.",PAIN ASSOCIATED WITH DYSMENORRHEA,ENDOMETRIOSIS
725258026,5/23/2015 23:21:32,1642440983,5/23/2015 23:19:52,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[ASSOCIATED_WITH],[ASSOCIATED_WITH],suggests,none,40,113,1,72,126,TWrex-cause,813882-FS1,"More chronic, cyclic pain, particularly PAIN ASSOCIATED WITH DYSMENORRHEA dyspareunia, and menorrhagia, suggests ENDOMETRIOSIS or adenomyosis.",PAIN ASSOCIATED WITH DYSMENORRHEA,ENDOMETRIOSIS
725258026,5/23/2015 23:24:02,1642442055,5/23/2015 23:23:12,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[ASSOCIATED_WITH],[ASSOCIATED_WITH],ASSOCIATED WITH,N/A,40,113,1,72,126,TWrex-cause,813882-FS1,"More chronic, cyclic pain, particularly PAIN ASSOCIATED WITH DYSMENORRHEA dyspareunia, and menorrhagia, suggests ENDOMETRIOSIS or adenomyosis.",PAIN ASSOCIATED WITH DYSMENORRHEA,ENDOMETRIOSIS
725258026,5/23/2015 23:26:20,1642443180,5/23/2015 23:24:33,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[ASSOCIATED_WITH] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]","pain, PAIN ASSOCIATED WITH",n/a,40,113,1,72,126,TWrex-cause,813882-FS1,"More chronic, cyclic pain, particularly PAIN ASSOCIATED WITH DYSMENORRHEA dyspareunia, and menorrhagia, suggests ENDOMETRIOSIS or adenomyosis.",PAIN ASSOCIATED WITH DYSMENORRHEA,ENDOMETRIOSIS
725258026,5/23/2015 23:35:13,1642447179,5/23/2015 23:34:41,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[SYMPTOM],[SYMPTOM],ASSOCIATED WITH,N/A,40,113,1,72,126,TWrex-cause,813882-FS1,"More chronic, cyclic pain, particularly PAIN ASSOCIATED WITH DYSMENORRHEA dyspareunia, and menorrhagia, suggests ENDOMETRIOSIS or adenomyosis.",PAIN ASSOCIATED WITH DYSMENORRHEA,ENDOMETRIOSIS
725258026,5/23/2015 23:44:28,1642451725,5/23/2015 23:44:12,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[SYMPTOM],[SYMPTOM],suggests,n/a,40,113,1,72,126,TWrex-cause,813882-FS1,"More chronic, cyclic pain, particularly PAIN ASSOCIATED WITH DYSMENORRHEA dyspareunia, and menorrhagia, suggests ENDOMETRIOSIS or adenomyosis.",PAIN ASSOCIATED WITH DYSMENORRHEA,ENDOMETRIOSIS
725258026,5/23/2015 23:53:04,1642455626,5/23/2015 23:52:21,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.161,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,40,113,1,72,126,TWrex-cause,813882-FS1,"More chronic, cyclic pain, particularly PAIN ASSOCIATED WITH DYSMENORRHEA dyspareunia, and menorrhagia, suggests ENDOMETRIOSIS or adenomyosis.",PAIN ASSOCIATED WITH DYSMENORRHEA,ENDOMETRIOSIS
725258026,5/24/2015 00:12:12,1642463881,5/24/2015 00:09:13,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[PREVENTS] [DIAGNOSE_BY_TEST_OR_DRUG],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]","dyspareunia, and",n/a,40,113,1,72,126,TWrex-cause,813882-FS1,"More chronic, cyclic pain, particularly PAIN ASSOCIATED WITH DYSMENORRHEA dyspareunia, and menorrhagia, suggests ENDOMETRIOSIS or adenomyosis.",PAIN ASSOCIATED WITH DYSMENORRHEA,ENDOMETRIOSIS
725258027,5/23/2015 21:55:53,1642399967,5/23/2015 21:55:07,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[PART_OF] [LOCATION],"[LOCATION]
[PART_OF]",remain the most common,N/A,140,24,-1,152,38,TWrex-cause,802993-FS1,"Chronic Conditions  The PNEUMOCONIOSES which were of great importance historically in North America and remain the most common occupational LUNG DISEASES in developing countries, continue to occur in the United States because of their very long latency from first exposure and because of a lack of compliance with regulation, mostly in construction, asbestos removal operations, sandblasting, and mining.",LUNG DISEASES,PNEUMOCONIOSES
725258027,5/23/2015 21:58:46,1642401139,5/23/2015 21:58:30,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[IS_A],[IS_A],remain,N/A,140,24,-1,152,38,TWrex-cause,802993-FS1,"Chronic Conditions  The PNEUMOCONIOSES which were of great importance historically in North America and remain the most common occupational LUNG DISEASES in developing countries, continue to occur in the United States because of their very long latency from first exposure and because of a lack of compliance with regulation, mostly in construction, asbestos removal operations, sandblasting, and mining.",LUNG DISEASES,PNEUMOCONIOSES
725258027,5/23/2015 22:00:44,1642401848,5/23/2015 21:59:15,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[OTHER],[OTHER],"Chronic Conditions The PNEUMOCONIOSES which were of great importance historically in North America and remain the most common occupational LUNG DISEASES in developing countries, continue to occur in the United States because of their very long latency from first exposure and because of a lack of compliance with regulation, mostly in construction, asbestos removal operations, sandblasting, and mining.",n/a,140,24,-1,152,38,TWrex-cause,802993-FS1,"Chronic Conditions  The PNEUMOCONIOSES which were of great importance historically in North America and remain the most common occupational LUNG DISEASES in developing countries, continue to occur in the United States because of their very long latency from first exposure and because of a lack of compliance with regulation, mostly in construction, asbestos removal operations, sandblasting, and mining.",LUNG DISEASES,PNEUMOCONIOSES
725258027,5/23/2015 22:04:40,1642403639,5/23/2015 22:04:08,false,elite,1.0,30064988,GBR,B4,Bradford,92.22.135.10,[IS_A],[IS_A],most common occupational LUNG DISEASES,N/A,140,24,-1,152,38,TWrex-cause,802993-FS1,"Chronic Conditions  The PNEUMOCONIOSES which were of great importance historically in North America and remain the most common occupational LUNG DISEASES in developing countries, continue to occur in the United States because of their very long latency from first exposure and because of a lack of compliance with regulation, mostly in construction, asbestos removal operations, sandblasting, and mining.",LUNG DISEASES,PNEUMOCONIOSES
725258027,5/23/2015 22:10:59,1642407074,5/23/2015 22:10:15,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[IS_A],[IS_A],PNEUMOCONIOSES remain the most common occupational LUNG DISEASES a,n/a,140,24,-1,152,38,TWrex-cause,802993-FS1,"Chronic Conditions  The PNEUMOCONIOSES which were of great importance historically in North America and remain the most common occupational LUNG DISEASES in developing countries, continue to occur in the United States because of their very long latency from first exposure and because of a lack of compliance with regulation, mostly in construction, asbestos removal operations, sandblasting, and mining.",LUNG DISEASES,PNEUMOCONIOSES
725258027,5/23/2015 22:12:56,1642407976,5/23/2015 22:11:19,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[IS_A],[IS_A],PNEUMOCONIOSES most common LUNG DISEASES,N/A,140,24,-1,152,38,TWrex-cause,802993-FS1,"Chronic Conditions  The PNEUMOCONIOSES which were of great importance historically in North America and remain the most common occupational LUNG DISEASES in developing countries, continue to occur in the United States because of their very long latency from first exposure and because of a lack of compliance with regulation, mostly in construction, asbestos removal operations, sandblasting, and mining.",LUNG DISEASES,PNEUMOCONIOSES
725258027,5/23/2015 22:13:01,1642408019,5/23/2015 22:11:54,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[IS_A],[IS_A],remain the most common occupational,n/a,140,24,-1,152,38,TWrex-cause,802993-FS1,"Chronic Conditions  The PNEUMOCONIOSES which were of great importance historically in North America and remain the most common occupational LUNG DISEASES in developing countries, continue to occur in the United States because of their very long latency from first exposure and because of a lack of compliance with regulation, mostly in construction, asbestos removal operations, sandblasting, and mining.",LUNG DISEASES,PNEUMOCONIOSES
725258027,5/23/2015 22:13:23,1642408227,5/23/2015 22:11:54,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[IS_A],[IS_A],most common occupational,n/a,140,24,-1,152,38,TWrex-cause,802993-FS1,"Chronic Conditions  The PNEUMOCONIOSES which were of great importance historically in North America and remain the most common occupational LUNG DISEASES in developing countries, continue to occur in the United States because of their very long latency from first exposure and because of a lack of compliance with regulation, mostly in construction, asbestos removal operations, sandblasting, and mining.",LUNG DISEASES,PNEUMOCONIOSES
725258027,5/23/2015 22:14:24,1642408769,5/23/2015 22:12:37,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[IS_A],[IS_A],the most common occupational LUNG DISEASES,N/A,140,24,-1,152,38,TWrex-cause,802993-FS1,"Chronic Conditions  The PNEUMOCONIOSES which were of great importance historically in North America and remain the most common occupational LUNG DISEASES in developing countries, continue to occur in the United States because of their very long latency from first exposure and because of a lack of compliance with regulation, mostly in construction, asbestos removal operations, sandblasting, and mining.",LUNG DISEASES,PNEUMOCONIOSES
725258027,5/23/2015 22:20:59,1642411969,5/23/2015 22:20:22,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[PART_OF],[PART_OF],The PNEUMOCONIOSES most common occupational LUNG DISEASES,n/a,140,24,-1,152,38,TWrex-cause,802993-FS1,"Chronic Conditions  The PNEUMOCONIOSES which were of great importance historically in North America and remain the most common occupational LUNG DISEASES in developing countries, continue to occur in the United States because of their very long latency from first exposure and because of a lack of compliance with regulation, mostly in construction, asbestos removal operations, sandblasting, and mining.",LUNG DISEASES,PNEUMOCONIOSES
725258027,5/23/2015 22:21:12,1642412064,5/23/2015 22:20:41,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[LOCATION],[LOCATION],"developing countries,",N/A,140,24,-1,152,38,TWrex-cause,802993-FS1,"Chronic Conditions  The PNEUMOCONIOSES which were of great importance historically in North America and remain the most common occupational LUNG DISEASES in developing countries, continue to occur in the United States because of their very long latency from first exposure and because of a lack of compliance with regulation, mostly in construction, asbestos removal operations, sandblasting, and mining.",LUNG DISEASES,PNEUMOCONIOSES
725258027,5/23/2015 22:27:28,1642415133,5/23/2015 22:26:39,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[OTHER],[OTHER],"Conditions The PNEUMOCONIOSES which were great importance historically North America remain the common occupational LUNG DISEASES in developing countries,",n/a,140,24,-1,152,38,TWrex-cause,802993-FS1,"Chronic Conditions  The PNEUMOCONIOSES which were of great importance historically in North America and remain the most common occupational LUNG DISEASES in developing countries, continue to occur in the United States because of their very long latency from first exposure and because of a lack of compliance with regulation, mostly in construction, asbestos removal operations, sandblasting, and mining.",LUNG DISEASES,PNEUMOCONIOSES
725258027,5/23/2015 22:30:57,1642416874,5/23/2015 22:29:34,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[IS_A],[IS_A],PNEUMOCONIOSES most common occupational LUNG DISEASES,n/a,140,24,-1,152,38,TWrex-cause,802993-FS1,"Chronic Conditions  The PNEUMOCONIOSES which were of great importance historically in North America and remain the most common occupational LUNG DISEASES in developing countries, continue to occur in the United States because of their very long latency from first exposure and because of a lack of compliance with regulation, mostly in construction, asbestos removal operations, sandblasting, and mining.",LUNG DISEASES,PNEUMOCONIOSES
725258027,5/23/2015 22:56:37,1642430089,5/23/2015 22:56:01,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[IS_A],[IS_A],remain the most common,N/A,140,24,-1,152,38,TWrex-cause,802993-FS1,"Chronic Conditions  The PNEUMOCONIOSES which were of great importance historically in North America and remain the most common occupational LUNG DISEASES in developing countries, continue to occur in the United States because of their very long latency from first exposure and because of a lack of compliance with regulation, mostly in construction, asbestos removal operations, sandblasting, and mining.",LUNG DISEASES,PNEUMOCONIOSES
725258027,5/23/2015 23:00:03,1642431785,5/23/2015 22:58:12,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[MANIFESTATION],[MANIFESTATION],continue occur,n/a,140,24,-1,152,38,TWrex-cause,802993-FS1,"Chronic Conditions  The PNEUMOCONIOSES which were of great importance historically in North America and remain the most common occupational LUNG DISEASES in developing countries, continue to occur in the United States because of their very long latency from first exposure and because of a lack of compliance with regulation, mostly in construction, asbestos removal operations, sandblasting, and mining.",LUNG DISEASES,PNEUMOCONIOSES
725258028,5/23/2015 22:14:05,1642408591,5/23/2015 22:13:13,false,elite,1.0,30064988,GBR,B4,Bradford,92.22.135.10,[LOCATION],[LOCATION],inflammation of the,N/A,62,0,-1,69,18,TWrex-cause,802873-FS1,"ACUTE PANCREATITIS  ACUTE PANCREATITIS is inflammation of the PANCREAS (and, sometimes, adjacent tissues) caused by the release of activated pancreatic enzymes.",PANCREAS,ACUTE PANCREATITIS
725258028,5/23/2015 22:16:40,1642409825,5/23/2015 22:16:24,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],ACUTE PANCREATITIS ACUTE PANCREATITIS is inflammation of the PANCREAS,n/a,62,0,-1,69,18,TWrex-cause,802873-FS1,"ACUTE PANCREATITIS  ACUTE PANCREATITIS is inflammation of the PANCREAS (and, sometimes, adjacent tissues) caused by the release of activated pancreatic enzymes.",PANCREAS,ACUTE PANCREATITIS
725258028,5/23/2015 22:29:46,1642416299,5/23/2015 22:29:16,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[SYMPTOM],[SYMPTOM],inflammation,N/A,62,0,-1,69,18,TWrex-cause,802873-FS1,"ACUTE PANCREATITIS  ACUTE PANCREATITIS is inflammation of the PANCREAS (and, sometimes, adjacent tissues) caused by the release of activated pancreatic enzymes.",PANCREAS,ACUTE PANCREATITIS
725258028,5/23/2015 22:31:26,1642417132,5/23/2015 22:29:33,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES],[CAUSES],ACUTE PANCREATITIS is inflammation of the PANCREAS caused by activated pancreatic enzymes.,N/A,62,0,-1,69,18,TWrex-cause,802873-FS1,"ACUTE PANCREATITIS  ACUTE PANCREATITIS is inflammation of the PANCREAS (and, sometimes, adjacent tissues) caused by the release of activated pancreatic enzymes.",PANCREAS,ACUTE PANCREATITIS
725258028,5/23/2015 22:32:44,1642417814,5/23/2015 22:31:33,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[LOCATION],[LOCATION],of the,N/A,62,0,-1,69,18,TWrex-cause,802873-FS1,"ACUTE PANCREATITIS  ACUTE PANCREATITIS is inflammation of the PANCREAS (and, sometimes, adjacent tissues) caused by the release of activated pancreatic enzymes.",PANCREAS,ACUTE PANCREATITIS
725258028,5/23/2015 22:34:59,1642418906,5/23/2015 22:34:26,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[CAUSES],[CAUSES],ACUTE PANCREATITIS ACUTE PANCREATITIS inflammation the PANCREAS caused by the release of activated pancreatic enzymes.,n/a,62,0,-1,69,18,TWrex-cause,802873-FS1,"ACUTE PANCREATITIS  ACUTE PANCREATITIS is inflammation of the PANCREAS (and, sometimes, adjacent tissues) caused by the release of activated pancreatic enzymes.",PANCREAS,ACUTE PANCREATITIS
725258028,5/23/2015 22:40:17,1642421789,5/23/2015 22:39:45,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[IS_A] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]",ACUTE PANCREATITIS ACUTE PANCREATITIS is inflammation of the PANCREAS,n/a,62,0,-1,69,18,TWrex-cause,802873-FS1,"ACUTE PANCREATITIS  ACUTE PANCREATITIS is inflammation of the PANCREAS (and, sometimes, adjacent tissues) caused by the release of activated pancreatic enzymes.",PANCREAS,ACUTE PANCREATITIS
725258028,5/23/2015 23:07:24,1642435166,5/23/2015 23:07:03,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[LOCATION],[LOCATION],inflammation of the,N/A,62,0,-1,69,18,TWrex-cause,802873-FS1,"ACUTE PANCREATITIS  ACUTE PANCREATITIS is inflammation of the PANCREAS (and, sometimes, adjacent tissues) caused by the release of activated pancreatic enzymes.",PANCREAS,ACUTE PANCREATITIS
725258028,5/23/2015 23:12:36,1642437351,5/23/2015 23:12:14,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[LOCATION],[LOCATION],inflammation of the,n/a,62,0,-1,69,18,TWrex-cause,802873-FS1,"ACUTE PANCREATITIS  ACUTE PANCREATITIS is inflammation of the PANCREAS (and, sometimes, adjacent tissues) caused by the release of activated pancreatic enzymes.",PANCREAS,ACUTE PANCREATITIS
725258028,5/23/2015 23:15:13,1642438453,5/23/2015 23:14:28,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],caused,none,62,0,-1,69,18,TWrex-cause,802873-FS1,"ACUTE PANCREATITIS  ACUTE PANCREATITIS is inflammation of the PANCREAS (and, sometimes, adjacent tissues) caused by the release of activated pancreatic enzymes.",PANCREAS,ACUTE PANCREATITIS
725258028,5/23/2015 23:15:16,1642438469,5/23/2015 23:14:53,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A] [CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[IS_A]
[PART_OF]",is of caused by of,N/A,62,0,-1,69,18,TWrex-cause,802873-FS1,"ACUTE PANCREATITIS  ACUTE PANCREATITIS is inflammation of the PANCREAS (and, sometimes, adjacent tissues) caused by the release of activated pancreatic enzymes.",PANCREAS,ACUTE PANCREATITIS
725258028,5/23/2015 23:20:23,1642440549,5/23/2015 23:19:51,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[CAUSES],[CAUSES],caused by,n/a,62,0,-1,69,18,TWrex-cause,802873-FS1,"ACUTE PANCREATITIS  ACUTE PANCREATITIS is inflammation of the PANCREAS (and, sometimes, adjacent tissues) caused by the release of activated pancreatic enzymes.",PANCREAS,ACUTE PANCREATITIS
725258028,5/23/2015 23:20:25,1642440558,5/23/2015 23:20:02,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],inflammation of the,N/A,62,0,-1,69,18,TWrex-cause,802873-FS1,"ACUTE PANCREATITIS  ACUTE PANCREATITIS is inflammation of the PANCREAS (and, sometimes, adjacent tissues) caused by the release of activated pancreatic enzymes.",PANCREAS,ACUTE PANCREATITIS
725258028,5/23/2015 23:30:39,1642445300,5/23/2015 23:29:20,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[LOCATION],[LOCATION],adjacent,N/A,62,0,-1,69,18,TWrex-cause,802873-FS1,"ACUTE PANCREATITIS  ACUTE PANCREATITIS is inflammation of the PANCREAS (and, sometimes, adjacent tissues) caused by the release of activated pancreatic enzymes.",PANCREAS,ACUTE PANCREATITIS
725258028,5/23/2015 23:42:26,1642450745,5/23/2015 23:42:12,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[IS_A],[IS_A],is of the,n/a,62,0,-1,69,18,TWrex-cause,802873-FS1,"ACUTE PANCREATITIS  ACUTE PANCREATITIS is inflammation of the PANCREAS (and, sometimes, adjacent tissues) caused by the release of activated pancreatic enzymes.",PANCREAS,ACUTE PANCREATITIS
725258029,5/24/2015 00:42:40,1642476509,5/24/2015 00:42:12,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[SYMPTOM],[SYMPTOM],diagnosed,n/a,4,121,1,7,133,TWrex-cause,814610-FS1,"The PAIN caused her to miss school frequently, but was not considered to be severe by her family physician who diagnosed DYSMENORRHEA",PAIN,DYSMENORRHEA
725258029,5/24/2015 00:50:51,1642479563,5/24/2015 00:50:37,false,elite,1.0,31848723,USA,VA,Manassas,192.96.205.155,[CAUSES],[CAUSES],PAIN DYSMENORRHEA,N/A,4,121,1,7,133,TWrex-cause,814610-FS1,"The PAIN caused her to miss school frequently, but was not considered to be severe by her family physician who diagnosed DYSMENORRHEA",PAIN,DYSMENORRHEA
725258029,5/24/2015 00:58:37,1642481978,5/24/2015 00:57:55,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]",diagnosed,N/A,4,121,1,7,133,TWrex-cause,814610-FS1,"The PAIN caused her to miss school frequently, but was not considered to be severe by her family physician who diagnosed DYSMENORRHEA",PAIN,DYSMENORRHEA
725258029,5/24/2015 00:58:44,1642482028,5/24/2015 00:58:15,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[OTHER],[OTHER],diagnosed DYSMENORRHEA,NA,4,121,1,7,133,TWrex-cause,814610-FS1,"The PAIN caused her to miss school frequently, but was not considered to be severe by her family physician who diagnosed DYSMENORRHEA",PAIN,DYSMENORRHEA
725258029,5/24/2015 01:41:01,1642495907,5/24/2015 01:40:49,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[CAUSES],[CAUSES],caused,N/A,4,121,1,7,133,TWrex-cause,814610-FS1,"The PAIN caused her to miss school frequently, but was not considered to be severe by her family physician who diagnosed DYSMENORRHEA",PAIN,DYSMENORRHEA
725258029,5/24/2015 01:48:02,1642498327,5/24/2015 01:47:50,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[CAUSES],[CAUSES],caused,N/A,4,121,1,7,133,TWrex-cause,814610-FS1,"The PAIN caused her to miss school frequently, but was not considered to be severe by her family physician who diagnosed DYSMENORRHEA",PAIN,DYSMENORRHEA
725258029,5/24/2015 01:54:49,1642500695,5/24/2015 01:54:37,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosed,N/A,4,121,1,7,133,TWrex-cause,814610-FS1,"The PAIN caused her to miss school frequently, but was not considered to be severe by her family physician who diagnosed DYSMENORRHEA",PAIN,DYSMENORRHEA
725258029,5/24/2015 02:01:49,1642502785,5/24/2015 02:01:38,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosed,N/A,4,121,1,7,133,TWrex-cause,814610-FS1,"The PAIN caused her to miss school frequently, but was not considered to be severe by her family physician who diagnosed DYSMENORRHEA",PAIN,DYSMENORRHEA
725258029,5/24/2015 02:09:25,1642505099,5/24/2015 02:09:11,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosed,N/A,4,121,1,7,133,TWrex-cause,814610-FS1,"The PAIN caused her to miss school frequently, but was not considered to be severe by her family physician who diagnosed DYSMENORRHEA",PAIN,DYSMENORRHEA
725258029,5/24/2015 02:27:03,1642510902,5/24/2015 02:26:19,false,prodege,1.0,17379068,CAN,NB,Saint John,142.162.106.83,[SYMPTOM],[SYMPTOM],diagnosed,N/A,4,121,1,7,133,TWrex-cause,814610-FS1,"The PAIN caused her to miss school frequently, but was not considered to be severe by her family physician who diagnosed DYSMENORRHEA",PAIN,DYSMENORRHEA
725258029,5/24/2015 02:36:32,1642513991,5/24/2015 02:36:05,false,elite,1.0,32306791,USA,DE,Wilmington,199.58.86.213,[SIDE_EFFECT],[SIDE_EFFECT],PAIN DYSMENORRHEA,N/A,4,121,1,7,133,TWrex-cause,814610-FS1,"The PAIN caused her to miss school frequently, but was not considered to be severe by her family physician who diagnosed DYSMENORRHEA",PAIN,DYSMENORRHEA
725258029,5/24/2015 02:58:34,1642520185,5/24/2015 02:58:10,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[SYMPTOM],[SYMPTOM],PAIN caused by DYSMENORRHEA,N/A,4,121,1,7,133,TWrex-cause,814610-FS1,"The PAIN caused her to miss school frequently, but was not considered to be severe by her family physician who diagnosed DYSMENORRHEA",PAIN,DYSMENORRHEA
725258029,5/24/2015 03:36:27,1642530608,5/24/2015 03:33:56,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[SYMPTOM],[SYMPTOM],who diagnosed DYSMENORRHEA,n/a,4,121,1,7,133,TWrex-cause,814610-FS1,"The PAIN caused her to miss school frequently, but was not considered to be severe by her family physician who diagnosed DYSMENORRHEA",PAIN,DYSMENORRHEA
725258029,5/24/2015 04:36:42,1642544027,5/24/2015 04:36:08,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[SYMPTOM],[SYMPTOM],who diagnosed,N/A,4,121,1,7,133,TWrex-cause,814610-FS1,"The PAIN caused her to miss school frequently, but was not considered to be severe by her family physician who diagnosed DYSMENORRHEA",PAIN,DYSMENORRHEA
725258029,5/24/2015 04:40:55,1642544969,5/24/2015 04:40:34,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[SIDE_EFFECT],[SIDE_EFFECT],diagnosed,n/a,4,121,1,7,133,TWrex-cause,814610-FS1,"The PAIN caused her to miss school frequently, but was not considered to be severe by her family physician who diagnosed DYSMENORRHEA",PAIN,DYSMENORRHEA
725258030,5/24/2015 00:37:08,1642474119,5/24/2015 00:36:45,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[MANIFESTATION],[MANIFESTATION],manifestations.,n/a,89,0,1,98,27,TWrex-cause,813368-FS1,FAMILIAL HEMIPLEGIC MIGRAINE (FHM) is a rare variant of migraine with aura accompanied by HEMIPLEGIA or hemiparesis and other manifestations.,HEMIPLEGIA,FAMILIAL HEMIPLEGIC MIGRAINE
725258030,5/24/2015 00:46:39,1642478089,5/24/2015 00:46:22,false,elite,1.0,31848723,USA,VA,Manassas,192.96.205.155,[CAUSES],[CAUSES],FAMILIAL HEMIPLEGIC MIGRAINE HEMIPLEGIA,N/A,89,0,1,98,27,TWrex-cause,813368-FS1,FAMILIAL HEMIPLEGIC MIGRAINE (FHM) is a rare variant of migraine with aura accompanied by HEMIPLEGIA or hemiparesis and other manifestations.,HEMIPLEGIA,FAMILIAL HEMIPLEGIC MIGRAINE
725258030,5/24/2015 00:51:54,1642479898,5/24/2015 00:50:47,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[MANIFESTATION],[MANIFESTATION],accompanied by,N/A,89,0,1,98,27,TWrex-cause,813368-FS1,FAMILIAL HEMIPLEGIC MIGRAINE (FHM) is a rare variant of migraine with aura accompanied by HEMIPLEGIA or hemiparesis and other manifestations.,HEMIPLEGIA,FAMILIAL HEMIPLEGIC MIGRAINE
725258030,5/24/2015 00:52:30,1642480045,5/24/2015 00:51:59,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[ASSOCIATED_WITH],[ASSOCIATED_WITH],accompanied by HEMIPLEGIA,NA,89,0,1,98,27,TWrex-cause,813368-FS1,FAMILIAL HEMIPLEGIC MIGRAINE (FHM) is a rare variant of migraine with aura accompanied by HEMIPLEGIA or hemiparesis and other manifestations.,HEMIPLEGIA,FAMILIAL HEMIPLEGIC MIGRAINE
725258030,5/24/2015 01:10:58,1642486346,5/24/2015 01:10:09,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[ASSOCIATED_WITH] [PART_OF],"[ASSOCIATED_WITH]
[PART_OF]",accompanied by,N/A,89,0,1,98,27,TWrex-cause,813368-FS1,FAMILIAL HEMIPLEGIC MIGRAINE (FHM) is a rare variant of migraine with aura accompanied by HEMIPLEGIA or hemiparesis and other manifestations.,HEMIPLEGIA,FAMILIAL HEMIPLEGIC MIGRAINE
725258030,5/24/2015 01:38:44,1642495076,5/24/2015 01:38:31,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[MANIFESTATION],[MANIFESTATION],manifestations.,N/A,89,0,1,98,27,TWrex-cause,813368-FS1,FAMILIAL HEMIPLEGIC MIGRAINE (FHM) is a rare variant of migraine with aura accompanied by HEMIPLEGIA or hemiparesis and other manifestations.,HEMIPLEGIA,FAMILIAL HEMIPLEGIC MIGRAINE
725258030,5/24/2015 01:46:01,1642497686,5/24/2015 01:45:48,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[SYMPTOM],[SYMPTOM],hemiparesis,N/A,89,0,1,98,27,TWrex-cause,813368-FS1,FAMILIAL HEMIPLEGIC MIGRAINE (FHM) is a rare variant of migraine with aura accompanied by HEMIPLEGIA or hemiparesis and other manifestations.,HEMIPLEGIA,FAMILIAL HEMIPLEGIC MIGRAINE
725258030,5/24/2015 01:52:47,1642499978,5/24/2015 01:52:36,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[MANIFESTATION],[MANIFESTATION],manifestations.,N/A,89,0,1,98,27,TWrex-cause,813368-FS1,FAMILIAL HEMIPLEGIC MIGRAINE (FHM) is a rare variant of migraine with aura accompanied by HEMIPLEGIA or hemiparesis and other manifestations.,HEMIPLEGIA,FAMILIAL HEMIPLEGIC MIGRAINE
725258030,5/24/2015 01:59:19,1642502107,5/24/2015 01:59:08,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[MANIFESTATION],[MANIFESTATION],manifestations.,N/A,89,0,1,98,27,TWrex-cause,813368-FS1,FAMILIAL HEMIPLEGIC MIGRAINE (FHM) is a rare variant of migraine with aura accompanied by HEMIPLEGIA or hemiparesis and other manifestations.,HEMIPLEGIA,FAMILIAL HEMIPLEGIC MIGRAINE
725258030,5/24/2015 02:07:14,1642504401,5/24/2015 02:07:04,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[SIDE_EFFECT],[SIDE_EFFECT],accompanied,N/A,89,0,1,98,27,TWrex-cause,813368-FS1,FAMILIAL HEMIPLEGIC MIGRAINE (FHM) is a rare variant of migraine with aura accompanied by HEMIPLEGIA or hemiparesis and other manifestations.,HEMIPLEGIA,FAMILIAL HEMIPLEGIC MIGRAINE
725258030,5/24/2015 02:13:27,1642506352,5/24/2015 02:12:06,false,prodege,1.0,17379068,CAN,NB,Saint John,142.162.106.83,[ASSOCIATED_WITH],[ASSOCIATED_WITH],variant,N/A,89,0,1,98,27,TWrex-cause,813368-FS1,FAMILIAL HEMIPLEGIC MIGRAINE (FHM) is a rare variant of migraine with aura accompanied by HEMIPLEGIA or hemiparesis and other manifestations.,HEMIPLEGIA,FAMILIAL HEMIPLEGIC MIGRAINE
725258030,5/24/2015 02:33:03,1642512710,5/24/2015 02:32:48,false,elite,1.0,32306791,USA,DE,Wilmington,199.58.86.213,[MANIFESTATION],[MANIFESTATION],HEMIPLEGIA manifestations.,N/A,89,0,1,98,27,TWrex-cause,813368-FS1,FAMILIAL HEMIPLEGIC MIGRAINE (FHM) is a rare variant of migraine with aura accompanied by HEMIPLEGIA or hemiparesis and other manifestations.,HEMIPLEGIA,FAMILIAL HEMIPLEGIC MIGRAINE
725258030,5/24/2015 02:36:24,1642513951,5/24/2015 02:36:08,false,elite,1.0,31913360,USA,VA,Manassas,207.244.77.3,[SYMPTOM],[SYMPTOM],HEMIPLEGIA,hfh,89,0,1,98,27,TWrex-cause,813368-FS1,FAMILIAL HEMIPLEGIC MIGRAINE (FHM) is a rare variant of migraine with aura accompanied by HEMIPLEGIA or hemiparesis and other manifestations.,HEMIPLEGIA,FAMILIAL HEMIPLEGIC MIGRAINE
725258030,5/24/2015 02:46:51,1642517022,5/24/2015 02:46:39,false,neodev,1.0,32562748,CAN,BC,Vancouver,108.180.140.140,[SYMPTOM] [CAUSES],"[CAUSES]
[SYMPTOM]",FAMILIAL HEMIPLEGIC MIGRAINE (FHM) HEMIPLEGIA,N/A,89,0,1,98,27,TWrex-cause,813368-FS1,FAMILIAL HEMIPLEGIC MIGRAINE (FHM) is a rare variant of migraine with aura accompanied by HEMIPLEGIA or hemiparesis and other manifestations.,HEMIPLEGIA,FAMILIAL HEMIPLEGIC MIGRAINE
725258030,5/24/2015 02:54:09,1642518956,5/24/2015 02:53:31,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[SYMPTOM],[SYMPTOM],FAMILIAL HEMIPLEGIC MIGRAINE is a migraine with aura accompanied by HEMIPLEGIA,N/A,89,0,1,98,27,TWrex-cause,813368-FS1,FAMILIAL HEMIPLEGIC MIGRAINE (FHM) is a rare variant of migraine with aura accompanied by HEMIPLEGIA or hemiparesis and other manifestations.,HEMIPLEGIA,FAMILIAL HEMIPLEGIC MIGRAINE
725258031,5/23/2015 20:35:18,1642360280,5/23/2015 20:35:02,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[CAUSES],[CAUSES],caused by,N/A,41,126,1,52,142,TWrex-cause,812710-FS1,"Curable forms of hypertension (secondary HYPERTENSION), which are relatively rare, may be caused by coarctation of the aorta, PHEOCHROMOCYTOMA renal artery stenosis, primary aldosteronism, and Cushing's syndrome.",HYPERTENSION,PHEOCHROMOCYTOMA
725258031,5/23/2015 20:41:22,1642363614,5/23/2015 20:40:36,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES],[CAUSES],"HYPERTENSION), caused by PHEOCHROMOCYTOMA renal artery stenosis,",N/A,41,126,1,52,142,TWrex-cause,812710-FS1,"Curable forms of hypertension (secondary HYPERTENSION), which are relatively rare, may be caused by coarctation of the aorta, PHEOCHROMOCYTOMA renal artery stenosis, primary aldosteronism, and Cushing's syndrome.",HYPERTENSION,PHEOCHROMOCYTOMA
725258031,5/23/2015 20:44:30,1642365403,5/23/2015 20:44:09,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],caused by,n/a,41,126,1,52,142,TWrex-cause,812710-FS1,"Curable forms of hypertension (secondary HYPERTENSION), which are relatively rare, may be caused by coarctation of the aorta, PHEOCHROMOCYTOMA renal artery stenosis, primary aldosteronism, and Cushing's syndrome.",HYPERTENSION,PHEOCHROMOCYTOMA
725258031,5/23/2015 20:48:38,1642367938,5/23/2015 20:48:28,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[CAUSES],[CAUSES],caused,-,41,126,1,52,142,TWrex-cause,812710-FS1,"Curable forms of hypertension (secondary HYPERTENSION), which are relatively rare, may be caused by coarctation of the aorta, PHEOCHROMOCYTOMA renal artery stenosis, primary aldosteronism, and Cushing's syndrome.",HYPERTENSION,PHEOCHROMOCYTOMA
725258031,5/23/2015 20:50:09,1642368703,5/23/2015 20:49:48,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],caused by,n/a,41,126,1,52,142,TWrex-cause,812710-FS1,"Curable forms of hypertension (secondary HYPERTENSION), which are relatively rare, may be caused by coarctation of the aorta, PHEOCHROMOCYTOMA renal artery stenosis, primary aldosteronism, and Cushing's syndrome.",HYPERTENSION,PHEOCHROMOCYTOMA
725258031,5/23/2015 20:53:31,1642370576,5/23/2015 20:52:51,false,instagc,1.0,30880172,USA,CA,Los Angeles,166.170.50.98,[ASSOCIATED_WITH],[ASSOCIATED_WITH],caused by,N/A,41,126,1,52,142,TWrex-cause,812710-FS1,"Curable forms of hypertension (secondary HYPERTENSION), which are relatively rare, may be caused by coarctation of the aorta, PHEOCHROMOCYTOMA renal artery stenosis, primary aldosteronism, and Cushing's syndrome.",HYPERTENSION,PHEOCHROMOCYTOMA
725258031,5/23/2015 20:57:52,1642372686,5/23/2015 20:56:20,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],"HYPERTENSION), may be caused by PHEOCHROMOCYTOMA",na,41,126,1,52,142,TWrex-cause,812710-FS1,"Curable forms of hypertension (secondary HYPERTENSION), which are relatively rare, may be caused by coarctation of the aorta, PHEOCHROMOCYTOMA renal artery stenosis, primary aldosteronism, and Cushing's syndrome.",HYPERTENSION,PHEOCHROMOCYTOMA
725258031,5/23/2015 20:58:34,1642373032,5/23/2015 20:58:16,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],may be caused by,n/a,41,126,1,52,142,TWrex-cause,812710-FS1,"Curable forms of hypertension (secondary HYPERTENSION), which are relatively rare, may be caused by coarctation of the aorta, PHEOCHROMOCYTOMA renal artery stenosis, primary aldosteronism, and Cushing's syndrome.",HYPERTENSION,PHEOCHROMOCYTOMA
725258031,5/23/2015 21:01:31,1642374406,5/23/2015 21:01:06,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],may be caused by,N/A,41,126,1,52,142,TWrex-cause,812710-FS1,"Curable forms of hypertension (secondary HYPERTENSION), which are relatively rare, may be caused by coarctation of the aorta, PHEOCHROMOCYTOMA renal artery stenosis, primary aldosteronism, and Cushing's syndrome.",HYPERTENSION,PHEOCHROMOCYTOMA
725258031,5/23/2015 21:11:58,1642379192,5/23/2015 21:11:25,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[CAUSES],[CAUSES],"HYPERTENSION), may be caused by PHEOCHROMOCYTOMA",n/a,41,126,1,52,142,TWrex-cause,812710-FS1,"Curable forms of hypertension (secondary HYPERTENSION), which are relatively rare, may be caused by coarctation of the aorta, PHEOCHROMOCYTOMA renal artery stenosis, primary aldosteronism, and Cushing's syndrome.",HYPERTENSION,PHEOCHROMOCYTOMA
725258031,5/23/2015 21:36:55,1642391495,5/23/2015 21:36:31,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[CAUSES],[CAUSES],may be caused by,N/A,41,126,1,52,142,TWrex-cause,812710-FS1,"Curable forms of hypertension (secondary HYPERTENSION), which are relatively rare, may be caused by coarctation of the aorta, PHEOCHROMOCYTOMA renal artery stenosis, primary aldosteronism, and Cushing's syndrome.",HYPERTENSION,PHEOCHROMOCYTOMA
725258031,5/23/2015 21:43:23,1642394606,5/23/2015 21:42:06,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES] [MANIFESTATION],"[CAUSES]
[MANIFESTATION]","Curable forms of hypertension (secondary HYPERTENSION), which are relatively rare, may be caused by coarctation of the aorta, PHEOCHROMOCYTOMA renal artery stenosis, primary aldosteronism, and Cushing's syndrome.",n/a,41,126,1,52,142,TWrex-cause,812710-FS1,"Curable forms of hypertension (secondary HYPERTENSION), which are relatively rare, may be caused by coarctation of the aorta, PHEOCHROMOCYTOMA renal artery stenosis, primary aldosteronism, and Cushing's syndrome.",HYPERTENSION,PHEOCHROMOCYTOMA
725258031,5/23/2015 21:46:49,1642396287,5/23/2015 21:46:03,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES],[CAUSES],may be caused by,N/A,41,126,1,52,142,TWrex-cause,812710-FS1,"Curable forms of hypertension (secondary HYPERTENSION), which are relatively rare, may be caused by coarctation of the aorta, PHEOCHROMOCYTOMA renal artery stenosis, primary aldosteronism, and Cushing's syndrome.",HYPERTENSION,PHEOCHROMOCYTOMA
725258031,5/23/2015 21:49:45,1642397550,5/23/2015 21:49:21,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[CAUSES],[CAUSES],may be caused,N/A,41,126,1,52,142,TWrex-cause,812710-FS1,"Curable forms of hypertension (secondary HYPERTENSION), which are relatively rare, may be caused by coarctation of the aorta, PHEOCHROMOCYTOMA renal artery stenosis, primary aldosteronism, and Cushing's syndrome.",HYPERTENSION,PHEOCHROMOCYTOMA
725258031,5/23/2015 21:51:07,1642398168,5/23/2015 21:49:59,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[CAUSES],[CAUSES],may be caused by,n/a,41,126,1,52,142,TWrex-cause,812710-FS1,"Curable forms of hypertension (secondary HYPERTENSION), which are relatively rare, may be caused by coarctation of the aorta, PHEOCHROMOCYTOMA renal artery stenosis, primary aldosteronism, and Cushing's syndrome.",HYPERTENSION,PHEOCHROMOCYTOMA
725258032,5/23/2015 22:11:54,1642407453,5/23/2015 22:10:58,false,elite,1.0,30064988,GBR,B4,Bradford,92.22.135.10,[OTHER],[OTHER],including,N/A,151,109,1,165,116,TWrex-cause,810257-FS1,"125  Since albumin is prepared from pooled human plasma, it is a potential vehicle for transmission of human VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,VIRUSES
725258032,5/23/2015 22:15:39,1642409322,5/23/2015 22:15:23,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],human VIRUSES including the causative agents of VIRAL HEPATITIS,n/a,151,109,1,165,116,TWrex-cause,810257-FS1,"125  Since albumin is prepared from pooled human plasma, it is a potential vehicle for transmission of human VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,VIRUSES
725258032,5/23/2015 22:25:57,1642414486,5/23/2015 22:24:42,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES],[CAUSES],vehicle for transmission of human VIRUSES including VIRAL HEPATITIS,N/A,151,109,1,165,116,TWrex-cause,810257-FS1,"125  Since albumin is prepared from pooled human plasma, it is a potential vehicle for transmission of human VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,VIRUSES
725258032,5/23/2015 22:27:42,1642415231,5/23/2015 22:26:58,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],VIRUSES,N/A,151,109,1,165,116,TWrex-cause,810257-FS1,"125  Since albumin is prepared from pooled human plasma, it is a potential vehicle for transmission of human VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,VIRUSES
725258032,5/23/2015 22:28:57,1642415831,5/23/2015 22:27:19,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[IS_A],[IS_A],VIRUSES including VIRAL HEPATITIS,N/A,151,109,1,165,116,TWrex-cause,810257-FS1,"125  Since albumin is prepared from pooled human plasma, it is a potential vehicle for transmission of human VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,VIRUSES
725258032,5/23/2015 22:33:12,1642417976,5/23/2015 22:32:35,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[CAUSES],[CAUSES],"125 Since albumin prepared from pooled human plasma, it is potential vehicle for transmission of human VIRUSES",n/a,151,109,1,165,116,TWrex-cause,810257-FS1,"125  Since albumin is prepared from pooled human plasma, it is a potential vehicle for transmission of human VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,VIRUSES
725258032,5/23/2015 22:37:02,1642420085,5/23/2015 22:36:26,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[IS_A] [PART_OF],"[IS_A]
[PART_OF]",VIRUSES including VIRAL HEPATITIS,n/a,151,109,1,165,116,TWrex-cause,810257-FS1,"125  Since albumin is prepared from pooled human plasma, it is a potential vehicle for transmission of human VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,VIRUSES
725258032,5/23/2015 23:06:20,1642434725,5/23/2015 23:06:00,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[CAUSES],[CAUSES],causative agents,N/A,151,109,1,165,116,TWrex-cause,810257-FS1,"125  Since albumin is prepared from pooled human plasma, it is a potential vehicle for transmission of human VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,VIRUSES
725258032,5/23/2015 23:10:54,1642436605,5/23/2015 23:10:10,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[CAUSES],[CAUSES],for transmission of,n/a,151,109,1,165,116,TWrex-cause,810257-FS1,"125  Since albumin is prepared from pooled human plasma, it is a potential vehicle for transmission of human VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,VIRUSES
725258032,5/23/2015 23:13:10,1642437646,5/23/2015 23:12:38,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],causative,none,151,109,1,165,116,TWrex-cause,810257-FS1,"125  Since albumin is prepared from pooled human plasma, it is a potential vehicle for transmission of human VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,VIRUSES
725258032,5/23/2015 23:13:12,1642437653,5/23/2015 23:12:37,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A] [PART_OF],"[IS_A]
[PART_OF]",is is a of of,N/A,151,109,1,165,116,TWrex-cause,810257-FS1,"125  Since albumin is prepared from pooled human plasma, it is a potential vehicle for transmission of human VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,VIRUSES
725258032,5/23/2015 23:15:52,1642438763,5/23/2015 23:15:27,false,instagc,1.0,24252915,GBR,K6,Portsmouth,78.146.11.229,[IS_A],[IS_A],including the causative agents of,N/a,151,109,1,165,116,TWrex-cause,810257-FS1,"125  Since albumin is prepared from pooled human plasma, it is a potential vehicle for transmission of human VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,VIRUSES
725258032,5/23/2015 23:16:44,1642439069,5/23/2015 23:15:18,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[ASSOCIATED_WITH] [CAUSES],"[CAUSES]
[ASSOCIATED_WITH]",including carry transmitting,n/a,151,109,1,165,116,TWrex-cause,810257-FS1,"125  Since albumin is prepared from pooled human plasma, it is a potential vehicle for transmission of human VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,VIRUSES
725258032,5/23/2015 23:18:43,1642439876,5/23/2015 23:18:11,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],causative,N/A,151,109,1,165,116,TWrex-cause,810257-FS1,"125  Since albumin is prepared from pooled human plasma, it is a potential vehicle for transmission of human VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,VIRUSES
725258032,5/23/2015 23:26:43,1642443389,5/23/2015 23:25:41,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[CAUSES],[CAUSES],causative,N?A,151,109,1,165,116,TWrex-cause,810257-FS1,"125  Since albumin is prepared from pooled human plasma, it is a potential vehicle for transmission of human VIRUSES including the causative agents of VIRAL HEPATITIS and HIV infection, and theoretically may carry a risk of transmitting the causative agent of Creutzfeldt Jakob disease (CJD) or variant CJD (vCJD.",VIRAL HEPATITIS,VIRUSES
725258033,5/23/2015 22:20:15,1642411556,5/23/2015 22:19:51,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],BRONCHOGENIC CARCINOMA is not a common cause of CHRONIC COUGH,n/a,53,5,1,65,27,TWrex-cause,813647-FS1,"62   BRONCHOGENIC CARCINOMA is not a common cause of CHRONIC COUGH but should be included in the differential diagnosis when the chest roentgenogram is abnormal, especially when the film shows centrally located lesions.",CHRONIC COUGH,BRONCHOGENIC CARCINOMA
725258033,5/23/2015 22:35:21,1642419062,5/23/2015 22:35:04,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],CHRONIC COUGH,N/A,53,5,1,65,27,TWrex-cause,813647-FS1,"62   BRONCHOGENIC CARCINOMA is not a common cause of CHRONIC COUGH but should be included in the differential diagnosis when the chest roentgenogram is abnormal, especially when the film shows centrally located lesions.",CHRONIC COUGH,BRONCHOGENIC CARCINOMA
725258033,5/23/2015 22:39:06,1642421172,5/23/2015 22:38:35,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]",BRONCHOGENIC CARCINOMA is common cause CHRONIC COUGH but should be included in the differential diagnosis,n/a,53,5,1,65,27,TWrex-cause,813647-FS1,"62   BRONCHOGENIC CARCINOMA is not a common cause of CHRONIC COUGH but should be included in the differential diagnosis when the chest roentgenogram is abnormal, especially when the film shows centrally located lesions.",CHRONIC COUGH,BRONCHOGENIC CARCINOMA
725258033,5/23/2015 22:42:03,1642422713,5/23/2015 22:40:33,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]",BRONCHOGENIC CARCINOMA is not a common cause of CHRONIC COUGH should be included in diagnosis,N/A,53,5,1,65,27,TWrex-cause,813647-FS1,"62   BRONCHOGENIC CARCINOMA is not a common cause of CHRONIC COUGH but should be included in the differential diagnosis when the chest roentgenogram is abnormal, especially when the film shows centrally located lesions.",CHRONIC COUGH,BRONCHOGENIC CARCINOMA
725258033,5/23/2015 22:44:19,1642423763,5/23/2015 22:43:03,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],cause,N/A,53,5,1,65,27,TWrex-cause,813647-FS1,"62   BRONCHOGENIC CARCINOMA is not a common cause of CHRONIC COUGH but should be included in the differential diagnosis when the chest roentgenogram is abnormal, especially when the film shows centrally located lesions.",CHRONIC COUGH,BRONCHOGENIC CARCINOMA
725258033,5/23/2015 22:45:05,1642424147,5/23/2015 22:44:40,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[CAUSES],[CAUSES],BRONCHOGENIC CARCINOMA cause of CHRONIC COUGH,n/a,53,5,1,65,27,TWrex-cause,813647-FS1,"62   BRONCHOGENIC CARCINOMA is not a common cause of CHRONIC COUGH but should be included in the differential diagnosis when the chest roentgenogram is abnormal, especially when the film shows centrally located lesions.",CHRONIC COUGH,BRONCHOGENIC CARCINOMA
725258033,5/23/2015 23:13:02,1642437538,5/23/2015 23:12:30,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[CAUSES],[CAUSES],not a common cause but should be included in the differential diagnosis,N/A,53,5,1,65,27,TWrex-cause,813647-FS1,"62   BRONCHOGENIC CARCINOMA is not a common cause of CHRONIC COUGH but should be included in the differential diagnosis when the chest roentgenogram is abnormal, especially when the film shows centrally located lesions.",CHRONIC COUGH,BRONCHOGENIC CARCINOMA
725258033,5/23/2015 23:17:46,1642439408,5/23/2015 23:17:17,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[CAUSES],[CAUSES],common cause,n/a,53,5,1,65,27,TWrex-cause,813647-FS1,"62   BRONCHOGENIC CARCINOMA is not a common cause of CHRONIC COUGH but should be included in the differential diagnosis when the chest roentgenogram is abnormal, especially when the film shows centrally located lesions.",CHRONIC COUGH,BRONCHOGENIC CARCINOMA
725258033,5/23/2015 23:23:38,1642441922,5/23/2015 23:22:50,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],included in differential diagnosis,none,53,5,1,65,27,TWrex-cause,813647-FS1,"62   BRONCHOGENIC CARCINOMA is not a common cause of CHRONIC COUGH but should be included in the differential diagnosis when the chest roentgenogram is abnormal, especially when the film shows centrally located lesions.",CHRONIC COUGH,BRONCHOGENIC CARCINOMA
725258033,5/23/2015 23:26:29,1642443277,5/23/2015 23:25:50,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],cause of,N/A,53,5,1,65,27,TWrex-cause,813647-FS1,"62   BRONCHOGENIC CARCINOMA is not a common cause of CHRONIC COUGH but should be included in the differential diagnosis when the chest roentgenogram is abnormal, especially when the film shows centrally located lesions.",CHRONIC COUGH,BRONCHOGENIC CARCINOMA
725258033,5/23/2015 23:28:33,1642444202,5/23/2015 23:27:47,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[CAUSES] [ASSOCIATED_WITH] [DIAGNOSE_BY_TEST_OR_DRUG] [LOCATION],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[LOCATION]
[ASSOCIATED_WITH]",cause of included in film shows located,n/a,53,5,1,65,27,TWrex-cause,813647-FS1,"62   BRONCHOGENIC CARCINOMA is not a common cause of CHRONIC COUGH but should be included in the differential diagnosis when the chest roentgenogram is abnormal, especially when the film shows centrally located lesions.",CHRONIC COUGH,BRONCHOGENIC CARCINOMA
725258033,5/23/2015 23:36:58,1642447991,5/23/2015 23:36:33,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[SYMPTOM],[SYMPTOM],diagnosis,N/A,53,5,1,65,27,TWrex-cause,813647-FS1,"62   BRONCHOGENIC CARCINOMA is not a common cause of CHRONIC COUGH but should be included in the differential diagnosis when the chest roentgenogram is abnormal, especially when the film shows centrally located lesions.",CHRONIC COUGH,BRONCHOGENIC CARCINOMA
725258033,5/23/2015 23:45:27,1642452162,5/23/2015 23:44:55,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[CAUSES],[CAUSES],cause of,n/a,53,5,1,65,27,TWrex-cause,813647-FS1,"62   BRONCHOGENIC CARCINOMA is not a common cause of CHRONIC COUGH but should be included in the differential diagnosis when the chest roentgenogram is abnormal, especially when the film shows centrally located lesions.",CHRONIC COUGH,BRONCHOGENIC CARCINOMA
725258033,5/23/2015 23:54:28,1642456178,5/23/2015 23:53:58,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.161,[PREVENTS] [CAUSES] [LOCATION] [NONE],"[PREVENTS]
[CAUSES]
[LOCATION]
[NONE]",no,no,53,5,1,65,27,TWrex-cause,813647-FS1,"62   BRONCHOGENIC CARCINOMA is not a common cause of CHRONIC COUGH but should be included in the differential diagnosis when the chest roentgenogram is abnormal, especially when the film shows centrally located lesions.",CHRONIC COUGH,BRONCHOGENIC CARCINOMA
725258033,5/24/2015 00:12:37,1642464108,5/24/2015 00:12:30,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",common cause of,n/a,53,5,1,65,27,TWrex-cause,813647-FS1,"62   BRONCHOGENIC CARCINOMA is not a common cause of CHRONIC COUGH but should be included in the differential diagnosis when the chest roentgenogram is abnormal, especially when the film shows centrally located lesions.",CHRONIC COUGH,BRONCHOGENIC CARCINOMA
725258034,5/23/2015 20:32:36,1642358968,5/23/2015 20:32:27,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[CAUSES],[CAUSES],cause,N/A,46,12,1,63,31,TWrex-cause,810538-FS1,The list of INGESTED SUBSTANCES said to cause ALLERGIC REACTIONS is seemingly endless.,ALLERGIC REACTIONS,INGESTED SUBSTANCES
725258034,5/23/2015 20:34:41,1642360028,5/23/2015 20:34:11,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CONTRAINDICATES],[CONTRAINDICATES],INGESTED SUBSTANCES cause ALLERGIC REACTIONS,N/A,46,12,1,63,31,TWrex-cause,810538-FS1,The list of INGESTED SUBSTANCES said to cause ALLERGIC REACTIONS is seemingly endless.,ALLERGIC REACTIONS,INGESTED SUBSTANCES
725258034,5/23/2015 20:40:13,1642362941,5/23/2015 20:40:03,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],cause,n/a,46,12,1,63,31,TWrex-cause,810538-FS1,The list of INGESTED SUBSTANCES said to cause ALLERGIC REACTIONS is seemingly endless.,ALLERGIC REACTIONS,INGESTED SUBSTANCES
725258034,5/23/2015 20:41:49,1642363833,5/23/2015 20:41:38,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],cause,n/a,46,12,1,63,31,TWrex-cause,810538-FS1,The list of INGESTED SUBSTANCES said to cause ALLERGIC REACTIONS is seemingly endless.,ALLERGIC REACTIONS,INGESTED SUBSTANCES
725258034,5/23/2015 20:45:55,1642366309,5/23/2015 20:45:03,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],INGESTED SUBSTANCES cause ALLERGIC REACTIONS,na,46,12,1,63,31,TWrex-cause,810538-FS1,The list of INGESTED SUBSTANCES said to cause ALLERGIC REACTIONS is seemingly endless.,ALLERGIC REACTIONS,INGESTED SUBSTANCES
725258034,5/23/2015 20:46:18,1642366533,5/23/2015 20:46:08,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[CAUSES],[CAUSES],cause,-,46,12,1,63,31,TWrex-cause,810538-FS1,The list of INGESTED SUBSTANCES said to cause ALLERGIC REACTIONS is seemingly endless.,ALLERGIC REACTIONS,INGESTED SUBSTANCES
725258034,5/23/2015 20:46:34,1642366711,5/23/2015 20:45:41,false,instagc,1.0,30880172,USA,CA,Los Angeles,166.170.50.98,[ASSOCIATED_WITH] [SIDE_EFFECT],"[ASSOCIATED_WITH]
[SIDE_EFFECT]",cause,N/A,46,12,1,63,31,TWrex-cause,810538-FS1,The list of INGESTED SUBSTANCES said to cause ALLERGIC REACTIONS is seemingly endless.,ALLERGIC REACTIONS,INGESTED SUBSTANCES
725258034,5/23/2015 20:47:28,1642367308,5/23/2015 20:47:14,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],said to cause,n/a,46,12,1,63,31,TWrex-cause,810538-FS1,The list of INGESTED SUBSTANCES said to cause ALLERGIC REACTIONS is seemingly endless.,ALLERGIC REACTIONS,INGESTED SUBSTANCES
725258034,5/23/2015 20:54:18,1642370985,5/23/2015 20:54:04,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],cause,N/A,46,12,1,63,31,TWrex-cause,810538-FS1,The list of INGESTED SUBSTANCES said to cause ALLERGIC REACTIONS is seemingly endless.,ALLERGIC REACTIONS,INGESTED SUBSTANCES
725258034,5/23/2015 20:55:59,1642371765,5/23/2015 20:55:47,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],said to cause,n/a,46,12,1,63,31,TWrex-cause,810538-FS1,The list of INGESTED SUBSTANCES said to cause ALLERGIC REACTIONS is seemingly endless.,ALLERGIC REACTIONS,INGESTED SUBSTANCES
725258034,5/23/2015 21:07:50,1642377315,5/23/2015 21:07:28,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[ASSOCIATED_WITH],[ASSOCIATED_WITH],said to cause,n/a,46,12,1,63,31,TWrex-cause,810538-FS1,The list of INGESTED SUBSTANCES said to cause ALLERGIC REACTIONS is seemingly endless.,ALLERGIC REACTIONS,INGESTED SUBSTANCES
725258034,5/23/2015 21:32:01,1642388917,5/23/2015 21:31:15,false,prodege,1.0,24403612,CAN,ON,Bowmanville,99.252.243.178,[CAUSES],[CAUSES],INGESTED SUBSTANCES said to cause ALLERGIC REACTIONS,N/A,46,12,1,63,31,TWrex-cause,810538-FS1,The list of INGESTED SUBSTANCES said to cause ALLERGIC REACTIONS is seemingly endless.,ALLERGIC REACTIONS,INGESTED SUBSTANCES
725258034,5/23/2015 21:32:05,1642388923,5/23/2015 21:31:41,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[CAUSES],[CAUSES],to cause,N/A,46,12,1,63,31,TWrex-cause,810538-FS1,The list of INGESTED SUBSTANCES said to cause ALLERGIC REACTIONS is seemingly endless.,ALLERGIC REACTIONS,INGESTED SUBSTANCES
725258034,5/23/2015 21:34:47,1642390400,5/23/2015 21:33:35,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES] [OTHER],"[CAUSES]
[OTHER]",The list of INGESTED SUBSTANCES said to cause ALLERGIC REACTIONS is seemingly endless.,n/a,46,12,1,63,31,TWrex-cause,810538-FS1,The list of INGESTED SUBSTANCES said to cause ALLERGIC REACTIONS is seemingly endless.,ALLERGIC REACTIONS,INGESTED SUBSTANCES
725258034,5/23/2015 21:35:47,1642390918,5/23/2015 21:35:27,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[CAUSES],[CAUSES],said to cause,n/a,46,12,1,63,31,TWrex-cause,810538-FS1,The list of INGESTED SUBSTANCES said to cause ALLERGIC REACTIONS is seemingly endless.,ALLERGIC REACTIONS,INGESTED SUBSTANCES
725258035,5/23/2015 23:32:18,1642445974,5/23/2015 23:31:50,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[MANIFESTATION],[MANIFESTATION],usually infects the,N/A,49,0,1,84,27,TWrex-cause,810937-FS1,CORYNEBACTERIUM DIPHTHERIAE  usually infects the NASOPHARYNX (RESPIRATORY DIPHTHERIA) or skin.,NASOPHARYNX (RESPIRATORY DIPHTHERIA),CORYNEBACTERIUM DIPHTHERIAE
725258035,5/23/2015 23:35:17,1642447202,5/23/2015 23:34:37,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[ASSOCIATED_WITH],[ASSOCIATED_WITH],infects,none,49,0,1,84,27,TWrex-cause,810937-FS1,CORYNEBACTERIUM DIPHTHERIAE  usually infects the NASOPHARYNX (RESPIRATORY DIPHTHERIA) or skin.,NASOPHARYNX (RESPIRATORY DIPHTHERIA),CORYNEBACTERIUM DIPHTHERIAE
725258035,5/23/2015 23:43:02,1642451095,5/23/2015 23:42:11,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[SYMPTOM],[SYMPTOM],infects,N/A,49,0,1,84,27,TWrex-cause,810937-FS1,CORYNEBACTERIUM DIPHTHERIAE  usually infects the NASOPHARYNX (RESPIRATORY DIPHTHERIA) or skin.,NASOPHARYNX (RESPIRATORY DIPHTHERIA),CORYNEBACTERIUM DIPHTHERIAE
725258035,5/23/2015 23:48:32,1642453521,5/23/2015 23:48:17,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[MANIFESTATION],[MANIFESTATION],infects the,n/a,49,0,1,84,27,TWrex-cause,810937-FS1,CORYNEBACTERIUM DIPHTHERIAE  usually infects the NASOPHARYNX (RESPIRATORY DIPHTHERIA) or skin.,NASOPHARYNX (RESPIRATORY DIPHTHERIA),CORYNEBACTERIUM DIPHTHERIAE
725258035,5/23/2015 23:57:04,1642457446,5/23/2015 23:56:52,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.161,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,49,0,1,84,27,TWrex-cause,810937-FS1,CORYNEBACTERIUM DIPHTHERIAE  usually infects the NASOPHARYNX (RESPIRATORY DIPHTHERIA) or skin.,NASOPHARYNX (RESPIRATORY DIPHTHERIA),CORYNEBACTERIUM DIPHTHERIAE
725258035,5/24/2015 00:28:53,1642470780,5/24/2015 00:28:21,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[LOCATION],[LOCATION],infects,n/a,49,0,1,84,27,TWrex-cause,810937-FS1,CORYNEBACTERIUM DIPHTHERIAE  usually infects the NASOPHARYNX (RESPIRATORY DIPHTHERIA) or skin.,NASOPHARYNX (RESPIRATORY DIPHTHERIA),CORYNEBACTERIUM DIPHTHERIAE
725258035,5/24/2015 00:37:42,1642474373,5/24/2015 00:36:48,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[OTHER],[OTHER],infects,na,49,0,1,84,27,TWrex-cause,810937-FS1,CORYNEBACTERIUM DIPHTHERIAE  usually infects the NASOPHARYNX (RESPIRATORY DIPHTHERIA) or skin.,NASOPHARYNX (RESPIRATORY DIPHTHERIA),CORYNEBACTERIUM DIPHTHERIAE
725258035,5/24/2015 00:42:12,1642476299,5/24/2015 00:41:55,false,elite,1.0,31848723,USA,VA,Manassas,192.96.205.155,[CAUSES],[CAUSES],CORYNEBACTERIUM DIPHTHERIAE NASOPHARYNX (RESPIRATORY DIPHTHERIA),N/A,49,0,1,84,27,TWrex-cause,810937-FS1,CORYNEBACTERIUM DIPHTHERIAE  usually infects the NASOPHARYNX (RESPIRATORY DIPHTHERIA) or skin.,NASOPHARYNX (RESPIRATORY DIPHTHERIA),CORYNEBACTERIUM DIPHTHERIAE
725258035,5/24/2015 00:42:19,1642476348,5/24/2015 00:41:45,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[LOCATION],[LOCATION],infects skin.,N/A,49,0,1,84,27,TWrex-cause,810937-FS1,CORYNEBACTERIUM DIPHTHERIAE  usually infects the NASOPHARYNX (RESPIRATORY DIPHTHERIA) or skin.,NASOPHARYNX (RESPIRATORY DIPHTHERIA),CORYNEBACTERIUM DIPHTHERIAE
725258035,5/24/2015 00:52:42,1642480082,5/24/2015 00:51:24,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[ASSOCIATED_WITH] [CAUSES],"[CAUSES]
[ASSOCIATED_WITH]",usually infects,N/A,49,0,1,84,27,TWrex-cause,810937-FS1,CORYNEBACTERIUM DIPHTHERIAE  usually infects the NASOPHARYNX (RESPIRATORY DIPHTHERIA) or skin.,NASOPHARYNX (RESPIRATORY DIPHTHERIA),CORYNEBACTERIUM DIPHTHERIAE
725258035,5/24/2015 01:30:20,1642492365,5/24/2015 01:28:11,false,clixsense,1.0,6375330,CAN,ON,Ottawa,209.195.106.138,[MANIFESTATION],[MANIFESTATION],usually infects the,none,49,0,1,84,27,TWrex-cause,810937-FS1,CORYNEBACTERIUM DIPHTHERIAE  usually infects the NASOPHARYNX (RESPIRATORY DIPHTHERIA) or skin.,NASOPHARYNX (RESPIRATORY DIPHTHERIA),CORYNEBACTERIUM DIPHTHERIAE
725258035,5/24/2015 01:35:59,1642494114,5/24/2015 01:35:47,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[CAUSES],[CAUSES],infects,N/A,49,0,1,84,27,TWrex-cause,810937-FS1,CORYNEBACTERIUM DIPHTHERIAE  usually infects the NASOPHARYNX (RESPIRATORY DIPHTHERIA) or skin.,NASOPHARYNX (RESPIRATORY DIPHTHERIA),CORYNEBACTERIUM DIPHTHERIAE
725258035,5/24/2015 01:43:13,1642496713,5/24/2015 01:43:00,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[CAUSES],[CAUSES],infects,N/A,49,0,1,84,27,TWrex-cause,810937-FS1,CORYNEBACTERIUM DIPHTHERIAE  usually infects the NASOPHARYNX (RESPIRATORY DIPHTHERIA) or skin.,NASOPHARYNX (RESPIRATORY DIPHTHERIA),CORYNEBACTERIUM DIPHTHERIAE
725258035,5/24/2015 01:49:58,1642498978,5/24/2015 01:49:38,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[CAUSES],[CAUSES],infects,N/A,49,0,1,84,27,TWrex-cause,810937-FS1,CORYNEBACTERIUM DIPHTHERIAE  usually infects the NASOPHARYNX (RESPIRATORY DIPHTHERIA) or skin.,NASOPHARYNX (RESPIRATORY DIPHTHERIA),CORYNEBACTERIUM DIPHTHERIAE
725258035,5/24/2015 01:59:35,1642502175,5/24/2015 01:59:22,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[LOCATION],[LOCATION],skin.,N/A,49,0,1,84,27,TWrex-cause,810937-FS1,CORYNEBACTERIUM DIPHTHERIAE  usually infects the NASOPHARYNX (RESPIRATORY DIPHTHERIA) or skin.,NASOPHARYNX (RESPIRATORY DIPHTHERIA),CORYNEBACTERIUM DIPHTHERIAE
725258036,5/23/2015 23:22:28,1642441461,5/23/2015 23:21:54,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[PREVENTS],[PREVENTS],periodic supplementation has been recommended,n/a,60,139,-1,79,158,TWrex-cause,805230-FS1,"127 ,   128 ,   129 ,   131   In developing countries where VITAMIN A DEFICIENCY is a public health problem, periodic supplementation with HIGH DOSE VITAMIN A (50,000 200,000 units, depending on age) has been recommended in certain high risk populations (i.e., postpartum women, children), with reduced doses recommended for pregnant women.",VITAMIN A DEFICIENCY,HIGH DOSE VITAMIN A
725258036,5/23/2015 23:31:04,1642445486,5/23/2015 23:30:45,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,60,139,-1,79,158,TWrex-cause,805230-FS1,"127 ,   128 ,   129 ,   131   In developing countries where VITAMIN A DEFICIENCY is a public health problem, periodic supplementation with HIGH DOSE VITAMIN A (50,000 200,000 units, depending on age) has been recommended in certain high risk populations (i.e., postpartum women, children), with reduced doses recommended for pregnant women.",VITAMIN A DEFICIENCY,HIGH DOSE VITAMIN A
725258036,5/23/2015 23:33:04,1642446352,5/23/2015 23:32:32,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[PREVENTS],[PREVENTS],periodic supplementation,none,60,139,-1,79,158,TWrex-cause,805230-FS1,"127 ,   128 ,   129 ,   131   In developing countries where VITAMIN A DEFICIENCY is a public health problem, periodic supplementation with HIGH DOSE VITAMIN A (50,000 200,000 units, depending on age) has been recommended in certain high risk populations (i.e., postpartum women, children), with reduced doses recommended for pregnant women.",VITAMIN A DEFICIENCY,HIGH DOSE VITAMIN A
725258036,5/23/2015 23:40:57,1642450073,5/23/2015 23:40:23,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],supplementation,N/A,60,139,-1,79,158,TWrex-cause,805230-FS1,"127 ,   128 ,   129 ,   131   In developing countries where VITAMIN A DEFICIENCY is a public health problem, periodic supplementation with HIGH DOSE VITAMIN A (50,000 200,000 units, depending on age) has been recommended in certain high risk populations (i.e., postpartum women, children), with reduced doses recommended for pregnant women.",VITAMIN A DEFICIENCY,HIGH DOSE VITAMIN A
725258036,5/23/2015 23:47:38,1642453130,5/23/2015 23:47:17,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[TREATS],[TREATS],recommended for,n/a,60,139,-1,79,158,TWrex-cause,805230-FS1,"127 ,   128 ,   129 ,   131   In developing countries where VITAMIN A DEFICIENCY is a public health problem, periodic supplementation with HIGH DOSE VITAMIN A (50,000 200,000 units, depending on age) has been recommended in certain high risk populations (i.e., postpartum women, children), with reduced doses recommended for pregnant women.",VITAMIN A DEFICIENCY,HIGH DOSE VITAMIN A
725258036,5/23/2015 23:56:23,1642457113,5/23/2015 23:56:12,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.161,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,60,139,-1,79,158,TWrex-cause,805230-FS1,"127 ,   128 ,   129 ,   131   In developing countries where VITAMIN A DEFICIENCY is a public health problem, periodic supplementation with HIGH DOSE VITAMIN A (50,000 200,000 units, depending on age) has been recommended in certain high risk populations (i.e., postpartum women, children), with reduced doses recommended for pregnant women.",VITAMIN A DEFICIENCY,HIGH DOSE VITAMIN A
725258036,5/24/2015 00:25:59,1642469847,5/24/2015 00:25:25,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[PREVENTS],[PREVENTS],high risk,n/a,60,139,-1,79,158,TWrex-cause,805230-FS1,"127 ,   128 ,   129 ,   131   In developing countries where VITAMIN A DEFICIENCY is a public health problem, periodic supplementation with HIGH DOSE VITAMIN A (50,000 200,000 units, depending on age) has been recommended in certain high risk populations (i.e., postpartum women, children), with reduced doses recommended for pregnant women.",VITAMIN A DEFICIENCY,HIGH DOSE VITAMIN A
725258036,5/24/2015 00:32:41,1642472154,5/24/2015 00:31:32,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[OTHER],[OTHER],periodic supplementation,na,60,139,-1,79,158,TWrex-cause,805230-FS1,"127 ,   128 ,   129 ,   131   In developing countries where VITAMIN A DEFICIENCY is a public health problem, periodic supplementation with HIGH DOSE VITAMIN A (50,000 200,000 units, depending on age) has been recommended in certain high risk populations (i.e., postpartum women, children), with reduced doses recommended for pregnant women.",VITAMIN A DEFICIENCY,HIGH DOSE VITAMIN A
725258036,5/24/2015 00:39:08,1642474968,5/24/2015 00:38:18,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],supplementation with,N/A,60,139,-1,79,158,TWrex-cause,805230-FS1,"127 ,   128 ,   129 ,   131   In developing countries where VITAMIN A DEFICIENCY is a public health problem, periodic supplementation with HIGH DOSE VITAMIN A (50,000 200,000 units, depending on age) has been recommended in certain high risk populations (i.e., postpartum women, children), with reduced doses recommended for pregnant women.",VITAMIN A DEFICIENCY,HIGH DOSE VITAMIN A
725258036,5/24/2015 00:41:04,1642475813,5/24/2015 00:40:46,false,elite,1.0,31848723,USA,VA,Manassas,192.96.205.155,[SYMPTOM],[SYMPTOM],countries VITAMIN DEFICIENCY DOSE VITAMIN,N/A,60,139,-1,79,158,TWrex-cause,805230-FS1,"127 ,   128 ,   129 ,   131   In developing countries where VITAMIN A DEFICIENCY is a public health problem, periodic supplementation with HIGH DOSE VITAMIN A (50,000 200,000 units, depending on age) has been recommended in certain high risk populations (i.e., postpartum women, children), with reduced doses recommended for pregnant women.",VITAMIN A DEFICIENCY,HIGH DOSE VITAMIN A
725258036,5/24/2015 00:44:01,1642476996,5/24/2015 00:43:06,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH] [SIDE_EFFECT],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[SIDE_EFFECT]","is a public health problem,",N/A,60,139,-1,79,158,TWrex-cause,805230-FS1,"127 ,   128 ,   129 ,   131   In developing countries where VITAMIN A DEFICIENCY is a public health problem, periodic supplementation with HIGH DOSE VITAMIN A (50,000 200,000 units, depending on age) has been recommended in certain high risk populations (i.e., postpartum women, children), with reduced doses recommended for pregnant women.",VITAMIN A DEFICIENCY,HIGH DOSE VITAMIN A
725258036,5/24/2015 00:56:53,1642481396,5/24/2015 00:56:42,false,neodev,1,31789301,USA,CA,San Jose,23.27.44.199,[NONE],[NONE],no,no,60,139,-1,79,158,TWrex-cause,805230-FS1,"127 ,   128 ,   129 ,   131   In developing countries where VITAMIN A DEFICIENCY is a public health problem, periodic supplementation with HIGH DOSE VITAMIN A (50,000 200,000 units, depending on age) has been recommended in certain high risk populations (i.e., postpartum women, children), with reduced doses recommended for pregnant women.",VITAMIN A DEFICIENCY,HIGH DOSE VITAMIN A
725258036,5/24/2015 01:24:57,1642490812,5/24/2015 01:23:59,false,clixsense,1.0,6375330,CAN,ON,Ottawa,209.195.106.138,[TREATS],[TREATS],periodic supplementation,None,60,139,-1,79,158,TWrex-cause,805230-FS1,"127 ,   128 ,   129 ,   131   In developing countries where VITAMIN A DEFICIENCY is a public health problem, periodic supplementation with HIGH DOSE VITAMIN A (50,000 200,000 units, depending on age) has been recommended in certain high risk populations (i.e., postpartum women, children), with reduced doses recommended for pregnant women.",VITAMIN A DEFICIENCY,HIGH DOSE VITAMIN A
725258036,5/24/2015 01:35:17,1642493849,5/24/2015 01:35:07,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],supplementation,N/A,60,139,-1,79,158,TWrex-cause,805230-FS1,"127 ,   128 ,   129 ,   131   In developing countries where VITAMIN A DEFICIENCY is a public health problem, periodic supplementation with HIGH DOSE VITAMIN A (50,000 200,000 units, depending on age) has been recommended in certain high risk populations (i.e., postpartum women, children), with reduced doses recommended for pregnant women.",VITAMIN A DEFICIENCY,HIGH DOSE VITAMIN A
725258036,5/24/2015 01:42:34,1642496479,5/24/2015 01:42:13,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[CAUSES],[CAUSES],supplementation,N/A,60,139,-1,79,158,TWrex-cause,805230-FS1,"127 ,   128 ,   129 ,   131   In developing countries where VITAMIN A DEFICIENCY is a public health problem, periodic supplementation with HIGH DOSE VITAMIN A (50,000 200,000 units, depending on age) has been recommended in certain high risk populations (i.e., postpartum women, children), with reduced doses recommended for pregnant women.",VITAMIN A DEFICIENCY,HIGH DOSE VITAMIN A
725258037,5/23/2015 20:32:51,1642359108,5/23/2015 20:32:38,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[ASSOCIATED_WITH],[ASSOCIATED_WITH],belonging,N/A,52,81,1,56,93,TWrex-cause,815032-FS1,"Pulex    (           audio )  [L., flea] A genus of FLEAS belonging to the order SIPHONAPTERA",FLEAS,SIPHONAPTERA
725258037,5/23/2015 20:35:24,1642360316,5/23/2015 20:34:42,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[IS_A],[IS_A],FLEAS belonging to the order SIPHONAPTERA,N/A,52,81,1,56,93,TWrex-cause,815032-FS1,"Pulex    (           audio )  [L., flea] A genus of FLEAS belonging to the order SIPHONAPTERA",FLEAS,SIPHONAPTERA
725258037,5/23/2015 20:40:29,1642363118,5/23/2015 20:40:15,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[IS_A],[IS_A],belonging to,n/a,52,81,1,56,93,TWrex-cause,815032-FS1,"Pulex    (           audio )  [L., flea] A genus of FLEAS belonging to the order SIPHONAPTERA",FLEAS,SIPHONAPTERA
725258037,5/23/2015 20:42:06,1642363942,5/23/2015 20:41:51,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[PART_OF],[PART_OF],belonging to,n/a,52,81,1,56,93,TWrex-cause,815032-FS1,"Pulex    (           audio )  [L., flea] A genus of FLEAS belonging to the order SIPHONAPTERA",FLEAS,SIPHONAPTERA
725258037,5/23/2015 20:46:32,1642366696,5/23/2015 20:46:20,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[PART_OF],[PART_OF],belonging,-,52,81,1,56,93,TWrex-cause,815032-FS1,"Pulex    (           audio )  [L., flea] A genus of FLEAS belonging to the order SIPHONAPTERA",FLEAS,SIPHONAPTERA
725258037,5/23/2015 20:47:32,1642367338,5/23/2015 20:46:36,false,instagc,1.0,30880172,USA,CA,Los Angeles,166.170.50.98,[PART_OF],[PART_OF],belonging to,N/A,52,81,1,56,93,TWrex-cause,815032-FS1,"Pulex    (           audio )  [L., flea] A genus of FLEAS belonging to the order SIPHONAPTERA",FLEAS,SIPHONAPTERA
725258037,5/23/2015 20:47:36,1642367380,5/23/2015 20:45:56,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[PART_OF],[PART_OF],FLEAS belonging to SIPHONAPTERA,na,52,81,1,56,93,TWrex-cause,815032-FS1,"Pulex    (           audio )  [L., flea] A genus of FLEAS belonging to the order SIPHONAPTERA",FLEAS,SIPHONAPTERA
725258037,5/23/2015 20:47:44,1642367450,5/23/2015 20:47:29,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[PART_OF],[PART_OF],belonging to the order,n/a,52,81,1,56,93,TWrex-cause,815032-FS1,"Pulex    (           audio )  [L., flea] A genus of FLEAS belonging to the order SIPHONAPTERA",FLEAS,SIPHONAPTERA
725258037,5/23/2015 20:55:42,1642371610,5/23/2015 20:54:22,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[PART_OF],[PART_OF],belonging to the order,N/A,52,81,1,56,93,TWrex-cause,815032-FS1,"Pulex    (           audio )  [L., flea] A genus of FLEAS belonging to the order SIPHONAPTERA",FLEAS,SIPHONAPTERA
725258037,5/23/2015 20:56:20,1642371972,5/23/2015 20:56:00,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[PART_OF],[PART_OF],belonging to the order,n/a,52,81,1,56,93,TWrex-cause,815032-FS1,"Pulex    (           audio )  [L., flea] A genus of FLEAS belonging to the order SIPHONAPTERA",FLEAS,SIPHONAPTERA
725258037,5/23/2015 21:08:17,1642377493,5/23/2015 21:07:51,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[ASSOCIATED_WITH] [PART_OF],"[ASSOCIATED_WITH]
[PART_OF]",FLEAS belonging to the order SIPHONAPTERA,n/a,52,81,1,56,93,TWrex-cause,815032-FS1,"Pulex    (           audio )  [L., flea] A genus of FLEAS belonging to the order SIPHONAPTERA",FLEAS,SIPHONAPTERA
725258037,5/23/2015 21:32:25,1642389094,5/23/2015 21:32:02,false,prodege,1.0,24403612,CAN,ON,Bowmanville,99.252.243.178,[PART_OF],[PART_OF],FLEAS belonging to SIPHONAPTERA,N/A,52,81,1,56,93,TWrex-cause,815032-FS1,"Pulex    (           audio )  [L., flea] A genus of FLEAS belonging to the order SIPHONAPTERA",FLEAS,SIPHONAPTERA
725258037,5/23/2015 21:32:31,1642389130,5/23/2015 21:32:06,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[SYMPTOM],[SYMPTOM],belonging to,N/A,52,81,1,56,93,TWrex-cause,815032-FS1,"Pulex    (           audio )  [L., flea] A genus of FLEAS belonging to the order SIPHONAPTERA",FLEAS,SIPHONAPTERA
725258037,5/23/2015 21:35:41,1642390876,5/23/2015 21:34:48,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[PART_OF] [OTHER],"[PART_OF]
[OTHER]","Pulex [L., flea] A genus of FLEAS belonging to the order SIPHONAPTERA",n/a,52,81,1,56,93,TWrex-cause,815032-FS1,"Pulex    (           audio )  [L., flea] A genus of FLEAS belonging to the order SIPHONAPTERA",FLEAS,SIPHONAPTERA
725258037,5/23/2015 21:42:57,1642394355,5/23/2015 21:42:27,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[IS_A] [PART_OF],"[IS_A]
[PART_OF]",belonging to the order,N/A,52,81,1,56,93,TWrex-cause,815032-FS1,"Pulex    (           audio )  [L., flea] A genus of FLEAS belonging to the order SIPHONAPTERA",FLEAS,SIPHONAPTERA
725258038,5/24/2015 00:36:16,1642473694,5/24/2015 00:35:30,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[SYMPTOM],[SYMPTOM],in,n/a,22,44,1,25,64,TWrex-cause,814185-FS1,Functional imaging of PAIN in patients with PRIMARY FIBROMYALGIA,PAIN,PRIMARY FIBROMYALGIA
725258038,5/24/2015 00:45:42,1642477771,5/24/2015 00:43:45,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[OTHER],[OTHER],Functional imaging of PAIN in patients with PRIMARY FIBROMYALGIA,na,22,44,1,25,64,TWrex-cause,814185-FS1,Functional imaging of PAIN in patients with PRIMARY FIBROMYALGIA,PAIN,PRIMARY FIBROMYALGIA
725258038,5/24/2015 00:45:43,1642477774,5/24/2015 00:45:20,false,elite,1.0,31848723,USA,VA,Manassas,192.96.205.155,[SIDE_EFFECT],[SIDE_EFFECT],PAIN PRIMARY FIBROMYALGIA,N/A,22,44,1,25,64,TWrex-cause,814185-FS1,Functional imaging of PAIN in patients with PRIMARY FIBROMYALGIA,PAIN,PRIMARY FIBROMYALGIA
725258038,5/24/2015 00:48:57,1642478922,5/24/2015 00:48:39,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],in patients with,N/A,22,44,1,25,64,TWrex-cause,814185-FS1,Functional imaging of PAIN in patients with PRIMARY FIBROMYALGIA,PAIN,PRIMARY FIBROMYALGIA
725258038,5/24/2015 01:08:01,1642485292,5/24/2015 01:06:39,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],in patients with,N/A,22,44,1,25,64,TWrex-cause,814185-FS1,Functional imaging of PAIN in patients with PRIMARY FIBROMYALGIA,PAIN,PRIMARY FIBROMYALGIA
725258038,5/24/2015 01:38:01,1642494838,5/24/2015 01:37:49,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,N/A,22,44,1,25,64,TWrex-cause,814185-FS1,Functional imaging of PAIN in patients with PRIMARY FIBROMYALGIA,PAIN,PRIMARY FIBROMYALGIA
725258038,5/24/2015 01:45:21,1642497525,5/24/2015 01:45:09,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[SYMPTOM],[SYMPTOM],with,N/A,22,44,1,25,64,TWrex-cause,814185-FS1,Functional imaging of PAIN in patients with PRIMARY FIBROMYALGIA,PAIN,PRIMARY FIBROMYALGIA
725258038,5/24/2015 01:52:03,1642499687,5/24/2015 01:51:49,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[CAUSES],[CAUSES],Functional,N/A,22,44,1,25,64,TWrex-cause,814185-FS1,Functional imaging of PAIN in patients with PRIMARY FIBROMYALGIA,PAIN,PRIMARY FIBROMYALGIA
725258038,5/24/2015 01:58:34,1642501912,5/24/2015 01:58:23,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[CONTRAINDICATES],[CONTRAINDICATES],patients,N/A,22,44,1,25,64,TWrex-cause,814185-FS1,Functional imaging of PAIN in patients with PRIMARY FIBROMYALGIA,PAIN,PRIMARY FIBROMYALGIA
725258038,5/24/2015 02:03:40,1642503322,5/24/2015 02:03:30,false,neodev,1.0,32562748,CAN,BC,Vancouver,108.180.140.140,[MANIFESTATION] [CAUSES],"[CAUSES]
[MANIFESTATION]",PAIN PRIMARY FIBROMYALGIA,Please,22,44,1,25,64,TWrex-cause,814185-FS1,Functional imaging of PAIN in patients with PRIMARY FIBROMYALGIA,PAIN,PRIMARY FIBROMYALGIA
725258038,5/24/2015 02:03:53,1642503406,5/24/2015 02:03:39,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[CONTRAINDICATES],[CONTRAINDICATES],patients,N/A,22,44,1,25,64,TWrex-cause,814185-FS1,Functional imaging of PAIN in patients with PRIMARY FIBROMYALGIA,PAIN,PRIMARY FIBROMYALGIA
725258038,5/24/2015 02:06:36,1642504217,5/24/2015 02:06:25,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[MANIFESTATION],[MANIFESTATION],with,N/A,22,44,1,25,64,TWrex-cause,814185-FS1,Functional imaging of PAIN in patients with PRIMARY FIBROMYALGIA,PAIN,PRIMARY FIBROMYALGIA
725258038,5/24/2015 02:09:35,1642505120,5/24/2015 02:09:01,false,prodege,1.0,17379068,CAN,NB,Saint John,142.162.106.83,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,N/A,22,44,1,25,64,TWrex-cause,814185-FS1,Functional imaging of PAIN in patients with PRIMARY FIBROMYALGIA,PAIN,PRIMARY FIBROMYALGIA
725258038,5/24/2015 02:31:52,1642512364,5/24/2015 02:31:21,false,elite,1.0,32306791,USA,DE,Wilmington,199.58.86.213,[CAUSES],[CAUSES],PAIN PRIMARY,N/A,22,44,1,25,64,TWrex-cause,814185-FS1,Functional imaging of PAIN in patients with PRIMARY FIBROMYALGIA,PAIN,PRIMARY FIBROMYALGIA
725258038,5/24/2015 02:35:29,1642513657,5/24/2015 02:35:07,false,elite,1.0,31913360,USA,VA,Manassas,207.244.77.2,[MANIFESTATION],[MANIFESTATION],FIBROMYALGIA,iuoil,22,44,1,25,64,TWrex-cause,814185-FS1,Functional imaging of PAIN in patients with PRIMARY FIBROMYALGIA,PAIN,PRIMARY FIBROMYALGIA
725258039,5/23/2015 20:32:26,1642358861,5/23/2015 20:32:08,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],after receiving,N/A,45,73,-1,53,99,TWrex-cause,803176-FS1,3]  Revised ACIP recommendation for avoiding PREGNANCY after receiving a RUBELLA CONTAINING VACCINE.,PREGNANCY,RUBELLA CONTAINING VACCINE
725258039,5/23/2015 20:34:09,1642359812,5/23/2015 20:33:33,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CONTRAINDICATES],[CONTRAINDICATES],recommendation for avoiding PREGNANCY after RUBELLA CONTAINING VACCINE.,N/A,45,73,-1,53,99,TWrex-cause,803176-FS1,3]  Revised ACIP recommendation for avoiding PREGNANCY after receiving a RUBELLA CONTAINING VACCINE.,PREGNANCY,RUBELLA CONTAINING VACCINE
725258039,5/23/2015 20:40:02,1642362784,5/23/2015 20:39:38,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],receiving,n/a,45,73,-1,53,99,TWrex-cause,803176-FS1,3]  Revised ACIP recommendation for avoiding PREGNANCY after receiving a RUBELLA CONTAINING VACCINE.,PREGNANCY,RUBELLA CONTAINING VACCINE
725258039,5/23/2015 20:41:37,1642363741,5/23/2015 20:41:23,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CONTRAINDICATES],[CONTRAINDICATES],avoiding,n/a,45,73,-1,53,99,TWrex-cause,803176-FS1,3]  Revised ACIP recommendation for avoiding PREGNANCY after receiving a RUBELLA CONTAINING VACCINE.,PREGNANCY,RUBELLA CONTAINING VACCINE
725258039,5/23/2015 20:45:00,1642365663,5/23/2015 20:43:54,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CONTRAINDICATES],[CONTRAINDICATES],avoiding PREGNANCY after receiving RUBELLA CONTAINING VACCINE.,na,45,73,-1,53,99,TWrex-cause,803176-FS1,3]  Revised ACIP recommendation for avoiding PREGNANCY after receiving a RUBELLA CONTAINING VACCINE.,PREGNANCY,RUBELLA CONTAINING VACCINE
725258039,5/23/2015 20:45:39,1642366060,5/23/2015 20:44:55,false,instagc,1.0,30880172,USA,CA,Los Angeles,166.170.50.98,[CONTRAINDICATES],[CONTRAINDICATES],avoiding after receiving,N/A,45,73,-1,53,99,TWrex-cause,803176-FS1,3]  Revised ACIP recommendation for avoiding PREGNANCY after receiving a RUBELLA CONTAINING VACCINE.,PREGNANCY,RUBELLA CONTAINING VACCINE
725258039,5/23/2015 20:46:06,1642366424,5/23/2015 20:45:35,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[OTHER],[OTHER],avoiding,-,45,73,-1,53,99,TWrex-cause,803176-FS1,3]  Revised ACIP recommendation for avoiding PREGNANCY after receiving a RUBELLA CONTAINING VACCINE.,PREGNANCY,RUBELLA CONTAINING VACCINE
725258039,5/23/2015 20:47:12,1642367083,5/23/2015 20:46:56,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CONTRAINDICATES],[CONTRAINDICATES],recommendation for avoiding,n/a,45,73,-1,53,99,TWrex-cause,803176-FS1,3]  Revised ACIP recommendation for avoiding PREGNANCY after receiving a RUBELLA CONTAINING VACCINE.,PREGNANCY,RUBELLA CONTAINING VACCINE
725258039,5/23/2015 20:54:00,1642370795,5/23/2015 20:51:41,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],avoiding after receiving a,N/A,45,73,-1,53,99,TWrex-cause,803176-FS1,3]  Revised ACIP recommendation for avoiding PREGNANCY after receiving a RUBELLA CONTAINING VACCINE.,PREGNANCY,RUBELLA CONTAINING VACCINE
725258039,5/23/2015 20:55:46,1642371656,5/23/2015 20:55:31,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CONTRAINDICATES],[CONTRAINDICATES],avoiding after receiving,n/a,45,73,-1,53,99,TWrex-cause,803176-FS1,3]  Revised ACIP recommendation for avoiding PREGNANCY after receiving a RUBELLA CONTAINING VACCINE.,PREGNANCY,RUBELLA CONTAINING VACCINE
725258039,5/23/2015 21:07:27,1642377102,5/23/2015 21:06:53,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[CONTRAINDICATES],[CONTRAINDICATES],recommendation for avoiding PREGNANCY after receiving,n/a,45,73,-1,53,99,TWrex-cause,803176-FS1,3]  Revised ACIP recommendation for avoiding PREGNANCY after receiving a RUBELLA CONTAINING VACCINE.,PREGNANCY,RUBELLA CONTAINING VACCINE
725258039,5/23/2015 21:31:13,1642388508,5/23/2015 21:30:45,false,prodege,1.0,24403612,CAN,ON,Bowmanville,99.252.243.178,[CAUSES],[CAUSES],PREGNANCY after receiving RUBELLA CONTAINING VACCINE.,N/A,45,73,-1,53,99,TWrex-cause,803176-FS1,3]  Revised ACIP recommendation for avoiding PREGNANCY after receiving a RUBELLA CONTAINING VACCINE.,PREGNANCY,RUBELLA CONTAINING VACCINE
725258039,5/23/2015 21:31:40,1642388728,5/23/2015 21:30:58,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[PREVENTS],[PREVENTS],receiving,N/A,45,73,-1,53,99,TWrex-cause,803176-FS1,3]  Revised ACIP recommendation for avoiding PREGNANCY after receiving a RUBELLA CONTAINING VACCINE.,PREGNANCY,RUBELLA CONTAINING VACCINE
725258039,5/23/2015 21:33:34,1642389695,5/23/2015 21:32:22,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SIDE_EFFECT] [LOCATION],"[LOCATION]
[SIDE_EFFECT]",Revised ACIP recommendation for avoiding PREGNANCY after receiving a RUBELLA CONTAINING VACCINE.,n/a,45,73,-1,53,99,TWrex-cause,803176-FS1,3]  Revised ACIP recommendation for avoiding PREGNANCY after receiving a RUBELLA CONTAINING VACCINE.,PREGNANCY,RUBELLA CONTAINING VACCINE
725258039,5/23/2015 21:35:26,1642390751,5/23/2015 21:34:32,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[CONTRAINDICATES],[CONTRAINDICATES],avoiding after receiving a,n/a,45,73,-1,53,99,TWrex-cause,803176-FS1,3]  Revised ACIP recommendation for avoiding PREGNANCY after receiving a RUBELLA CONTAINING VACCINE.,PREGNANCY,RUBELLA CONTAINING VACCINE
725258040,5/23/2015 20:40:36,1642363217,5/23/2015 20:39:57,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[PART_OF],[PART_OF],patients with,N/A,95,117,-1,98,153,TWrex-cause,802121-FS1,"Other figures show sensory processing in the spinal cord dorsal horn, physical findings in the FEET of patients with BILATERAL FOOT PAIN FROM SMALL FIBER polyneuropathy, illustrate how examination can identify specific nerve injuries causing chronic pain, and provide classification of chronic pain syndromes.",FEET,BILATERAL FOOT PAIN FROM SMALL FIBER
725258040,5/23/2015 20:47:44,1642367445,5/23/2015 20:47:27,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],of patients with,n/a,95,117,-1,98,153,TWrex-cause,802121-FS1,"Other figures show sensory processing in the spinal cord dorsal horn, physical findings in the FEET of patients with BILATERAL FOOT PAIN FROM SMALL FIBER polyneuropathy, illustrate how examination can identify specific nerve injuries causing chronic pain, and provide classification of chronic pain syndromes.",FEET,BILATERAL FOOT PAIN FROM SMALL FIBER
725258040,5/23/2015 20:50:47,1642369131,5/23/2015 20:49:57,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],FEET of patients with BILATERAL FOOT PAIN FROM SMALL FIBER,N/A,95,117,-1,98,153,TWrex-cause,802121-FS1,"Other figures show sensory processing in the spinal cord dorsal horn, physical findings in the FEET of patients with BILATERAL FOOT PAIN FROM SMALL FIBER polyneuropathy, illustrate how examination can identify specific nerve injuries causing chronic pain, and provide classification of chronic pain syndromes.",FEET,BILATERAL FOOT PAIN FROM SMALL FIBER
725258040,5/23/2015 20:54:01,1642370808,5/23/2015 20:53:40,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[LOCATION],[LOCATION],in,n/a,95,117,-1,98,153,TWrex-cause,802121-FS1,"Other figures show sensory processing in the spinal cord dorsal horn, physical findings in the FEET of patients with BILATERAL FOOT PAIN FROM SMALL FIBER polyneuropathy, illustrate how examination can identify specific nerve injuries causing chronic pain, and provide classification of chronic pain syndromes.",FEET,BILATERAL FOOT PAIN FROM SMALL FIBER
725258040,5/23/2015 21:03:32,1642375188,5/23/2015 21:03:13,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[LOCATION],[LOCATION],findings in the,n/a,95,117,-1,98,153,TWrex-cause,802121-FS1,"Other figures show sensory processing in the spinal cord dorsal horn, physical findings in the FEET of patients with BILATERAL FOOT PAIN FROM SMALL FIBER polyneuropathy, illustrate how examination can identify specific nerve injuries causing chronic pain, and provide classification of chronic pain syndromes.",FEET,BILATERAL FOOT PAIN FROM SMALL FIBER
725258040,5/23/2015 21:03:52,1642375339,5/23/2015 21:03:05,false,instagc,1.0,30880172,USA,CA,Los Angeles,166.170.50.98,[PART_OF],[PART_OF],of patients with,N/A,95,117,-1,98,153,TWrex-cause,802121-FS1,"Other figures show sensory processing in the spinal cord dorsal horn, physical findings in the FEET of patients with BILATERAL FOOT PAIN FROM SMALL FIBER polyneuropathy, illustrate how examination can identify specific nerve injuries causing chronic pain, and provide classification of chronic pain syndromes.",FEET,BILATERAL FOOT PAIN FROM SMALL FIBER
725258040,5/23/2015 21:09:53,1642378184,5/23/2015 21:09:05,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[LOCATION],[LOCATION],"in FEET of patients with BILATERAL FOOT PAIN FROM SMALL FIBER polyneuropathy,",na,95,117,-1,98,153,TWrex-cause,802121-FS1,"Other figures show sensory processing in the spinal cord dorsal horn, physical findings in the FEET of patients with BILATERAL FOOT PAIN FROM SMALL FIBER polyneuropathy, illustrate how examination can identify specific nerve injuries causing chronic pain, and provide classification of chronic pain syndromes.",FEET,BILATERAL FOOT PAIN FROM SMALL FIBER
725258040,5/23/2015 21:12:40,1642379575,5/23/2015 21:12:14,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],of patients with,N/A,95,117,-1,98,153,TWrex-cause,802121-FS1,"Other figures show sensory processing in the spinal cord dorsal horn, physical findings in the FEET of patients with BILATERAL FOOT PAIN FROM SMALL FIBER polyneuropathy, illustrate how examination can identify specific nerve injuries causing chronic pain, and provide classification of chronic pain syndromes.",FEET,BILATERAL FOOT PAIN FROM SMALL FIBER
725258040,5/23/2015 21:42:56,1642394354,5/23/2015 21:42:19,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[SYMPTOM],[SYMPTOM],processing in,N/A,95,117,-1,98,153,TWrex-cause,802121-FS1,"Other figures show sensory processing in the spinal cord dorsal horn, physical findings in the FEET of patients with BILATERAL FOOT PAIN FROM SMALL FIBER polyneuropathy, illustrate how examination can identify specific nerve injuries causing chronic pain, and provide classification of chronic pain syndromes.",FEET,BILATERAL FOOT PAIN FROM SMALL FIBER
725258040,5/23/2015 21:53:34,1642399084,5/23/2015 21:53:07,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[LOCATION],[LOCATION],in the FEET of patients with,N/A,95,117,-1,98,153,TWrex-cause,802121-FS1,"Other figures show sensory processing in the spinal cord dorsal horn, physical findings in the FEET of patients with BILATERAL FOOT PAIN FROM SMALL FIBER polyneuropathy, illustrate how examination can identify specific nerve injuries causing chronic pain, and provide classification of chronic pain syndromes.",FEET,BILATERAL FOOT PAIN FROM SMALL FIBER
725258040,5/23/2015 21:56:28,1642400186,5/23/2015 21:55:17,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"Other figures show sensory processing in the spinal cord dorsal horn, physical findings in the FEET of patients with BILATERAL FOOT PAIN FROM SMALL FIBER polyneuropathy, illustrate how examination can identify specific nerve injuries causing chronic pain, and provide classification of chronic pain syndromes.",n/a,95,117,-1,98,153,TWrex-cause,802121-FS1,"Other figures show sensory processing in the spinal cord dorsal horn, physical findings in the FEET of patients with BILATERAL FOOT PAIN FROM SMALL FIBER polyneuropathy, illustrate how examination can identify specific nerve injuries causing chronic pain, and provide classification of chronic pain syndromes.",FEET,BILATERAL FOOT PAIN FROM SMALL FIBER
725258040,5/23/2015 21:57:06,1642400423,5/23/2015 21:56:23,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[PART_OF],[PART_OF],of,N/A,95,117,-1,98,153,TWrex-cause,802121-FS1,"Other figures show sensory processing in the spinal cord dorsal horn, physical findings in the FEET of patients with BILATERAL FOOT PAIN FROM SMALL FIBER polyneuropathy, illustrate how examination can identify specific nerve injuries causing chronic pain, and provide classification of chronic pain syndromes.",FEET,BILATERAL FOOT PAIN FROM SMALL FIBER
725258040,5/23/2015 22:01:36,1642402228,5/23/2015 22:00:54,false,elite,1.0,30064988,GBR,B4,Bradford,92.22.135.10,[OTHER],[OTHER],physical findings in,N/A,95,117,-1,98,153,TWrex-cause,802121-FS1,"Other figures show sensory processing in the spinal cord dorsal horn, physical findings in the FEET of patients with BILATERAL FOOT PAIN FROM SMALL FIBER polyneuropathy, illustrate how examination can identify specific nerve injuries causing chronic pain, and provide classification of chronic pain syndromes.",FEET,BILATERAL FOOT PAIN FROM SMALL FIBER
725258040,5/23/2015 22:07:55,1642405449,5/23/2015 22:07:08,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[LOCATION],[LOCATION],in the of,n/a,95,117,-1,98,153,TWrex-cause,802121-FS1,"Other figures show sensory processing in the spinal cord dorsal horn, physical findings in the FEET of patients with BILATERAL FOOT PAIN FROM SMALL FIBER polyneuropathy, illustrate how examination can identify specific nerve injuries causing chronic pain, and provide classification of chronic pain syndromes.",FEET,BILATERAL FOOT PAIN FROM SMALL FIBER
725258040,5/23/2015 22:08:15,1642405645,5/23/2015 22:07:09,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[SYMPTOM],[SYMPTOM],of patients with,n/a,95,117,-1,98,153,TWrex-cause,802121-FS1,"Other figures show sensory processing in the spinal cord dorsal horn, physical findings in the FEET of patients with BILATERAL FOOT PAIN FROM SMALL FIBER polyneuropathy, illustrate how examination can identify specific nerve injuries causing chronic pain, and provide classification of chronic pain syndromes.",FEET,BILATERAL FOOT PAIN FROM SMALL FIBER
725258041,5/23/2015 23:34:17,1642446770,5/23/2015 23:33:59,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,71,33,-1,94,54,TWrex-cause,803453-FS1,"Chan AS, Tang KC, Fung KK et al. SINGLE DOSE OFLOXACIN in treatment of UNCOMPLICATED GONORRHOEA",UNCOMPLICATED GONORRHOEA,SINGLE DOSE OFLOXACIN
725258041,5/23/2015 23:46:20,1642452647,5/23/2015 23:46:06,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],treatment,N/A,71,33,-1,94,54,TWrex-cause,803453-FS1,"Chan AS, Tang KC, Fung KK et al. SINGLE DOSE OFLOXACIN in treatment of UNCOMPLICATED GONORRHOEA",UNCOMPLICATED GONORRHOEA,SINGLE DOSE OFLOXACIN
725258041,5/23/2015 23:49:55,1642454134,5/23/2015 23:49:47,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[TREATS],[TREATS],treatment of,n/a,71,33,-1,94,54,TWrex-cause,803453-FS1,"Chan AS, Tang KC, Fung KK et al. SINGLE DOSE OFLOXACIN in treatment of UNCOMPLICATED GONORRHOEA",UNCOMPLICATED GONORRHOEA,SINGLE DOSE OFLOXACIN
725258041,5/24/2015 00:33:58,1642472756,5/24/2015 00:33:38,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],treatment,n/a,71,33,-1,94,54,TWrex-cause,803453-FS1,"Chan AS, Tang KC, Fung KK et al. SINGLE DOSE OFLOXACIN in treatment of UNCOMPLICATED GONORRHOEA",UNCOMPLICATED GONORRHOEA,SINGLE DOSE OFLOXACIN
725258041,5/24/2015 00:42:09,1642476285,5/24/2015 00:41:04,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[OTHER],[OTHER],treatment of UNCOMPLICATED GONORRHOEA,na,71,33,-1,94,54,TWrex-cause,803453-FS1,"Chan AS, Tang KC, Fung KK et al. SINGLE DOSE OFLOXACIN in treatment of UNCOMPLICATED GONORRHOEA",UNCOMPLICATED GONORRHOEA,SINGLE DOSE OFLOXACIN
725258041,5/24/2015 00:44:38,1642477224,5/24/2015 00:44:16,false,elite,1.0,31848723,USA,VA,Manassas,192.96.205.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],SINGLE DOSE OFLOXACIN UNCOMPLICATED GONORRHOEA,N/A,71,33,-1,94,54,TWrex-cause,803453-FS1,"Chan AS, Tang KC, Fung KK et al. SINGLE DOSE OFLOXACIN in treatment of UNCOMPLICATED GONORRHOEA",UNCOMPLICATED GONORRHOEA,SINGLE DOSE OFLOXACIN
725258041,5/24/2015 00:47:09,1642478245,5/24/2015 00:46:21,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,71,33,-1,94,54,TWrex-cause,803453-FS1,"Chan AS, Tang KC, Fung KK et al. SINGLE DOSE OFLOXACIN in treatment of UNCOMPLICATED GONORRHOEA",UNCOMPLICATED GONORRHOEA,SINGLE DOSE OFLOXACIN
725258041,5/24/2015 01:04:24,1642483895,5/24/2015 01:03:49,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[TREATS],[TREATS],in treatment of,N/A,71,33,-1,94,54,TWrex-cause,803453-FS1,"Chan AS, Tang KC, Fung KK et al. SINGLE DOSE OFLOXACIN in treatment of UNCOMPLICATED GONORRHOEA",UNCOMPLICATED GONORRHOEA,SINGLE DOSE OFLOXACIN
725258041,5/24/2015 01:37:20,1642494547,5/24/2015 01:37:09,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],treatment,N/A,71,33,-1,94,54,TWrex-cause,803453-FS1,"Chan AS, Tang KC, Fung KK et al. SINGLE DOSE OFLOXACIN in treatment of UNCOMPLICATED GONORRHOEA",UNCOMPLICATED GONORRHOEA,SINGLE DOSE OFLOXACIN
725258041,5/24/2015 01:44:39,1642497220,5/24/2015 01:44:27,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],treatment,N/A,71,33,-1,94,54,TWrex-cause,803453-FS1,"Chan AS, Tang KC, Fung KK et al. SINGLE DOSE OFLOXACIN in treatment of UNCOMPLICATED GONORRHOEA",UNCOMPLICATED GONORRHOEA,SINGLE DOSE OFLOXACIN
725258041,5/24/2015 01:51:22,1642499464,5/24/2015 01:51:11,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],treatment,N/A,71,33,-1,94,54,TWrex-cause,803453-FS1,"Chan AS, Tang KC, Fung KK et al. SINGLE DOSE OFLOXACIN in treatment of UNCOMPLICATED GONORRHOEA",UNCOMPLICATED GONORRHOEA,SINGLE DOSE OFLOXACIN
725258041,5/24/2015 01:57:50,1642501708,5/24/2015 01:57:37,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[TREATS],[TREATS],treatment,N/A,71,33,-1,94,54,TWrex-cause,803453-FS1,"Chan AS, Tang KC, Fung KK et al. SINGLE DOSE OFLOXACIN in treatment of UNCOMPLICATED GONORRHOEA",UNCOMPLICATED GONORRHOEA,SINGLE DOSE OFLOXACIN
725258041,5/24/2015 02:02:58,1642503136,5/24/2015 02:02:18,false,neodev,1.0,32562748,CAN,BC,Vancouver,108.180.140.140,[PREVENTS] [LOCATION],"[PREVENTS]
[LOCATION]",OFLOXACIN UNCOMPLICATED GONORRHOEA,I didn't,71,33,-1,94,54,TWrex-cause,803453-FS1,"Chan AS, Tang KC, Fung KK et al. SINGLE DOSE OFLOXACIN in treatment of UNCOMPLICATED GONORRHOEA",UNCOMPLICATED GONORRHOEA,SINGLE DOSE OFLOXACIN
725258041,5/24/2015 02:03:04,1642503173,5/24/2015 02:02:46,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[TREATS],[TREATS],treatment,N/A,71,33,-1,94,54,TWrex-cause,803453-FS1,"Chan AS, Tang KC, Fung KK et al. SINGLE DOSE OFLOXACIN in treatment of UNCOMPLICATED GONORRHOEA",UNCOMPLICATED GONORRHOEA,SINGLE DOSE OFLOXACIN
725258041,5/24/2015 02:07:15,1642504446,5/24/2015 02:04:21,false,prodege,1.0,17379068,CAN,NB,Saint John,142.162.106.83,[TREATS],[TREATS],treatment,N/A,71,33,-1,94,54,TWrex-cause,803453-FS1,"Chan AS, Tang KC, Fung KK et al. SINGLE DOSE OFLOXACIN in treatment of UNCOMPLICATED GONORRHOEA",UNCOMPLICATED GONORRHOEA,SINGLE DOSE OFLOXACIN
725258042,5/23/2015 23:32:56,1642446302,5/23/2015 23:32:41,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,91,41,-1,108,62,TWrex-cause,803574-FS1,"Phillips RE, Warrell DA, White NJ et al. INTRAVENOUS QUINIDINE for the treatment of severe FALCIPARUM MALARIA",FALCIPARUM MALARIA,INTRAVENOUS QUINIDINE
725258042,5/23/2015 23:36:59,1642447990,5/23/2015 23:36:16,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],treatment,none,91,41,-1,108,62,TWrex-cause,803574-FS1,"Phillips RE, Warrell DA, White NJ et al. INTRAVENOUS QUINIDINE for the treatment of severe FALCIPARUM MALARIA",FALCIPARUM MALARIA,INTRAVENOUS QUINIDINE
725258042,5/23/2015 23:44:13,1642451674,5/23/2015 23:43:33,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],treatment,N/A,91,41,-1,108,62,TWrex-cause,803574-FS1,"Phillips RE, Warrell DA, White NJ et al. INTRAVENOUS QUINIDINE for the treatment of severe FALCIPARUM MALARIA",FALCIPARUM MALARIA,INTRAVENOUS QUINIDINE
725258042,5/23/2015 23:49:03,1642453747,5/23/2015 23:48:53,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[TREATS],[TREATS],treatment of,n/a,91,41,-1,108,62,TWrex-cause,803574-FS1,"Phillips RE, Warrell DA, White NJ et al. INTRAVENOUS QUINIDINE for the treatment of severe FALCIPARUM MALARIA",FALCIPARUM MALARIA,INTRAVENOUS QUINIDINE
725258042,5/23/2015 23:57:31,1642457666,5/23/2015 23:57:20,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.161,[LOCATION] [CAUSES] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,91,41,-1,108,62,TWrex-cause,803574-FS1,"Phillips RE, Warrell DA, White NJ et al. INTRAVENOUS QUINIDINE for the treatment of severe FALCIPARUM MALARIA",FALCIPARUM MALARIA,INTRAVENOUS QUINIDINE
725258042,5/24/2015 00:32:25,1642472055,5/24/2015 00:29:36,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],treatment,n/a,91,41,-1,108,62,TWrex-cause,803574-FS1,"Phillips RE, Warrell DA, White NJ et al. INTRAVENOUS QUINIDINE for the treatment of severe FALCIPARUM MALARIA",FALCIPARUM MALARIA,INTRAVENOUS QUINIDINE
725258042,5/24/2015 00:38:49,1642474802,5/24/2015 00:38:22,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[OTHER],[OTHER],treatment of FALCIPARUM MALARIA,na,91,41,-1,108,62,TWrex-cause,803574-FS1,"Phillips RE, Warrell DA, White NJ et al. INTRAVENOUS QUINIDINE for the treatment of severe FALCIPARUM MALARIA",FALCIPARUM MALARIA,INTRAVENOUS QUINIDINE
725258042,5/24/2015 00:42:52,1642476621,5/24/2015 00:42:36,false,elite,1.0,31848723,USA,VA,Manassas,192.96.205.155,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Warrell INTRAVENOUS QUINIDINE FALCIPARUM MALARIA,N/A,91,41,-1,108,62,TWrex-cause,803574-FS1,"Phillips RE, Warrell DA, White NJ et al. INTRAVENOUS QUINIDINE for the treatment of severe FALCIPARUM MALARIA",FALCIPARUM MALARIA,INTRAVENOUS QUINIDINE
725258042,5/24/2015 00:43:54,1642476950,5/24/2015 00:43:17,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,91,41,-1,108,62,TWrex-cause,803574-FS1,"Phillips RE, Warrell DA, White NJ et al. INTRAVENOUS QUINIDINE for the treatment of severe FALCIPARUM MALARIA",FALCIPARUM MALARIA,INTRAVENOUS QUINIDINE
725258042,5/24/2015 00:56:43,1642481339,5/24/2015 00:55:20,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[TREATS],[TREATS],for the treatment of,N/A,91,41,-1,108,62,TWrex-cause,803574-FS1,"Phillips RE, Warrell DA, White NJ et al. INTRAVENOUS QUINIDINE for the treatment of severe FALCIPARUM MALARIA",FALCIPARUM MALARIA,INTRAVENOUS QUINIDINE
725258042,5/24/2015 01:32:12,1642492878,5/24/2015 01:31:24,false,clixsense,1.0,6375330,CAN,ON,Ottawa,209.195.106.138,[TREATS],[TREATS],for the treatment,none,91,41,-1,108,62,TWrex-cause,803574-FS1,"Phillips RE, Warrell DA, White NJ et al. INTRAVENOUS QUINIDINE for the treatment of severe FALCIPARUM MALARIA",FALCIPARUM MALARIA,INTRAVENOUS QUINIDINE
725258042,5/24/2015 01:36:26,1642494264,5/24/2015 01:36:14,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],treatment,N/A,91,41,-1,108,62,TWrex-cause,803574-FS1,"Phillips RE, Warrell DA, White NJ et al. INTRAVENOUS QUINIDINE for the treatment of severe FALCIPARUM MALARIA",FALCIPARUM MALARIA,INTRAVENOUS QUINIDINE
725258042,5/24/2015 01:43:39,1642496910,5/24/2015 01:43:28,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],treatment,N/A,91,41,-1,108,62,TWrex-cause,803574-FS1,"Phillips RE, Warrell DA, White NJ et al. INTRAVENOUS QUINIDINE for the treatment of severe FALCIPARUM MALARIA",FALCIPARUM MALARIA,INTRAVENOUS QUINIDINE
725258042,5/24/2015 01:50:24,1642499112,5/24/2015 01:50:13,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],treatment,N/A,91,41,-1,108,62,TWrex-cause,803574-FS1,"Phillips RE, Warrell DA, White NJ et al. INTRAVENOUS QUINIDINE for the treatment of severe FALCIPARUM MALARIA",FALCIPARUM MALARIA,INTRAVENOUS QUINIDINE
725258042,5/24/2015 01:56:49,1642501473,5/24/2015 01:56:36,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[TREATS],[TREATS],treatment,N/A,91,41,-1,108,62,TWrex-cause,803574-FS1,"Phillips RE, Warrell DA, White NJ et al. INTRAVENOUS QUINIDINE for the treatment of severe FALCIPARUM MALARIA",FALCIPARUM MALARIA,INTRAVENOUS QUINIDINE
725258043,5/23/2015 23:34:57,1642447017,5/23/2015 23:34:37,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],in boys indicate,N/A,32,90,1,44,110,TWrex-cause,814189-FS1,"Athetosis, self mutilation, and HYPERURICEMIA in boys indicate Lesch Nyhan syndrome (see  LESCH NYHAN SYNDROME.",HYPERURICEMIA,LESCH NYHAN SYNDROME
725258043,5/23/2015 23:46:57,1642452879,5/23/2015 23:46:39,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[MANIFESTATION],[MANIFESTATION],indicate,N/A,32,90,1,44,110,TWrex-cause,814189-FS1,"Athetosis, self mutilation, and HYPERURICEMIA in boys indicate Lesch Nyhan syndrome (see  LESCH NYHAN SYNDROME.",HYPERURICEMIA,LESCH NYHAN SYNDROME
725258043,5/24/2015 00:35:29,1642473398,5/24/2015 00:35:00,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[MANIFESTATION],[MANIFESTATION],indicate,n/a,32,90,1,44,110,TWrex-cause,814189-FS1,"Athetosis, self mutilation, and HYPERURICEMIA in boys indicate Lesch Nyhan syndrome (see  LESCH NYHAN SYNDROME.",HYPERURICEMIA,LESCH NYHAN SYNDROME
725258043,5/24/2015 00:43:43,1642476900,5/24/2015 00:42:55,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[OTHER],[OTHER],indicate Lesch Nyhan syndrome,na,32,90,1,44,110,TWrex-cause,814189-FS1,"Athetosis, self mutilation, and HYPERURICEMIA in boys indicate Lesch Nyhan syndrome (see  LESCH NYHAN SYNDROME.",HYPERURICEMIA,LESCH NYHAN SYNDROME
725258043,5/24/2015 00:45:18,1642477530,5/24/2015 00:45:01,false,elite,1.0,31848723,USA,VA,Manassas,192.96.205.155,[CAUSES],[CAUSES],HYPERURICEMIA LESCH NYHAN SYNDROME.,N/A,32,90,1,44,110,TWrex-cause,814189-FS1,"Athetosis, self mutilation, and HYPERURICEMIA in boys indicate Lesch Nyhan syndrome (see  LESCH NYHAN SYNDROME.",HYPERURICEMIA,LESCH NYHAN SYNDROME
725258043,5/24/2015 00:48:38,1642478754,5/24/2015 00:47:30,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[SYMPTOM],[SYMPTOM],indicate,N/A,32,90,1,44,110,TWrex-cause,814189-FS1,"Athetosis, self mutilation, and HYPERURICEMIA in boys indicate Lesch Nyhan syndrome (see  LESCH NYHAN SYNDROME.",HYPERURICEMIA,LESCH NYHAN SYNDROME
725258043,5/24/2015 01:06:22,1642484675,5/24/2015 01:05:22,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[DIAGNOSE_BY_TEST_OR_DRUG] [SYMPTOM] [MANIFESTATION],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SYMPTOM]
[MANIFESTATION]",in boys indicate,N/A,32,90,1,44,110,TWrex-cause,814189-FS1,"Athetosis, self mutilation, and HYPERURICEMIA in boys indicate Lesch Nyhan syndrome (see  LESCH NYHAN SYNDROME.",HYPERURICEMIA,LESCH NYHAN SYNDROME
725258043,5/24/2015 01:37:47,1642494738,5/24/2015 01:37:36,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[SYMPTOM],[SYMPTOM],syndrome,N/A,32,90,1,44,110,TWrex-cause,814189-FS1,"Athetosis, self mutilation, and HYPERURICEMIA in boys indicate Lesch Nyhan syndrome (see  LESCH NYHAN SYNDROME.",HYPERURICEMIA,LESCH NYHAN SYNDROME
725258043,5/24/2015 01:45:08,1642497438,5/24/2015 01:44:55,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[SYMPTOM],[SYMPTOM],syndrome,N/A,32,90,1,44,110,TWrex-cause,814189-FS1,"Athetosis, self mutilation, and HYPERURICEMIA in boys indicate Lesch Nyhan syndrome (see  LESCH NYHAN SYNDROME.",HYPERURICEMIA,LESCH NYHAN SYNDROME
725258043,5/24/2015 01:51:48,1642499590,5/24/2015 01:51:37,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[SYMPTOM],[SYMPTOM],syndrome,N/A,32,90,1,44,110,TWrex-cause,814189-FS1,"Athetosis, self mutilation, and HYPERURICEMIA in boys indicate Lesch Nyhan syndrome (see  LESCH NYHAN SYNDROME.",HYPERURICEMIA,LESCH NYHAN SYNDROME
725258043,5/24/2015 01:58:20,1642501847,5/24/2015 01:58:08,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[SYMPTOM],[SYMPTOM],syndrome,N/A,32,90,1,44,110,TWrex-cause,814189-FS1,"Athetosis, self mutilation, and HYPERURICEMIA in boys indicate Lesch Nyhan syndrome (see  LESCH NYHAN SYNDROME.",HYPERURICEMIA,LESCH NYHAN SYNDROME
725258043,5/24/2015 02:03:29,1642503249,5/24/2015 02:03:13,false,neodev,1.0,32562748,CAN,BC,Vancouver,108.180.140.140,[CAUSES] [PART_OF],"[CAUSES]
[PART_OF]",HYPERURICEMIA LESCH NYHAN,I didn't do it,32,90,1,44,110,TWrex-cause,814189-FS1,"Athetosis, self mutilation, and HYPERURICEMIA in boys indicate Lesch Nyhan syndrome (see  LESCH NYHAN SYNDROME.",HYPERURICEMIA,LESCH NYHAN SYNDROME
725258043,5/24/2015 02:03:38,1642503319,5/24/2015 02:03:23,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[SYMPTOM],[SYMPTOM],syndrome,N/A,32,90,1,44,110,TWrex-cause,814189-FS1,"Athetosis, self mutilation, and HYPERURICEMIA in boys indicate Lesch Nyhan syndrome (see  LESCH NYHAN SYNDROME.",HYPERURICEMIA,LESCH NYHAN SYNDROME
725258043,5/24/2015 02:06:23,1642504129,5/24/2015 02:06:12,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[SYMPTOM],[SYMPTOM],syndrome,N/A,32,90,1,44,110,TWrex-cause,814189-FS1,"Athetosis, self mutilation, and HYPERURICEMIA in boys indicate Lesch Nyhan syndrome (see  LESCH NYHAN SYNDROME.",HYPERURICEMIA,LESCH NYHAN SYNDROME
725258043,5/24/2015 02:09:00,1642504977,5/24/2015 02:08:21,false,prodege,1.0,17379068,CAN,NB,Saint John,142.162.106.83,[ASSOCIATED_WITH],[ASSOCIATED_WITH],indicate,N/A,32,90,1,44,110,TWrex-cause,814189-FS1,"Athetosis, self mutilation, and HYPERURICEMIA in boys indicate Lesch Nyhan syndrome (see  LESCH NYHAN SYNDROME.",HYPERURICEMIA,LESCH NYHAN SYNDROME
725258044,5/23/2015 20:34:25,1642359929,5/23/2015 20:34:02,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[SYMPTOM],[SYMPTOM],has been reported,N/A,250,74,1,262,104,TWrex-cause,814740-FS1,"230    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefotaxime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
725258044,5/23/2015 20:39:30,1642362498,5/23/2015 20:38:09,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[SYMPTOM],[SYMPTOM],ANTIBIOTIC ASSOCIATED DIARRHEA has been reported from MILD DIARRHEA,N/A,250,74,1,262,104,TWrex-cause,814740-FS1,"230    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefotaxime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
725258044,5/23/2015 20:43:38,1642364811,5/23/2015 20:43:05,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],been reported,n/a,250,74,1,262,104,TWrex-cause,814740-FS1,"230    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefotaxime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
725258044,5/23/2015 20:48:02,1642367614,5/23/2015 20:47:28,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[OTHER],[OTHER],"infectives,",-,250,74,1,262,104,TWrex-cause,814740-FS1,"230    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefotaxime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
725258044,5/23/2015 20:49:15,1642368235,5/23/2015 20:48:58,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[IS_A],[IS_A],DIARRHEA,n/a,250,74,1,262,104,TWrex-cause,814740-FS1,"230    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefotaxime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
725258044,5/23/2015 20:50:56,1642369200,5/23/2015 20:49:32,false,instagc,1.0,30880172,USA,CA,Los Angeles,166.170.50.98,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"reported with nearly all anti infectives,",N/A,250,74,1,262,104,TWrex-cause,814740-FS1,"230    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefotaxime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
725258044,5/23/2015 20:52:50,1642370260,5/23/2015 20:50:55,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],ANTIBIOTIC ASSOCIATED may range from MILD DIARRHEA to fatal colitis.,na,250,74,1,262,104,TWrex-cause,814740-FS1,"230    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefotaxime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
725258044,5/23/2015 20:57:38,1642372607,5/23/2015 20:57:15,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[PART_OF],[PART_OF],may range in severity,n/a,250,74,1,262,104,TWrex-cause,814740-FS1,"230    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefotaxime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
725258044,5/23/2015 20:58:55,1642373177,5/23/2015 20:57:18,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[IS_A] [PART_OF],"[IS_A]
[PART_OF]",may range in severity from,N/A,250,74,1,262,104,TWrex-cause,814740-FS1,"230    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefotaxime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
725258044,5/23/2015 21:10:28,1642378542,5/23/2015 21:09:58,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[PART_OF],[PART_OF],also known as,n/a,250,74,1,262,104,TWrex-cause,814740-FS1,"230    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefotaxime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
725258044,5/23/2015 21:35:27,1642390769,5/23/2015 21:34:43,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,250,74,1,262,104,TWrex-cause,814740-FS1,"230    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefotaxime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
725258044,5/23/2015 21:39:54,1642393065,5/23/2015 21:38:46,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[MANIFESTATION],[MANIFESTATION],"C. difficile associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefotaxime, and may range in severity from MILD DIARRHEA to fatal colitis.",n/a,250,74,1,262,104,TWrex-cause,814740-FS1,"230    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefotaxime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
725258044,5/23/2015 21:45:10,1642395468,5/23/2015 21:44:29,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[SIDE_EFFECT],[SIDE_EFFECT],has been reported with,N/A,250,74,1,262,104,TWrex-cause,814740-FS1,"230    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefotaxime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
725258044,5/23/2015 21:47:46,1642396696,5/23/2015 21:46:01,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[IS_A],[IS_A],also known as,n/a,250,74,1,262,104,TWrex-cause,814740-FS1,"230    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefotaxime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
725258044,5/23/2015 21:49:12,1642397343,5/23/2015 21:46:40,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[IS_A],[IS_A],and may range in severity from,n/a,250,74,1,262,104,TWrex-cause,814740-FS1,"230    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefotaxime, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
725258045,5/23/2015 21:57:23,1642400546,5/23/2015 21:57:01,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[PREVENTS],[PREVENTS],can prevent,N/A,105,2,-1,117,21,TWrex-cause,805118-FS1,• HEPATITIS A VACCINE or immunoglobulin administered within 2 weeks of exposure can prevent or attenuate HAV INFECTION.,HAV INFECTION,HEPATITIS A VACCINE
725258045,5/23/2015 22:00:51,1642401917,5/23/2015 22:00:23,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[PREVENTS],[PREVENTS],prevent,N/A,105,2,-1,117,21,TWrex-cause,805118-FS1,• HEPATITIS A VACCINE or immunoglobulin administered within 2 weeks of exposure can prevent or attenuate HAV INFECTION.,HAV INFECTION,HEPATITIS A VACCINE
725258045,5/23/2015 22:07:13,1642405051,5/23/2015 22:06:46,false,elite,1.0,30064988,GBR,B4,Bradford,92.22.135.10,[PREVENTS],[PREVENTS],prevent,N/A,105,2,-1,117,21,TWrex-cause,805118-FS1,• HEPATITIS A VACCINE or immunoglobulin administered within 2 weeks of exposure can prevent or attenuate HAV INFECTION.,HAV INFECTION,HEPATITIS A VACCINE
725258045,5/23/2015 22:12:37,1642407851,5/23/2015 22:11:58,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[PREVENTS],[PREVENTS],HEPATITIS A VACCINE can prevent HAV INFECTION.,n/a,105,2,-1,117,21,TWrex-cause,805118-FS1,• HEPATITIS A VACCINE or immunoglobulin administered within 2 weeks of exposure can prevent or attenuate HAV INFECTION.,HAV INFECTION,HEPATITIS A VACCINE
725258045,5/23/2015 22:16:30,1642409750,5/23/2015 22:15:50,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[PREVENTS],[PREVENTS],can prevent,n/a,105,2,-1,117,21,TWrex-cause,805118-FS1,• HEPATITIS A VACCINE or immunoglobulin administered within 2 weeks of exposure can prevent or attenuate HAV INFECTION.,HAV INFECTION,HEPATITIS A VACCINE
725258045,5/23/2015 22:16:34,1642409795,5/23/2015 22:15:50,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[PREVENTS],[PREVENTS],HEPATITIS A VACCINE can prevent HAV INFECTION.,N/A,105,2,-1,117,21,TWrex-cause,805118-FS1,• HEPATITIS A VACCINE or immunoglobulin administered within 2 weeks of exposure can prevent or attenuate HAV INFECTION.,HAV INFECTION,HEPATITIS A VACCINE
725258045,5/23/2015 22:18:05,1642410506,5/23/2015 22:16:20,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[PREVENTS],[PREVENTS],can prevent,n/a,105,2,-1,117,21,TWrex-cause,805118-FS1,• HEPATITIS A VACCINE or immunoglobulin administered within 2 weeks of exposure can prevent or attenuate HAV INFECTION.,HAV INFECTION,HEPATITIS A VACCINE
725258045,5/23/2015 22:18:59,1642411009,5/23/2015 22:17:54,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[PREVENTS],[PREVENTS],can prevent,N/A,105,2,-1,117,21,TWrex-cause,805118-FS1,• HEPATITIS A VACCINE or immunoglobulin administered within 2 weeks of exposure can prevent or attenuate HAV INFECTION.,HAV INFECTION,HEPATITIS A VACCINE
725258045,5/23/2015 22:22:37,1642412942,5/23/2015 22:22:15,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],HAV INFECTION.,N/A,105,2,-1,117,21,TWrex-cause,805118-FS1,• HEPATITIS A VACCINE or immunoglobulin administered within 2 weeks of exposure can prevent or attenuate HAV INFECTION.,HAV INFECTION,HEPATITIS A VACCINE
725258045,5/23/2015 22:23:03,1642413113,5/23/2015 22:22:48,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[PREVENTS],[PREVENTS],HEPATITIS A VACCINE can prevent HAV INFECTION.,n/a,105,2,-1,117,21,TWrex-cause,805118-FS1,• HEPATITIS A VACCINE or immunoglobulin administered within 2 weeks of exposure can prevent or attenuate HAV INFECTION.,HAV INFECTION,HEPATITIS A VACCINE
725258045,5/23/2015 22:29:26,1642416079,5/23/2015 22:29:00,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[PREVENTS],[PREVENTS],HEPATITIS A VACCINE immunoglobulin administered within 2 weeks of exposure can prevent or attenuate HAV INFECTION.,n/a,105,2,-1,117,21,TWrex-cause,805118-FS1,• HEPATITIS A VACCINE or immunoglobulin administered within 2 weeks of exposure can prevent or attenuate HAV INFECTION.,HAV INFECTION,HEPATITIS A VACCINE
725258045,5/23/2015 22:33:04,1642417898,5/23/2015 22:32:32,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[PREVENTS],[PREVENTS],HEPATITIS A VACCINE can prevent HAV INFECTION.,n/a,105,2,-1,117,21,TWrex-cause,805118-FS1,• HEPATITIS A VACCINE or immunoglobulin administered within 2 weeks of exposure can prevent or attenuate HAV INFECTION.,HAV INFECTION,HEPATITIS A VACCINE
725258045,5/23/2015 22:59:13,1642431417,5/23/2015 22:58:31,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[PREVENTS],[PREVENTS],can prevent,N/A,105,2,-1,117,21,TWrex-cause,805118-FS1,• HEPATITIS A VACCINE or immunoglobulin administered within 2 weeks of exposure can prevent or attenuate HAV INFECTION.,HAV INFECTION,HEPATITIS A VACCINE
725258045,5/23/2015 23:06:08,1642434632,5/23/2015 23:04:38,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[ASSOCIATED_WITH] [TREATS],"[TREATS]
[ASSOCIATED_WITH]",prevent attenuate,n/a,105,2,-1,117,21,TWrex-cause,805118-FS1,• HEPATITIS A VACCINE or immunoglobulin administered within 2 weeks of exposure can prevent or attenuate HAV INFECTION.,HAV INFECTION,HEPATITIS A VACCINE
725258045,5/23/2015 23:06:08,1642434637,5/23/2015 23:05:43,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[PREVENTS],[PREVENTS],can prevent or attenuate,n/a,105,2,-1,117,21,TWrex-cause,805118-FS1,• HEPATITIS A VACCINE or immunoglobulin administered within 2 weeks of exposure can prevent or attenuate HAV INFECTION.,HAV INFECTION,HEPATITIS A VACCINE
725258046,5/23/2015 20:39:56,1642362757,5/23/2015 20:39:38,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],treatment,N/A,87,33,-1,148,41,TWrex-cause,800741-FS1,"Kvien TK, Hoyeraal HM, Sandstad BNAPROXEN and acetylsalicylic acid in the treatment of PAUCIARTICULAR AND POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS: assessment of tolerance and efficacy in a single centre 24 week double blind parallel study.",PAUCIARTICULAR AND POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS,NAPROXEN
725258046,5/23/2015 20:47:26,1642367295,5/23/2015 20:47:13,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treatment,n/a,87,33,-1,148,41,TWrex-cause,800741-FS1,"Kvien TK, Hoyeraal HM, Sandstad BNAPROXEN and acetylsalicylic acid in the treatment of PAUCIARTICULAR AND POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS: assessment of tolerance and efficacy in a single centre 24 week double blind parallel study.",PAUCIARTICULAR AND POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS,NAPROXEN
725258046,5/23/2015 20:49:56,1642368566,5/23/2015 20:49:20,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],BNAPROXEN treatment of PAUCIARTICULAR AND POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS:,N/A,87,33,-1,148,41,TWrex-cause,800741-FS1,"Kvien TK, Hoyeraal HM, Sandstad BNAPROXEN and acetylsalicylic acid in the treatment of PAUCIARTICULAR AND POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS: assessment of tolerance and efficacy in a single centre 24 week double blind parallel study.",PAUCIARTICULAR AND POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS,NAPROXEN
725258046,5/23/2015 20:53:39,1642370661,5/23/2015 20:53:19,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],treatment of,n/a,87,33,-1,148,41,TWrex-cause,800741-FS1,"Kvien TK, Hoyeraal HM, Sandstad BNAPROXEN and acetylsalicylic acid in the treatment of PAUCIARTICULAR AND POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS: assessment of tolerance and efficacy in a single centre 24 week double blind parallel study.",PAUCIARTICULAR AND POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS,NAPROXEN
725258046,5/23/2015 21:02:22,1642374768,5/23/2015 21:01:36,false,instagc,1.0,30880172,USA,CA,Los Angeles,166.170.50.98,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],study.,N/A,87,33,-1,148,41,TWrex-cause,800741-FS1,"Kvien TK, Hoyeraal HM, Sandstad BNAPROXEN and acetylsalicylic acid in the treatment of PAUCIARTICULAR AND POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS: assessment of tolerance and efficacy in a single centre 24 week double blind parallel study.",PAUCIARTICULAR AND POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS,NAPROXEN
725258046,5/23/2015 21:03:07,1642375006,5/23/2015 21:02:22,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],in the treatment of,n/a,87,33,-1,148,41,TWrex-cause,800741-FS1,"Kvien TK, Hoyeraal HM, Sandstad BNAPROXEN and acetylsalicylic acid in the treatment of PAUCIARTICULAR AND POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS: assessment of tolerance and efficacy in a single centre 24 week double blind parallel study.",PAUCIARTICULAR AND POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS,NAPROXEN
725258046,5/23/2015 21:09:02,1642377773,5/23/2015 21:07:35,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],BNAPROXEN in treatment of PAUCIARTICULAR AND POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS:,na,87,33,-1,148,41,TWrex-cause,800741-FS1,"Kvien TK, Hoyeraal HM, Sandstad BNAPROXEN and acetylsalicylic acid in the treatment of PAUCIARTICULAR AND POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS: assessment of tolerance and efficacy in a single centre 24 week double blind parallel study.",PAUCIARTICULAR AND POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS,NAPROXEN
725258046,5/23/2015 21:12:10,1642379290,5/23/2015 21:11:50,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment of,N/A,87,33,-1,148,41,TWrex-cause,800741-FS1,"Kvien TK, Hoyeraal HM, Sandstad BNAPROXEN and acetylsalicylic acid in the treatment of PAUCIARTICULAR AND POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS: assessment of tolerance and efficacy in a single centre 24 week double blind parallel study.",PAUCIARTICULAR AND POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS,NAPROXEN
725258046,5/23/2015 21:42:17,1642394036,5/23/2015 21:41:52,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],in the treatment of,N/A,87,33,-1,148,41,TWrex-cause,800741-FS1,"Kvien TK, Hoyeraal HM, Sandstad BNAPROXEN and acetylsalicylic acid in the treatment of PAUCIARTICULAR AND POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS: assessment of tolerance and efficacy in a single centre 24 week double blind parallel study.",PAUCIARTICULAR AND POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS,NAPROXEN
725258046,5/23/2015 21:53:05,1642398904,5/23/2015 21:52:43,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],in the treatment of,N/A,87,33,-1,148,41,TWrex-cause,800741-FS1,"Kvien TK, Hoyeraal HM, Sandstad BNAPROXEN and acetylsalicylic acid in the treatment of PAUCIARTICULAR AND POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS: assessment of tolerance and efficacy in a single centre 24 week double blind parallel study.",PAUCIARTICULAR AND POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS,NAPROXEN
725258046,5/23/2015 21:55:16,1642399768,5/23/2015 21:54:16,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",Sandstad BNAPROXEN and acetylsalicylic acid in the treatment of PAUCIARTICULAR AND POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS:,n/a,87,33,-1,148,41,TWrex-cause,800741-FS1,"Kvien TK, Hoyeraal HM, Sandstad BNAPROXEN and acetylsalicylic acid in the treatment of PAUCIARTICULAR AND POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS: assessment of tolerance and efficacy in a single centre 24 week double blind parallel study.",PAUCIARTICULAR AND POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS,NAPROXEN
725258046,5/23/2015 21:56:22,1642400168,5/23/2015 21:55:59,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],treatment,N/A,87,33,-1,148,41,TWrex-cause,800741-FS1,"Kvien TK, Hoyeraal HM, Sandstad BNAPROXEN and acetylsalicylic acid in the treatment of PAUCIARTICULAR AND POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS: assessment of tolerance and efficacy in a single centre 24 week double blind parallel study.",PAUCIARTICULAR AND POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS,NAPROXEN
725258046,5/23/2015 22:00:52,1642401924,5/23/2015 22:00:08,false,elite,1.0,30064988,GBR,B4,Bradford,92.22.135.10,[TREATS],[TREATS],treatment,N/A,87,33,-1,148,41,TWrex-cause,800741-FS1,"Kvien TK, Hoyeraal HM, Sandstad BNAPROXEN and acetylsalicylic acid in the treatment of PAUCIARTICULAR AND POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS: assessment of tolerance and efficacy in a single centre 24 week double blind parallel study.",PAUCIARTICULAR AND POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS,NAPROXEN
725258046,5/23/2015 22:06:55,1642404901,5/23/2015 22:04:51,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[TREATS],[TREATS],in the treatment of,n/a,87,33,-1,148,41,TWrex-cause,800741-FS1,"Kvien TK, Hoyeraal HM, Sandstad BNAPROXEN and acetylsalicylic acid in the treatment of PAUCIARTICULAR AND POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS: assessment of tolerance and efficacy in a single centre 24 week double blind parallel study.",PAUCIARTICULAR AND POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS,NAPROXEN
725258046,5/23/2015 22:08:09,1642405564,5/23/2015 22:06:48,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treatment,N/A,87,33,-1,148,41,TWrex-cause,800741-FS1,"Kvien TK, Hoyeraal HM, Sandstad BNAPROXEN and acetylsalicylic acid in the treatment of PAUCIARTICULAR AND POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS: assessment of tolerance and efficacy in a single centre 24 week double blind parallel study.",PAUCIARTICULAR AND POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS,NAPROXEN
725258047,5/23/2015 21:56:21,1642400166,5/23/2015 21:55:54,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[ASSOCIATED_WITH],[ASSOCIATED_WITH],in,N/A,19,120,1,35,133,TWrex-cause,812445-FS1,"Latex Sensitivity  LATEX SENSITIVITY is an exaggerated immune response to water soluble proteins in latex products (eg, RUBBER GLOVES dental dams, condoms, tubing for respiratory equipment, catheters, enema tips with inflatable latex cuffs), causing urticaria, angioedema, a nd anaphylaxis.",LATEX SENSITIVITY,RUBBER GLOVES
725258047,5/23/2015 21:59:29,1642401341,5/23/2015 21:58:49,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]","(eg,",N/A,19,120,1,35,133,TWrex-cause,812445-FS1,"Latex Sensitivity  LATEX SENSITIVITY is an exaggerated immune response to water soluble proteins in latex products (eg, RUBBER GLOVES dental dams, condoms, tubing for respiratory equipment, catheters, enema tips with inflatable latex cuffs), causing urticaria, angioedema, a nd anaphylaxis.",LATEX SENSITIVITY,RUBBER GLOVES
725258047,5/23/2015 22:05:38,1642404056,5/23/2015 22:04:42,false,elite,1.0,30064988,GBR,B4,Bradford,92.22.135.10,[OTHER],[OTHER],immune response,N/A,19,120,1,35,133,TWrex-cause,812445-FS1,"Latex Sensitivity  LATEX SENSITIVITY is an exaggerated immune response to water soluble proteins in latex products (eg, RUBBER GLOVES dental dams, condoms, tubing for respiratory equipment, catheters, enema tips with inflatable latex cuffs), causing urticaria, angioedema, a nd anaphylaxis.",LATEX SENSITIVITY,RUBBER GLOVES
725258047,5/23/2015 22:11:23,1642407213,5/23/2015 22:11:00,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],"Latex Sensitivity is an immune response proteins in latex products (eg, RUBBER GLOVES",n/a,19,120,1,35,133,TWrex-cause,812445-FS1,"Latex Sensitivity  LATEX SENSITIVITY is an exaggerated immune response to water soluble proteins in latex products (eg, RUBBER GLOVES dental dams, condoms, tubing for respiratory equipment, catheters, enema tips with inflatable latex cuffs), causing urticaria, angioedema, a nd anaphylaxis.",LATEX SENSITIVITY,RUBBER GLOVES
725258047,5/23/2015 22:14:15,1642408650,5/23/2015 22:13:02,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[CAUSES],[CAUSES],immune response to water soluble proteins in latex products,n/a,19,120,1,35,133,TWrex-cause,812445-FS1,"Latex Sensitivity  LATEX SENSITIVITY is an exaggerated immune response to water soluble proteins in latex products (eg, RUBBER GLOVES dental dams, condoms, tubing for respiratory equipment, catheters, enema tips with inflatable latex cuffs), causing urticaria, angioedema, a nd anaphylaxis.",LATEX SENSITIVITY,RUBBER GLOVES
725258047,5/23/2015 22:14:20,1642408738,5/23/2015 22:12:57,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[SIDE_EFFECT] [CAUSES],"[CAUSES]
[SIDE_EFFECT]","LATEX SENSITIVITY is immune response latex products (eg, RUBBER GLOVES",N/A,19,120,1,35,133,TWrex-cause,812445-FS1,"Latex Sensitivity  LATEX SENSITIVITY is an exaggerated immune response to water soluble proteins in latex products (eg, RUBBER GLOVES dental dams, condoms, tubing for respiratory equipment, catheters, enema tips with inflatable latex cuffs), causing urticaria, angioedema, a nd anaphylaxis.",LATEX SENSITIVITY,RUBBER GLOVES
725258047,5/23/2015 22:15:07,1642409039,5/23/2015 22:13:24,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[CAUSES],[CAUSES],is an exaggerated immune response to water soluble proteins in latex products,n/a,19,120,1,35,133,TWrex-cause,812445-FS1,"Latex Sensitivity  LATEX SENSITIVITY is an exaggerated immune response to water soluble proteins in latex products (eg, RUBBER GLOVES dental dams, condoms, tubing for respiratory equipment, catheters, enema tips with inflatable latex cuffs), causing urticaria, angioedema, a nd anaphylaxis.",LATEX SENSITIVITY,RUBBER GLOVES
725258047,5/23/2015 22:15:34,1642409298,5/23/2015 22:14:25,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],"response to latex (eg, RUBBER GLOVES",N/A,19,120,1,35,133,TWrex-cause,812445-FS1,"Latex Sensitivity  LATEX SENSITIVITY is an exaggerated immune response to water soluble proteins in latex products (eg, RUBBER GLOVES dental dams, condoms, tubing for respiratory equipment, catheters, enema tips with inflatable latex cuffs), causing urticaria, angioedema, a nd anaphylaxis.",LATEX SENSITIVITY,RUBBER GLOVES
725258047,5/23/2015 22:21:28,1642412191,5/23/2015 22:21:14,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],LATEX SENSITIVITY,N/A,19,120,1,35,133,TWrex-cause,812445-FS1,"Latex Sensitivity  LATEX SENSITIVITY is an exaggerated immune response to water soluble proteins in latex products (eg, RUBBER GLOVES dental dams, condoms, tubing for respiratory equipment, catheters, enema tips with inflatable latex cuffs), causing urticaria, angioedema, a nd anaphylaxis.",LATEX SENSITIVITY,RUBBER GLOVES
725258047,5/23/2015 22:21:41,1642412366,5/23/2015 22:21:00,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[SIDE_EFFECT],[SIDE_EFFECT],LATEX SENSITIVITY is an exaggerated immune response to RUBBER GLOVES,n/a,19,120,1,35,133,TWrex-cause,812445-FS1,"Latex Sensitivity  LATEX SENSITIVITY is an exaggerated immune response to water soluble proteins in latex products (eg, RUBBER GLOVES dental dams, condoms, tubing for respiratory equipment, catheters, enema tips with inflatable latex cuffs), causing urticaria, angioedema, a nd anaphylaxis.",LATEX SENSITIVITY,RUBBER GLOVES
725258047,5/23/2015 22:28:00,1642415382,5/23/2015 22:27:29,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[CAUSES],[CAUSES],Latex Sensitivity LATEX SENSITIVITY is an exaggerated immune response to water soluble proteins in latex products,n/a,19,120,1,35,133,TWrex-cause,812445-FS1,"Latex Sensitivity  LATEX SENSITIVITY is an exaggerated immune response to water soluble proteins in latex products (eg, RUBBER GLOVES dental dams, condoms, tubing for respiratory equipment, catheters, enema tips with inflatable latex cuffs), causing urticaria, angioedema, a nd anaphylaxis.",LATEX SENSITIVITY,RUBBER GLOVES
725258047,5/23/2015 22:31:47,1642417313,5/23/2015 22:30:58,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[ASSOCIATED_WITH],[ASSOCIATED_WITH],LATEX SENSITIVITY is response to RUBBER GLOVES,n/a,19,120,1,35,133,TWrex-cause,812445-FS1,"Latex Sensitivity  LATEX SENSITIVITY is an exaggerated immune response to water soluble proteins in latex products (eg, RUBBER GLOVES dental dams, condoms, tubing for respiratory equipment, catheters, enema tips with inflatable latex cuffs), causing urticaria, angioedema, a nd anaphylaxis.",LATEX SENSITIVITY,RUBBER GLOVES
725258047,5/23/2015 22:57:49,1642430730,5/23/2015 22:56:38,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[OTHER],[OTHER],"(eg,",N/A,19,120,1,35,133,TWrex-cause,812445-FS1,"Latex Sensitivity  LATEX SENSITIVITY is an exaggerated immune response to water soluble proteins in latex products (eg, RUBBER GLOVES dental dams, condoms, tubing for respiratory equipment, catheters, enema tips with inflatable latex cuffs), causing urticaria, angioedema, a nd anaphylaxis.",LATEX SENSITIVITY,RUBBER GLOVES
725258047,5/23/2015 23:01:49,1642432722,5/23/2015 23:00:05,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[CAUSES] [MANIFESTATION] [ASSOCIATED_WITH],"[CAUSES]
[MANIFESTATION]
[ASSOCIATED_WITH]",response to with causing,n/a,19,120,1,35,133,TWrex-cause,812445-FS1,"Latex Sensitivity  LATEX SENSITIVITY is an exaggerated immune response to water soluble proteins in latex products (eg, RUBBER GLOVES dental dams, condoms, tubing for respiratory equipment, catheters, enema tips with inflatable latex cuffs), causing urticaria, angioedema, a nd anaphylaxis.",LATEX SENSITIVITY,RUBBER GLOVES
725258047,5/23/2015 23:06:46,1642434862,5/23/2015 23:06:09,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[ASSOCIATED_WITH],[ASSOCIATED_WITH],immune response to water soluble proteins,n/a,19,120,1,35,133,TWrex-cause,812445-FS1,"Latex Sensitivity  LATEX SENSITIVITY is an exaggerated immune response to water soluble proteins in latex products (eg, RUBBER GLOVES dental dams, condoms, tubing for respiratory equipment, catheters, enema tips with inflatable latex cuffs), causing urticaria, angioedema, a nd anaphylaxis.",LATEX SENSITIVITY,RUBBER GLOVES
725258048,5/23/2015 21:57:40,1642400672,5/23/2015 21:57:24,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],treatment in,N/A,134,65,-1,148,79,TWrex-cause,800588-FS1,"Garg SK, Carmain JA, Braddy KC, et al: Pre meal insulin analogue INSULIN LISPRO vs Humulin R insulin treatment in young subjects with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN LISPRO
725258048,5/23/2015 22:01:08,1642402019,5/23/2015 22:00:52,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],treatment,N/A,134,65,-1,148,79,TWrex-cause,800588-FS1,"Garg SK, Carmain JA, Braddy KC, et al: Pre meal insulin analogue INSULIN LISPRO vs Humulin R insulin treatment in young subjects with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN LISPRO
725258048,5/23/2015 22:07:43,1642405326,5/23/2015 22:07:16,false,elite,1.0,30064988,GBR,B4,Bradford,92.22.135.10,[TREATS],[TREATS],treatment,N/A,134,65,-1,148,79,TWrex-cause,800588-FS1,"Garg SK, Carmain JA, Braddy KC, et al: Pre meal insulin analogue INSULIN LISPRO vs Humulin R insulin treatment in young subjects with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN LISPRO
725258048,5/23/2015 22:13:01,1642408020,5/23/2015 22:12:39,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],INSULIN LISPRO in young subjects with TYPE 1 DIABETES,n/a,134,65,-1,148,79,TWrex-cause,800588-FS1,"Garg SK, Carmain JA, Braddy KC, et al: Pre meal insulin analogue INSULIN LISPRO vs Humulin R insulin treatment in young subjects with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN LISPRO
725258048,5/23/2015 22:17:25,1642410234,5/23/2015 22:16:35,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],INSULIN LISPRO insulin treatment with TYPE 1 DIABETES,N/A,134,65,-1,148,79,TWrex-cause,800588-FS1,"Garg SK, Carmain JA, Braddy KC, et al: Pre meal insulin analogue INSULIN LISPRO vs Humulin R insulin treatment in young subjects with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN LISPRO
725258048,5/23/2015 22:17:31,1642410263,5/23/2015 22:16:31,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[TREATS],[TREATS],Pre meal insulin analogue,n/a,134,65,-1,148,79,TWrex-cause,800588-FS1,"Garg SK, Carmain JA, Braddy KC, et al: Pre meal insulin analogue INSULIN LISPRO vs Humulin R insulin treatment in young subjects with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN LISPRO
725258048,5/23/2015 22:18:24,1642410724,5/23/2015 22:18:06,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[TREATS],[TREATS],treatment,n/a,134,65,-1,148,79,TWrex-cause,800588-FS1,"Garg SK, Carmain JA, Braddy KC, et al: Pre meal insulin analogue INSULIN LISPRO vs Humulin R insulin treatment in young subjects with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN LISPRO
725258048,5/23/2015 22:20:05,1642411535,5/23/2015 22:18:59,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treatment,N/A,134,65,-1,148,79,TWrex-cause,800588-FS1,"Garg SK, Carmain JA, Braddy KC, et al: Pre meal insulin analogue INSULIN LISPRO vs Humulin R insulin treatment in young subjects with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN LISPRO
725258048,5/23/2015 22:23:36,1642413353,5/23/2015 22:23:04,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[TREATS],[TREATS],INSULIN LISPRO treatment in subjects with,n/a,134,65,-1,148,79,TWrex-cause,800588-FS1,"Garg SK, Carmain JA, Braddy KC, et al: Pre meal insulin analogue INSULIN LISPRO vs Humulin R insulin treatment in young subjects with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN LISPRO
725258048,5/23/2015 22:24:30,1642413791,5/23/2015 22:22:39,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],INSULIN,N/A,134,65,-1,148,79,TWrex-cause,800588-FS1,"Garg SK, Carmain JA, Braddy KC, et al: Pre meal insulin analogue INSULIN LISPRO vs Humulin R insulin treatment in young subjects with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN LISPRO
725258048,5/23/2015 22:29:51,1642416341,5/23/2015 22:29:27,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],INSULIN LISPRO vs Humulin R insulin treatment,n/a,134,65,-1,148,79,TWrex-cause,800588-FS1,"Garg SK, Carmain JA, Braddy KC, et al: Pre meal insulin analogue INSULIN LISPRO vs Humulin R insulin treatment in young subjects with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN LISPRO
725258048,5/23/2015 22:33:43,1642418273,5/23/2015 22:33:05,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[TREATS],[TREATS],INSULIN LISPRO treatment in TYPE 1 DIABETES,n/a,134,65,-1,148,79,TWrex-cause,800588-FS1,"Garg SK, Carmain JA, Braddy KC, et al: Pre meal insulin analogue INSULIN LISPRO vs Humulin R insulin treatment in young subjects with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN LISPRO
725258048,5/23/2015 22:59:27,1642431574,5/23/2015 22:59:15,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[TREATS],[TREATS],treatment,N/A,134,65,-1,148,79,TWrex-cause,800588-FS1,"Garg SK, Carmain JA, Braddy KC, et al: Pre meal insulin analogue INSULIN LISPRO vs Humulin R insulin treatment in young subjects with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN LISPRO
725258048,5/23/2015 23:07:05,1642435011,5/23/2015 23:06:09,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[TREATS] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]",treatment with,n/a,134,65,-1,148,79,TWrex-cause,800588-FS1,"Garg SK, Carmain JA, Braddy KC, et al: Pre meal insulin analogue INSULIN LISPRO vs Humulin R insulin treatment in young subjects with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN LISPRO
725258048,5/23/2015 23:08:06,1642435482,5/23/2015 23:06:47,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[TREATS],[TREATS],treatment,n/a,134,65,-1,148,79,TWrex-cause,800588-FS1,"Garg SK, Carmain JA, Braddy KC, et al: Pre meal insulin analogue INSULIN LISPRO vs Humulin R insulin treatment in young subjects with TYPE 1 DIABETES",TYPE 1 DIABETES,INSULIN LISPRO
725258049,5/23/2015 20:34:00,1642359736,5/23/2015 20:33:39,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],trial.,N/A,90,46,-1,129,72,TWrex-cause,800589-FS1,"DeVeaugh Geiss J, Moroz G, Biederman J et al. CLOMIPRAMINE HYDROCHLORIDE in childhood and ADOLESCENT OBSESSIVE COMPULSIVE DISORDER: a multicenter trial.",ADOLESCENT OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE HYDROCHLORIDE
725258049,5/23/2015 20:38:03,1642361668,5/23/2015 20:36:58,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],CLOMIPRAMINE HYDROCHLORIDE in ADOLESCENT OBSESSIVE COMPULSIVE DISORDER:,N/A,90,46,-1,129,72,TWrex-cause,800589-FS1,"DeVeaugh Geiss J, Moroz G, Biederman J et al. CLOMIPRAMINE HYDROCHLORIDE in childhood and ADOLESCENT OBSESSIVE COMPULSIVE DISORDER: a multicenter trial.",ADOLESCENT OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE HYDROCHLORIDE
725258049,5/23/2015 20:43:04,1642364422,5/23/2015 20:42:43,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],in,n/a,90,46,-1,129,72,TWrex-cause,800589-FS1,"DeVeaugh Geiss J, Moroz G, Biederman J et al. CLOMIPRAMINE HYDROCHLORIDE in childhood and ADOLESCENT OBSESSIVE COMPULSIVE DISORDER: a multicenter trial.",ADOLESCENT OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE HYDROCHLORIDE
725258049,5/23/2015 20:47:27,1642367296,5/23/2015 20:46:58,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[OTHER],[OTHER],trial.,-,90,46,-1,129,72,TWrex-cause,800589-FS1,"DeVeaugh Geiss J, Moroz G, Biederman J et al. CLOMIPRAMINE HYDROCHLORIDE in childhood and ADOLESCENT OBSESSIVE COMPULSIVE DISORDER: a multicenter trial.",ADOLESCENT OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE HYDROCHLORIDE
725258049,5/23/2015 20:48:57,1642368081,5/23/2015 20:48:26,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],trial.,n/a,90,46,-1,129,72,TWrex-cause,800589-FS1,"DeVeaugh Geiss J, Moroz G, Biederman J et al. CLOMIPRAMINE HYDROCHLORIDE in childhood and ADOLESCENT OBSESSIVE COMPULSIVE DISORDER: a multicenter trial.",ADOLESCENT OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE HYDROCHLORIDE
725258049,5/23/2015 20:49:29,1642368365,5/23/2015 20:48:48,false,instagc,1.0,30880172,USA,CA,Los Angeles,166.170.50.98,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],trial.,N/A,90,46,-1,129,72,TWrex-cause,800589-FS1,"DeVeaugh Geiss J, Moroz G, Biederman J et al. CLOMIPRAMINE HYDROCHLORIDE in childhood and ADOLESCENT OBSESSIVE COMPULSIVE DISORDER: a multicenter trial.",ADOLESCENT OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE HYDROCHLORIDE
725258049,5/23/2015 20:50:52,1642369176,5/23/2015 20:49:26,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],CLOMIPRAMINE HYDROCHLORIDE ADOLESCENT OBSESSIVE COMPULSIVE DISORDER: a trial.,na,90,46,-1,129,72,TWrex-cause,800589-FS1,"DeVeaugh Geiss J, Moroz G, Biederman J et al. CLOMIPRAMINE HYDROCHLORIDE in childhood and ADOLESCENT OBSESSIVE COMPULSIVE DISORDER: a multicenter trial.",ADOLESCENT OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE HYDROCHLORIDE
725258049,5/23/2015 20:57:14,1642372435,5/23/2015 20:56:46,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],in childhood and,N/A,90,46,-1,129,72,TWrex-cause,800589-FS1,"DeVeaugh Geiss J, Moroz G, Biederman J et al. CLOMIPRAMINE HYDROCHLORIDE in childhood and ADOLESCENT OBSESSIVE COMPULSIVE DISORDER: a multicenter trial.",ADOLESCENT OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE HYDROCHLORIDE
725258049,5/23/2015 20:57:14,1642372436,5/23/2015 20:56:52,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],multicenter trial.,n/a,90,46,-1,129,72,TWrex-cause,800589-FS1,"DeVeaugh Geiss J, Moroz G, Biederman J et al. CLOMIPRAMINE HYDROCHLORIDE in childhood and ADOLESCENT OBSESSIVE COMPULSIVE DISORDER: a multicenter trial.",ADOLESCENT OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE HYDROCHLORIDE
725258049,5/23/2015 21:09:57,1642378249,5/23/2015 21:09:21,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[OTHER],[OTHER],a multicenter trial.,n/a,90,46,-1,129,72,TWrex-cause,800589-FS1,"DeVeaugh Geiss J, Moroz G, Biederman J et al. CLOMIPRAMINE HYDROCHLORIDE in childhood and ADOLESCENT OBSESSIVE COMPULSIVE DISORDER: a multicenter trial.",ADOLESCENT OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE HYDROCHLORIDE
725258049,5/23/2015 21:34:42,1642390336,5/23/2015 21:34:04,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],trial.,N/A,90,46,-1,129,72,TWrex-cause,800589-FS1,"DeVeaugh Geiss J, Moroz G, Biederman J et al. CLOMIPRAMINE HYDROCHLORIDE in childhood and ADOLESCENT OBSESSIVE COMPULSIVE DISORDER: a multicenter trial.",ADOLESCENT OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE HYDROCHLORIDE
725258049,5/23/2015 21:38:45,1642392458,5/23/2015 21:37:46,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]",CLOMIPRAMINE HYDROCHLORIDE in childhood and ADOLESCENT OBSESSIVE COMPULSIVE DISORDER:,n/a,90,46,-1,129,72,TWrex-cause,800589-FS1,"DeVeaugh Geiss J, Moroz G, Biederman J et al. CLOMIPRAMINE HYDROCHLORIDE in childhood and ADOLESCENT OBSESSIVE COMPULSIVE DISORDER: a multicenter trial.",ADOLESCENT OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE HYDROCHLORIDE
725258049,5/23/2015 21:44:27,1642395164,5/23/2015 21:42:58,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],in childhood and,N/A,90,46,-1,129,72,TWrex-cause,800589-FS1,"DeVeaugh Geiss J, Moroz G, Biederman J et al. CLOMIPRAMINE HYDROCHLORIDE in childhood and ADOLESCENT OBSESSIVE COMPULSIVE DISORDER: a multicenter trial.",ADOLESCENT OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE HYDROCHLORIDE
725258049,5/23/2015 21:46:00,1642395959,5/23/2015 21:44:29,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[SYMPTOM],[SYMPTOM],in,n/a,90,46,-1,129,72,TWrex-cause,800589-FS1,"DeVeaugh Geiss J, Moroz G, Biederman J et al. CLOMIPRAMINE HYDROCHLORIDE in childhood and ADOLESCENT OBSESSIVE COMPULSIVE DISORDER: a multicenter trial.",ADOLESCENT OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE HYDROCHLORIDE
725258049,5/23/2015 21:46:39,1642396212,5/23/2015 21:45:41,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],a multicenter trial.,n/a,90,46,-1,129,72,TWrex-cause,800589-FS1,"DeVeaugh Geiss J, Moroz G, Biederman J et al. CLOMIPRAMINE HYDROCHLORIDE in childhood and ADOLESCENT OBSESSIVE COMPULSIVE DISORDER: a multicenter trial.",ADOLESCENT OBSESSIVE COMPULSIVE DISORDER,CLOMIPRAMINE HYDROCHLORIDE
725258050,5/23/2015 20:37:43,1642361434,5/23/2015 20:37:30,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],for,N/A,22,0,-1,46,17,TWrex-cause,804947-FS1,"BOTULINUM A TOXIN for CRANIAL CERVICAL DYSTONIA: double blind, placebo controlled study.",CRANIAL CERVICAL DYSTONIA,BOTULINUM A TOXIN
725258050,5/23/2015 20:46:08,1642366438,5/23/2015 20:45:53,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],for,n/a,22,0,-1,46,17,TWrex-cause,804947-FS1,"BOTULINUM A TOXIN for CRANIAL CERVICAL DYSTONIA: double blind, placebo controlled study.",CRANIAL CERVICAL DYSTONIA,BOTULINUM A TOXIN
725258050,5/23/2015 20:46:18,1642366541,5/23/2015 20:45:50,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],BOTULINUM A TOXIN for CRANIAL CERVICAL DYSTONIA:,N/A,22,0,-1,46,17,TWrex-cause,804947-FS1,"BOTULINUM A TOXIN for CRANIAL CERVICAL DYSTONIA: double blind, placebo controlled study.",CRANIAL CERVICAL DYSTONIA,BOTULINUM A TOXIN
725258050,5/23/2015 20:52:03,1642369816,5/23/2015 20:51:48,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],for placebo controlled study.,n/a,22,0,-1,46,17,TWrex-cause,804947-FS1,"BOTULINUM A TOXIN for CRANIAL CERVICAL DYSTONIA: double blind, placebo controlled study.",CRANIAL CERVICAL DYSTONIA,BOTULINUM A TOXIN
725258050,5/23/2015 20:58:30,1642372994,5/23/2015 20:57:50,false,instagc,1.0,30880172,USA,CA,Los Angeles,166.170.50.98,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],for,N/A,22,0,-1,46,17,TWrex-cause,804947-FS1,"BOTULINUM A TOXIN for CRANIAL CERVICAL DYSTONIA: double blind, placebo controlled study.",CRANIAL CERVICAL DYSTONIA,BOTULINUM A TOXIN
725258050,5/23/2015 21:00:30,1642373855,5/23/2015 21:00:14,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],for study.,n/a,22,0,-1,46,17,TWrex-cause,804947-FS1,"BOTULINUM A TOXIN for CRANIAL CERVICAL DYSTONIA: double blind, placebo controlled study.",CRANIAL CERVICAL DYSTONIA,BOTULINUM A TOXIN
725258050,5/23/2015 21:04:32,1642375602,5/23/2015 21:03:07,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],BOTULINUM A TOXIN for CRANIAL CERVICAL DYSTONIA:,na,22,0,-1,46,17,TWrex-cause,804947-FS1,"BOTULINUM A TOXIN for CRANIAL CERVICAL DYSTONIA: double blind, placebo controlled study.",CRANIAL CERVICAL DYSTONIA,BOTULINUM A TOXIN
725258050,5/23/2015 21:09:14,1642377907,5/23/2015 21:08:42,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],for,N/A,22,0,-1,46,17,TWrex-cause,804947-FS1,"BOTULINUM A TOXIN for CRANIAL CERVICAL DYSTONIA: double blind, placebo controlled study.",CRANIAL CERVICAL DYSTONIA,BOTULINUM A TOXIN
725258050,5/23/2015 21:39:50,1642393019,5/23/2015 21:39:09,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[PREVENTS],[PREVENTS],controlled,N/A,22,0,-1,46,17,TWrex-cause,804947-FS1,"BOTULINUM A TOXIN for CRANIAL CERVICAL DYSTONIA: double blind, placebo controlled study.",CRANIAL CERVICAL DYSTONIA,BOTULINUM A TOXIN
725258050,5/23/2015 21:50:21,1642397896,5/23/2015 21:49:34,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",BOTULINUM A TOXIN for CRANIAL CERVICAL DYSTONIA:,n/a,22,0,-1,46,17,TWrex-cause,804947-FS1,"BOTULINUM A TOXIN for CRANIAL CERVICAL DYSTONIA: double blind, placebo controlled study.",CRANIAL CERVICAL DYSTONIA,BOTULINUM A TOXIN
725258050,5/23/2015 21:51:00,1642398145,5/23/2015 21:50:29,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],for,N/A,22,0,-1,46,17,TWrex-cause,804947-FS1,"BOTULINUM A TOXIN for CRANIAL CERVICAL DYSTONIA: double blind, placebo controlled study.",CRANIAL CERVICAL DYSTONIA,BOTULINUM A TOXIN
725258050,5/23/2015 21:53:06,1642398903,5/23/2015 21:52:46,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],for,N/A,22,0,-1,46,17,TWrex-cause,804947-FS1,"BOTULINUM A TOXIN for CRANIAL CERVICAL DYSTONIA: double blind, placebo controlled study.",CRANIAL CERVICAL DYSTONIA,BOTULINUM A TOXIN
725258050,5/23/2015 21:55:15,1642399755,5/23/2015 21:54:21,false,elite,1.0,30064988,GBR,B4,Bradford,92.22.135.10,[OTHER] [IS_A],"[IS_A]
[OTHER]",placebo controlled study.,N/A,22,0,-1,46,17,TWrex-cause,804947-FS1,"BOTULINUM A TOXIN for CRANIAL CERVICAL DYSTONIA: double blind, placebo controlled study.",CRANIAL CERVICAL DYSTONIA,BOTULINUM A TOXIN
725258050,5/23/2015 21:56:58,1642400344,5/23/2015 21:55:15,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[TREATS],[TREATS],for,n/a,22,0,-1,46,17,TWrex-cause,804947-FS1,"BOTULINUM A TOXIN for CRANIAL CERVICAL DYSTONIA: double blind, placebo controlled study.",CRANIAL CERVICAL DYSTONIA,BOTULINUM A TOXIN
725258050,5/23/2015 22:05:26,1642403961,5/23/2015 22:04:20,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],for,N/A,22,0,-1,46,17,TWrex-cause,804947-FS1,"BOTULINUM A TOXIN for CRANIAL CERVICAL DYSTONIA: double blind, placebo controlled study.",CRANIAL CERVICAL DYSTONIA,BOTULINUM A TOXIN
725258051,5/23/2015 20:39:13,1642362328,5/23/2015 20:38:59,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[CAUSES],[CAUSES],caused by,N/A,29,50,1,37,72,TWrex-cause,810549-FS1,101  Tularemia  Treatment of TULAREMIA caused by  FRANCISELLA TULARENSIS,TULAREMIA,FRANCISELLA TULARENSIS
725258051,5/23/2015 20:46:53,1642366912,5/23/2015 20:46:42,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],caused by,n/a,29,50,1,37,72,TWrex-cause,810549-FS1,101  Tularemia  Treatment of TULAREMIA caused by  FRANCISELLA TULARENSIS,TULAREMIA,FRANCISELLA TULARENSIS
725258051,5/23/2015 20:48:26,1642367823,5/23/2015 20:47:58,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES],[CAUSES],TULAREMIA caused by FRANCISELLA TULARENSIS,N/A,29,50,1,37,72,TWrex-cause,810549-FS1,101  Tularemia  Treatment of TULAREMIA caused by  FRANCISELLA TULARENSIS,TULAREMIA,FRANCISELLA TULARENSIS
725258051,5/23/2015 20:53:01,1642370379,5/23/2015 20:52:44,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],caused by,n/a,29,50,1,37,72,TWrex-cause,810549-FS1,101  Tularemia  Treatment of TULAREMIA caused by  FRANCISELLA TULARENSIS,TULAREMIA,FRANCISELLA TULARENSIS
725258051,5/23/2015 21:00:56,1642374054,5/23/2015 21:00:23,false,instagc,1.0,30880172,USA,CA,Los Angeles,166.170.50.98,[ASSOCIATED_WITH],[ASSOCIATED_WITH],caused by,N/A,29,50,1,37,72,TWrex-cause,810549-FS1,101  Tularemia  Treatment of TULAREMIA caused by  FRANCISELLA TULARENSIS,TULAREMIA,FRANCISELLA TULARENSIS
725258051,5/23/2015 21:01:52,1642374530,5/23/2015 21:01:40,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],caused by,n/a,29,50,1,37,72,TWrex-cause,810549-FS1,101  Tularemia  Treatment of TULAREMIA caused by  FRANCISELLA TULARENSIS,TULAREMIA,FRANCISELLA TULARENSIS
725258051,5/23/2015 21:07:01,1642376857,5/23/2015 21:06:35,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],TULAREMIA caused by FRANCISELLA TULARENSIS,na,29,50,1,37,72,TWrex-cause,810549-FS1,101  Tularemia  Treatment of TULAREMIA caused by  FRANCISELLA TULARENSIS,TULAREMIA,FRANCISELLA TULARENSIS
725258051,5/23/2015 21:11:02,1642378820,5/23/2015 21:10:43,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],caused by,N/A,29,50,1,37,72,TWrex-cause,810549-FS1,101  Tularemia  Treatment of TULAREMIA caused by  FRANCISELLA TULARENSIS,TULAREMIA,FRANCISELLA TULARENSIS
725258051,5/23/2015 21:41:24,1642393630,5/23/2015 21:41:01,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[CAUSES],[CAUSES],caused by,N/A,29,50,1,37,72,TWrex-cause,810549-FS1,101  Tularemia  Treatment of TULAREMIA caused by  FRANCISELLA TULARENSIS,TULAREMIA,FRANCISELLA TULARENSIS
725258051,5/23/2015 21:52:20,1642398611,5/23/2015 21:52:05,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES],[CAUSES],caused by,N/A,29,50,1,37,72,TWrex-cause,810549-FS1,101  Tularemia  Treatment of TULAREMIA caused by  FRANCISELLA TULARENSIS,TULAREMIA,FRANCISELLA TULARENSIS
725258051,5/23/2015 21:53:30,1642399046,5/23/2015 21:52:38,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],Tularemia Treatment of TULAREMIA caused by FRANCISELLA TULARENSIS,n/a,29,50,1,37,72,TWrex-cause,810549-FS1,101  Tularemia  Treatment of TULAREMIA caused by  FRANCISELLA TULARENSIS,TULAREMIA,FRANCISELLA TULARENSIS
725258051,5/23/2015 21:54:53,1642399660,5/23/2015 21:54:41,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[CAUSES],[CAUSES],caused by,N/A,29,50,1,37,72,TWrex-cause,810549-FS1,101  Tularemia  Treatment of TULAREMIA caused by  FRANCISELLA TULARENSIS,TULAREMIA,FRANCISELLA TULARENSIS
725258051,5/23/2015 21:59:26,1642401334,5/23/2015 21:57:17,false,elite,1.0,30064988,GBR,B4,Bradford,92.22.135.10,[CAUSES],[CAUSES],caused by,N/A,29,50,1,37,72,TWrex-cause,810549-FS1,101  Tularemia  Treatment of TULAREMIA caused by  FRANCISELLA TULARENSIS,TULAREMIA,FRANCISELLA TULARENSIS
725258051,5/23/2015 22:04:18,1642403436,5/23/2015 22:02:42,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[CAUSES],[CAUSES],caused by,n/a,29,50,1,37,72,TWrex-cause,810549-FS1,101  Tularemia  Treatment of TULAREMIA caused by  FRANCISELLA TULARENSIS,TULAREMIA,FRANCISELLA TULARENSIS
725258051,5/23/2015 22:07:07,1642404990,5/23/2015 22:06:29,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[TREATS] [CAUSES],"[TREATS]
[CAUSES]",Treatment of TULAREMIA caused by,n/a,29,50,1,37,72,TWrex-cause,810549-FS1,101  Tularemia  Treatment of TULAREMIA caused by  FRANCISELLA TULARENSIS,TULAREMIA,FRANCISELLA TULARENSIS
725258052,5/23/2015 21:58:00,1642400774,5/23/2015 21:57:42,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[SYMPTOM],[SYMPTOM],can be the presenting symptom.,N/A,172,21,1,175,42,TWrex-cause,814909-FS1,"No trauma history in MERALGIA PARESTHETICA Multiple sclerosis  Generally optic neuritis, intranuclear ophthalmoplegia, sensorimotor or cerebellar symptoms before pain, but PAIN can be the presenting symptom.",PAIN,MERALGIA PARESTHETICA
725258052,5/23/2015 22:01:45,1642402281,5/23/2015 22:01:09,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[SYMPTOM],[SYMPTOM],symptom.,N/A,172,21,1,175,42,TWrex-cause,814909-FS1,"No trauma history in MERALGIA PARESTHETICA Multiple sclerosis  Generally optic neuritis, intranuclear ophthalmoplegia, sensorimotor or cerebellar symptoms before pain, but PAIN can be the presenting symptom.",PAIN,MERALGIA PARESTHETICA
725258052,5/23/2015 22:08:18,1642405644,5/23/2015 22:07:45,false,elite,1.0,30064988,GBR,B4,Bradford,92.22.135.10,[SYMPTOM],[SYMPTOM],symptom.,N/A,172,21,1,175,42,TWrex-cause,814909-FS1,"No trauma history in MERALGIA PARESTHETICA Multiple sclerosis  Generally optic neuritis, intranuclear ophthalmoplegia, sensorimotor or cerebellar symptoms before pain, but PAIN can be the presenting symptom.",PAIN,MERALGIA PARESTHETICA
725258052,5/23/2015 22:13:22,1642408206,5/23/2015 22:13:02,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],MERALGIA PARESTHETICA PAIN can be the presenting symptom.,n/a,172,21,1,175,42,TWrex-cause,814909-FS1,"No trauma history in MERALGIA PARESTHETICA Multiple sclerosis  Generally optic neuritis, intranuclear ophthalmoplegia, sensorimotor or cerebellar symptoms before pain, but PAIN can be the presenting symptom.",PAIN,MERALGIA PARESTHETICA
725258052,5/23/2015 22:18:07,1642410545,5/23/2015 22:17:32,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[SYMPTOM],[SYMPTOM],can be the presenting symptom.,n/a,172,21,1,175,42,TWrex-cause,814909-FS1,"No trauma history in MERALGIA PARESTHETICA Multiple sclerosis  Generally optic neuritis, intranuclear ophthalmoplegia, sensorimotor or cerebellar symptoms before pain, but PAIN can be the presenting symptom.",PAIN,MERALGIA PARESTHETICA
725258052,5/23/2015 22:18:23,1642410711,5/23/2015 22:17:26,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[SYMPTOM],[SYMPTOM],in MERALGIA PARESTHETICA PAIN presenting symptom.,N/A,172,21,1,175,42,TWrex-cause,814909-FS1,"No trauma history in MERALGIA PARESTHETICA Multiple sclerosis  Generally optic neuritis, intranuclear ophthalmoplegia, sensorimotor or cerebellar symptoms before pain, but PAIN can be the presenting symptom.",PAIN,MERALGIA PARESTHETICA
725258052,5/23/2015 22:19:11,1642411178,5/23/2015 22:18:26,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[SYMPTOM],[SYMPTOM],can be the presenting symptom.,n /a,172,21,1,175,42,TWrex-cause,814909-FS1,"No trauma history in MERALGIA PARESTHETICA Multiple sclerosis  Generally optic neuritis, intranuclear ophthalmoplegia, sensorimotor or cerebellar symptoms before pain, but PAIN can be the presenting symptom.",PAIN,MERALGIA PARESTHETICA
725258052,5/23/2015 22:21:38,1642412328,5/23/2015 22:20:07,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],can be the presenting symptom.,N/A,172,21,1,175,42,TWrex-cause,814909-FS1,"No trauma history in MERALGIA PARESTHETICA Multiple sclerosis  Generally optic neuritis, intranuclear ophthalmoplegia, sensorimotor or cerebellar symptoms before pain, but PAIN can be the presenting symptom.",PAIN,MERALGIA PARESTHETICA
725258052,5/23/2015 22:24:10,1642413649,5/23/2015 22:23:57,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[SYMPTOM],[SYMPTOM],can be the presenting symptom.,n/a,172,21,1,175,42,TWrex-cause,814909-FS1,"No trauma history in MERALGIA PARESTHETICA Multiple sclerosis  Generally optic neuritis, intranuclear ophthalmoplegia, sensorimotor or cerebellar symptoms before pain, but PAIN can be the presenting symptom.",PAIN,MERALGIA PARESTHETICA
725258052,5/23/2015 22:25:06,1642414111,5/23/2015 22:24:30,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],Multiple sclerosis,N/A,172,21,1,175,42,TWrex-cause,814909-FS1,"No trauma history in MERALGIA PARESTHETICA Multiple sclerosis  Generally optic neuritis, intranuclear ophthalmoplegia, sensorimotor or cerebellar symptoms before pain, but PAIN can be the presenting symptom.",PAIN,MERALGIA PARESTHETICA
725258052,5/23/2015 22:30:47,1642416760,5/23/2015 22:29:54,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[SYMPTOM],[SYMPTOM],"MERALGIA PARESTHETICA Multiple sclerosis Generally optic neuritis, intranuclear ophthalmoplegia, sensorimotor cerebellar symptoms before pain, but can be the presenting symptom.",n/a,172,21,1,175,42,TWrex-cause,814909-FS1,"No trauma history in MERALGIA PARESTHETICA Multiple sclerosis  Generally optic neuritis, intranuclear ophthalmoplegia, sensorimotor or cerebellar symptoms before pain, but PAIN can be the presenting symptom.",PAIN,MERALGIA PARESTHETICA
725258052,5/23/2015 22:34:24,1642418656,5/23/2015 22:33:45,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[SYMPTOM],[SYMPTOM],in MERALGIA PARESTHETICA PAIN can be the presenting symptom.,n/a,172,21,1,175,42,TWrex-cause,814909-FS1,"No trauma history in MERALGIA PARESTHETICA Multiple sclerosis  Generally optic neuritis, intranuclear ophthalmoplegia, sensorimotor or cerebellar symptoms before pain, but PAIN can be the presenting symptom.",PAIN,MERALGIA PARESTHETICA
725258052,5/23/2015 22:59:48,1642431692,5/23/2015 22:59:28,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[SYMPTOM],[SYMPTOM],PAIN can be the presenting symptom.,N/A,172,21,1,175,42,TWrex-cause,814909-FS1,"No trauma history in MERALGIA PARESTHETICA Multiple sclerosis  Generally optic neuritis, intranuclear ophthalmoplegia, sensorimotor or cerebellar symptoms before pain, but PAIN can be the presenting symptom.",PAIN,MERALGIA PARESTHETICA
725258052,5/23/2015 23:08:30,1642435668,5/23/2015 23:08:07,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[SYMPTOM],[SYMPTOM],symptoms,n/a,172,21,1,175,42,TWrex-cause,814909-FS1,"No trauma history in MERALGIA PARESTHETICA Multiple sclerosis  Generally optic neuritis, intranuclear ophthalmoplegia, sensorimotor or cerebellar symptoms before pain, but PAIN can be the presenting symptom.",PAIN,MERALGIA PARESTHETICA
725258052,5/23/2015 23:08:37,1642435707,5/23/2015 23:07:06,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[SYMPTOM],[SYMPTOM],symptoms symptom.,n/a,172,21,1,175,42,TWrex-cause,814909-FS1,"No trauma history in MERALGIA PARESTHETICA Multiple sclerosis  Generally optic neuritis, intranuclear ophthalmoplegia, sensorimotor or cerebellar symptoms before pain, but PAIN can be the presenting symptom.",PAIN,MERALGIA PARESTHETICA
725258053,5/23/2015 23:34:36,1642446882,5/23/2015 23:34:18,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],management of,N/A,79,38,-1,103,49,TWrex-cause,805242-FS1,"Cole CH, Rogers PCJ, Pritchard S et alTHALIDOMIDE in the management of chronic GRAFT VERSUS HOST DISEASE in children following bone marrow transplantation.",GRAFT VERSUS HOST DISEASE,THALIDOMIDE
725258053,5/23/2015 23:46:38,1642452785,5/23/2015 23:46:22,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],management,N/A,79,38,-1,103,49,TWrex-cause,805242-FS1,"Cole CH, Rogers PCJ, Pritchard S et alTHALIDOMIDE in the management of chronic GRAFT VERSUS HOST DISEASE in children following bone marrow transplantation.",GRAFT VERSUS HOST DISEASE,THALIDOMIDE
725258053,5/24/2015 00:34:59,1642473159,5/24/2015 00:33:59,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],management,n/a,79,38,-1,103,49,TWrex-cause,805242-FS1,"Cole CH, Rogers PCJ, Pritchard S et alTHALIDOMIDE in the management of chronic GRAFT VERSUS HOST DISEASE in children following bone marrow transplantation.",GRAFT VERSUS HOST DISEASE,THALIDOMIDE
725258053,5/24/2015 00:42:54,1642476637,5/24/2015 00:42:10,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[OTHER],[OTHER],management of chronic GRAFT VERSUS HOST DISEASE,na,79,38,-1,103,49,TWrex-cause,805242-FS1,"Cole CH, Rogers PCJ, Pritchard S et alTHALIDOMIDE in the management of chronic GRAFT VERSUS HOST DISEASE in children following bone marrow transplantation.",GRAFT VERSUS HOST DISEASE,THALIDOMIDE
725258053,5/24/2015 00:44:58,1642477365,5/24/2015 00:44:40,false,elite,1.0,31848723,USA,VA,Manassas,192.96.205.155,[SYMPTOM],[SYMPTOM],alTHALIDOMIDE GRAFT VERSUS HOST DISEASE,N/A,79,38,-1,103,49,TWrex-cause,805242-FS1,"Cole CH, Rogers PCJ, Pritchard S et alTHALIDOMIDE in the management of chronic GRAFT VERSUS HOST DISEASE in children following bone marrow transplantation.",GRAFT VERSUS HOST DISEASE,THALIDOMIDE
725258053,5/24/2015 00:47:29,1642478353,5/24/2015 00:47:11,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],management of,N/A,79,38,-1,103,49,TWrex-cause,805242-FS1,"Cole CH, Rogers PCJ, Pritchard S et alTHALIDOMIDE in the management of chronic GRAFT VERSUS HOST DISEASE in children following bone marrow transplantation.",GRAFT VERSUS HOST DISEASE,THALIDOMIDE
725258053,5/24/2015 01:05:12,1642484197,5/24/2015 01:04:33,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",in the management of,N/A,79,38,-1,103,49,TWrex-cause,805242-FS1,"Cole CH, Rogers PCJ, Pritchard S et alTHALIDOMIDE in the management of chronic GRAFT VERSUS HOST DISEASE in children following bone marrow transplantation.",GRAFT VERSUS HOST DISEASE,THALIDOMIDE
725258053,5/24/2015 01:37:34,1642494675,5/24/2015 01:37:22,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[MANIFESTATION],[MANIFESTATION],management,N/A,79,38,-1,103,49,TWrex-cause,805242-FS1,"Cole CH, Rogers PCJ, Pritchard S et alTHALIDOMIDE in the management of chronic GRAFT VERSUS HOST DISEASE in children following bone marrow transplantation.",GRAFT VERSUS HOST DISEASE,THALIDOMIDE
725258053,5/24/2015 01:44:53,1642497281,5/24/2015 01:44:41,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[LOCATION],[LOCATION],of,N/A,79,38,-1,103,49,TWrex-cause,805242-FS1,"Cole CH, Rogers PCJ, Pritchard S et alTHALIDOMIDE in the management of chronic GRAFT VERSUS HOST DISEASE in children following bone marrow transplantation.",GRAFT VERSUS HOST DISEASE,THALIDOMIDE
725258053,5/24/2015 01:51:36,1642499543,5/24/2015 01:51:24,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],chronic,N/A,79,38,-1,103,49,TWrex-cause,805242-FS1,"Cole CH, Rogers PCJ, Pritchard S et alTHALIDOMIDE in the management of chronic GRAFT VERSUS HOST DISEASE in children following bone marrow transplantation.",GRAFT VERSUS HOST DISEASE,THALIDOMIDE
725258053,5/24/2015 01:58:06,1642501782,5/24/2015 01:57:52,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[TREATS],[TREATS],management,N/A,79,38,-1,103,49,TWrex-cause,805242-FS1,"Cole CH, Rogers PCJ, Pritchard S et alTHALIDOMIDE in the management of chronic GRAFT VERSUS HOST DISEASE in children following bone marrow transplantation.",GRAFT VERSUS HOST DISEASE,THALIDOMIDE
725258053,5/24/2015 02:03:12,1642503212,5/24/2015 02:02:58,false,neodev,1.0,32562748,CAN,BC,Vancouver,108.180.140.140,[ASSOCIATED_WITH] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]",alTHALIDOMIDE chronic GRAFT,I did not,79,38,-1,103,49,TWrex-cause,805242-FS1,"Cole CH, Rogers PCJ, Pritchard S et alTHALIDOMIDE in the management of chronic GRAFT VERSUS HOST DISEASE in children following bone marrow transplantation.",GRAFT VERSUS HOST DISEASE,THALIDOMIDE
725258053,5/24/2015 02:03:22,1642503247,5/24/2015 02:03:07,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[LOCATION],[LOCATION],chronic,N/A,79,38,-1,103,49,TWrex-cause,805242-FS1,"Cole CH, Rogers PCJ, Pritchard S et alTHALIDOMIDE in the management of chronic GRAFT VERSUS HOST DISEASE in children following bone marrow transplantation.",GRAFT VERSUS HOST DISEASE,THALIDOMIDE
725258053,5/24/2015 02:06:10,1642504081,5/24/2015 02:05:48,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[MANIFESTATION],[MANIFESTATION],management,N/A,79,38,-1,103,49,TWrex-cause,805242-FS1,"Cole CH, Rogers PCJ, Pritchard S et alTHALIDOMIDE in the management of chronic GRAFT VERSUS HOST DISEASE in children following bone marrow transplantation.",GRAFT VERSUS HOST DISEASE,THALIDOMIDE
725258053,5/24/2015 02:08:20,1642504832,5/24/2015 02:07:17,false,prodege,1.0,17379068,CAN,NB,Saint John,142.162.106.83,[ASSOCIATED_WITH],[ASSOCIATED_WITH],management,N/A,79,38,-1,103,49,TWrex-cause,805242-FS1,"Cole CH, Rogers PCJ, Pritchard S et alTHALIDOMIDE in the management of chronic GRAFT VERSUS HOST DISEASE in children following bone marrow transplantation.",GRAFT VERSUS HOST DISEASE,THALIDOMIDE
725258054,5/23/2015 23:32:40,1642446171,5/23/2015 23:32:20,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,comparing,157,116,-1,176,136,TWrex-cause,803466-FS1,"Webster GF, Berson D, Stein LF et al. Efficacy and tolerability of once daily tazarotene 0.1% gel versus once daily TRETINOIN 0.025% GEL in the treatment of FACIAL ACNE VULGARIS: a randomized trial.",FACIAL ACNE VULGARIS,TRETINOIN 0.025% GEL
725258054,5/23/2015 23:36:15,1642447640,5/23/2015 23:35:18,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],treatment,none,157,116,-1,176,136,TWrex-cause,803466-FS1,"Webster GF, Berson D, Stein LF et al. Efficacy and tolerability of once daily tazarotene 0.1% gel versus once daily TRETINOIN 0.025% GEL in the treatment of FACIAL ACNE VULGARIS: a randomized trial.",FACIAL ACNE VULGARIS,TRETINOIN 0.025% GEL
725258054,5/23/2015 23:43:32,1642451290,5/23/2015 23:43:03,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],treatment,N/A,157,116,-1,176,136,TWrex-cause,803466-FS1,"Webster GF, Berson D, Stein LF et al. Efficacy and tolerability of once daily tazarotene 0.1% gel versus once daily TRETINOIN 0.025% GEL in the treatment of FACIAL ACNE VULGARIS: a randomized trial.",FACIAL ACNE VULGARIS,TRETINOIN 0.025% GEL
725258054,5/23/2015 23:48:52,1642453655,5/23/2015 23:48:33,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[TREATS],[TREATS],treatment of,n/a,157,116,-1,176,136,TWrex-cause,803466-FS1,"Webster GF, Berson D, Stein LF et al. Efficacy and tolerability of once daily tazarotene 0.1% gel versus once daily TRETINOIN 0.025% GEL in the treatment of FACIAL ACNE VULGARIS: a randomized trial.",FACIAL ACNE VULGARIS,TRETINOIN 0.025% GEL
725258054,5/23/2015 23:57:17,1642457595,5/23/2015 23:57:05,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.161,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,157,116,-1,176,136,TWrex-cause,803466-FS1,"Webster GF, Berson D, Stein LF et al. Efficacy and tolerability of once daily tazarotene 0.1% gel versus once daily TRETINOIN 0.025% GEL in the treatment of FACIAL ACNE VULGARIS: a randomized trial.",FACIAL ACNE VULGARIS,TRETINOIN 0.025% GEL
725258054,5/24/2015 00:29:35,1642470973,5/24/2015 00:28:54,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],treatment,n/a,157,116,-1,176,136,TWrex-cause,803466-FS1,"Webster GF, Berson D, Stein LF et al. Efficacy and tolerability of once daily tazarotene 0.1% gel versus once daily TRETINOIN 0.025% GEL in the treatment of FACIAL ACNE VULGARIS: a randomized trial.",FACIAL ACNE VULGARIS,TRETINOIN 0.025% GEL
725258054,5/24/2015 00:38:21,1642474658,5/24/2015 00:37:43,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[OTHER],[OTHER],treatment of FACIAL ACNE VULGARIS:,na,157,116,-1,176,136,TWrex-cause,803466-FS1,"Webster GF, Berson D, Stein LF et al. Efficacy and tolerability of once daily tazarotene 0.1% gel versus once daily TRETINOIN 0.025% GEL in the treatment of FACIAL ACNE VULGARIS: a randomized trial.",FACIAL ACNE VULGARIS,TRETINOIN 0.025% GEL
725258054,5/24/2015 00:42:34,1642476462,5/24/2015 00:42:15,false,elite,1.0,31848723,USA,VA,Manassas,192.96.205.155,[SYMPTOM],[SYMPTOM],TRETINOIN FACIAL ACNE VULGARIS:,N/A,157,116,-1,176,136,TWrex-cause,803466-FS1,"Webster GF, Berson D, Stein LF et al. Efficacy and tolerability of once daily tazarotene 0.1% gel versus once daily TRETINOIN 0.025% GEL in the treatment of FACIAL ACNE VULGARIS: a randomized trial.",FACIAL ACNE VULGARIS,TRETINOIN 0.025% GEL
725258054,5/24/2015 00:43:16,1642476729,5/24/2015 00:42:20,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,157,116,-1,176,136,TWrex-cause,803466-FS1,"Webster GF, Berson D, Stein LF et al. Efficacy and tolerability of once daily tazarotene 0.1% gel versus once daily TRETINOIN 0.025% GEL in the treatment of FACIAL ACNE VULGARIS: a randomized trial.",FACIAL ACNE VULGARIS,TRETINOIN 0.025% GEL
725258054,5/24/2015 00:54:27,1642480537,5/24/2015 00:53:22,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[TREATS],[TREATS],in the treatment of,N/A,157,116,-1,176,136,TWrex-cause,803466-FS1,"Webster GF, Berson D, Stein LF et al. Efficacy and tolerability of once daily tazarotene 0.1% gel versus once daily TRETINOIN 0.025% GEL in the treatment of FACIAL ACNE VULGARIS: a randomized trial.",FACIAL ACNE VULGARIS,TRETINOIN 0.025% GEL
725258054,5/24/2015 01:31:23,1642492715,5/24/2015 01:30:21,false,clixsense,1.0,6375330,CAN,ON,Ottawa,209.195.106.138,[TREATS],[TREATS],in the treatment,none,157,116,-1,176,136,TWrex-cause,803466-FS1,"Webster GF, Berson D, Stein LF et al. Efficacy and tolerability of once daily tazarotene 0.1% gel versus once daily TRETINOIN 0.025% GEL in the treatment of FACIAL ACNE VULGARIS: a randomized trial.",FACIAL ACNE VULGARIS,TRETINOIN 0.025% GEL
725258054,5/24/2015 01:36:13,1642494184,5/24/2015 01:36:02,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],treatment,N/A,157,116,-1,176,136,TWrex-cause,803466-FS1,"Webster GF, Berson D, Stein LF et al. Efficacy and tolerability of once daily tazarotene 0.1% gel versus once daily TRETINOIN 0.025% GEL in the treatment of FACIAL ACNE VULGARIS: a randomized trial.",FACIAL ACNE VULGARIS,TRETINOIN 0.025% GEL
725258054,5/24/2015 01:43:26,1642496796,5/24/2015 01:43:14,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],treatment,N/A,157,116,-1,176,136,TWrex-cause,803466-FS1,"Webster GF, Berson D, Stein LF et al. Efficacy and tolerability of once daily tazarotene 0.1% gel versus once daily TRETINOIN 0.025% GEL in the treatment of FACIAL ACNE VULGARIS: a randomized trial.",FACIAL ACNE VULGARIS,TRETINOIN 0.025% GEL
725258054,5/24/2015 01:50:11,1642499068,5/24/2015 01:50:00,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],treatment,N/A,157,116,-1,176,136,TWrex-cause,803466-FS1,"Webster GF, Berson D, Stein LF et al. Efficacy and tolerability of once daily tazarotene 0.1% gel versus once daily TRETINOIN 0.025% GEL in the treatment of FACIAL ACNE VULGARIS: a randomized trial.",FACIAL ACNE VULGARIS,TRETINOIN 0.025% GEL
725258054,5/24/2015 01:56:34,1642501374,5/24/2015 01:56:19,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[TREATS],[TREATS],treatment,N/A,157,116,-1,176,136,TWrex-cause,803466-FS1,"Webster GF, Berson D, Stein LF et al. Efficacy and tolerability of once daily tazarotene 0.1% gel versus once daily TRETINOIN 0.025% GEL in the treatment of FACIAL ACNE VULGARIS: a randomized trial.",FACIAL ACNE VULGARIS,TRETINOIN 0.025% GEL
725258055,5/24/2015 00:41:37,1642476021,5/24/2015 00:40:40,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[NONE],[NONE],n/a,this is a list,10,168,1,21,184,TWrex-cause,813543-FS1,"Vomiting, HEPATOMEGALY poor growth, lethargy, diarrhea, and septicemia (usually  Escherichia coli ) develop, as does renal dysfunction (eg, proteinuria, aminoaciduria, FANCONI SYNDROME leading to metabolic acidosis and edema.",HEPATOMEGALY,FANCONI SYNDROME
725258055,5/24/2015 00:49:02,1642478956,5/24/2015 00:48:46,false,elite,1.0,31848723,USA,VA,Manassas,192.96.205.155,[SYMPTOM],[SYMPTOM],HEPATOMEGALY FANCONI SYNDROME,N/A,10,168,1,21,184,TWrex-cause,813543-FS1,"Vomiting, HEPATOMEGALY poor growth, lethargy, diarrhea, and septicemia (usually  Escherichia coli ) develop, as does renal dysfunction (eg, proteinuria, aminoaciduria, FANCONI SYNDROME leading to metabolic acidosis and edema.",HEPATOMEGALY,FANCONI SYNDROME
725258055,5/24/2015 00:57:20,1642481497,5/24/2015 00:56:24,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"develop, as does",N/A,10,168,1,21,184,TWrex-cause,813543-FS1,"Vomiting, HEPATOMEGALY poor growth, lethargy, diarrhea, and septicemia (usually  Escherichia coli ) develop, as does renal dysfunction (eg, proteinuria, aminoaciduria, FANCONI SYNDROME leading to metabolic acidosis and edema.",HEPATOMEGALY,FANCONI SYNDROME
725258055,5/24/2015 00:57:33,1642481594,5/24/2015 00:56:33,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"develop, as does",NA,10,168,1,21,184,TWrex-cause,813543-FS1,"Vomiting, HEPATOMEGALY poor growth, lethargy, diarrhea, and septicemia (usually  Escherichia coli ) develop, as does renal dysfunction (eg, proteinuria, aminoaciduria, FANCONI SYNDROME leading to metabolic acidosis and edema.",HEPATOMEGALY,FANCONI SYNDROME
725258055,5/24/2015 01:40:30,1642495695,5/24/2015 01:40:11,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[LOCATION],[LOCATION],"growth,",N/A,10,168,1,21,184,TWrex-cause,813543-FS1,"Vomiting, HEPATOMEGALY poor growth, lethargy, diarrhea, and septicemia (usually  Escherichia coli ) develop, as does renal dysfunction (eg, proteinuria, aminoaciduria, FANCONI SYNDROME leading to metabolic acidosis and edema.",HEPATOMEGALY,FANCONI SYNDROME
725258055,5/24/2015 01:47:36,1642498140,5/24/2015 01:47:25,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[LOCATION],[LOCATION],"develop,",N/A,10,168,1,21,184,TWrex-cause,813543-FS1,"Vomiting, HEPATOMEGALY poor growth, lethargy, diarrhea, and septicemia (usually  Escherichia coli ) develop, as does renal dysfunction (eg, proteinuria, aminoaciduria, FANCONI SYNDROME leading to metabolic acidosis and edema.",HEPATOMEGALY,FANCONI SYNDROME
725258055,5/24/2015 01:54:23,1642500501,5/24/2015 01:54:11,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[MANIFESTATION],[MANIFESTATION],leading,N/A,10,168,1,21,184,TWrex-cause,813543-FS1,"Vomiting, HEPATOMEGALY poor growth, lethargy, diarrhea, and septicemia (usually  Escherichia coli ) develop, as does renal dysfunction (eg, proteinuria, aminoaciduria, FANCONI SYNDROME leading to metabolic acidosis and edema.",HEPATOMEGALY,FANCONI SYNDROME
725258055,5/24/2015 02:01:21,1642502674,5/24/2015 02:01:08,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[MANIFESTATION],[MANIFESTATION],dysfunction,N/A,10,168,1,21,184,TWrex-cause,813543-FS1,"Vomiting, HEPATOMEGALY poor growth, lethargy, diarrhea, and septicemia (usually  Escherichia coli ) develop, as does renal dysfunction (eg, proteinuria, aminoaciduria, FANCONI SYNDROME leading to metabolic acidosis and edema.",HEPATOMEGALY,FANCONI SYNDROME
725258055,5/24/2015 02:08:56,1642504971,5/24/2015 02:08:43,false,elite,1.0,30654968,USA,OR,Portland,67.213.218.73,[SYMPTOM],[SYMPTOM],"lethargy,",N/A,10,168,1,21,184,TWrex-cause,813543-FS1,"Vomiting, HEPATOMEGALY poor growth, lethargy, diarrhea, and septicemia (usually  Escherichia coli ) develop, as does renal dysfunction (eg, proteinuria, aminoaciduria, FANCONI SYNDROME leading to metabolic acidosis and edema.",HEPATOMEGALY,FANCONI SYNDROME
725258055,5/24/2015 02:25:13,1642510478,5/24/2015 02:23:59,false,prodege,1.0,17379068,CAN,NB,Saint John,142.162.106.83,[MANIFESTATION],[MANIFESTATION],leading,N/A,10,168,1,21,184,TWrex-cause,813543-FS1,"Vomiting, HEPATOMEGALY poor growth, lethargy, diarrhea, and septicemia (usually  Escherichia coli ) develop, as does renal dysfunction (eg, proteinuria, aminoaciduria, FANCONI SYNDROME leading to metabolic acidosis and edema.",HEPATOMEGALY,FANCONI SYNDROME
725258055,5/24/2015 02:35:21,1642513633,5/24/2015 02:35:01,false,elite,1.0,32306791,USA,DE,Wilmington,199.58.86.213,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"aminoaciduria, SYNDROME",N/A,10,168,1,21,184,TWrex-cause,813543-FS1,"Vomiting, HEPATOMEGALY poor growth, lethargy, diarrhea, and septicemia (usually  Escherichia coli ) develop, as does renal dysfunction (eg, proteinuria, aminoaciduria, FANCONI SYNDROME leading to metabolic acidosis and edema.",HEPATOMEGALY,FANCONI SYNDROME
725258055,5/24/2015 02:37:50,1642514331,5/24/2015 02:37:41,false,elite,1.0,31913360,USA,VA,Manassas,207.244.77.3,[MANIFESTATION],[MANIFESTATION],(usually,jhjj,10,168,1,21,184,TWrex-cause,813543-FS1,"Vomiting, HEPATOMEGALY poor growth, lethargy, diarrhea, and septicemia (usually  Escherichia coli ) develop, as does renal dysfunction (eg, proteinuria, aminoaciduria, FANCONI SYNDROME leading to metabolic acidosis and edema.",HEPATOMEGALY,FANCONI SYNDROME
725258055,5/24/2015 02:57:51,1642520042,5/24/2015 02:57:30,false,clixsense,1.0,32549163,CAN,MB,Winnipeg,206.45.167.246,[SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]","HEPATOMEGALY develop, as does FANCONI SYNDROME",N/A,10,168,1,21,184,TWrex-cause,813543-FS1,"Vomiting, HEPATOMEGALY poor growth, lethargy, diarrhea, and septicemia (usually  Escherichia coli ) develop, as does renal dysfunction (eg, proteinuria, aminoaciduria, FANCONI SYNDROME leading to metabolic acidosis and edema.",HEPATOMEGALY,FANCONI SYNDROME
725258055,5/24/2015 03:07:50,1642523298,5/24/2015 03:07:08,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]","Vomiting, HEPATOMEGALY poor growth, lethargy, diarrhea, septicemia develop,",n/a,10,168,1,21,184,TWrex-cause,813543-FS1,"Vomiting, HEPATOMEGALY poor growth, lethargy, diarrhea, and septicemia (usually  Escherichia coli ) develop, as does renal dysfunction (eg, proteinuria, aminoaciduria, FANCONI SYNDROME leading to metabolic acidosis and edema.",HEPATOMEGALY,FANCONI SYNDROME
725258055,5/24/2015 03:31:57,1642529671,5/24/2015 03:29:08,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,[CAUSES],[CAUSES],"develop, dysfunction",n/a,10,168,1,21,184,TWrex-cause,813543-FS1,"Vomiting, HEPATOMEGALY poor growth, lethargy, diarrhea, and septicemia (usually  Escherichia coli ) develop, as does renal dysfunction (eg, proteinuria, aminoaciduria, FANCONI SYNDROME leading to metabolic acidosis and edema.",HEPATOMEGALY,FANCONI SYNDROME
725258056,5/23/2015 20:28:35,1642356970,5/23/2015 20:28:02,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],DOPAMINE for the treatment of HYPERDYNAMIC SEPTIC SHOCK,N/A,101,71,-1,125,79,TWrex-cause,800477-FS1,"2]  Martin C, Papazian L, Perrin G, Saux P, Gouin F. Norepinephrine or DOPAMINE for the treatment of HYPERDYNAMIC SEPTIC SHOCK",HYPERDYNAMIC SEPTIC SHOCK,DOPAMINE
725258056,5/23/2015 20:31:47,1642358547,5/23/2015 20:31:34,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[TREATS],[TREATS],for the treatment of,N/A,101,71,-1,125,79,TWrex-cause,800477-FS1,"2]  Martin C, Papazian L, Perrin G, Saux P, Gouin F. Norepinephrine or DOPAMINE for the treatment of HYPERDYNAMIC SEPTIC SHOCK",HYPERDYNAMIC SEPTIC SHOCK,DOPAMINE
725258056,5/23/2015 20:39:19,1642362352,5/23/2015 20:39:08,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatment,n/a,101,71,-1,125,79,TWrex-cause,800477-FS1,"2]  Martin C, Papazian L, Perrin G, Saux P, Gouin F. Norepinephrine or DOPAMINE for the treatment of HYPERDYNAMIC SEPTIC SHOCK",HYPERDYNAMIC SEPTIC SHOCK,DOPAMINE
725258056,5/23/2015 20:40:59,1642363417,5/23/2015 20:40:42,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treatment,n/a,101,71,-1,125,79,TWrex-cause,800477-FS1,"2]  Martin C, Papazian L, Perrin G, Saux P, Gouin F. Norepinephrine or DOPAMINE for the treatment of HYPERDYNAMIC SEPTIC SHOCK",HYPERDYNAMIC SEPTIC SHOCK,DOPAMINE
725258056,5/23/2015 20:42:59,1642364369,5/23/2015 20:42:09,false,instagc,1.0,30880172,USA,CA,Los Angeles,166.170.50.98,[OTHER],[OTHER],treatment of,Treated by,101,71,-1,125,79,TWrex-cause,800477-FS1,"2]  Martin C, Papazian L, Perrin G, Saux P, Gouin F. Norepinephrine or DOPAMINE for the treatment of HYPERDYNAMIC SEPTIC SHOCK",HYPERDYNAMIC SEPTIC SHOCK,DOPAMINE
725258056,5/23/2015 20:43:07,1642364479,5/23/2015 20:42:14,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],DOPAMINE for treatment of HYPERDYNAMIC SEPTIC SHOCK,na,101,71,-1,125,79,TWrex-cause,800477-FS1,"2]  Martin C, Papazian L, Perrin G, Saux P, Gouin F. Norepinephrine or DOPAMINE for the treatment of HYPERDYNAMIC SEPTIC SHOCK",HYPERDYNAMIC SEPTIC SHOCK,DOPAMINE
725258056,5/23/2015 20:45:15,1642365814,5/23/2015 20:44:57,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[TREATS],[TREATS],treatment,-,101,71,-1,125,79,TWrex-cause,800477-FS1,"2]  Martin C, Papazian L, Perrin G, Saux P, Gouin F. Norepinephrine or DOPAMINE for the treatment of HYPERDYNAMIC SEPTIC SHOCK",HYPERDYNAMIC SEPTIC SHOCK,DOPAMINE
725258056,5/23/2015 20:46:31,1642366693,5/23/2015 20:46:16,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],for the treatment of,n/a,101,71,-1,125,79,TWrex-cause,800477-FS1,"2]  Martin C, Papazian L, Perrin G, Saux P, Gouin F. Norepinephrine or DOPAMINE for the treatment of HYPERDYNAMIC SEPTIC SHOCK",HYPERDYNAMIC SEPTIC SHOCK,DOPAMINE
725258056,5/23/2015 20:49:55,1642368550,5/23/2015 20:49:16,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment of,N/A,101,71,-1,125,79,TWrex-cause,800477-FS1,"2]  Martin C, Papazian L, Perrin G, Saux P, Gouin F. Norepinephrine or DOPAMINE for the treatment of HYPERDYNAMIC SEPTIC SHOCK",HYPERDYNAMIC SEPTIC SHOCK,DOPAMINE
725258056,5/23/2015 20:55:02,1642371265,5/23/2015 20:54:46,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],for the treatment of,n/a,101,71,-1,125,79,TWrex-cause,800477-FS1,"2]  Martin C, Papazian L, Perrin G, Saux P, Gouin F. Norepinephrine or DOPAMINE for the treatment of HYPERDYNAMIC SEPTIC SHOCK",HYPERDYNAMIC SEPTIC SHOCK,DOPAMINE
725258056,5/23/2015 21:06:03,1642376215,5/23/2015 21:05:28,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[TREATS],[TREATS],for the treatment of,n/a,101,71,-1,125,79,TWrex-cause,800477-FS1,"2]  Martin C, Papazian L, Perrin G, Saux P, Gouin F. Norepinephrine or DOPAMINE for the treatment of HYPERDYNAMIC SEPTIC SHOCK",HYPERDYNAMIC SEPTIC SHOCK,DOPAMINE
725258056,5/23/2015 21:29:17,1642387593,5/23/2015 21:28:58,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],for treatment of,N/A,101,71,-1,125,79,TWrex-cause,800477-FS1,"2]  Martin C, Papazian L, Perrin G, Saux P, Gouin F. Norepinephrine or DOPAMINE for the treatment of HYPERDYNAMIC SEPTIC SHOCK",HYPERDYNAMIC SEPTIC SHOCK,DOPAMINE
725258056,5/23/2015 21:30:11,1642388005,5/23/2015 21:29:42,false,prodege,1.0,24403612,CAN,ON,Bowmanville,99.252.243.178,[TREATS],[TREATS],DOPAMINE for treatment of HYPERDYNAMIC SEPTIC SHOCK,N/A,101,71,-1,125,79,TWrex-cause,800477-FS1,"2]  Martin C, Papazian L, Perrin G, Saux P, Gouin F. Norepinephrine or DOPAMINE for the treatment of HYPERDYNAMIC SEPTIC SHOCK",HYPERDYNAMIC SEPTIC SHOCK,DOPAMINE
725258056,5/23/2015 21:31:09,1642388480,5/23/2015 21:30:23,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS],[TREATS],Norepinephrine or DOPAMINE for the treatment of HYPERDYNAMIC SEPTIC SHOCK,n/a,101,71,-1,125,79,TWrex-cause,800477-FS1,"2]  Martin C, Papazian L, Perrin G, Saux P, Gouin F. Norepinephrine or DOPAMINE for the treatment of HYPERDYNAMIC SEPTIC SHOCK",HYPERDYNAMIC SEPTIC SHOCK,DOPAMINE
725258056,5/23/2015 21:32:53,1642389347,5/23/2015 21:32:12,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[TREATS],[TREATS],for the treatment of,n/a,101,71,-1,125,79,TWrex-cause,800477-FS1,"2]  Martin C, Papazian L, Perrin G, Saux P, Gouin F. Norepinephrine or DOPAMINE for the treatment of HYPERDYNAMIC SEPTIC SHOCK",HYPERDYNAMIC SEPTIC SHOCK,DOPAMINE
725258057,5/23/2015 20:33:38,1642359500,5/23/2015 20:33:09,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[PART_OF],[PART_OF],be part of,N/A,57,158,1,83,161,TWrex-cause,813667-FS1,"Organ specific autoimmune diseases, such as thyroiditis, AUTOIMMUNE HEMOLYTIC ANEMIA and idiopathic thrombocytopenia, frequently accompany and may be part of SLE",AUTOIMMUNE HEMOLYTIC ANEMIA,SLE
725258057,5/23/2015 20:36:57,1642361071,5/23/2015 20:36:01,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],AUTOIMMUNE HEMOLYTIC ANEMIA may be part of SLE,N/A,57,158,1,83,161,TWrex-cause,813667-FS1,"Organ specific autoimmune diseases, such as thyroiditis, AUTOIMMUNE HEMOLYTIC ANEMIA and idiopathic thrombocytopenia, frequently accompany and may be part of SLE",AUTOIMMUNE HEMOLYTIC ANEMIA,SLE
725258057,5/23/2015 20:42:42,1642364263,5/23/2015 20:42:23,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[PART_OF],[PART_OF],be part of,n/a,57,158,1,83,161,TWrex-cause,813667-FS1,"Organ specific autoimmune diseases, such as thyroiditis, AUTOIMMUNE HEMOLYTIC ANEMIA and idiopathic thrombocytopenia, frequently accompany and may be part of SLE",AUTOIMMUNE HEMOLYTIC ANEMIA,SLE
725258057,5/23/2015 20:46:57,1642366928,5/23/2015 20:46:45,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[PART_OF],[PART_OF],part of,-,57,158,1,83,161,TWrex-cause,813667-FS1,"Organ specific autoimmune diseases, such as thyroiditis, AUTOIMMUNE HEMOLYTIC ANEMIA and idiopathic thrombocytopenia, frequently accompany and may be part of SLE",AUTOIMMUNE HEMOLYTIC ANEMIA,SLE
725258057,5/23/2015 20:48:25,1642367824,5/23/2015 20:48:00,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[PART_OF],[PART_OF],part of,n/a,57,158,1,83,161,TWrex-cause,813667-FS1,"Organ specific autoimmune diseases, such as thyroiditis, AUTOIMMUNE HEMOLYTIC ANEMIA and idiopathic thrombocytopenia, frequently accompany and may be part of SLE",AUTOIMMUNE HEMOLYTIC ANEMIA,SLE
725258057,5/23/2015 20:48:46,1642367989,5/23/2015 20:48:19,false,instagc,1.0,30880172,USA,CA,Los Angeles,166.170.50.98,[PART_OF],[PART_OF],part of,N/A,57,158,1,83,161,TWrex-cause,813667-FS1,"Organ specific autoimmune diseases, such as thyroiditis, AUTOIMMUNE HEMOLYTIC ANEMIA and idiopathic thrombocytopenia, frequently accompany and may be part of SLE",AUTOIMMUNE HEMOLYTIC ANEMIA,SLE
725258057,5/23/2015 20:49:25,1642368343,5/23/2015 20:48:12,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[PART_OF],[PART_OF],AUTOIMMUNE HEMOLYTIC ANEMIA may be part of SLE,na,57,158,1,83,161,TWrex-cause,813667-FS1,"Organ specific autoimmune diseases, such as thyroiditis, AUTOIMMUNE HEMOLYTIC ANEMIA and idiopathic thrombocytopenia, frequently accompany and may be part of SLE",AUTOIMMUNE HEMOLYTIC ANEMIA,SLE
725258057,5/23/2015 20:56:41,1642372110,5/23/2015 20:56:12,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[ASSOCIATED_WITH] [PART_OF],"[ASSOCIATED_WITH]
[PART_OF]",frequently accompany and may be part of,N/A,57,158,1,83,161,TWrex-cause,813667-FS1,"Organ specific autoimmune diseases, such as thyroiditis, AUTOIMMUNE HEMOLYTIC ANEMIA and idiopathic thrombocytopenia, frequently accompany and may be part of SLE",AUTOIMMUNE HEMOLYTIC ANEMIA,SLE
725258057,5/23/2015 20:56:51,1642372244,5/23/2015 20:56:33,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[ASSOCIATED_WITH],[ASSOCIATED_WITH],accompany and may be part of,n/a,57,158,1,83,161,TWrex-cause,813667-FS1,"Organ specific autoimmune diseases, such as thyroiditis, AUTOIMMUNE HEMOLYTIC ANEMIA and idiopathic thrombocytopenia, frequently accompany and may be part of SLE",AUTOIMMUNE HEMOLYTIC ANEMIA,SLE
725258057,5/23/2015 21:09:20,1642377952,5/23/2015 21:08:43,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[PART_OF],[PART_OF],may be part of,n/a,57,158,1,83,161,TWrex-cause,813667-FS1,"Organ specific autoimmune diseases, such as thyroiditis, AUTOIMMUNE HEMOLYTIC ANEMIA and idiopathic thrombocytopenia, frequently accompany and may be part of SLE",AUTOIMMUNE HEMOLYTIC ANEMIA,SLE
725258057,5/23/2015 21:33:31,1642389669,5/23/2015 21:32:51,false,prodege,1.0,24403612,CAN,ON,Bowmanville,99.252.243.178,[PART_OF],[PART_OF],AUTOIMMUNE ANEMIA may be part of SLE,N/A,57,158,1,83,161,TWrex-cause,813667-FS1,"Organ specific autoimmune diseases, such as thyroiditis, AUTOIMMUNE HEMOLYTIC ANEMIA and idiopathic thrombocytopenia, frequently accompany and may be part of SLE",AUTOIMMUNE HEMOLYTIC ANEMIA,SLE
725258057,5/23/2015 21:34:03,1642389964,5/23/2015 21:33:34,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[PART_OF],[PART_OF],may be part of,N/A,57,158,1,83,161,TWrex-cause,813667-FS1,"Organ specific autoimmune diseases, such as thyroiditis, AUTOIMMUNE HEMOLYTIC ANEMIA and idiopathic thrombocytopenia, frequently accompany and may be part of SLE",AUTOIMMUNE HEMOLYTIC ANEMIA,SLE
725258057,5/23/2015 21:37:23,1642391751,5/23/2015 21:36:31,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[PART_OF] [MANIFESTATION],"[MANIFESTATION]
[PART_OF]",frequently accompany and may be part of,N/A,57,158,1,83,161,TWrex-cause,813667-FS1,"Organ specific autoimmune diseases, such as thyroiditis, AUTOIMMUNE HEMOLYTIC ANEMIA and idiopathic thrombocytopenia, frequently accompany and may be part of SLE",AUTOIMMUNE HEMOLYTIC ANEMIA,SLE
725258057,5/23/2015 21:37:45,1642391914,5/23/2015 21:36:51,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[MANIFESTATION] [PART_OF],"[MANIFESTATION]
[PART_OF]","Organ specific autoimmune diseases, such as thyroiditis, AUTOIMMUNE HEMOLYTIC ANEMIA and idiopathic thrombocytopenia, frequently accompany and may be part of SLE",n/a,57,158,1,83,161,TWrex-cause,813667-FS1,"Organ specific autoimmune diseases, such as thyroiditis, AUTOIMMUNE HEMOLYTIC ANEMIA and idiopathic thrombocytopenia, frequently accompany and may be part of SLE",AUTOIMMUNE HEMOLYTIC ANEMIA,SLE
725258057,5/23/2015 21:42:26,1642394125,5/23/2015 21:41:47,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[PART_OF] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[PART_OF]",frequently accompany and may be part of,N/A,57,158,1,83,161,TWrex-cause,813667-FS1,"Organ specific autoimmune diseases, such as thyroiditis, AUTOIMMUNE HEMOLYTIC ANEMIA and idiopathic thrombocytopenia, frequently accompany and may be part of SLE",AUTOIMMUNE HEMOLYTIC ANEMIA,SLE
725258058,5/23/2015 22:17:35,1642410298,5/23/2015 22:17:17,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with AUTISM including FRAGILE X SYNDROME,n/a,59,91,1,64,109,TWrex-cause,812737-FS1,"• There are many known testable conditions associated with AUTISM including Rett syndrome, FRAGILE X SYNDROME and tuberous sclerosis.",AUTISM,FRAGILE X SYNDROME
725258058,5/23/2015 22:31:28,1642417136,5/23/2015 22:30:54,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[SYMPTOM],[SYMPTOM],tuberous sclerosis.,N/A,59,91,1,64,109,TWrex-cause,812737-FS1,"• There are many known testable conditions associated with AUTISM including Rett syndrome, FRAGILE X SYNDROME and tuberous sclerosis.",AUTISM,FRAGILE X SYNDROME
725258058,5/23/2015 22:34:35,1642418752,5/23/2015 22:32:41,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with AUTISM FRAGILE X SYNDROME,N/A,59,91,1,64,109,TWrex-cause,812737-FS1,"• There are many known testable conditions associated with AUTISM including Rett syndrome, FRAGILE X SYNDROME and tuberous sclerosis.",AUTISM,FRAGILE X SYNDROME
725258058,5/23/2015 22:35:17,1642419042,5/23/2015 22:33:53,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,59,91,1,64,109,TWrex-cause,812737-FS1,"• There are many known testable conditions associated with AUTISM including Rett syndrome, FRAGILE X SYNDROME and tuberous sclerosis.",AUTISM,FRAGILE X SYNDROME
725258058,5/23/2015 22:35:48,1642419287,5/23/2015 22:35:25,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"testable conditions associated AUTISM including Rett syndrome, FRAGILE X SYNDROME and tuberous sclerosis.",n/a,59,91,1,64,109,TWrex-cause,812737-FS1,"• There are many known testable conditions associated with AUTISM including Rett syndrome, FRAGILE X SYNDROME and tuberous sclerosis.",AUTISM,FRAGILE X SYNDROME
725258058,5/23/2015 22:41:50,1642422613,5/23/2015 22:41:26,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[ASSOCIATED_WITH],[ASSOCIATED_WITH],conditions associated with AUTISM FRAGILE X SYNDROME,n/a,59,91,1,64,109,TWrex-cause,812737-FS1,"• There are many known testable conditions associated with AUTISM including Rett syndrome, FRAGILE X SYNDROME and tuberous sclerosis.",AUTISM,FRAGILE X SYNDROME
725258058,5/23/2015 23:08:04,1642435442,5/23/2015 23:07:44,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,59,91,1,64,109,TWrex-cause,812737-FS1,"• There are many known testable conditions associated with AUTISM including Rett syndrome, FRAGILE X SYNDROME and tuberous sclerosis.",AUTISM,FRAGILE X SYNDROME
725258058,5/23/2015 23:14:05,1642438014,5/23/2015 23:13:07,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,n/a,59,91,1,64,109,TWrex-cause,812737-FS1,"• There are many known testable conditions associated with AUTISM including Rett syndrome, FRAGILE X SYNDROME and tuberous sclerosis.",AUTISM,FRAGILE X SYNDROME
725258058,5/23/2015 23:17:15,1642439267,5/23/2015 23:16:17,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],associated,none,59,91,1,64,109,TWrex-cause,812737-FS1,"• There are many known testable conditions associated with AUTISM including Rett syndrome, FRAGILE X SYNDROME and tuberous sclerosis.",AUTISM,FRAGILE X SYNDROME
725258058,5/23/2015 23:22:07,1642441373,5/23/2015 23:21:31,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,59,91,1,64,109,TWrex-cause,812737-FS1,"• There are many known testable conditions associated with AUTISM including Rett syndrome, FRAGILE X SYNDROME and tuberous sclerosis.",AUTISM,FRAGILE X SYNDROME
725258058,5/23/2015 23:22:10,1642441384,5/23/2015 23:21:28,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[ASSOCIATED_WITH] [PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[PART_OF]",testable associated with including,n/a,59,91,1,64,109,TWrex-cause,812737-FS1,"• There are many known testable conditions associated with AUTISM including Rett syndrome, FRAGILE X SYNDROME and tuberous sclerosis.",AUTISM,FRAGILE X SYNDROME
725258058,5/23/2015 23:31:33,1642445715,5/23/2015 23:31:08,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[SYMPTOM],[SYMPTOM],associated with,N/A,59,91,1,64,109,TWrex-cause,812737-FS1,"• There are many known testable conditions associated with AUTISM including Rett syndrome, FRAGILE X SYNDROME and tuberous sclerosis.",AUTISM,FRAGILE X SYNDROME
725258058,5/23/2015 23:42:56,1642451005,5/23/2015 23:42:43,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],testable conditions associated,n/a,59,91,1,64,109,TWrex-cause,812737-FS1,"• There are many known testable conditions associated with AUTISM including Rett syndrome, FRAGILE X SYNDROME and tuberous sclerosis.",AUTISM,FRAGILE X SYNDROME
725258058,5/23/2015 23:51:26,1642454768,5/23/2015 23:51:16,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.161,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,59,91,1,64,109,TWrex-cause,812737-FS1,"• There are many known testable conditions associated with AUTISM including Rett syndrome, FRAGILE X SYNDROME and tuberous sclerosis.",AUTISM,FRAGILE X SYNDROME
725258058,5/24/2015 00:06:09,1642461304,5/24/2015 00:04:44,false,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,[MANIFESTATION],[MANIFESTATION],conditions associated,N/A,59,91,1,64,109,TWrex-cause,812737-FS1,"• There are many known testable conditions associated with AUTISM including Rett syndrome, FRAGILE X SYNDROME and tuberous sclerosis.",AUTISM,FRAGILE X SYNDROME
725258059,5/23/2015 20:35:50,1642360489,5/23/2015 20:35:36,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[CAUSES],[CAUSES],causes of,N/A,29,91,1,47,113,TWrex-cause,813707-FS1,"The most important causes of SEVERE HYPERTHERMIA are heatstroke, neuroleptic syndrome, and MALIGNANT HYPERTHERMIA of anesthesia.",SEVERE HYPERTHERMIA,MALIGNANT HYPERTHERMIA
725258059,5/23/2015 20:42:53,1642364337,5/23/2015 20:42:13,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES],[CAUSES],most important causes of SEVERE HYPERTHERMIA MALIGNANT HYPERTHERMIA of anesthesia.,N/A,29,91,1,47,113,TWrex-cause,813707-FS1,"The most important causes of SEVERE HYPERTHERMIA are heatstroke, neuroleptic syndrome, and MALIGNANT HYPERTHERMIA of anesthesia.",SEVERE HYPERTHERMIA,MALIGNANT HYPERTHERMIA
725258059,5/23/2015 20:45:02,1642365670,5/23/2015 20:44:46,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[PREVENTS],[PREVENTS],causes,n/a,29,91,1,47,113,TWrex-cause,813707-FS1,"The most important causes of SEVERE HYPERTHERMIA are heatstroke, neuroleptic syndrome, and MALIGNANT HYPERTHERMIA of anesthesia.",SEVERE HYPERTHERMIA,MALIGNANT HYPERTHERMIA
725258059,5/23/2015 20:50:42,1642369064,5/23/2015 20:50:28,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],causes of,n/a,29,91,1,47,113,TWrex-cause,813707-FS1,"The most important causes of SEVERE HYPERTHERMIA are heatstroke, neuroleptic syndrome, and MALIGNANT HYPERTHERMIA of anesthesia.",SEVERE HYPERTHERMIA,MALIGNANT HYPERTHERMIA
725258059,5/23/2015 20:55:00,1642371264,5/23/2015 20:54:09,false,instagc,1.0,30880172,USA,CA,Los Angeles,166.170.50.98,[ASSOCIATED_WITH],[ASSOCIATED_WITH],causes of,N/A,29,91,1,47,113,TWrex-cause,813707-FS1,"The most important causes of SEVERE HYPERTHERMIA are heatstroke, neuroleptic syndrome, and MALIGNANT HYPERTHERMIA of anesthesia.",SEVERE HYPERTHERMIA,MALIGNANT HYPERTHERMIA
725258059,5/23/2015 20:59:12,1642373356,5/23/2015 20:58:59,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],important causes are,n/a,29,91,1,47,113,TWrex-cause,813707-FS1,"The most important causes of SEVERE HYPERTHERMIA are heatstroke, neuroleptic syndrome, and MALIGNANT HYPERTHERMIA of anesthesia.",SEVERE HYPERTHERMIA,MALIGNANT HYPERTHERMIA
725258059,5/23/2015 20:59:42,1642373598,5/23/2015 20:59:10,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],causes of SEVERE HYPERTHERMIA are MALIGNANT HYPERTHERMIA,na,29,91,1,47,113,TWrex-cause,813707-FS1,"The most important causes of SEVERE HYPERTHERMIA are heatstroke, neuroleptic syndrome, and MALIGNANT HYPERTHERMIA of anesthesia.",SEVERE HYPERTHERMIA,MALIGNANT HYPERTHERMIA
725258059,5/23/2015 21:03:39,1642375242,5/23/2015 21:03:11,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],causes of,N/A,29,91,1,47,113,TWrex-cause,813707-FS1,"The most important causes of SEVERE HYPERTHERMIA are heatstroke, neuroleptic syndrome, and MALIGNANT HYPERTHERMIA of anesthesia.",SEVERE HYPERTHERMIA,MALIGNANT HYPERTHERMIA
725258059,5/23/2015 21:13:12,1642379716,5/23/2015 21:12:46,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[ASSOCIATED_WITH],[ASSOCIATED_WITH],important causes,n/a,29,91,1,47,113,TWrex-cause,813707-FS1,"The most important causes of SEVERE HYPERTHERMIA are heatstroke, neuroleptic syndrome, and MALIGNANT HYPERTHERMIA of anesthesia.",SEVERE HYPERTHERMIA,MALIGNANT HYPERTHERMIA
725258059,5/23/2015 21:37:41,1642391894,5/23/2015 21:37:22,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[CAUSES],[CAUSES],causes are,N/A,29,91,1,47,113,TWrex-cause,813707-FS1,"The most important causes of SEVERE HYPERTHERMIA are heatstroke, neuroleptic syndrome, and MALIGNANT HYPERTHERMIA of anesthesia.",SEVERE HYPERTHERMIA,MALIGNANT HYPERTHERMIA
725258059,5/23/2015 21:45:09,1642395461,5/23/2015 21:44:11,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],"The most important causes of SEVERE HYPERTHERMIA are heatstroke, neuroleptic syndrome, and MALIGNANT HYPERTHERMIA of anesthesia.",n/a,29,91,1,47,113,TWrex-cause,813707-FS1,"The most important causes of SEVERE HYPERTHERMIA are heatstroke, neuroleptic syndrome, and MALIGNANT HYPERTHERMIA of anesthesia.",SEVERE HYPERTHERMIA,MALIGNANT HYPERTHERMIA
725258059,5/23/2015 21:47:45,1642396694,5/23/2015 21:47:26,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES],[CAUSES],The most important causes of,N/A,29,91,1,47,113,TWrex-cause,813707-FS1,"The most important causes of SEVERE HYPERTHERMIA are heatstroke, neuroleptic syndrome, and MALIGNANT HYPERTHERMIA of anesthesia.",SEVERE HYPERTHERMIA,MALIGNANT HYPERTHERMIA
725258059,5/23/2015 21:50:46,1642398079,5/23/2015 21:50:23,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[CAUSES],[CAUSES],causes,N/A,29,91,1,47,113,TWrex-cause,813707-FS1,"The most important causes of SEVERE HYPERTHERMIA are heatstroke, neuroleptic syndrome, and MALIGNANT HYPERTHERMIA of anesthesia.",SEVERE HYPERTHERMIA,MALIGNANT HYPERTHERMIA
725258059,5/23/2015 21:51:58,1642398485,5/23/2015 21:51:12,false,elite,1.0,30064988,GBR,B4,Bradford,92.22.135.10,[CAUSES],[CAUSES],causes,N/A,29,91,1,47,113,TWrex-cause,813707-FS1,"The most important causes of SEVERE HYPERTHERMIA are heatstroke, neuroleptic syndrome, and MALIGNANT HYPERTHERMIA of anesthesia.",SEVERE HYPERTHERMIA,MALIGNANT HYPERTHERMIA
725258059,5/23/2015 21:51:58,1642398497,5/23/2015 21:51:09,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[CAUSES],[CAUSES],causes of,n/a,29,91,1,47,113,TWrex-cause,813707-FS1,"The most important causes of SEVERE HYPERTHERMIA are heatstroke, neuroleptic syndrome, and MALIGNANT HYPERTHERMIA of anesthesia.",SEVERE HYPERTHERMIA,MALIGNANT HYPERTHERMIA
725258060,5/23/2015 22:21:31,1642412238,5/23/2015 22:21:13,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],CYCLOPHOSPHAMIDE before pregnancy may be switched to azathioprine before PREGNANCY,n/a,113,15,1,121,31,TWrex-cause,811807-FS1,• Women taking CYCLOPHOSPHAMIDE or mycophenolate mofetil before pregnancy may be switched to azathioprine before PREGNANCY,PREGNANCY,CYCLOPHOSPHAMIDE
725258060,5/23/2015 22:36:40,1642419846,5/23/2015 22:36:24,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],CYCLOPHOSPHAMIDE,N/A,113,15,1,121,31,TWrex-cause,811807-FS1,• Women taking CYCLOPHOSPHAMIDE or mycophenolate mofetil before pregnancy may be switched to azathioprine before PREGNANCY,PREGNANCY,CYCLOPHOSPHAMIDE
725258060,5/23/2015 22:40:40,1642421953,5/23/2015 22:40:04,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],CYCLOPHOSPHAMIDE mycophenolate mofetil before pregnancy may switched to azathioprine before PREGNANCY,n/a,113,15,1,121,31,TWrex-cause,811807-FS1,• Women taking CYCLOPHOSPHAMIDE or mycophenolate mofetil before pregnancy may be switched to azathioprine before PREGNANCY,PREGNANCY,CYCLOPHOSPHAMIDE
725258060,5/23/2015 22:46:46,1642425160,5/23/2015 22:46:11,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[ASSOCIATED_WITH] [OTHER],"[ASSOCIATED_WITH]
[OTHER]",CYCLOPHOSPHAMIDE may be switched to azathioprine before PREGNANCY,n/a,113,15,1,121,31,TWrex-cause,811807-FS1,• Women taking CYCLOPHOSPHAMIDE or mycophenolate mofetil before pregnancy may be switched to azathioprine before PREGNANCY,PREGNANCY,CYCLOPHOSPHAMIDE
725258060,5/23/2015 23:15:26,1642438572,5/23/2015 23:14:47,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[CONTRAINDICATES],[CONTRAINDICATES],may be switched to azathioprine before PREGNANCY,N/A,113,15,1,121,31,TWrex-cause,811807-FS1,• Women taking CYCLOPHOSPHAMIDE or mycophenolate mofetil before pregnancy may be switched to azathioprine before PREGNANCY,PREGNANCY,CYCLOPHOSPHAMIDE
725258060,5/23/2015 23:19:47,1642440254,5/23/2015 23:19:04,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[CONTRAINDICATES],[CONTRAINDICATES],may be switched to,n/a,113,15,1,121,31,TWrex-cause,811807-FS1,• Women taking CYCLOPHOSPHAMIDE or mycophenolate mofetil before pregnancy may be switched to azathioprine before PREGNANCY,PREGNANCY,CYCLOPHOSPHAMIDE
725258060,5/23/2015 23:27:43,1642443835,5/23/2015 23:26:37,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CONTRAINDICATES],[CONTRAINDICATES],switched,none,113,15,1,121,31,TWrex-cause,811807-FS1,• Women taking CYCLOPHOSPHAMIDE or mycophenolate mofetil before pregnancy may be switched to azathioprine before PREGNANCY,PREGNANCY,CYCLOPHOSPHAMIDE
725258060,5/23/2015 23:28:56,1642444349,5/23/2015 23:28:03,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],taking,N/A,113,15,1,121,31,TWrex-cause,811807-FS1,• Women taking CYCLOPHOSPHAMIDE or mycophenolate mofetil before pregnancy may be switched to azathioprine before PREGNANCY,PREGNANCY,CYCLOPHOSPHAMIDE
725258060,5/23/2015 23:32:26,1642446047,5/23/2015 23:30:20,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[IS_A] [SYMPTOM],"[SYMPTOM]
[IS_A]",before switched to,n/a,113,15,1,121,31,TWrex-cause,811807-FS1,• Women taking CYCLOPHOSPHAMIDE or mycophenolate mofetil before pregnancy may be switched to azathioprine before PREGNANCY,PREGNANCY,CYCLOPHOSPHAMIDE
725258060,5/23/2015 23:38:24,1642448707,5/23/2015 23:37:56,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[CONTRAINDICATES],[CONTRAINDICATES],switched,N/A,113,15,1,121,31,TWrex-cause,811807-FS1,• Women taking CYCLOPHOSPHAMIDE or mycophenolate mofetil before pregnancy may be switched to azathioprine before PREGNANCY,PREGNANCY,CYCLOPHOSPHAMIDE
725258060,5/23/2015 23:46:19,1642452653,5/23/2015 23:46:05,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[TREATS],[TREATS],taking,n/a,113,15,1,121,31,TWrex-cause,811807-FS1,• Women taking CYCLOPHOSPHAMIDE or mycophenolate mofetil before pregnancy may be switched to azathioprine before PREGNANCY,PREGNANCY,CYCLOPHOSPHAMIDE
725258060,5/23/2015 23:55:30,1642456705,5/23/2015 23:55:19,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.161,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,113,15,1,121,31,TWrex-cause,811807-FS1,• Women taking CYCLOPHOSPHAMIDE or mycophenolate mofetil before pregnancy may be switched to azathioprine before PREGNANCY,PREGNANCY,CYCLOPHOSPHAMIDE
725258060,5/24/2015 00:22:46,1642468478,5/24/2015 00:20:59,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[CONTRAINDICATES],[CONTRAINDICATES],switched,na,113,15,1,121,31,TWrex-cause,811807-FS1,• Women taking CYCLOPHOSPHAMIDE or mycophenolate mofetil before pregnancy may be switched to azathioprine before PREGNANCY,PREGNANCY,CYCLOPHOSPHAMIDE
725258060,5/24/2015 00:24:02,1642469073,5/24/2015 00:23:04,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[CONTRAINDICATES],[CONTRAINDICATES],switched to,n/a,113,15,1,121,31,TWrex-cause,811807-FS1,• Women taking CYCLOPHOSPHAMIDE or mycophenolate mofetil before pregnancy may be switched to azathioprine before PREGNANCY,PREGNANCY,CYCLOPHOSPHAMIDE
725258060,5/24/2015 00:36:19,1642473723,5/24/2015 00:34:36,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CONTRAINDICATES],[CONTRAINDICATES],may be switched,N/A,113,15,1,121,31,TWrex-cause,811807-FS1,• Women taking CYCLOPHOSPHAMIDE or mycophenolate mofetil before pregnancy may be switched to azathioprine before PREGNANCY,PREGNANCY,CYCLOPHOSPHAMIDE
725258061,5/23/2015 23:17:36,1642439379,5/23/2015 23:17:08,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[CAUSES],[CAUSES],resulting in,N/A,137,0,1,151,30,TWrex-cause,814087-FS1,FAMILIAL ADENOMATOUS POLYPOSIS  FAMILIAL ADENOMATOUS POLYPOSIS is a hereditary disorder causing numerous colonic polyps and resulting in COLON CARCINOMA by age 40.,COLON CARCINOMA,FAMILIAL ADENOMATOUS POLYPOSIS
725258061,5/23/2015 23:21:52,1642441231,5/23/2015 23:21:30,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[CAUSES],[CAUSES],resulting in,n/a,137,0,1,151,30,TWrex-cause,814087-FS1,FAMILIAL ADENOMATOUS POLYPOSIS  FAMILIAL ADENOMATOUS POLYPOSIS is a hereditary disorder causing numerous colonic polyps and resulting in COLON CARCINOMA by age 40.,COLON CARCINOMA,FAMILIAL ADENOMATOUS POLYPOSIS
725258061,5/23/2015 23:30:38,1642445302,5/23/2015 23:30:17,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],causing,N/A,137,0,1,151,30,TWrex-cause,814087-FS1,FAMILIAL ADENOMATOUS POLYPOSIS  FAMILIAL ADENOMATOUS POLYPOSIS is a hereditary disorder causing numerous colonic polyps and resulting in COLON CARCINOMA by age 40.,COLON CARCINOMA,FAMILIAL ADENOMATOUS POLYPOSIS
725258061,5/23/2015 23:32:31,1642446091,5/23/2015 23:30:34,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],causing,none,137,0,1,151,30,TWrex-cause,814087-FS1,FAMILIAL ADENOMATOUS POLYPOSIS  FAMILIAL ADENOMATOUS POLYPOSIS is a hereditary disorder causing numerous colonic polyps and resulting in COLON CARCINOMA by age 40.,COLON CARCINOMA,FAMILIAL ADENOMATOUS POLYPOSIS
725258061,5/23/2015 23:40:22,1642449786,5/23/2015 23:39:51,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[SYMPTOM],[SYMPTOM],causing,N/A,137,0,1,151,30,TWrex-cause,814087-FS1,FAMILIAL ADENOMATOUS POLYPOSIS  FAMILIAL ADENOMATOUS POLYPOSIS is a hereditary disorder causing numerous colonic polyps and resulting in COLON CARCINOMA by age 40.,COLON CARCINOMA,FAMILIAL ADENOMATOUS POLYPOSIS
725258061,5/23/2015 23:47:16,1642452975,5/23/2015 23:46:49,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[CAUSES],[CAUSES],resulting in,n/a,137,0,1,151,30,TWrex-cause,814087-FS1,FAMILIAL ADENOMATOUS POLYPOSIS  FAMILIAL ADENOMATOUS POLYPOSIS is a hereditary disorder causing numerous colonic polyps and resulting in COLON CARCINOMA by age 40.,COLON CARCINOMA,FAMILIAL ADENOMATOUS POLYPOSIS
725258061,5/23/2015 23:56:10,1642457040,5/23/2015 23:56:00,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.44.161,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,137,0,1,151,30,TWrex-cause,814087-FS1,FAMILIAL ADENOMATOUS POLYPOSIS  FAMILIAL ADENOMATOUS POLYPOSIS is a hereditary disorder causing numerous colonic polyps and resulting in COLON CARCINOMA by age 40.,COLON CARCINOMA,FAMILIAL ADENOMATOUS POLYPOSIS
725258061,5/24/2015 00:25:24,1642469620,5/24/2015 00:24:47,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[CAUSES],[CAUSES],resulting in,n/a,137,0,1,151,30,TWrex-cause,814087-FS1,FAMILIAL ADENOMATOUS POLYPOSIS  FAMILIAL ADENOMATOUS POLYPOSIS is a hereditary disorder causing numerous colonic polyps and resulting in COLON CARCINOMA by age 40.,COLON CARCINOMA,FAMILIAL ADENOMATOUS POLYPOSIS
725258061,5/24/2015 00:31:30,1642471710,5/24/2015 00:29:56,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[OTHER],[OTHER],resulting in,na,137,0,1,151,30,TWrex-cause,814087-FS1,FAMILIAL ADENOMATOUS POLYPOSIS  FAMILIAL ADENOMATOUS POLYPOSIS is a hereditary disorder causing numerous colonic polyps and resulting in COLON CARCINOMA by age 40.,COLON CARCINOMA,FAMILIAL ADENOMATOUS POLYPOSIS
725258061,5/24/2015 00:38:17,1642474616,5/24/2015 00:37:43,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],resulting in,N/A,137,0,1,151,30,TWrex-cause,814087-FS1,FAMILIAL ADENOMATOUS POLYPOSIS  FAMILIAL ADENOMATOUS POLYPOSIS is a hereditary disorder causing numerous colonic polyps and resulting in COLON CARCINOMA by age 40.,COLON CARCINOMA,FAMILIAL ADENOMATOUS POLYPOSIS
725258061,5/24/2015 00:40:44,1642475646,5/24/2015 00:40:10,false,elite,1.0,31848723,USA,VA,Manassas,192.96.205.155,[SYMPTOM],[SYMPTOM],FAMILIAL ADENOMATOUS COLON CARCINOMA,N/A,137,0,1,151,30,TWrex-cause,814087-FS1,FAMILIAL ADENOMATOUS POLYPOSIS  FAMILIAL ADENOMATOUS POLYPOSIS is a hereditary disorder causing numerous colonic polyps and resulting in COLON CARCINOMA by age 40.,COLON CARCINOMA,FAMILIAL ADENOMATOUS POLYPOSIS
725258061,5/24/2015 00:42:37,1642476495,5/24/2015 00:41:36,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[CAUSES],[CAUSES],causing numerous,N/A,137,0,1,151,30,TWrex-cause,814087-FS1,FAMILIAL ADENOMATOUS POLYPOSIS  FAMILIAL ADENOMATOUS POLYPOSIS is a hereditary disorder causing numerous colonic polyps and resulting in COLON CARCINOMA by age 40.,COLON CARCINOMA,FAMILIAL ADENOMATOUS POLYPOSIS
725258061,5/24/2015 00:56:40,1642481319,5/24/2015 00:56:30,false,neodev,1.0,31789301,USA,CA,San Jose,23.27.44.199,[NONE],[NONE],no,no,137,0,1,151,30,TWrex-cause,814087-FS1,FAMILIAL ADENOMATOUS POLYPOSIS  FAMILIAL ADENOMATOUS POLYPOSIS is a hereditary disorder causing numerous colonic polyps and resulting in COLON CARCINOMA by age 40.,COLON CARCINOMA,FAMILIAL ADENOMATOUS POLYPOSIS
725258061,5/24/2015 01:23:58,1642490569,5/24/2015 01:22:29,false,clixsense,1.0,6375330,CAN,ON,Ottawa,209.195.106.138,[MANIFESTATION],[MANIFESTATION],causing and resulting,None,137,0,1,151,30,TWrex-cause,814087-FS1,FAMILIAL ADENOMATOUS POLYPOSIS  FAMILIAL ADENOMATOUS POLYPOSIS is a hereditary disorder causing numerous colonic polyps and resulting in COLON CARCINOMA by age 40.,COLON CARCINOMA,FAMILIAL ADENOMATOUS POLYPOSIS
725258061,5/24/2015 01:35:05,1642493777,5/24/2015 01:34:52,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[CAUSES],[CAUSES],resulting,N/A,137,0,1,151,30,TWrex-cause,814087-FS1,FAMILIAL ADENOMATOUS POLYPOSIS  FAMILIAL ADENOMATOUS POLYPOSIS is a hereditary disorder causing numerous colonic polyps and resulting in COLON CARCINOMA by age 40.,COLON CARCINOMA,FAMILIAL ADENOMATOUS POLYPOSIS
725258062,5/23/2015 20:23:38,1642354638,5/23/2015 20:22:43,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],frequency of BENZODIAZEPINE TOLERANCE dependence patients on other DRUGS,N/A,64,135,1,87,140,TWrex-cause,811250-FS1,1  Drug and Alcohol Dependence  Possible increased frequency of BENZODIAZEPINE TOLERANCE and dependence in patients dependent on other DRUGS or alcohol; use with caution.,BENZODIAZEPINE TOLERANCE,DRUGS
725258062,5/23/2015 20:30:05,1642357734,5/23/2015 20:29:36,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[CONTRAINDICATES] [TREATS],"[TREATS]
[CONTRAINDICATES]",use with caution.,N/A,64,135,1,87,140,TWrex-cause,811250-FS1,1  Drug and Alcohol Dependence  Possible increased frequency of BENZODIAZEPINE TOLERANCE and dependence in patients dependent on other DRUGS or alcohol; use with caution.,BENZODIAZEPINE TOLERANCE,DRUGS
725258062,5/23/2015 20:36:39,1642360928,5/23/2015 20:35:14,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SIDE_EFFECT],[SIDE_EFFECT],BENZODIAZEPINE in patients on DRUGS,na,64,135,1,87,140,TWrex-cause,811250-FS1,1  Drug and Alcohol Dependence  Possible increased frequency of BENZODIAZEPINE TOLERANCE and dependence in patients dependent on other DRUGS or alcohol; use with caution.,BENZODIAZEPINE TOLERANCE,DRUGS
725258062,5/23/2015 20:37:37,1642361383,5/23/2015 20:36:46,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],and,n/a,64,135,1,87,140,TWrex-cause,811250-FS1,1  Drug and Alcohol Dependence  Possible increased frequency of BENZODIAZEPINE TOLERANCE and dependence in patients dependent on other DRUGS or alcohol; use with caution.,BENZODIAZEPINE TOLERANCE,DRUGS
725258062,5/23/2015 20:37:46,1642361473,5/23/2015 20:37:11,false,instagc,1.0,30880172,USA,CA,Los Angeles,166.170.50.98,[ASSOCIATED_WITH] [SIDE_EFFECT],"[ASSOCIATED_WITH]
[SIDE_EFFECT]",dependent on other,N/A,64,135,1,87,140,TWrex-cause,811250-FS1,1  Drug and Alcohol Dependence  Possible increased frequency of BENZODIAZEPINE TOLERANCE and dependence in patients dependent on other DRUGS or alcohol; use with caution.,BENZODIAZEPINE TOLERANCE,DRUGS
725258062,5/23/2015 20:39:24,1642362396,5/23/2015 20:38:59,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],dependence,n/a,64,135,1,87,140,TWrex-cause,811250-FS1,1  Drug and Alcohol Dependence  Possible increased frequency of BENZODIAZEPINE TOLERANCE and dependence in patients dependent on other DRUGS or alcohol; use with caution.,BENZODIAZEPINE TOLERANCE,DRUGS
725258062,5/23/2015 20:40:28,1642363119,5/23/2015 20:40:02,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[NONE],[NONE],none,none,64,135,1,87,140,TWrex-cause,811250-FS1,1  Drug and Alcohol Dependence  Possible increased frequency of BENZODIAZEPINE TOLERANCE and dependence in patients dependent on other DRUGS or alcohol; use with caution.,BENZODIAZEPINE TOLERANCE,DRUGS
725258062,5/23/2015 20:40:43,1642363283,5/23/2015 20:38:24,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],dependence,N/A,64,135,1,87,140,TWrex-cause,811250-FS1,1  Drug and Alcohol Dependence  Possible increased frequency of BENZODIAZEPINE TOLERANCE and dependence in patients dependent on other DRUGS or alcohol; use with caution.,BENZODIAZEPINE TOLERANCE,DRUGS
725258062,5/23/2015 20:43:13,1642364531,5/23/2015 20:42:23,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[ASSOCIATED_WITH],[ASSOCIATED_WITH],dependence,-,64,135,1,87,140,TWrex-cause,811250-FS1,1  Drug and Alcohol Dependence  Possible increased frequency of BENZODIAZEPINE TOLERANCE and dependence in patients dependent on other DRUGS or alcohol; use with caution.,BENZODIAZEPINE TOLERANCE,DRUGS
725258062,5/23/2015 20:44:42,1642365509,5/23/2015 20:44:22,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[SIDE_EFFECT],[SIDE_EFFECT],dependence,n/a,64,135,1,87,140,TWrex-cause,811250-FS1,1  Drug and Alcohol Dependence  Possible increased frequency of BENZODIAZEPINE TOLERANCE and dependence in patients dependent on other DRUGS or alcohol; use with caution.,BENZODIAZEPINE TOLERANCE,DRUGS
725258062,5/23/2015 20:53:14,1642370461,5/23/2015 20:52:39,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[NONE],[NONE],n/a,other drugs,64,135,1,87,140,TWrex-cause,811250-FS1,1  Drug and Alcohol Dependence  Possible increased frequency of BENZODIAZEPINE TOLERANCE and dependence in patients dependent on other DRUGS or alcohol; use with caution.,BENZODIAZEPINE TOLERANCE,DRUGS
725258062,5/23/2015 21:01:39,1642374455,5/23/2015 21:01:06,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[IS_A],[IS_A],dependence on other,n/a,64,135,1,87,140,TWrex-cause,811250-FS1,1  Drug and Alcohol Dependence  Possible increased frequency of BENZODIAZEPINE TOLERANCE and dependence in patients dependent on other DRUGS or alcohol; use with caution.,BENZODIAZEPINE TOLERANCE,DRUGS
725258062,5/23/2015 21:15:02,1642380564,5/23/2015 21:14:51,false,prodege,1.0,2143114,CAN,BC,Vancouver,24.85.153.181,[TREATS],[TREATS],BENZODIAZEPINE,n/a,64,135,1,87,140,TWrex-cause,811250-FS1,1  Drug and Alcohol Dependence  Possible increased frequency of BENZODIAZEPINE TOLERANCE and dependence in patients dependent on other DRUGS or alcohol; use with caution.,BENZODIAZEPINE TOLERANCE,DRUGS
725258062,5/23/2015 21:15:33,1642380774,5/23/2015 21:14:57,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[ASSOCIATED_WITH],[ASSOCIATED_WITH],dependent on other,N/A,64,135,1,87,140,TWrex-cause,811250-FS1,1  Drug and Alcohol Dependence  Possible increased frequency of BENZODIAZEPINE TOLERANCE and dependence in patients dependent on other DRUGS or alcohol; use with caution.,BENZODIAZEPINE TOLERANCE,DRUGS
725258062,5/23/2015 21:27:26,1642386604,5/23/2015 21:26:31,false,prodege,1.0,24403612,CAN,ON,Bowmanville,99.252.243.178,[MANIFESTATION],[MANIFESTATION],BENZODIAZEPINE TOLERANCE and dependence in DRUGS,N/A,64,135,1,87,140,TWrex-cause,811250-FS1,1  Drug and Alcohol Dependence  Possible increased frequency of BENZODIAZEPINE TOLERANCE and dependence in patients dependent on other DRUGS or alcohol; use with caution.,BENZODIAZEPINE TOLERANCE,DRUGS
725258063,5/23/2015 22:04:04,1642403358,5/23/2015 22:03:32,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[PREVENTS],[PREVENTS],to prevent,N/A,69,13,-1,86,30,TWrex-cause,800086-FS1,• Administer MAGNESIUM SULFATE to patients with eclampsia to prevent RECURRENT SEIZURES,RECURRENT SEIZURES,MAGNESIUM SULFATE
725258063,5/23/2015 22:10:56,1642407038,5/23/2015 22:10:23,false,elite,1.0,30064988,GBR,B4,Bradford,92.22.135.10,[PREVENTS],[PREVENTS],prevent,N/A,69,13,-1,86,30,TWrex-cause,800086-FS1,• Administer MAGNESIUM SULFATE to patients with eclampsia to prevent RECURRENT SEIZURES,RECURRENT SEIZURES,MAGNESIUM SULFATE
725258063,5/23/2015 22:15:22,1642409215,5/23/2015 22:15:09,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[PREVENTS],[PREVENTS],MAGNESIUM SULFATE to patients with eclampsia to prevent RECURRENT SEIZURES,n/a,69,13,-1,86,30,TWrex-cause,800086-FS1,• Administer MAGNESIUM SULFATE to patients with eclampsia to prevent RECURRENT SEIZURES,RECURRENT SEIZURES,MAGNESIUM SULFATE
725258063,5/23/2015 22:22:11,1642412697,5/23/2015 22:21:33,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[PREVENTS],[PREVENTS],to prevent,n/a,69,13,-1,86,30,TWrex-cause,800086-FS1,• Administer MAGNESIUM SULFATE to patients with eclampsia to prevent RECURRENT SEIZURES,RECURRENT SEIZURES,MAGNESIUM SULFATE
725258063,5/23/2015 22:24:42,1642413941,5/23/2015 22:23:48,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[PREVENTS],[PREVENTS],MAGNESIUM SULFATE to prevent RECURRENT SEIZURES,N/A,69,13,-1,86,30,TWrex-cause,800086-FS1,• Administer MAGNESIUM SULFATE to patients with eclampsia to prevent RECURRENT SEIZURES,RECURRENT SEIZURES,MAGNESIUM SULFATE
725258063,5/23/2015 22:26:58,1642414936,5/23/2015 22:26:37,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[SYMPTOM],[SYMPTOM],eclampsia,N/A,69,13,-1,86,30,TWrex-cause,800086-FS1,• Administer MAGNESIUM SULFATE to patients with eclampsia to prevent RECURRENT SEIZURES,RECURRENT SEIZURES,MAGNESIUM SULFATE
725258063,5/23/2015 22:27:18,1642415061,5/23/2015 22:25:12,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[PREVENTS],[PREVENTS],to prevent,N/A,69,13,-1,86,30,TWrex-cause,800086-FS1,• Administer MAGNESIUM SULFATE to patients with eclampsia to prevent RECURRENT SEIZURES,RECURRENT SEIZURES,MAGNESIUM SULFATE
725258063,5/23/2015 22:32:35,1642417725,5/23/2015 22:32:16,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",Administer MAGNESIUM SULFATE patients with eclampsia prevent RECURRENT SEIZURES,n/a,69,13,-1,86,30,TWrex-cause,800086-FS1,• Administer MAGNESIUM SULFATE to patients with eclampsia to prevent RECURRENT SEIZURES,RECURRENT SEIZURES,MAGNESIUM SULFATE
725258063,5/23/2015 22:36:24,1642419662,5/23/2015 22:36:05,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[PREVENTS],[PREVENTS],MAGNESIUM SULFATE to prevent RECURRENT SEIZURES,n/a,69,13,-1,86,30,TWrex-cause,800086-FS1,• Administer MAGNESIUM SULFATE to patients with eclampsia to prevent RECURRENT SEIZURES,RECURRENT SEIZURES,MAGNESIUM SULFATE
725258063,5/23/2015 23:05:58,1642434574,5/23/2015 23:05:44,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[PREVENTS],[PREVENTS],prevent,N/A,69,13,-1,86,30,TWrex-cause,800086-FS1,• Administer MAGNESIUM SULFATE to patients with eclampsia to prevent RECURRENT SEIZURES,RECURRENT SEIZURES,MAGNESIUM SULFATE
725258063,5/23/2015 23:10:09,1642436284,5/23/2015 23:09:48,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[TREATS],[TREATS],to prevent,n/a,69,13,-1,86,30,TWrex-cause,800086-FS1,• Administer MAGNESIUM SULFATE to patients with eclampsia to prevent RECURRENT SEIZURES,RECURRENT SEIZURES,MAGNESIUM SULFATE
725258063,5/23/2015 23:12:34,1642437361,5/23/2015 23:12:21,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,N/A,69,13,-1,86,30,TWrex-cause,800086-FS1,• Administer MAGNESIUM SULFATE to patients with eclampsia to prevent RECURRENT SEIZURES,RECURRENT SEIZURES,MAGNESIUM SULFATE
725258063,5/23/2015 23:12:38,1642437363,5/23/2015 23:12:19,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[PREVENTS],[PREVENTS],prevent,none,69,13,-1,86,30,TWrex-cause,800086-FS1,• Administer MAGNESIUM SULFATE to patients with eclampsia to prevent RECURRENT SEIZURES,RECURRENT SEIZURES,MAGNESIUM SULFATE
725258063,5/23/2015 23:15:17,1642438511,5/23/2015 23:14:10,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[ASSOCIATED_WITH] [PREVENTS] [TREATS],"[TREATS]
[PREVENTS]
[ASSOCIATED_WITH]",Administer with prevent,n/a,69,13,-1,86,30,TWrex-cause,800086-FS1,• Administer MAGNESIUM SULFATE to patients with eclampsia to prevent RECURRENT SEIZURES,RECURRENT SEIZURES,MAGNESIUM SULFATE
725258063,5/23/2015 23:15:26,1642438570,5/23/2015 23:15:07,false,instagc,1.0,24252915,GBR,K6,Portsmouth,78.146.11.229,[PREVENTS],[PREVENTS],to patients with eclampsia to prevent,N/a,69,13,-1,86,30,TWrex-cause,800086-FS1,• Administer MAGNESIUM SULFATE to patients with eclampsia to prevent RECURRENT SEIZURES,RECURRENT SEIZURES,MAGNESIUM SULFATE
725258064,5/23/2015 20:29:33,1642357473,5/23/2015 20:28:37,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],analysis of MYCOBACTERIUM LEPRAE DNA AND MRNA human biopsy material from LEPROSY,N/A,115,51,1,121,84,TWrex-cause,811650-FS1,2009 06 01  Quantitative real time PCR analysis of MYCOBACTERIUM LEPRAE DNA AND MRNA in human biopsy material from LEPROSY and reactional cases.,LEPROSY,MYCOBACTERIUM LEPRAE DNA AND MRNA
725258064,5/23/2015 20:32:07,1642358689,5/23/2015 20:31:49,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,[OTHER],[OTHER],analysis,N/A,115,51,1,121,84,TWrex-cause,811650-FS1,2009 06 01  Quantitative real time PCR analysis of MYCOBACTERIUM LEPRAE DNA AND MRNA in human biopsy material from LEPROSY and reactional cases.,LEPROSY,MYCOBACTERIUM LEPRAE DNA AND MRNA
725258064,5/23/2015 20:39:37,1642362599,5/23/2015 20:39:20,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[IS_A],[IS_A],of,n/a,115,51,1,121,84,TWrex-cause,811650-FS1,2009 06 01  Quantitative real time PCR analysis of MYCOBACTERIUM LEPRAE DNA AND MRNA in human biopsy material from LEPROSY and reactional cases.,LEPROSY,MYCOBACTERIUM LEPRAE DNA AND MRNA
725258064,5/23/2015 20:41:22,1642363607,5/23/2015 20:41:01,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],analysis,n/a,115,51,1,121,84,TWrex-cause,811650-FS1,2009 06 01  Quantitative real time PCR analysis of MYCOBACTERIUM LEPRAE DNA AND MRNA in human biopsy material from LEPROSY and reactional cases.,LEPROSY,MYCOBACTERIUM LEPRAE DNA AND MRNA
725258064,5/23/2015 20:43:52,1642364927,5/23/2015 20:43:09,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[PART_OF],[PART_OF],MYCOBACTERIUM LEPRAE DNA AND MRNA from LEPROSY,na,115,51,1,121,84,TWrex-cause,811650-FS1,2009 06 01  Quantitative real time PCR analysis of MYCOBACTERIUM LEPRAE DNA AND MRNA in human biopsy material from LEPROSY and reactional cases.,LEPROSY,MYCOBACTERIUM LEPRAE DNA AND MRNA
725258064,5/23/2015 20:44:53,1642365587,5/23/2015 20:43:01,false,instagc,1.0,30880172,USA,CA,Los Angeles,166.170.50.98,[ASSOCIATED_WITH],[ASSOCIATED_WITH],analysis of in human biopsy material from,N/A,115,51,1,121,84,TWrex-cause,811650-FS1,2009 06 01  Quantitative real time PCR analysis of MYCOBACTERIUM LEPRAE DNA AND MRNA in human biopsy material from LEPROSY and reactional cases.,LEPROSY,MYCOBACTERIUM LEPRAE DNA AND MRNA
725258064,5/23/2015 20:45:34,1642365997,5/23/2015 20:45:17,false,cointasker,1.0,21783324,NLD,"","",31.151.239.133,[OTHER],[OTHER],analysis,-,115,51,1,121,84,TWrex-cause,811650-FS1,2009 06 01  Quantitative real time PCR analysis of MYCOBACTERIUM LEPRAE DNA AND MRNA in human biopsy material from LEPROSY and reactional cases.,LEPROSY,MYCOBACTERIUM LEPRAE DNA AND MRNA
725258064,5/23/2015 20:46:55,1642366916,5/23/2015 20:46:32,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[PART_OF],[PART_OF],in material from LEPROSY,n/a,115,51,1,121,84,TWrex-cause,811650-FS1,2009 06 01  Quantitative real time PCR analysis of MYCOBACTERIUM LEPRAE DNA AND MRNA in human biopsy material from LEPROSY and reactional cases.,LEPROSY,MYCOBACTERIUM LEPRAE DNA AND MRNA
725258064,5/23/2015 20:51:38,1642369550,5/23/2015 20:49:58,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],in human biopsy material from,N/A,115,51,1,121,84,TWrex-cause,811650-FS1,2009 06 01  Quantitative real time PCR analysis of MYCOBACTERIUM LEPRAE DNA AND MRNA in human biopsy material from LEPROSY and reactional cases.,LEPROSY,MYCOBACTERIUM LEPRAE DNA AND MRNA
725258064,5/23/2015 20:55:31,1642371504,5/23/2015 20:55:03,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[MANIFESTATION] [ASSOCIATED_WITH],"[MANIFESTATION]
[ASSOCIATED_WITH]",analysis in human biopsy material,n/a,115,51,1,121,84,TWrex-cause,811650-FS1,2009 06 01  Quantitative real time PCR analysis of MYCOBACTERIUM LEPRAE DNA AND MRNA in human biopsy material from LEPROSY and reactional cases.,LEPROSY,MYCOBACTERIUM LEPRAE DNA AND MRNA
725258064,5/23/2015 21:06:53,1642376740,5/23/2015 21:06:04,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],human biopsy material from,n/a,115,51,1,121,84,TWrex-cause,811650-FS1,2009 06 01  Quantitative real time PCR analysis of MYCOBACTERIUM LEPRAE DNA AND MRNA in human biopsy material from LEPROSY and reactional cases.,LEPROSY,MYCOBACTERIUM LEPRAE DNA AND MRNA
725258064,5/23/2015 21:29:59,1642387882,5/23/2015 21:29:19,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[MANIFESTATION],[MANIFESTATION],analysis of,N/A,115,51,1,121,84,TWrex-cause,811650-FS1,2009 06 01  Quantitative real time PCR analysis of MYCOBACTERIUM LEPRAE DNA AND MRNA in human biopsy material from LEPROSY and reactional cases.,LEPROSY,MYCOBACTERIUM LEPRAE DNA AND MRNA
725258064,5/23/2015 21:30:45,1642388237,5/23/2015 21:30:12,false,prodege,1.0,24403612,CAN,ON,Bowmanville,99.252.243.178,[CAUSES],[CAUSES],MYCOBACTERIUM LEPRAE DNA AND MRNA from LEPROSY,N/A,115,51,1,121,84,TWrex-cause,811650-FS1,2009 06 01  Quantitative real time PCR analysis of MYCOBACTERIUM LEPRAE DNA AND MRNA in human biopsy material from LEPROSY and reactional cases.,LEPROSY,MYCOBACTERIUM LEPRAE DNA AND MRNA
725258064,5/23/2015 21:32:21,1642389059,5/23/2015 21:31:10,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[MANIFESTATION],[MANIFESTATION],Quantitative real time PCR analysis of MYCOBACTERIUM LEPRAE DNA AND MRNA in human biopsy material from LEPROSY and reactional cases.,n/a,115,51,1,121,84,TWrex-cause,811650-FS1,2009 06 01  Quantitative real time PCR analysis of MYCOBACTERIUM LEPRAE DNA AND MRNA in human biopsy material from LEPROSY and reactional cases.,LEPROSY,MYCOBACTERIUM LEPRAE DNA AND MRNA
725258064,5/23/2015 21:34:30,1642390246,5/23/2015 21:32:54,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[OTHER],[OTHER],analysis of in human biopsy material from,n/a,115,51,1,121,84,TWrex-cause,811650-FS1,2009 06 01  Quantitative real time PCR analysis of MYCOBACTERIUM LEPRAE DNA AND MRNA in human biopsy material from LEPROSY and reactional cases.,LEPROSY,MYCOBACTERIUM LEPRAE DNA AND MRNA
725258065,5/23/2015 21:58:17,1642400937,5/23/2015 21:58:01,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES],[CAUSES],but also causes,N/A,114,36,1,134,62,TWrex-cause,812101-FS1,Features of acclimatization include SUSTAINED HYPERVENTILATION which increases tissue oxygenation but also causes RESPIRATORY ALKALOSIS,RESPIRATORY ALKALOSIS,SUSTAINED HYPERVENTILATION
725258065,5/23/2015 22:02:00,1642402377,5/23/2015 22:01:46,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[CAUSES],[CAUSES],causes,N/A,114,36,1,134,62,TWrex-cause,812101-FS1,Features of acclimatization include SUSTAINED HYPERVENTILATION which increases tissue oxygenation but also causes RESPIRATORY ALKALOSIS,RESPIRATORY ALKALOSIS,SUSTAINED HYPERVENTILATION
725258065,5/23/2015 22:08:49,1642405913,5/23/2015 22:08:20,false,elite,1.0,30064988,GBR,B4,Bradford,92.22.135.10,[CAUSES],[CAUSES],causes,N/A,114,36,1,134,62,TWrex-cause,812101-FS1,Features of acclimatization include SUSTAINED HYPERVENTILATION which increases tissue oxygenation but also causes RESPIRATORY ALKALOSIS,RESPIRATORY ALKALOSIS,SUSTAINED HYPERVENTILATION
725258065,5/23/2015 22:14:08,1642408608,5/23/2015 22:13:23,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],SUSTAINED HYPERVENTILATION causes RESPIRATORY ALKALOSIS,n/a,114,36,1,134,62,TWrex-cause,812101-FS1,Features of acclimatization include SUSTAINED HYPERVENTILATION which increases tissue oxygenation but also causes RESPIRATORY ALKALOSIS,RESPIRATORY ALKALOSIS,SUSTAINED HYPERVENTILATION
725258065,5/23/2015 22:18:36,1642410833,5/23/2015 22:18:08,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.154.251,[CAUSES],[CAUSES],also causes,n/a,114,36,1,134,62,TWrex-cause,812101-FS1,Features of acclimatization include SUSTAINED HYPERVENTILATION which increases tissue oxygenation but also causes RESPIRATORY ALKALOSIS,RESPIRATORY ALKALOSIS,SUSTAINED HYPERVENTILATION
725258065,5/23/2015 22:19:32,1642411346,5/23/2015 22:19:13,false,neodev,1.0,27039189,NLD,03,Warnsveld,213.93.50.164,[CAUSES],[CAUSES],causes,n/a,114,36,1,134,62,TWrex-cause,812101-FS1,Features of acclimatization include SUSTAINED HYPERVENTILATION which increases tissue oxygenation but also causes RESPIRATORY ALKALOSIS,RESPIRATORY ALKALOSIS,SUSTAINED HYPERVENTILATION
725258065,5/23/2015 22:20:17,1642411557,5/23/2015 22:18:25,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES],[CAUSES],SUSTAINED HYPERVENTILATION causes RESPIRATORY ALKALOSIS,N/A,114,36,1,134,62,TWrex-cause,812101-FS1,Features of acclimatization include SUSTAINED HYPERVENTILATION which increases tissue oxygenation but also causes RESPIRATORY ALKALOSIS,RESPIRATORY ALKALOSIS,SUSTAINED HYPERVENTILATION
725258065,5/23/2015 22:22:46,1642412997,5/23/2015 22:21:39,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],causes,N/A,114,36,1,134,62,TWrex-cause,812101-FS1,Features of acclimatization include SUSTAINED HYPERVENTILATION which increases tissue oxygenation but also causes RESPIRATORY ALKALOSIS,RESPIRATORY ALKALOSIS,SUSTAINED HYPERVENTILATION
725258065,5/23/2015 22:25:39,1642414398,5/23/2015 22:25:07,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],HYPERVENTILATION,N/A,114,36,1,134,62,TWrex-cause,812101-FS1,Features of acclimatization include SUSTAINED HYPERVENTILATION which increases tissue oxygenation but also causes RESPIRATORY ALKALOSIS,RESPIRATORY ALKALOSIS,SUSTAINED HYPERVENTILATION
725258065,5/23/2015 22:31:22,1642417084,5/23/2015 22:30:47,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[CAUSES] [SYMPTOM],"[CAUSES]
[SYMPTOM]",acclimatization include SUSTAINED HYPERVENTILATION which increases tissue oxygenation but also causes RESPIRATORY ALKALOSIS,n/a,114,36,1,134,62,TWrex-cause,812101-FS1,Features of acclimatization include SUSTAINED HYPERVENTILATION which increases tissue oxygenation but also causes RESPIRATORY ALKALOSIS,RESPIRATORY ALKALOSIS,SUSTAINED HYPERVENTILATION
725258065,5/23/2015 22:34:54,1642418858,5/23/2015 22:34:25,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[CAUSES],[CAUSES],SUSTAINED HYPERVENTILATION causes RESPIRATORY ALKALOSIS,n/a,114,36,1,134,62,TWrex-cause,812101-FS1,Features of acclimatization include SUSTAINED HYPERVENTILATION which increases tissue oxygenation but also causes RESPIRATORY ALKALOSIS,RESPIRATORY ALKALOSIS,SUSTAINED HYPERVENTILATION
725258065,5/23/2015 23:04:05,1642433835,5/23/2015 23:03:56,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[CAUSES],[CAUSES],causes,N/A,114,36,1,134,62,TWrex-cause,812101-FS1,Features of acclimatization include SUSTAINED HYPERVENTILATION which increases tissue oxygenation but also causes RESPIRATORY ALKALOSIS,RESPIRATORY ALKALOSIS,SUSTAINED HYPERVENTILATION
725258065,5/23/2015 23:08:49,1642435751,5/23/2015 23:08:31,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[CAUSES],[CAUSES],causes,n/a,114,36,1,134,62,TWrex-cause,812101-FS1,Features of acclimatization include SUSTAINED HYPERVENTILATION which increases tissue oxygenation but also causes RESPIRATORY ALKALOSIS,RESPIRATORY ALKALOSIS,SUSTAINED HYPERVENTILATION
725258065,5/23/2015 23:09:31,1642436018,5/23/2015 23:08:39,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[ASSOCIATED_WITH] [CAUSES],"[CAUSES]
[ASSOCIATED_WITH]",include which increases causes,n/a,114,36,1,134,62,TWrex-cause,812101-FS1,Features of acclimatization include SUSTAINED HYPERVENTILATION which increases tissue oxygenation but also causes RESPIRATORY ALKALOSIS,RESPIRATORY ALKALOSIS,SUSTAINED HYPERVENTILATION
725258065,5/23/2015 23:10:02,1642436239,5/23/2015 23:09:25,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[PART_OF] [CAUSES],"[CAUSES]
[PART_OF]",of causes,N/A,114,36,1,134,62,TWrex-cause,812101-FS1,Features of acclimatization include SUSTAINED HYPERVENTILATION which increases tissue oxygenation but also causes RESPIRATORY ALKALOSIS,RESPIRATORY ALKALOSIS,SUSTAINED HYPERVENTILATION
725258066,5/23/2015 23:33:32,1642446507,5/23/2015 23:33:12,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,138,71,-1,159,81,TWrex-cause,803478-FS1,"Thibonnier M, Lardoux MD, Corvol P. Comparative trial of labetalol and ACEBUTOLOL alone or associated with dihydralazine, in treatment of ESSENTIAL HYPERTENSION",ESSENTIAL HYPERTENSION,ACEBUTOLOL
725258066,5/23/2015 23:39:26,1642449253,5/23/2015 23:38:06,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],treatment,none,138,71,-1,159,81,TWrex-cause,803478-FS1,"Thibonnier M, Lardoux MD, Corvol P. Comparative trial of labetalol and ACEBUTOLOL alone or associated with dihydralazine, in treatment of ESSENTIAL HYPERTENSION",ESSENTIAL HYPERTENSION,ACEBUTOLOL
725258066,5/23/2015 23:45:29,1642452173,5/23/2015 23:44:46,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],treatment,N/A,138,71,-1,159,81,TWrex-cause,803478-FS1,"Thibonnier M, Lardoux MD, Corvol P. Comparative trial of labetalol and ACEBUTOLOL alone or associated with dihydralazine, in treatment of ESSENTIAL HYPERTENSION",ESSENTIAL HYPERTENSION,ACEBUTOLOL
725258066,5/23/2015 23:49:32,1642453989,5/23/2015 23:49:20,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[TREATS],[TREATS],treatment of,n/a,138,71,-1,159,81,TWrex-cause,803478-FS1,"Thibonnier M, Lardoux MD, Corvol P. Comparative trial of labetalol and ACEBUTOLOL alone or associated with dihydralazine, in treatment of ESSENTIAL HYPERTENSION",ESSENTIAL HYPERTENSION,ACEBUTOLOL
725258066,5/24/2015 00:32:59,1642472309,5/24/2015 00:32:45,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],treatment,n/a,138,71,-1,159,81,TWrex-cause,803478-FS1,"Thibonnier M, Lardoux MD, Corvol P. Comparative trial of labetalol and ACEBUTOLOL alone or associated with dihydralazine, in treatment of ESSENTIAL HYPERTENSION",ESSENTIAL HYPERTENSION,ACEBUTOLOL
725258066,5/24/2015 00:40:19,1642475444,5/24/2015 00:39:33,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[OTHER],[OTHER],treatment of ESSENTIAL HYPERTENSION,na,138,71,-1,159,81,TWrex-cause,803478-FS1,"Thibonnier M, Lardoux MD, Corvol P. Comparative trial of labetalol and ACEBUTOLOL alone or associated with dihydralazine, in treatment of ESSENTIAL HYPERTENSION",ESSENTIAL HYPERTENSION,ACEBUTOLOL
725258066,5/24/2015 00:43:33,1642476827,5/24/2015 00:43:16,false,elite,1.0,31848723,USA,VA,Manassas,192.96.205.155,[SYMPTOM],[SYMPTOM],ACEBUTOLOL ESSENTIAL HYPERTENSION,N/A,138,71,-1,159,81,TWrex-cause,803478-FS1,"Thibonnier M, Lardoux MD, Corvol P. Comparative trial of labetalol and ACEBUTOLOL alone or associated with dihydralazine, in treatment of ESSENTIAL HYPERTENSION",ESSENTIAL HYPERTENSION,ACEBUTOLOL
725258066,5/24/2015 00:45:11,1642477478,5/24/2015 00:44:55,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,138,71,-1,159,81,TWrex-cause,803478-FS1,"Thibonnier M, Lardoux MD, Corvol P. Comparative trial of labetalol and ACEBUTOLOL alone or associated with dihydralazine, in treatment of ESSENTIAL HYPERTENSION",ESSENTIAL HYPERTENSION,ACEBUTOLOL
725258066,5/24/2015 01:01:23,1642483008,5/24/2015 00:59:56,false,neodev,1.0,31294288,USA,IL,Chicago,99.198.108.118,[TREATS] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]","associated with dihydralazine, in treatment of",N/A,138,71,-1,159,81,TWrex-cause,803478-FS1,"Thibonnier M, Lardoux MD, Corvol P. Comparative trial of labetalol and ACEBUTOLOL alone or associated with dihydralazine, in treatment of ESSENTIAL HYPERTENSION",ESSENTIAL HYPERTENSION,ACEBUTOLOL
725258066,5/24/2015 01:34:00,1642493419,5/24/2015 01:32:55,false,clixsense,1.0,6375330,CAN,ON,Ottawa,209.195.106.138,[TREATS],[TREATS],in treatment of,none,138,71,-1,159,81,TWrex-cause,803478-FS1,"Thibonnier M, Lardoux MD, Corvol P. Comparative trial of labetalol and ACEBUTOLOL alone or associated with dihydralazine, in treatment of ESSENTIAL HYPERTENSION",ESSENTIAL HYPERTENSION,ACEBUTOLOL
725258066,5/24/2015 01:36:53,1642494413,5/24/2015 01:36:42,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,138,71,-1,159,81,TWrex-cause,803478-FS1,"Thibonnier M, Lardoux MD, Corvol P. Comparative trial of labetalol and ACEBUTOLOL alone or associated with dihydralazine, in treatment of ESSENTIAL HYPERTENSION",ESSENTIAL HYPERTENSION,ACEBUTOLOL
725258066,5/24/2015 01:44:09,1642497057,5/24/2015 01:43:53,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,138,71,-1,159,81,TWrex-cause,803478-FS1,"Thibonnier M, Lardoux MD, Corvol P. Comparative trial of labetalol and ACEBUTOLOL alone or associated with dihydralazine, in treatment of ESSENTIAL HYPERTENSION",ESSENTIAL HYPERTENSION,ACEBUTOLOL
725258066,5/24/2015 01:50:54,1642499283,5/24/2015 01:50:39,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,138,71,-1,159,81,TWrex-cause,803478-FS1,"Thibonnier M, Lardoux MD, Corvol P. Comparative trial of labetalol and ACEBUTOLOL alone or associated with dihydralazine, in treatment of ESSENTIAL HYPERTENSION",ESSENTIAL HYPERTENSION,ACEBUTOLOL
725258066,5/24/2015 01:57:19,1642501585,5/24/2015 01:57:07,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,138,71,-1,159,81,TWrex-cause,803478-FS1,"Thibonnier M, Lardoux MD, Corvol P. Comparative trial of labetalol and ACEBUTOLOL alone or associated with dihydralazine, in treatment of ESSENTIAL HYPERTENSION",ESSENTIAL HYPERTENSION,ACEBUTOLOL
725258066,5/24/2015 02:04:19,1642503562,5/24/2015 02:04:08,false,elite,1.0,31502056,USA,VA,Manassas,198.7.58.103,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,138,71,-1,159,81,TWrex-cause,803478-FS1,"Thibonnier M, Lardoux MD, Corvol P. Comparative trial of labetalol and ACEBUTOLOL alone or associated with dihydralazine, in treatment of ESSENTIAL HYPERTENSION",ESSENTIAL HYPERTENSION,ACEBUTOLOL
725258067,5/23/2015 22:12:38,1642407859,5/23/2015 22:11:57,false,elite,1.0,30064988,GBR,B4,Bradford,92.22.135.10,[OTHER],[OTHER],after,N/A,0,144,-1,28,161,TWrex-cause,803996-FS1,PENILE CONDYLOMA WITH EROSION after Imiquimod Therapy  Characteristic condyloma over the penile shaft and foreskin with adjacent erosions after IMIQUIMOD THERAPY.,PENILE CONDYLOMA WITH EROSION,IMIQUIMOD THERAPY
725258067,5/23/2015 22:16:01,1642409444,5/23/2015 22:15:41,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],PENILE CONDYLOMA WITH EROSION after Therapy after IMIQUIMOD THERAPY.,n/a,0,144,-1,28,161,TWrex-cause,803996-FS1,PENILE CONDYLOMA WITH EROSION after Imiquimod Therapy  Characteristic condyloma over the penile shaft and foreskin with adjacent erosions after IMIQUIMOD THERAPY.,PENILE CONDYLOMA WITH EROSION,IMIQUIMOD THERAPY
725258067,5/23/2015 22:27:37,1642415202,5/23/2015 22:25:58,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],PENILE CONDYLOMA WITH EROSION after IMIQUIMOD THERAPY.,N/A,0,144,-1,28,161,TWrex-cause,803996-FS1,PENILE CONDYLOMA WITH EROSION after Imiquimod Therapy  Characteristic condyloma over the penile shaft and foreskin with adjacent erosions after IMIQUIMOD THERAPY.,PENILE CONDYLOMA WITH EROSION,IMIQUIMOD THERAPY
725258067,5/23/2015 22:28:21,1642415575,5/23/2015 22:27:43,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],IMIQUIMOD THERAPY.,N/A,0,144,-1,28,161,TWrex-cause,803996-FS1,PENILE CONDYLOMA WITH EROSION after Imiquimod Therapy  Characteristic condyloma over the penile shaft and foreskin with adjacent erosions after IMIQUIMOD THERAPY.,PENILE CONDYLOMA WITH EROSION,IMIQUIMOD THERAPY
725258067,5/23/2015 22:30:11,1642416482,5/23/2015 22:29:00,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],THERAPY.,N/A,0,144,-1,28,161,TWrex-cause,803996-FS1,PENILE CONDYLOMA WITH EROSION after Imiquimod Therapy  Characteristic condyloma over the penile shaft and foreskin with adjacent erosions after IMIQUIMOD THERAPY.,PENILE CONDYLOMA WITH EROSION,IMIQUIMOD THERAPY
725258067,5/23/2015 22:33:58,1642418396,5/23/2015 22:33:13,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[CAUSES],[CAUSES],PENILE CONDYLOMA WITH EROSION after Imiquimod Therapy Characteristic condyloma over the penile shaft foreskin,n/a,0,144,-1,28,161,TWrex-cause,803996-FS1,PENILE CONDYLOMA WITH EROSION after Imiquimod Therapy  Characteristic condyloma over the penile shaft and foreskin with adjacent erosions after IMIQUIMOD THERAPY.,PENILE CONDYLOMA WITH EROSION,IMIQUIMOD THERAPY
725258067,5/23/2015 22:39:08,1642421182,5/23/2015 22:37:03,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[SIDE_EFFECT] [OTHER],"[SIDE_EFFECT]
[OTHER]",PENILE CONDYLOMA WITH EROSION after IMIQUIMOD THERAPY.,n/a,0,144,-1,28,161,TWrex-cause,803996-FS1,PENILE CONDYLOMA WITH EROSION after Imiquimod Therapy  Characteristic condyloma over the penile shaft and foreskin with adjacent erosions after IMIQUIMOD THERAPY.,PENILE CONDYLOMA WITH EROSION,IMIQUIMOD THERAPY
725258067,5/23/2015 23:06:44,1642434861,5/23/2015 23:06:22,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[CAUSES],[CAUSES],after,N/A,0,144,-1,28,161,TWrex-cause,803996-FS1,PENILE CONDYLOMA WITH EROSION after Imiquimod Therapy  Characteristic condyloma over the penile shaft and foreskin with adjacent erosions after IMIQUIMOD THERAPY.,PENILE CONDYLOMA WITH EROSION,IMIQUIMOD THERAPY
725258067,5/23/2015 23:11:24,1642436852,5/23/2015 23:10:55,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[TREATS],[TREATS],Imiquimod Therapy,n/a,0,144,-1,28,161,TWrex-cause,803996-FS1,PENILE CONDYLOMA WITH EROSION after Imiquimod Therapy  Characteristic condyloma over the penile shaft and foreskin with adjacent erosions after IMIQUIMOD THERAPY.,PENILE CONDYLOMA WITH EROSION,IMIQUIMOD THERAPY
725258067,5/23/2015 23:14:00,1642437972,5/23/2015 23:13:15,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,N/A,0,144,-1,28,161,TWrex-cause,803996-FS1,PENILE CONDYLOMA WITH EROSION after Imiquimod Therapy  Characteristic condyloma over the penile shaft and foreskin with adjacent erosions after IMIQUIMOD THERAPY.,PENILE CONDYLOMA WITH EROSION,IMIQUIMOD THERAPY
725258067,5/23/2015 23:14:05,1642438010,5/23/2015 23:13:11,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[SIDE_EFFECT],[SIDE_EFFECT],after,none,0,144,-1,28,161,TWrex-cause,803996-FS1,PENILE CONDYLOMA WITH EROSION after Imiquimod Therapy  Characteristic condyloma over the penile shaft and foreskin with adjacent erosions after IMIQUIMOD THERAPY.,PENILE CONDYLOMA WITH EROSION,IMIQUIMOD THERAPY
725258067,5/23/2015 23:18:48,1642439909,5/23/2015 23:16:45,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[ASSOCIATED_WITH],[ASSOCIATED_WITH],WITH with,n/a,0,144,-1,28,161,TWrex-cause,803996-FS1,PENILE CONDYLOMA WITH EROSION after Imiquimod Therapy  Characteristic condyloma over the penile shaft and foreskin with adjacent erosions after IMIQUIMOD THERAPY.,PENILE CONDYLOMA WITH EROSION,IMIQUIMOD THERAPY
725258067,5/23/2015 23:19:24,1642440089,5/23/2015 23:18:50,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],THERAPY.,N/A,0,144,-1,28,161,TWrex-cause,803996-FS1,PENILE CONDYLOMA WITH EROSION after Imiquimod Therapy  Characteristic condyloma over the penile shaft and foreskin with adjacent erosions after IMIQUIMOD THERAPY.,PENILE CONDYLOMA WITH EROSION,IMIQUIMOD THERAPY
725258067,5/23/2015 23:27:43,1642443837,5/23/2015 23:26:44,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[SIDE_EFFECT],[SIDE_EFFECT],after,N/A,0,144,-1,28,161,TWrex-cause,803996-FS1,PENILE CONDYLOMA WITH EROSION after Imiquimod Therapy  Characteristic condyloma over the penile shaft and foreskin with adjacent erosions after IMIQUIMOD THERAPY.,PENILE CONDYLOMA WITH EROSION,IMIQUIMOD THERAPY
725258067,5/23/2015 23:44:10,1642451637,5/23/2015 23:43:42,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[SYMPTOM],[SYMPTOM],Characteristic condyloma over the,n/a,0,144,-1,28,161,TWrex-cause,803996-FS1,PENILE CONDYLOMA WITH EROSION after Imiquimod Therapy  Characteristic condyloma over the penile shaft and foreskin with adjacent erosions after IMIQUIMOD THERAPY.,PENILE CONDYLOMA WITH EROSION,IMIQUIMOD THERAPY
